index	sentence	label
0	@PROTEIN$ enables Ca2+-activated @COMPOUND$-conductance in epithelia.	1
1	Here, we used a human neuronal cell line MC65 conditional expression of an amyloid precursor protein fragment (@PROTEIN$) to investigate the protection mechanism of epigallocatechin gallate (EGCG), the main constituent of @COMPOUND$.	0
2	Here, we used a human neuronal cell line MC65 conditional expression of an amyloid precursor protein fragment (@PROTEIN$) to investigate the protection mechanism of @COMPOUND$), the main constituent of green tea.	0
3	In addition, we demonstrated that Hsp20, @PROTEIN$ and HspB8 induced interleukin-6 production in cultured pericytes and astrocytes, which could be antagonized by @COMPOUND$, whereas other sHsps and A beta were inactive, suggesting that sHsps may be among the key mediators of the local inflammatory response associated with HCHWA-D and AD lesions.	0
4	In addition, we demonstrated that Hsp20, HspB2 and HspB8 induced @PROTEIN$ production in cultured pericytes and astrocytes, which could be antagonized by @COMPOUND$, whereas other sHsps and A beta were inactive, suggesting that sHsps may be among the key mediators of the local inflammatory response associated with HCHWA-D and AD lesions.	1
5	In addition, we demonstrated that Hsp20, HspB2 and @PROTEIN$ induced interleukin-6 production in cultured pericytes and astrocytes, which could be antagonized by @COMPOUND$, whereas other sHsps and A beta were inactive, suggesting that sHsps may be among the key mediators of the local inflammatory response associated with HCHWA-D and AD lesions.	0
6	SR-BI binds @PROTEIN$ (HDL) and mediates the selective transfer of cholesteryl esters and @COMPOUND$ from circulating HDL to cells.	0
7	@PROTEIN$ binds high-density lipoproteins (HDL) and mediates the selective transfer of cholesteryl esters and @COMPOUND$ from circulating HDL to cells.	1
8	Thus, @PROTEIN$ influences neural and cognitive processes, a finding that highlights the contribution of @COMPOUND$ and alpha-tocopherol homeostasis in proper cognitive function.	0
9	Thus, @PROTEIN$ influences neural and cognitive processes, a finding that highlights the contribution of cholesterol and @COMPOUND$ homeostasis in proper cognitive function.	0
10	Although @PROTEIN$4 has been repeatedly associated with altered sphingomyelin and @COMPOUND$ levels in tissue culture and rodent models, there has not been a direct quantification of sphingomyelin or sterol levels in the brains of patients with different forms of ApoE.	1
11	@PROTEIN$ modified the association between cholesterol and cognitive decline, and the association between the ratio of @COMPOUND$ to cholesterol and cognitive functioning.	1
12	@PROTEIN$ modified the association between @COMPOUND$ and cognitive decline, and the association between the ratio of 27-hydroxycholesterol to cholesterol and cognitive functioning.	1
13	Here we show that during growth in media containing @COMPOUND$ and in complex medium without glucose RamB activates expression of the @PROTEIN$ gene, encoding the E1p subunit of the pyruvate dehydrogenase complex.	0
14	The mood stabilizers @COMPOUND$ and valproate selectively activate the promoter IV of @PROTEIN$ in neurons.	1
15	The mood stabilizers lithium and @COMPOUND$ selectively activate the promoter IV of @PROTEIN$ in neurons.	1
16	We showed that @COMPOUND$-induced activation of promoter IV was mimicked by pharmacological inhibition of GSK-3 or short interfering RNA (siRNA)-mediated gene silencing of @PROTEIN$ or GSK-3beta isoforms.	1
17	We showed that @COMPOUND$-induced activation of promoter IV was mimicked by pharmacological inhibition of GSK-3 or short interfering RNA (siRNA)-mediated gene silencing of GSK-3alpha or @PROTEIN$ isoforms.	1
18	We showed that @COMPOUND$-induced activation of promoter IV was mimicked by pharmacological inhibition of @PROTEIN$ or short interfering RNA (siRNA)-mediated gene silencing of GSK-3alpha or GSK-3beta isoforms.	1
19	Furthermore, treatment with other HDAC inhibitors, @COMPOUND$ and trichostatin A, or transfection with an HDAC1-specific siRNA also activated @PROTEIN$ promoter IV.	1
20	Furthermore, treatment with other HDAC inhibitors, sodium butyrate and @COMPOUND$, or transfection with an HDAC1-specific siRNA also activated @PROTEIN$ promoter IV.	1
21	Our study demonstrates for the first time that @PROTEIN$ and HDAC are respective initial targets for @COMPOUND$ and VPA to activate BDNF promoter IV, and that this BDNF induction involves a novel responsive region in promoter IV of the BDNF gene.	1
22	Our study demonstrates for the first time that GSK-3 and HDAC are respective initial targets for @COMPOUND$ and VPA to activate @PROTEIN$ promoter IV, and that this BDNF induction involves a novel responsive region in promoter IV of the BDNF gene.	0
23	Addition of biphasic @PROTEIN$ aspart 30 to optimized metformin and @COMPOUND$ treatment of type 2 diabetes mellitus: The ACTION Study (Achieving Control Through Insulin plus Oral ageNts).	0
24	Addition of biphasic @PROTEIN$ aspart 30 to optimized @COMPOUND$ and pioglitazone treatment of type 2 diabetes mellitus: The ACTION Study (Achieving Control Through Insulin plus Oral ageNts).	0
25	Addition of biphasic insulin aspart 30 to optimized metformin and @COMPOUND$ treatment of type 2 diabetes mellitus: The ACTION Study (Achieving Control Through @PROTEIN$ plus Oral ageNts).	0
26	Addition of biphasic insulin aspart 30 to optimized @COMPOUND$ and pioglitazone treatment of type 2 diabetes mellitus: The ACTION Study (Achieving Control Through @PROTEIN$ plus Oral ageNts).	0
27	Efficacy and safety of biphasic @PROTEIN$ aspart (BIAsp 30, 30% short-acting and 70% intermediate-acting insulin aspart) added to an optimized treatment of metformin and @COMPOUND$ (met/pio) were compared with treatment with optimized met/pio in type 2 diabetes patients.	0
28	Efficacy and safety of biphasic @PROTEIN$ aspart (BIAsp 30, 30% short-acting and 70% intermediate-acting insulin aspart) added to an optimized treatment of @COMPOUND$ and pioglitazone (met/pio) were compared with treatment with optimized met/pio in type 2 diabetes patients.	0
29	@COMPOUND$ (NAA) is converted into aspartate and acetate by @PROTEIN$.	1
30	N-acetylaspartic acid (NAA) is converted into @COMPOUND$ and acetate by @PROTEIN$.	1
31	N-acetylaspartic acid (NAA) is converted into aspartate and @COMPOUND$ by @PROTEIN$.	1
32	Based on these validities we identified alterations in the @PROTEIN$ gene in the CA1 and amygdala regions, specifically in exposed PTSD-like rats, which were normalized after treatment with @COMPOUND$.	1
33	@PROTEIN$ (Cox-2) is a key enzyme in the conversion of @COMPOUND$ to prostaglandins that has been shown to have a particular importance in the progression of several malignancies including nasopharyngeal carcinoma (NPC).	1
34	Cyclooxygenase-2 (@PROTEIN$) is a key enzyme in the conversion of @COMPOUND$ to prostaglandins that has been shown to have a particular importance in the progression of several malignancies including nasopharyngeal carcinoma (NPC).	1
35	@COMPOUND$ inhalation induced: (1) a transient bronchial inflammation, dominated by neutrophils; (2) a neutrophilia of the blood that persisted for up to 4 weeks; (3) a transient increased bronchial reactivity, and (4) a significant increase in @PROTEIN$ activity in the BALF.	1
36	In conclusion, our results show that FSH and bFGF increase @COMPOUND$ levels in Sertoli cells through stimulation of the de novo synthesis and recycling by upregulating @PROTEIN$ and GR expression respectively.	0
37	@PROTEIN$ mutation impairs cholinergic modulation of synaptic plasticity and suppresses @COMPOUND$ currents in hippocampus slices.	1
38	@COMPOUND$ also decreased brain Abeta peptides, beta-secretase activity and expression, and the level of @PROTEIN$ (an APP C-terminal fragment following cleavage by beta-secretase) in the transgenic mice.	1
39	@COMPOUND$ also decreased brain Abeta peptides, beta-secretase activity and expression, and the level of C99 (an @PROTEIN$ C-terminal fragment following cleavage by beta-secretase) in the transgenic mice.	1
40	@COMPOUND$ rapidly phosphorylated Akt and endothelial @PROTEIN$ (eNOS) in human endothelial cells.	1
41	@COMPOUND$ rapidly phosphorylated Akt and endothelial nitric oxide synthase (@PROTEIN$) in human endothelial cells.	1
42	@COMPOUND$ rapidly phosphorylated @PROTEIN$ and endothelial nitric oxide synthase (eNOS) in human endothelial cells.	1
43	@COMPOUND$ is an endogenous vasodilator gas produced by the enzyme @PROTEIN$ (HO).	1
44	The long pentraxin 3 (@PROTEIN$) is a multifunctional soluble pattern recognition receptor, involved in several processes ranging from innate resistance and inflammation to clearance of apoptotic cells and organization of @COMPOUND$-rich extracellular matrices.	1
45	The @PROTEIN$ gene product forms part of a complex with the glucocorticoid receptor and can modulate @COMPOUND$-binding affinity.	1
46	The FKBP5 gene product forms part of a complex with the @PROTEIN$ and can modulate @COMPOUND$-binding affinity.	1
47	Serum adipocyte @PROTEIN$ levels in patients with type 2 diabetes mellitus and obesity: the influence of @COMPOUND$ treatment.	0
48	@COMPOUND$ enemas upregulate @PROTEIN$ genes expression but decrease adherent mucus thickness in mice colon.	1
49	We demonstrated that @COMPOUND$ stimulated the gene expression of both secreted (@PROTEIN$) and membrane-linked (Muc1, Muc3, Muc4) mucins.	1
50	We demonstrated that @COMPOUND$ stimulated the gene expression of both secreted (Muc2) and membrane-linked (@PROTEIN$, Muc3, Muc4) mucins.	1
51	Abnormally high CSF 3-OMD occurs frequently for RLS patients indicating either increased @COMPOUND$ synthesis, limitations in l-dopa decarboxylation or increased @PROTEIN$/COMT activity, or some combination of these.	0
52	Abnormally high CSF 3-OMD occurs frequently for RLS patients indicating either increased @COMPOUND$ synthesis, limitations in l-dopa decarboxylation or increased MAT/@PROTEIN$ activity, or some combination of these.	0
53	To test this hypothesis, we investigated whether disruption of the oxytocin gene (@PROTEIN$-/-) made mice more susceptible to the psychosis-related effects of amphetamine (Amp), @COMPOUND$ (Apo) and phencyclidine (PCP).	0
54	To test this hypothesis, we investigated whether disruption of the @PROTEIN$ gene (Oxt-/-) made mice more susceptible to the psychosis-related effects of amphetamine (@COMPOUND$), apomorphine (Apo) and phencyclidine (PCP).	0
55	To test this hypothesis, we investigated whether disruption of the @PROTEIN$ gene (Oxt-/-) made mice more susceptible to the psychosis-related effects of amphetamine (Amp), @COMPOUND$ (Apo) and phencyclidine (PCP).	0
56	To test this hypothesis, we investigated whether disruption of the @PROTEIN$ gene (Oxt-/-) made mice more susceptible to the psychosis-related effects of @COMPOUND$ (Amp), apomorphine (Apo) and phencyclidine (PCP).	0
57	To test this hypothesis, we investigated whether disruption of the oxytocin gene (@PROTEIN$-/-) made mice more susceptible to the psychosis-related effects of @COMPOUND$ (Amp), apomorphine (Apo) and phencyclidine (PCP).	0
58	To test this hypothesis, we investigated whether disruption of the oxytocin gene (@PROTEIN$-/-) made mice more susceptible to the psychosis-related effects of amphetamine (Amp), apomorphine (Apo) and @COMPOUND$ (PCP).	0
59	To test this hypothesis, we investigated whether disruption of the @PROTEIN$ gene (Oxt-/-) made mice more susceptible to the psychosis-related effects of amphetamine (Amp), apomorphine (Apo) and @COMPOUND$ (PCP).	0
60	To test this hypothesis, we investigated whether disruption of the oxytocin gene (@PROTEIN$-/-) made mice more susceptible to the psychosis-related effects of amphetamine (@COMPOUND$), apomorphine (Apo) and phencyclidine (PCP).	0
61	The mood stabilizers @COMPOUND$ and valproate activate the @PROTEIN$ pathway in prefrontal cortex and hippocampus and potentiate ERK pathway-mediated neurite growth, neuronal survival and hippocampal neurogenesis.	1
62	The mood stabilizers lithium and @COMPOUND$ activate the @PROTEIN$ pathway in prefrontal cortex and hippocampus and potentiate ERK pathway-mediated neurite growth, neuronal survival and hippocampal neurogenesis.	1
63	RT(2) Profiler PCR Array was used to identify differentially expressed genes in Dox and/or @COMPOUND$ treatment groups, based on significance of results 4 genes were selected: MDR1, Bcl2, P53 and @PROTEIN$ D1.	1
64	RT(2) Profiler PCR Array was used to identify differentially expressed genes in Dox and/or @COMPOUND$ treatment groups, based on significance of results 4 genes were selected: MDR1, Bcl2, @PROTEIN$ and Cyclin D1.	1
65	RT(2) Profiler PCR Array was used to identify differentially expressed genes in Dox and/or @COMPOUND$ treatment groups, based on significance of results 4 genes were selected: @PROTEIN$, Bcl2, P53 and Cyclin D1.	1
66	RT(2) Profiler PCR Array was used to identify differentially expressed genes in Dox and/or @COMPOUND$ treatment groups, based on significance of results 4 genes were selected: MDR1, @PROTEIN$, P53 and Cyclin D1.	1
67	The array and western blotting showed that Bcl2 and @PROTEIN$ D1 expression were down regulated; P53 expression was not affected while MDR1 was over expressed by combination of @COMPOUND$ with Dox.	1
68	The array and western blotting showed that Bcl2 and Cyclin D1 expression were down regulated; P53 expression was not affected while @PROTEIN$ was over expressed by combination of @COMPOUND$ with Dox.	1
69	The array and western blotting showed that Bcl2 and Cyclin D1 expression were down regulated; @PROTEIN$ expression was not affected while MDR1 was over expressed by combination of @COMPOUND$ with Dox.	0
70	The array and western blotting showed that @PROTEIN$ and Cyclin D1 expression were down regulated; P53 expression was not affected while MDR1 was over expressed by combination of @COMPOUND$ with Dox.	1
71	In conclusion, @COMPOUND$ chemosensitizes resistant breast cancer cells to Dox cytotoxicity by down regulating expression of Bcl2 and @PROTEIN$ D1, augmenting caspase 3 activity as well as inducing cell cycle block in G(1) and S phases.	1
72	In conclusion, @COMPOUND$ chemosensitizes resistant breast cancer cells to Dox cytotoxicity by down regulating expression of @PROTEIN$ and Cyclin D1, augmenting caspase 3 activity as well as inducing cell cycle block in G(1) and S phases.	1
73	Therapeutic @COMPOUND$/@PROTEIN$ activation promotes the angiogenic phenotype in the ERalpha negative MDA-MB-435 breast cancer model.	1
74	At the time, @PROTEIN$ activity was significantly inhibited and gamma-glutamyl @COMPOUND$ increased by ACA exposure.	0
75	The effect of the polymorphism is non-conservative and results in a glutamine to @COMPOUND$ change (Gln460Arg), which is likely to affect @PROTEIN$ dimerization and protein-protein interactions.	1
76	The effect of the polymorphism is non-conservative and results in a @COMPOUND$ to arginine change (Gln460Arg), which is likely to affect @PROTEIN$ dimerization and protein-protein interactions.	1
77	) @COMPOUND$ (-) and H2O2 in H. plumaeforme was respectively related to the low activity of @PROTEIN$ and the decreased activity of CAT.	1
78	) O2 (-) and @COMPOUND$ in H. plumaeforme was respectively related to the low activity of SOD and the decreased activity of @PROTEIN$.	1
79	) O2 (-) and @COMPOUND$ in H. plumaeforme was respectively related to the low activity of @PROTEIN$ and the decreased activity of CAT.	1
80	) @COMPOUND$ (-) and H2O2 in H. plumaeforme was respectively related to the low activity of SOD and the decreased activity of @PROTEIN$.	1
81	Since then, the efforts of numerous investigators have led to the following conclusions: (a) This enzyme is indeed the molecular machine for the @COMPOUND$-dependent and-coupled transport of Na (+) and K(+) across the plasma membrane of a living cell in which such a process (@PROTEIN$) is detected.	1
82	Since then, the efforts of numerous investigators have led to the following conclusions: (a) This enzyme is indeed the molecular machine for the ATP-dependent and-coupled transport of @COMPOUND$ (+) and K(+) across the plasma membrane of a living cell in which such a process (@PROTEIN$) is detected.	1
83	Affinity electrophoresis analysis provided evidence that carboxymethylated dextran polymers grafted with high amounts of @COMPOUND$ groups (named DMCB) interact with @PROTEIN$.	1
84	Affinity electrophoresis analysis provided evidence that carboxymethylated @COMPOUND$ polymers grafted with high amounts of benzylamide groups (named DMCB) interact with @PROTEIN$.	1
85	Peripheral venous levels of @COMPOUND$, @PROTEIN$, follicle stimulating hormone (FSH), luteinizing hormone (LH), thyroid stimulating hormone (TSH), malondialdehyde and glycosylated haemoglobin (HbA(1)c) were obtained in all subjects.	0
86	Peripheral venous levels of testosterone, @PROTEIN$, follicle stimulating hormone (FSH), luteinizing hormone (LH), thyroid stimulating hormone (TSH), @COMPOUND$ and glycosylated haemoglobin (HbA(1)c) were obtained in all subjects.	0
87	@PROTEIN$ and two additional catalase isozymes were induced by @COMPOUND$ or bensulfuron-methyl in S. maltophilia WZ2, but not in E. coli K12.	1
88	MnSOD and two additional @PROTEIN$ isozymes were induced by @COMPOUND$ or bensulfuron-methyl in S. maltophilia WZ2, but not in E. coli K12.	1
89	@PROTEIN$ and two additional catalase isozymes were induced by quinclorac or @COMPOUND$ in S. maltophilia WZ2, but not in E. coli K12.	1
90	MnSOD and two additional @PROTEIN$ isozymes were induced by quinclorac or @COMPOUND$ in S. maltophilia WZ2, but not in E. coli K12.	1
91	Moreover, @PROTEIN$ (except gamma4) reduce the ion channel block by the synthetic Joro spider toxin analog @COMPOUND$ (NASP).	1
92	Moreover, @PROTEIN$ (except gamma4) reduce the ion channel block by the synthetic @COMPOUND$ analog 1-naphthylacetyl spermine (NASP).	0
93	The dose of @PROTEIN$ (2.5 microg/kg) was chosen to mimic the @COMPOUND$ concentrations seen during mixing of unfamiliar sows.	0
94	Degradation analysis over 8 weeks in the presence of 10 mg/L @PROTEIN$ showed a 50% decrease in total weight and an 80% decrease in @COMPOUND$ molecular weight.	1
95	Fluo-3 staining used in flow cytometry and video microscopy revealed an oxysterol-induced @COMPOUND$+) influx, varying according to the oxysterol studied, leading to the activation of the MEK/@PROTEIN$/2 pathway as demonstrated by Western blot analysis.	1
96	"To determine if response to endocrine therapy of breast cancer can be predicted by either a metabolic ""flare reaction"" detected by positron emission tomography (PET) with 2-((18)F)-fluoro-@COMPOUND$ (FDG), induced by an estradiol challenge, or by @PROTEIN$ (ER) status, determined by PET with the estrogen analog 16alpha-((18)F)fluoroestradiol-17beta (FES)."	0
97	"To determine if response to endocrine therapy of breast cancer can be predicted by either a metabolic ""flare reaction"" detected by positron emission tomography (PET) with 2-((18)F)-fluoro-2-deoxyglucose (FDG), induced by an @COMPOUND$ challenge, or by @PROTEIN$ (ER) status, determined by PET with the estrogen analog 16alpha-((18)F)fluoroestradiol-17beta (FES)."	0
98	Myeloperoxidase (@PROTEIN$) is an endogenous oxidant enzyme that generates reactive @COMPOUND$ species (ROS).	1
99	In present study, we investigated the combined effect of @COMPOUND$ and baicalin on pancreatic damage and pancreatitis associated lung injury, as well as tissue @PROTEIN$ expression in the setting of AP.	0
100	In present study, we investigated the combined effect of emodin and @COMPOUND$ on pancreatic damage and pancreatitis associated lung injury, as well as tissue @PROTEIN$ expression in the setting of AP.	0
101	In the current study, we knocked down @PROTEIN$ expression using cognate siRNA during low-dose @COMPOUND$ treatment to induce apoptosis in two human glioblastoma U138MG and U251MG cell lines.	1
102	Based on these findings, altered expression of @PROTEIN$ in most areas of the striatum suggests that widespread changes to the myelin structure could be associated with the adaptive changes following chronic @COMPOUND$ abuse.	1
103	No correlation was detected between serum @PROTEIN$ level and @COMPOUND$-25(OH)D3, which was under normal range in 60% of the patients.	0
104	The effects on the early secretory pathway in HEK293 cells were: reduction of the rate of ER-to-Golgi transport of the vesicular stomatitis virus glycoprotein (VSVG), slowed accumulation of a Golgi marker plasmid in pre-Golgi structures after @COMPOUND$ treatment and inhibition of cargo concentration of the neuronal glutamate transporter @PROTEIN$ (EAAC1) into transpor complexes in HEK293 cells, an effect that could be completely reversed in the presence of an excess of Rab1.	0
105	The effects on the early secretory pathway in HEK293 cells were: reduction of the rate of ER-to-Golgi transport of the vesicular stomatitis virus @PROTEIN$ (VSVG), slowed accumulation of a Golgi marker plasmid in pre-Golgi structures after @COMPOUND$ treatment and inhibition of cargo concentration of the neuronal glutamate transporter excitatory amino-acid carrier 1 (EAAC1) into transpor complexes in HEK293 cells, an effect that could be completely reversed in the presence of an excess of Rab1.	0
106	The effects on the early secretory pathway in HEK293 cells were: reduction of the rate of ER-to-Golgi transport of the vesicular stomatitis virus glycoprotein (VSVG), slowed accumulation of a Golgi marker plasmid in pre-Golgi structures after @COMPOUND$ treatment and inhibition of cargo concentration of the neuronal glutamate transporter excitatory amino-acid carrier 1 (EAAC1) into transpor complexes in HEK293 cells, an effect that could be completely reversed in the presence of an excess of @PROTEIN$.	0
107	The effects on the early secretory pathway in HEK293 cells were: reduction of the rate of ER-to-Golgi transport of the vesicular stomatitis virus glycoprotein (VSVG), slowed accumulation of a Golgi marker plasmid in pre-Golgi structures after @COMPOUND$ treatment and inhibition of cargo concentration of the neuronal glutamate transporter excitatory amino-acid carrier 1 (@PROTEIN$) into transpor complexes in HEK293 cells, an effect that could be completely reversed in the presence of an excess of Rab1.	0
108	Furthermore, @COMPOUND$ down-regulated GA-induced phosphorylation of extracellular signal-regulated kinase (@PROTEIN$)1/2, one of the critical regulators of Cx43.	1
109	Furthermore, @COMPOUND$ down-regulated GA-induced phosphorylation of extracellular signal-regulated kinase (ERK)1/2, one of the critical regulators of @PROTEIN$.	1
110	@COMPOUND$ accumulated cells in S phase of the cell cycle and reduced @PROTEIN$ expression.	1
111	Wright staining and ApopTag assay showed, respectively, morphological and biochemical features of apoptosis in glioblastoma cells following exposure to 200 units/ml @PROTEIN$ for 48 h. Induction of differentiation was associated with decreases in levels of nuclear factor kappa B (NFkappaB), inducible @COMPOUND$ synthase (iNOS), and production of nitric oxide (NO) so as to increase sensitivity to IFN-gamma for apoptosis.	0
112	Wright staining and ApopTag assay showed, respectively, morphological and biochemical features of apoptosis in glioblastoma cells following exposure to 200 units/ml IFN-gamma for 48 h. Induction of differentiation was associated with decreases in levels of nuclear factor kappa B (NFkappaB), inducible @COMPOUND$ synthase (@PROTEIN$), and production of nitric oxide (NO) so as to increase sensitivity to IFN-gamma for apoptosis.	0
113	In women, @PROTEIN$ levels were higher in individuals with diagnosed ischemic heart disease (IHD) and increased with triglycerides (TG) and @COMPOUND$ level.	0
114	Using a cell culture model of synaptic NMDA receptor-dependent synaptic potentiation, we find that this is mediated exclusively by NR2B-containing @PROTEIN$, as implicated by NR2B-specific antagonists and the use of selective vs. non-selective doses of the NR2A-preferring antagonist @COMPOUND$-AAM077.	1
115	@COMPOUND$ protects against doxorubicin-induced cardiomyopathy: upregulation of @PROTEIN$ and Erk phosphorylation in a rat model.	1
116	Intracellular oxidative status was assessed by analysis of @COMPOUND$/GSSG levels and time course of ROS production and @PROTEIN$ (GR) activity.	0
117	Intracellular oxidative status was assessed by analysis of GSH/@COMPOUND$ levels and time course of ROS production and @PROTEIN$ (GR) activity.	0
118	A recently discussed cardiovascular risk factor, asymmetric dimethylarginine (@COMPOUND$), is known to act as an endogenous inhibitor of endothelial @PROTEIN$.	1
119	A recently discussed cardiovascular risk factor, @COMPOUND$ (ADMA), is known to act as an endogenous inhibitor of endothelial @PROTEIN$.	1
120	The net exercise-induced increase in 6-keto-PGF (1alpha) concentration, expressed as the difference between the end-exercise minus pre-exercise concentration positively correlated with VO(2max) (r=0.78, p=0.004) as well as with the net VO(2) increase at exhaustion (r=0.81, p=0.003), but not with other respiratory, cardiac, metabolic or inflammatory parameters of the exercise (minute ventilation, heart rate, plasma @COMPOUND$, IL-6 or @PROTEIN$ concentrations).	0
121	The net exercise-induced increase in 6-keto-PGF (1alpha) concentration, expressed as the difference between the end-exercise minus pre-exercise concentration positively correlated with VO(2max) (r=0.78, p=0.004) as well as with the net VO(2) increase at exhaustion (r=0.81, p=0.003), but not with other respiratory, cardiac, metabolic or inflammatory parameters of the exercise (minute ventilation, heart rate, plasma @COMPOUND$, @PROTEIN$ or TNF-alpha concentrations).	0
122	The net exercise-induced increase in 6-keto-@PROTEIN$ (1alpha) concentration, expressed as the difference between the end-exercise minus pre-exercise concentration positively correlated with VO(2max) (r=0.78, p=0.004) as well as with the net VO(2) increase at exhaustion (r=0.81, p=0.003), but not with other respiratory, cardiac, metabolic or inflammatory parameters of the exercise (minute ventilation, heart rate, plasma @COMPOUND$, IL-6 or TNF-alpha concentrations).	0
123	Joint action of three drugs, namely of @COMPOUND$+ IL-3+ @PROTEIN$, produced significantly higher numbers of GM-CFC in comparison with the combinations of IB-MECA+ IL-3, IB-MECA+ GM-CSF, or IL-3+ GM-CSF.	0
124	Joint action of three drugs, namely of @COMPOUND$+ @PROTEIN$+ GM-CSF, produced significantly higher numbers of GM-CFC in comparison with the combinations of IB-MECA+ IL-3, IB-MECA+ GM-CSF, or IL-3+ GM-CSF.	0
125	Treatment with @COMPOUND$ activated glucose metabolism in INS-1 cells in high-glucose culture conditions, and appeared to maximize the BM-derived IPCs ability to synthesize @PROTEIN$.	1
126	Treatment with benfotiamine activated @COMPOUND$ metabolism in INS-1 cells in high-glucose culture conditions, and appeared to maximize the BM-derived IPCs ability to synthesize @PROTEIN$.	0
127	Benfotiamine was not shown to induce the glucose receptor Glut-2, however it was shown to activate @PROTEIN$, the enzyme responsible for conversion of glucose to @COMPOUND$.	1
128	Benfotiamine was not shown to induce the glucose receptor @PROTEIN$, however it was shown to activate glucokinase, the enzyme responsible for conversion of glucose to @COMPOUND$.	0
129	@COMPOUND$ was not shown to induce the glucose receptor Glut-2, however it was shown to activate @PROTEIN$, the enzyme responsible for conversion of glucose to glucose-6-phosphate.	1
130	@COMPOUND$ was not shown to induce the glucose receptor @PROTEIN$, however it was shown to activate glucokinase, the enzyme responsible for conversion of glucose to glucose-6-phosphate.	0
131	Histologic examination investigated deposition of extracellular matrix (ECM) including collagen, elastin, @COMPOUND$ (HA), @PROTEIN$, and decorin in the lamina propria of the scarred vocal folds.	0
132	Histologic examination investigated deposition of extracellular matrix (ECM) including collagen, @PROTEIN$, @COMPOUND$ (HA), fibronectin, and decorin in the lamina propria of the scarred vocal folds.	0
133	Histologic examination investigated deposition of extracellular matrix (@PROTEIN$) including collagen, elastin, @COMPOUND$ (HA), fibronectin, and decorin in the lamina propria of the scarred vocal folds.	0
134	In-vitro regeneration of @COMPOUND$ inhibited electric eel @PROTEIN$ by bis-pyridinium oximes bearing xylene linker.	1
135	In-vitro regeneration of sarin inhibited electric eel @PROTEIN$ by bis-pyridinium oximes bearing @COMPOUND$ linker.	1
136	A series of bis-pyridinium oximes connected by @COMPOUND$ linker were synthesized and their in-vitro reactivation potential was evaluated against @PROTEIN$ (AChE) inhibited by nerve agent, sarin.	0
137	A series of bis-pyridinium oximes connected by xylene linker were synthesized and their in-vitro reactivation potential was evaluated against @PROTEIN$ (AChE) inhibited by nerve agent, @COMPOUND$.	0
138	A series of bis-pyridinium oximes connected by @COMPOUND$ linker were synthesized and their in-vitro reactivation potential was evaluated against acetylcholinesterase (@PROTEIN$) inhibited by nerve agent, sarin.	0
139	A series of bis-pyridinium oximes connected by xylene linker were synthesized and their in-vitro reactivation potential was evaluated against acetylcholinesterase (@PROTEIN$) inhibited by nerve agent, @COMPOUND$.	0
140	Recent studies have focused on possible functional disorders of the enteric nervous system within the abomasal wall, since cattle with abomasal displacement have an increased activity of neuronal @PROTEIN$, as well as decreased @COMPOUND$ sensitivity.	0
141	We hypothesise that @COMPOUND$ acts as a chemical or pharmacological chaperone, and suggest amino acid supplementation as a possible therapy in @PROTEIN$ mutations with mild phenotypes.	0
142	Glutamate @COMPOUND$ ligase (@PROTEIN$), synthesizing gamma-glutamylcysteine from glutamate and cysteine, is the rate-limiting enzyme in glutathione (GSH) biosynthesis.	1
143	Glutamate cysteine ligase (@PROTEIN$), synthesizing gamma-glutamylcysteine from glutamate and cysteine, is the rate-limiting enzyme in glutathione (@COMPOUND$) biosynthesis.	1
144	@PROTEIN$ (GCL), synthesizing gamma-glutamylcysteine from @COMPOUND$ and cysteine, is the rate-limiting enzyme in glutathione (GSH) biosynthesis.	1
145	Glutamate cysteine ligase (@PROTEIN$), synthesizing @COMPOUND$ from glutamate and cysteine, is the rate-limiting enzyme in glutathione (GSH) biosynthesis.	1
146	@PROTEIN$ (GCL), synthesizing @COMPOUND$ from glutamate and cysteine, is the rate-limiting enzyme in glutathione (GSH) biosynthesis.	1
147	Glutamate cysteine ligase (@PROTEIN$), synthesizing gamma-glutamylcysteine from @COMPOUND$ and cysteine, is the rate-limiting enzyme in glutathione (GSH) biosynthesis.	1
148	@PROTEIN$ (GCL), synthesizing gamma-glutamylcysteine from glutamate and cysteine, is the rate-limiting enzyme in @COMPOUND$ (GSH) biosynthesis.	1
149	Glutamate cysteine ligase (@PROTEIN$), synthesizing gamma-glutamylcysteine from glutamate and cysteine, is the rate-limiting enzyme in @COMPOUND$ (GSH) biosynthesis.	1
150	@PROTEIN$ (GCL), synthesizing gamma-glutamylcysteine from glutamate and cysteine, is the rate-limiting enzyme in glutathione (@COMPOUND$) biosynthesis.	1
151	Role of serotonin @PROTEIN$ receptors in the antidepressant-like effect and the antinociceptive effect of @COMPOUND$ in mice.	1
152	In contrast, the antinociceptive effect of @COMPOUND$ is probably potentiated due to the blockade of somatodendritic @PROTEIN$ receptors in the same raphe nuclei, facilitating the descending monoaminergic pain control system.	1
153	Moreover, @PROTEIN$ hydrolysis of baicalin sequentially yielded glucuronic acid and @COMPOUND$ as confirmed by co-TLC with authentic samples.	1
154	Moreover, @PROTEIN$ hydrolysis of @COMPOUND$ sequentially yielded glucuronic acid and baicalein as confirmed by co-TLC with authentic samples.	1
155	The effect of this diet alone or after 2 weeks of treatment with @COMPOUND$ or glimepiride on glucose homeostasis, lipid profile, and levels of resistin and @PROTEIN$ was studied.	0
156	The effect of this diet alone or after 2 weeks of treatment with rosiglitazone or @COMPOUND$ on glucose homeostasis, lipid profile, and levels of resistin and @PROTEIN$ was studied.	0
157	Rosiglitazone corrected the altered parameters measured, except for liver TGs ; similarly, @COMPOUND$ reinstated the inverted parameters but raised @PROTEIN$ level and, consequently, the HOMA index.	1
158	@COMPOUND$ corrected the altered parameters measured, except for liver TGs ; similarly, glimepiride reinstated the inverted parameters but raised @PROTEIN$ level and, consequently, the HOMA index.	0
159	Rosiglitazone corrected the altered parameters measured, except for liver @COMPOUND$ ; similarly, glimepiride reinstated the inverted parameters but raised @PROTEIN$ level and, consequently, the HOMA index.	0
160	@COMPOUND$ protects from hepatic reperfusion injury through inhibition of IKK and @PROTEIN$ pathways and modification of cell proliferation.	1
161	@COMPOUND$ significantly improved animal survival and decreased transaminase levels, the indices for necrosis, liver damage, leukocyte infiltration, and @PROTEIN$ expression.	1
162	Here, we examine the effect of resistin on @COMPOUND$ uptake in human trophoblast cells and we demonstrate that transplacental glucose transport is mediated by @PROTEIN$ (GLUT)-1.	1
163	@COMPOUND$-, Gly-Pro-Met- and Ala-Ala-Phe-N'-(2-hexyl-1,3-dioxo-2,3-dihydro-1H-benzo(de)isoquinolin-6-yl)-hydrazides are synthesized by guanidinium/uronium type condensing reagent and used as fluorogenic substrates to localize @PROTEIN$ and tripeptidyl peptidase I activities in mammalian tissue sections.	1
164	Gly-Pro-, Gly-Pro-Met- and Ala-Ala-Phe-N'-(2-hexyl-1,3-dioxo-2,3-dihydro-1H-benzo(de)isoquinolin-6-yl)-hydrazides are synthesized by @COMPOUND$/uronium type condensing reagent and used as fluorogenic substrates to localize @PROTEIN$ and tripeptidyl peptidase I activities in mammalian tissue sections.	1
165	@COMPOUND$-, Gly-Pro-Met- and Ala-Ala-Phe-N'-(2-hexyl-1,3-dioxo-2,3-dihydro-1H-benzo(de)isoquinolin-6-yl)-hydrazides are synthesized by guanidinium/uronium type condensing reagent and used as fluorogenic substrates to localize dipeptidyl peptidase IV and @PROTEIN$ activities in mammalian tissue sections.	1
166	Gly-Pro-, Gly-Pro-Met- and Ala-Ala-Phe-N'-(2-hexyl-1,3-dioxo-2,3-dihydro-1H-benzo(de)isoquinolin-6-yl)-hydrazides are synthesized by @COMPOUND$/uronium type condensing reagent and used as fluorogenic substrates to localize dipeptidyl peptidase IV and @PROTEIN$ activities in mammalian tissue sections.	0
167	However, increased blood @COMPOUND$ (200 mg/dl) significantly impaired the inhibitory effect of ASA (84% for @PROTEIN$.005; 48% for P-selectin, P=NS).	0
168	On the other hand, the levels of oxidized glutathione (@COMPOUND$), lipid peroxidation, protein carbonylation, DNA fragmentation, concentration of superoxide radicals and activities of cytochrome P450 enzymes (@PROTEIN$ P450s) have been found to increase due to cadmium intoxication.	0
169	On the other hand, the levels of oxidized glutathione (GSSG), lipid peroxidation, protein carbonylation, DNA fragmentation, concentration of superoxide radicals and activities of cytochrome P450 enzymes (@PROTEIN$ P450s) have been found to increase due to @COMPOUND$ intoxication.	1
170	On the other hand, the levels of oxidized glutathione (@COMPOUND$), lipid peroxidation, protein carbonylation, DNA fragmentation, concentration of superoxide radicals and activities of @PROTEIN$ enzymes (CYP P450s) have been found to increase due to cadmium intoxication.	0
171	On the other hand, the levels of @COMPOUND$ (GSSG), lipid peroxidation, protein carbonylation, DNA fragmentation, concentration of superoxide radicals and activities of @PROTEIN$ enzymes (CYP P450s) have been found to increase due to cadmium intoxication.	0
172	On the other hand, the levels of oxidized glutathione (GSSG), lipid peroxidation, protein carbonylation, DNA fragmentation, concentration of superoxide radicals and activities of @PROTEIN$ enzymes (CYP P450s) have been found to increase due to @COMPOUND$ intoxication.	1
173	On the other hand, the levels of oxidized glutathione (GSSG), lipid peroxidation, protein carbonylation, DNA fragmentation, concentration of @COMPOUND$ radicals and activities of cytochrome P450 enzymes (@PROTEIN$ P450s) have been found to increase due to cadmium intoxication.	0
174	On the other hand, the levels of @COMPOUND$ (GSSG), lipid peroxidation, protein carbonylation, DNA fragmentation, concentration of superoxide radicals and activities of cytochrome P450 enzymes (@PROTEIN$ P450s) have been found to increase due to cadmium intoxication.	0
175	On the other hand, the levels of oxidized glutathione (GSSG), lipid peroxidation, protein carbonylation, DNA fragmentation, concentration of @COMPOUND$ radicals and activities of @PROTEIN$ enzymes (CYP P450s) have been found to increase due to cadmium intoxication.	0
176	This paper describes (1) the preparation of the intact oligosaccharides from @PROTEIN$ (II(3)NeuAcGgOse(4) Cer) and GbOse(4) Cer as examples to show the use of CGase to prepare intact @COMPOUND$ chains from GSLs, and (2) the specificity and detergent requirements of Rhodococcal EGCases for the release of glycan chains from different GSLs.	0
177	The discovery of the PLN/@PROTEIN$ interaction therefore unveils an important new link between @COMPOUND$+) homeostasis and cell survival, with significant therapeutic potential.	0
178	The discovery of the @PROTEIN$/HAX-1 interaction therefore unveils an important new link between @COMPOUND$+) homeostasis and cell survival, with significant therapeutic potential.	0
179	Cross-linked @PROTEIN$ (1/2) heteromers showed strongly reduced or absent function that was selectively recovered upon treatment with @COMPOUND$.	1
180	Permeabilization of K. marxianus cells in relation to @PROTEIN$ activity was carried out using cetyltrimethyl ammonium bromide (@COMPOUND$) to avoid the problem of enzyme extraction.	1
181	Permeabilization of K. marxianus cells in relation to @PROTEIN$ activity was carried out using cetyltrimethyl @COMPOUND$ (CTAB) to avoid the problem of enzyme extraction.	1
182	Incorporation of bromodeoxyuridine into newly synthesized DNA and the concentration of vinculin, beta-actin, osteopontin, and @PROTEIN$ in cells on the scaffolds of all pore sizes were similar to the values obtained on standard tissue culture @COMPOUND$, which indicated good biocompatibility of the scaffolds.	0
183	Incorporation of @COMPOUND$ into newly synthesized DNA and the concentration of @PROTEIN$, beta-actin, osteopontin, and osteocalcin in cells on the scaffolds of all pore sizes were similar to the values obtained on standard tissue culture polystyrene, which indicated good biocompatibility of the scaffolds.	0
184	Incorporation of bromodeoxyuridine into newly synthesized DNA and the concentration of @PROTEIN$, beta-actin, osteopontin, and osteocalcin in cells on the scaffolds of all pore sizes were similar to the values obtained on standard tissue culture @COMPOUND$, which indicated good biocompatibility of the scaffolds.	0
185	Incorporation of @COMPOUND$ into newly synthesized DNA and the concentration of vinculin, @PROTEIN$, osteopontin, and osteocalcin in cells on the scaffolds of all pore sizes were similar to the values obtained on standard tissue culture polystyrene, which indicated good biocompatibility of the scaffolds.	0
186	Incorporation of @COMPOUND$ into newly synthesized DNA and the concentration of vinculin, beta-actin, osteopontin, and @PROTEIN$ in cells on the scaffolds of all pore sizes were similar to the values obtained on standard tissue culture polystyrene, which indicated good biocompatibility of the scaffolds.	0
187	Incorporation of bromodeoxyuridine into newly synthesized DNA and the concentration of vinculin, @PROTEIN$, osteopontin, and osteocalcin in cells on the scaffolds of all pore sizes were similar to the values obtained on standard tissue culture @COMPOUND$, which indicated good biocompatibility of the scaffolds.	0
188	Prediction of @PROTEIN$ receptor binding affinity of substituted 1-(3,3-diphenylpropyl)-@COMPOUND$ amides and ureas based on the heuristic method, support vector machine and projection pursuit regression.	1
189	TT-induced increases in @COMPOUND$, adrenocorticotropic hormone and prolactin were reduced only after 3-h @PROTEIN$.	0
190	TT-induced increases in @COMPOUND$, @PROTEIN$ and prolactin were reduced only after 3-h REC.	0
191	TT-induced increases in @COMPOUND$, adrenocorticotropic hormone and @PROTEIN$ were reduced only after 3-h REC.	0
192	@COMPOUND$ inhibits vascular superoxide production induced by endothelin-1 : Role of NADPH oxidase, uncoupled eNOS and @PROTEIN$.	0
193	@COMPOUND$ inhibits vascular superoxide production induced by endothelin-1 : Role of NADPH oxidase, uncoupled @PROTEIN$ and PKC.	0
194	Quercetin inhibits vascular @COMPOUND$ production induced by endothelin-1 : Role of NADPH oxidase, uncoupled eNOS and @PROTEIN$.	0
195	Quercetin inhibits vascular @COMPOUND$ production induced by endothelin-1 : Role of NADPH oxidase, uncoupled @PROTEIN$ and PKC.	0
196	Quercetin inhibits vascular @COMPOUND$ production induced by @PROTEIN$ : Role of NADPH oxidase, uncoupled eNOS and PKC.	1
197	@COMPOUND$ inhibits vascular superoxide production induced by @PROTEIN$ : Role of NADPH oxidase, uncoupled eNOS and PKC.	1
198	Furthermore, ET-1 increased intracellular O(2*)(-) production in all layers of the vessel, protein expression of NADPH oxidase subunit @PROTEIN$ (phox) without affecting p22 (phox) expression and lucigenin-enhanced chemiluminescence signal stimulated by @COMPOUND$.	0
199	Furthermore, ET-1 increased intracellular O(2*)(-) production in all layers of the vessel, protein expression of NADPH oxidase subunit p47 (phox) without affecting @PROTEIN$ (phox) expression and lucigenin-enhanced chemiluminescence signal stimulated by @COMPOUND$.	0
200	A new series of @COMPOUND$ and aurone derivatives have been synthesized and tested for in vitro @PROTEIN$ inhibitory activity by modified Ellman method.	0
201	@COMPOUND$ differentially alter @PROTEIN$ (2alpha) and PGE (2) release from bovine trophoblast and endometrial tissues during short-term culture.	1
202	@COMPOUND$ differentially alter PGF (2alpha) and @PROTEIN$ (2) release from bovine trophoblast and endometrial tissues during short-term culture.	1
203	Two studies tested the hypothesis that eicosapentaenoic (20:5omega3; EPA), docosahexaenoic acids (22:6omega3; DHA) or linoleic acid (C18 :2omega6; @COMPOUND$) reduced bovine endometrial and trophoblast prostaglandin F(2alpha) (PGF (2alpha)) and prostaglandin E(2) (@PROTEIN$ (2)) release during short-term culture.	1
204	Two studies tested the hypothesis that eicosapentaenoic (20:5omega3; EPA), docosahexaenoic acids (22:6omega3; DHA) or linoleic acid (C18 :2omega6; @COMPOUND$) reduced bovine endometrial and trophoblast prostaglandin F(2alpha) (@PROTEIN$ (2alpha)) and prostaglandin E(2) (PGE (2)) release during short-term culture.	1
205	Two studies tested the hypothesis that eicosapentaenoic (20:5omega3; EPA), @COMPOUND$ (22:6omega3; DHA) or linoleic acid (C18 :2omega6; LIN) reduced bovine endometrial and trophoblast prostaglandin F(2alpha) (PGF (2alpha)) and prostaglandin E(2) (@PROTEIN$ (2)) release during short-term culture.	1
206	Two studies tested the hypothesis that eicosapentaenoic (20:5omega3; EPA), docosahexaenoic acids (22:6omega3; DHA) or @COMPOUND$ (C18 :2omega6; LIN) reduced bovine endometrial and trophoblast prostaglandin F(2alpha) (PGF (2alpha)) and prostaglandin E(2) (@PROTEIN$ (2)) release during short-term culture.	1
207	Two studies tested the hypothesis that eicosapentaenoic (20:5omega3; EPA), docosahexaenoic acids (22:6omega3; DHA) or @COMPOUND$ (C18 :2omega6; LIN) reduced bovine endometrial and trophoblast prostaglandin F(2alpha) (@PROTEIN$ (2alpha)) and prostaglandin E(2) (PGE (2)) release during short-term culture.	1
208	Two studies tested the hypothesis that eicosapentaenoic (20:5omega3; EPA), @COMPOUND$ (22:6omega3; DHA) or linoleic acid (C18 :2omega6; LIN) reduced bovine endometrial and trophoblast prostaglandin F(2alpha) (@PROTEIN$ (2alpha)) and prostaglandin E(2) (PGE (2)) release during short-term culture.	1
209	@PROTEIN$ (DXS) catalyses the first committed step of the 2C-methyl-D-erythritol-4-phosphate (@COMPOUND$) pathway, which is an alternative isoprenoids biosynthetic route that has been recently discovered.	1
210	@PROTEIN$ (DXS) catalyses the first committed step of the 2C-methyl-@COMPOUND$ (MEP) pathway, which is an alternative isoprenoids biosynthetic route that has been recently discovered.	1
211	The gene expressions of CYP1A1 and @PROTEIN$ in the placenta increased significantly in @COMPOUND$-treated groups on GD 15 and GD 18, but returned to the level similar to the corresponding control on GD 21.	1
212	The gene expressions of @PROTEIN$ and CYP2E1 in the placenta increased significantly in @COMPOUND$-treated groups on GD 15 and GD 18, but returned to the level similar to the corresponding control on GD 21.	1
213	In @COMPOUND$ group, there was a decrease of @PROTEIN$ expression on GD 15, GD 18, and GD 21, with the most significant decrease on GD 15.	1
214	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), catalase, glutathione peroxidase (GPx), glutathione-S-transferase (@PROTEIN$), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum glucose, and levels of glutathione (@COMPOUND$) and glycosylated hemoglobin (GHb) in blood.	0
215	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), catalase, @COMPOUND$ peroxidase (GPx), glutathione-S-transferase (@PROTEIN$), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum glucose, and levels of glutathione (GSH) and glycosylated hemoglobin (GHb) in blood.	0
216	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), @PROTEIN$, glutathione peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum @COMPOUND$, and levels of glutathione (GSH) and glycosylated hemoglobin (GHb) in blood.	0
217	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of @PROTEIN$ (SOD), catalase, glutathione peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum glucose, and levels of glutathione (@COMPOUND$) and glycosylated hemoglobin (GHb) in blood.	0
218	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), catalase, glutathione peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum glucose, and levels of glutathione (@COMPOUND$) and glycosylated @PROTEIN$ (GHb) in blood.	0
219	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (@PROTEIN$), catalase, glutathione peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum glucose, and levels of glutathione (@COMPOUND$) and glycosylated hemoglobin (GHb) in blood.	0
220	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), catalase, @COMPOUND$ peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (@PROTEIN$) in erythrocytes, serum glucose, and levels of glutathione (GSH) and glycosylated hemoglobin (GHb) in blood.	0
221	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (@PROTEIN$), activities of superoxide dismutase (SOD), catalase, glutathione peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum glucose, and levels of glutathione (@COMPOUND$) and glycosylated hemoglobin (GHb) in blood.	0
222	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), catalase, glutathione peroxidase (GPx), @PROTEIN$ (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum @COMPOUND$, and levels of glutathione (GSH) and glycosylated hemoglobin (GHb) in blood.	0
223	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), catalase, glutathione peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and @PROTEIN$ (AChE) in erythrocytes, serum @COMPOUND$, and levels of glutathione (GSH) and glycosylated hemoglobin (GHb) in blood.	0
224	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (@PROTEIN$), catalase, @COMPOUND$ peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum glucose, and levels of glutathione (GSH) and glycosylated hemoglobin (GHb) in blood.	0
225	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of @PROTEIN$ (SOD), catalase, glutathione peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum @COMPOUND$, and levels of glutathione (GSH) and glycosylated hemoglobin (GHb) in blood.	0
226	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), catalase, @PROTEIN$ (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum @COMPOUND$, and levels of glutathione (GSH) and glycosylated hemoglobin (GHb) in blood.	0
227	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), @PROTEIN$, @COMPOUND$ peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum glucose, and levels of glutathione (GSH) and glycosylated hemoglobin (GHb) in blood.	0
228	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), catalase, @COMPOUND$ peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and @PROTEIN$ (AChE) in erythrocytes, serum glucose, and levels of glutathione (GSH) and glycosylated hemoglobin (GHb) in blood.	0
229	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), catalase, glutathione peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum @COMPOUND$, and levels of glutathione (GSH) and glycosylated @PROTEIN$ (GHb) in blood.	0
230	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), catalase, @PROTEIN$ (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum glucose, and levels of glutathione (@COMPOUND$) and glycosylated hemoglobin (GHb) in blood.	0
231	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (@PROTEIN$), activities of superoxide dismutase (SOD), catalase, @COMPOUND$ peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum glucose, and levels of glutathione (GSH) and glycosylated hemoglobin (GHb) in blood.	0
232	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), catalase, glutathione peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (@PROTEIN$) in erythrocytes, serum @COMPOUND$, and levels of glutathione (GSH) and glycosylated hemoglobin (GHb) in blood.	0
233	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), catalase, glutathione peroxidase (GPx), @PROTEIN$ (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum glucose, and levels of glutathione (@COMPOUND$) and glycosylated hemoglobin (GHb) in blood.	0
234	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of @PROTEIN$ (SOD), catalase, @COMPOUND$ peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum glucose, and levels of glutathione (GSH) and glycosylated hemoglobin (GHb) in blood.	0
235	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (@PROTEIN$), catalase, glutathione peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum @COMPOUND$, and levels of glutathione (GSH) and glycosylated hemoglobin (GHb) in blood.	0
236	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (@PROTEIN$), activities of superoxide dismutase (SOD), catalase, glutathione peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum @COMPOUND$, and levels of glutathione (GSH) and glycosylated hemoglobin (GHb) in blood.	0
237	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), catalase, glutathione peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and @PROTEIN$ (AChE) in erythrocytes, serum glucose, and levels of glutathione (@COMPOUND$) and glycosylated hemoglobin (GHb) in blood.	0
238	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), catalase, glutathione peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (@PROTEIN$) in erythrocytes, serum glucose, and levels of glutathione (@COMPOUND$) and glycosylated hemoglobin (GHb) in blood.	0
239	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), catalase, @COMPOUND$ peroxidase (GPx), @PROTEIN$ (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum glucose, and levels of glutathione (GSH) and glycosylated hemoglobin (GHb) in blood.	0
240	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), catalase, @COMPOUND$ peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum glucose, and levels of glutathione (GSH) and glycosylated @PROTEIN$ (GHb) in blood.	0
241	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), @PROTEIN$, glutathione peroxidase (GPx), glutathione-S-transferase (GST), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum glucose, and levels of glutathione (@COMPOUND$) and glycosylated hemoglobin (GHb) in blood.	0
242	At term, the impact of their coexposure was assessed by evaluating lipid peroxidation (LPO), activities of superoxide dismutase (SOD), catalase, glutathione peroxidase (GPx), glutathione-S-transferase (@PROTEIN$), different ATPases and acetylcholinesterase (AChE) in erythrocytes, serum @COMPOUND$, and levels of glutathione (GSH) and glycosylated hemoglobin (GHb) in blood.	0
243	mRNA and protein levels of @PROTEIN$, Fas, and caspase-8, which are closely related to cell apoptosis by a death ligand/receptor-dependent apoptosis pathway, were increased by @COMPOUND$ treatment.	1
244	mRNA and protein levels of TNF-alpha, @PROTEIN$, and caspase-8, which are closely related to cell apoptosis by a death ligand/receptor-dependent apoptosis pathway, were increased by @COMPOUND$ treatment.	1
245	Taken together, the findings of this study have demonstrated that @COMPOUND$ could induce apoptosis in hepa1c1c7 cells by regulating @PROTEIN$ and inhibiting the expression of Bcl-2.	1
246	Taken together, the findings of this study have demonstrated that @COMPOUND$ could induce apoptosis in hepa1c1c7 cells by regulating Fas ligands and inhibiting the expression of @PROTEIN$.	1
247	Three proteins, porcine somatotropin, bovine @PROTEIN$, and immunoglobulin, as well as materials with a strong calorimetric glass transition (T(g)), that is, @COMPOUND$ and poly(vinypyrrolidone) (PVP), were studied by both TSC and differential scanning calorimetry (DSC).	0
248	Three proteins, porcine @PROTEIN$, bovine serum albumin, and immunoglobulin, as well as materials with a strong calorimetric glass transition (T(g)), that is, @COMPOUND$ and poly(vinypyrrolidone) (PVP), were studied by both TSC and differential scanning calorimetry (DSC).	0
249	Only the @PROTEIN$ of pI 5.4 and superior to 7.6 hydrolyze the @COMPOUND$.	1
250	To investigate this relationship, we used actively growing young Sprague-Dawley rats and @COMPOUND$, one of the angiogenesis inhibitor (AI) to reveal the relationship of angiogenesis in the effect of @PROTEIN$.	0
251	Functional polymorphisms in the @PROTEIN$ and serotonin transporter genes, and depression and fatigue induced by interferon-alpha and @COMPOUND$ treatment.	1
252	Towards this end, we propose a fixed-length alpha-numeric code for representing N-linked @COMPOUND$ structures commonly found in secreted @PROTEIN$ from mammalian cell cultures.	1
253	There was a significant increase in @PROTEIN$ oxidase activity at 2.5 mg/L, which might indicate @COMPOUND$'s disruption of the mitochondrial membrane and subsequently ATP synthesis.	1
254	There was a significant increase in @PROTEIN$ oxidase activity at 2.5 mg/L, which might indicate irgarol's disruption of the mitochondrial membrane and subsequently @COMPOUND$ synthesis.	1
255	Furthermore @COMPOUND$ treatment markedly decreased the levels of TNF-alpha, IL-6 and MCP-1, reduced myocardial infiltration of macrophages and significantly increased myocardial and serum levels of the anti-inflammatory cytokine @PROTEIN$.	1
256	Furthermore @COMPOUND$ treatment markedly decreased the levels of TNF-alpha, IL-6 and @PROTEIN$, reduced myocardial infiltration of macrophages and significantly increased myocardial and serum levels of the anti-inflammatory cytokine IL-10.	1
257	Furthermore @COMPOUND$ treatment markedly decreased the levels of TNF-alpha, @PROTEIN$ and MCP-1, reduced myocardial infiltration of macrophages and significantly increased myocardial and serum levels of the anti-inflammatory cytokine IL-10.	1
258	Furthermore @COMPOUND$ treatment markedly decreased the levels of @PROTEIN$, IL-6 and MCP-1, reduced myocardial infiltration of macrophages and significantly increased myocardial and serum levels of the anti-inflammatory cytokine IL-10.	1
259	She had a mutation in @PROTEIN$ gene consisting of an aminoacid change of Alanine to @COMPOUND$ in exon 5 (A382V).	1
260	She had a mutation in @PROTEIN$ gene consisting of an aminoacid change of @COMPOUND$ to Valine in exon 5 (A382V).	1
261	However, @COMPOUND$ exhibited more potency in reducing @PROTEIN$ activity than methiocarb.	1
262	However, methomyl exhibited more potency in reducing @PROTEIN$ activity than @COMPOUND$.	1
263	Furthermore, among the ROS scavenging antioxidant defense genes studied here, mRNA levels of salicylic acid-binding (SAbind) catalase (CAT) and lignin-forming @PROTEIN$ (POX) were found to be increased by proline and @COMPOUND$ under salt stress.	1
264	Furthermore, among the ROS scavenging antioxidant defense genes studied here, mRNA levels of salicylic acid-binding (SAbind) catalase (CAT) and lignin-forming peroxidase (@PROTEIN$) were found to be increased by @COMPOUND$ and betaine under salt stress.	1
265	Furthermore, among the ROS scavenging antioxidant defense genes studied here, mRNA levels of salicylic acid-binding (SAbind) catalase (CAT) and lignin-forming @PROTEIN$ (POX) were found to be increased by @COMPOUND$ and betaine under salt stress.	1
266	Furthermore, among the ROS scavenging antioxidant defense genes studied here, mRNA levels of salicylic acid-binding (SAbind) catalase (@PROTEIN$) and lignin-forming peroxidase (POX) were found to be increased by @COMPOUND$ and betaine under salt stress.	1
267	Furthermore, among the ROS scavenging antioxidant defense genes studied here, mRNA levels of salicylic acid-binding (SAbind) catalase (@PROTEIN$) and lignin-forming peroxidase (POX) were found to be increased by proline and @COMPOUND$ under salt stress.	1
268	Furthermore, among the ROS scavenging antioxidant defense genes studied here, mRNA levels of salicylic acid-binding (SAbind) @PROTEIN$ (CAT) and lignin-forming peroxidase (POX) were found to be increased by @COMPOUND$ and betaine under salt stress.	1
269	Furthermore, among the ROS scavenging antioxidant defense genes studied here, mRNA levels of salicylic acid-binding (SAbind) @PROTEIN$ (CAT) and lignin-forming peroxidase (POX) were found to be increased by proline and @COMPOUND$ under salt stress.	1
270	Furthermore, among the ROS scavenging antioxidant defense genes studied here, mRNA levels of salicylic acid-binding (SAbind) catalase (CAT) and lignin-forming peroxidase (@PROTEIN$) were found to be increased by proline and @COMPOUND$ under salt stress.	1
271	@PROTEIN$ (EC 3.2.1.52) are lysosomal enzymes that remove terminal beta-glycosidically bound N-acetylglucosamine and @COMPOUND$ residues from a number of glycoconjugates.	1
272	@PROTEIN$ (EC 3.2.1.52) are lysosomal enzymes that remove terminal beta-glycosidically bound @COMPOUND$ and N-acetylgalactosamine residues from a number of glycoconjugates.	1
273	In androgen-independent PC-3 cells, @COMPOUND$ also induced apoptosis by mechanisms that were partially inhibited by pan-caspase inhibition but were partially @PROTEIN$ dependent.	1
274	A differential regulation of the two @COMPOUND$ synthesizing enzymes (GAD65 and @PROTEIN$) parallels GABAergic neuron differentiation.	1
275	A differential regulation of the two @COMPOUND$ synthesizing enzymes (@PROTEIN$ and GAD67) parallels GABAergic neuron differentiation.	1
276	The increased levels of hepatic @COMPOUND$ and @PROTEIN$ activity and decreased levels of TBARS and nitrite were also observed in UDCA-treated BDL rats.	0
277	In the induction phase, the @COMPOUND$ feed rate had a significant effect on the specific expression rate of rhG-@PROTEIN$.	1
278	@COMPOUND$ potently reduces vascular inflammation and arteriosclerosis in @PROTEIN$-deficient ApoE ko mice.	1
279	Feeding long-chain n-3 polyunsaturated fatty acids during gestation increases intestinal @COMPOUND$ absorption potentially via the acute activation of @PROTEIN$.	0
280	Feeding long-chain n-3 @COMPOUND$ during gestation increases intestinal glucose absorption potentially via the acute activation of @PROTEIN$.	1
281	Furthermore, adding @COMPOUND$ (DHA) or an AMP-activated protein kinase (@PROTEIN$.05) in intestinal preparations obtained from the offspring fed the control diet, devoid of the PFO product and containing minimal concentrations of n-3 PUFA.	0
282	Furthermore, adding @COMPOUND$ (DHA) or an AMP-activated @PROTEIN$ (AMPK.05) in intestinal preparations obtained from the offspring fed the control diet, devoid of the PFO product and containing minimal concentrations of n-3 PUFA.	0
283	Furthermore, adding @COMPOUND$ (DHA) or an @PROTEIN$-activated protein kinase (AMPK.05) in intestinal preparations obtained from the offspring fed the control diet, devoid of the PFO product and containing minimal concentrations of n-3 PUFA.	0
284	In adulthood, @COMPOUND$ secreted by the testes is converted into estrogens by the preoptic @PROTEIN$.	1
285	The model was used to investigate how on-treatment @PROTEIN$ related to baseline CRP and estimated treatment effects with @COMPOUND$.	1
286	In addition, synthesis of collagen and @PROTEIN$ in the vascular wall were significantly increased by @COMPOUND$.	1
287	Organic cations (@COMPOUND$) are primarily excreted via vectorial transport by various renal organic cation transporters (@PROTEIN$).	1
288	In a rat ARF model, induction of ARF by @COMPOUND$ (UN) treatment significantly decreased the levels of @PROTEIN$ (slc22a2) mRNA and protein in the kidney medulla.	1
289	Platelet reactivity and @COMPOUND$ resistance are associated with the H2 haplotype of the P2Y12-@PROTEIN$ receptor gene.	1
290	Platelet reactivity and @COMPOUND$ resistance are associated with the H2 haplotype of the @PROTEIN$-ADP receptor gene.	1
291	We have proposed that @COMPOUND$ (CsA), despite being a @PROTEIN$, will activate PKC in B cells, thus promoting Epstein-Barr virus (EBV)-induced transformation.	1
292	We have proposed that @COMPOUND$ (CsA), despite being a calcineurin inhibitor, will activate @PROTEIN$ in B cells, thus promoting Epstein-Barr virus (EBV)-induced transformation.	1
293	Using both physiologically achievable (2 microM) and supraphysiological (10 microM) concentrations, we investigated the ability of @COMPOUND$ and its predominant human metabolites to attenuate the expression of vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1) and monocyte chemoattractant protein-1 (MCP-1) in human umbilical artery smooth muscle cells (HUASMC) activated by tumor necrosis factor-alpha (@PROTEIN$).	0
294	Using both physiologically achievable (2 microM) and supraphysiological (10 microM) concentrations, we investigated the ability of @COMPOUND$ and its predominant human metabolites to attenuate the expression of vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1) and @PROTEIN$ (MCP-1) in human umbilical artery smooth muscle cells (HUASMC) activated by tumor necrosis factor-alpha (TNFalpha).	0
295	Using both physiologically achievable (2 microM) and supraphysiological (10 microM) concentrations, we investigated the ability of @COMPOUND$ and its predominant human metabolites to attenuate the expression of vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1) and monocyte chemoattractant protein-1 (MCP-1) in human umbilical artery smooth muscle cells (HUASMC) activated by @PROTEIN$-alpha (TNFalpha).	0
296	Using both physiologically achievable (2 microM) and supraphysiological (10 microM) concentrations, we investigated the ability of @COMPOUND$ and its predominant human metabolites to attenuate the expression of vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (@PROTEIN$) and monocyte chemoattractant protein-1 (MCP-1) in human umbilical artery smooth muscle cells (HUASMC) activated by tumor necrosis factor-alpha (TNFalpha).	0
297	Using both physiologically achievable (2 microM) and supraphysiological (10 microM) concentrations, we investigated the ability of @COMPOUND$ and its predominant human metabolites to attenuate the expression of vascular cell adhesion molecule-1 (VCAM-1), intercellular adhesion molecule-1 (ICAM-1) and monocyte chemoattractant protein-1 (@PROTEIN$) in human umbilical artery smooth muscle cells (HUASMC) activated by tumor necrosis factor-alpha (TNFalpha).	0
298	Using both physiologically achievable (2 microM) and supraphysiological (10 microM) concentrations, we investigated the ability of @COMPOUND$ and its predominant human metabolites to attenuate the expression of vascular cell adhesion molecule-1 (@PROTEIN$), intercellular adhesion molecule-1 (ICAM-1) and monocyte chemoattractant protein-1 (MCP-1) in human umbilical artery smooth muscle cells (HUASMC) activated by tumor necrosis factor-alpha (TNFalpha).	0
299	In its active form, @COMPOUND$ (TPP), it is a co-enzyme for several enzymes, including @PROTEIN$.	1
300	Pigs fed the high-@COMPOUND$ diet moreover had an increased concentration of trimethyllysine (TML), a reduced mRNA abundance of @PROTEIN$ and reduced concentrations of gamma-butyrobetaine (BB) in muscle, indicating that the conversion of TML into BB in muscle was impaired.	0
301	Pigs fed the high-lysine diet moreover had an increased concentration of @COMPOUND$ (TML), a reduced mRNA abundance of @PROTEIN$ and reduced concentrations of gamma-butyrobetaine (BB) in muscle, indicating that the conversion of TML into BB in muscle was impaired.	0
302	Pigs fed the high-lysine diet moreover had an increased concentration of trimethyllysine (TML), a reduced mRNA abundance of @PROTEIN$ and reduced concentrations of @COMPOUND$ (BB) in muscle, indicating that the conversion of TML into BB in muscle was impaired.	0
303	The cells exposed to 10 microM (@COMPOUND$ for 3 h or to 40 microM (15S)-HETE for 6 h showed increased expression of Fas ligand and @PROTEIN$ (Fas-associated death domain), caspase 8 activation, Bid (BH3-interacting domain death agonist) cleavage, decrease in mitochondrial membrane potential, cytochrome c release, caspase 3 activation, PARP-1 (poly(ADP-ribose) polymerase-1) cleavage and DNA fragmentation, suggesting the involvement of both extrinsic and intrinsic death pathways.	1
304	The cells exposed to 10 microM (@COMPOUND$ for 3 h or to 40 microM (15S)-HETE for 6 h showed increased expression of @PROTEIN$ ligand and FADD (Fas-associated death domain), caspase 8 activation, Bid (BH3-interacting domain death agonist) cleavage, decrease in mitochondrial membrane potential, cytochrome c release, caspase 3 activation, PARP-1 (poly(ADP-ribose) polymerase-1) cleavage and DNA fragmentation, suggesting the involvement of both extrinsic and intrinsic death pathways.	1
305	The cells exposed to 10 microM (15S)-HPETE for 3 h or to 40 microM (@COMPOUND$ for 6 h showed increased expression of Fas ligand and FADD (Fas-associated death domain), caspase 8 activation, Bid (@PROTEIN$) cleavage, decrease in mitochondrial membrane potential, cytochrome c release, caspase 3 activation, PARP-1 (poly(ADP-ribose) polymerase-1) cleavage and DNA fragmentation, suggesting the involvement of both extrinsic and intrinsic death pathways.	1
306	The cells exposed to 10 microM (15S)-HPETE for 3 h or to 40 microM (@COMPOUND$ for 6 h showed increased expression of @PROTEIN$ ligand and FADD (Fas-associated death domain), caspase 8 activation, Bid (BH3-interacting domain death agonist) cleavage, decrease in mitochondrial membrane potential, cytochrome c release, caspase 3 activation, PARP-1 (poly(ADP-ribose) polymerase-1) cleavage and DNA fragmentation, suggesting the involvement of both extrinsic and intrinsic death pathways.	1
307	The cells exposed to 10 microM (15S)-HPETE for 3 h or to 40 microM (@COMPOUND$ for 6 h showed increased expression of Fas ligand and FADD (Fas-associated death domain), caspase 8 activation, Bid (BH3-interacting domain death agonist) cleavage, decrease in mitochondrial membrane potential, cytochrome c release, caspase 3 activation, PARP-1 (poly(@PROTEIN$-ribose) polymerase-1) cleavage and DNA fragmentation, suggesting the involvement of both extrinsic and intrinsic death pathways.	1
308	The cells exposed to 10 microM (15S)-HPETE for 3 h or to 40 microM (@COMPOUND$ for 6 h showed increased expression of Fas ligand and FADD (Fas-associated death domain), caspase 8 activation, Bid (BH3-interacting domain death agonist) cleavage, decrease in mitochondrial membrane potential, @PROTEIN$ release, caspase 3 activation, PARP-1 (poly(ADP-ribose) polymerase-1) cleavage and DNA fragmentation, suggesting the involvement of both extrinsic and intrinsic death pathways.	1
309	The cells exposed to 10 microM (15S)-HPETE for 3 h or to 40 microM (@COMPOUND$ for 6 h showed increased expression of @PROTEIN$ and FADD (Fas-associated death domain), caspase 8 activation, Bid (BH3-interacting domain death agonist) cleavage, decrease in mitochondrial membrane potential, cytochrome c release, caspase 3 activation, PARP-1 (poly(ADP-ribose) polymerase-1) cleavage and DNA fragmentation, suggesting the involvement of both extrinsic and intrinsic death pathways.	1
310	The cells exposed to 10 microM (@COMPOUND$ for 3 h or to 40 microM (15S)-HETE for 6 h showed increased expression of @PROTEIN$ and FADD (Fas-associated death domain), caspase 8 activation, Bid (BH3-interacting domain death agonist) cleavage, decrease in mitochondrial membrane potential, cytochrome c release, caspase 3 activation, PARP-1 (poly(ADP-ribose) polymerase-1) cleavage and DNA fragmentation, suggesting the involvement of both extrinsic and intrinsic death pathways.	1
311	The cells exposed to 10 microM (15S)-HPETE for 3 h or to 40 microM (@COMPOUND$ for 6 h showed increased expression of Fas ligand and @PROTEIN$ (Fas-associated death domain), caspase 8 activation, Bid (BH3-interacting domain death agonist) cleavage, decrease in mitochondrial membrane potential, cytochrome c release, caspase 3 activation, PARP-1 (poly(ADP-ribose) polymerase-1) cleavage and DNA fragmentation, suggesting the involvement of both extrinsic and intrinsic death pathways.	1
312	The cells exposed to 10 microM (@COMPOUND$ for 3 h or to 40 microM (15S)-HETE for 6 h showed increased expression of Fas ligand and FADD (Fas-associated death domain), caspase 8 activation, Bid (BH3-interacting domain death agonist) cleavage, decrease in mitochondrial membrane potential, cytochrome c release, caspase 3 activation, PARP-1 (poly(@PROTEIN$-ribose) polymerase-1) cleavage and DNA fragmentation, suggesting the involvement of both extrinsic and intrinsic death pathways.	1
313	The cells exposed to 10 microM (15S)-HPETE for 3 h or to 40 microM (@COMPOUND$ for 6 h showed increased expression of Fas ligand and FADD (Fas-associated death domain), caspase 8 activation, Bid (BH3-interacting domain death agonist) cleavage, decrease in mitochondrial membrane potential, cytochrome c release, caspase 3 activation, @PROTEIN$ (poly(ADP-ribose) polymerase-1) cleavage and DNA fragmentation, suggesting the involvement of both extrinsic and intrinsic death pathways.	1
314	The cells exposed to 10 microM (@COMPOUND$ for 3 h or to 40 microM (15S)-HETE for 6 h showed increased expression of Fas ligand and FADD (Fas-associated death domain), caspase 8 activation, Bid (BH3-interacting domain death agonist) cleavage, decrease in mitochondrial membrane potential, @PROTEIN$ release, caspase 3 activation, PARP-1 (poly(ADP-ribose) polymerase-1) cleavage and DNA fragmentation, suggesting the involvement of both extrinsic and intrinsic death pathways.	1
315	The cells exposed to 10 microM (@COMPOUND$ for 3 h or to 40 microM (15S)-HETE for 6 h showed increased expression of Fas ligand and FADD (Fas-associated death domain), caspase 8 activation, Bid (@PROTEIN$) cleavage, decrease in mitochondrial membrane potential, cytochrome c release, caspase 3 activation, PARP-1 (poly(ADP-ribose) polymerase-1) cleavage and DNA fragmentation, suggesting the involvement of both extrinsic and intrinsic death pathways.	1
316	The cells exposed to 10 microM (@COMPOUND$ for 3 h or to 40 microM (15S)-HETE for 6 h showed increased expression of Fas ligand and FADD (Fas-associated death domain), caspase 8 activation, Bid (BH3-interacting domain death agonist) cleavage, decrease in mitochondrial membrane potential, cytochrome c release, caspase 3 activation, @PROTEIN$ (poly(ADP-ribose) polymerase-1) cleavage and DNA fragmentation, suggesting the involvement of both extrinsic and intrinsic death pathways.	1
317	@COMPOUND$ inhibits vasa vasorum neovascularization in aortas of @PROTEIN$ (-/-)/LDL(-/-) double knockout mice.	0
318	Treatment of ECs with anthocyanins cyanidin-3-O-beta-glucoside (Cy-3-g) and @COMPOUND$ (Pn-3-g) prevents @PROTEIN$-induced endothelial activation by inhibiting production of proinflammatory cytokines and matrix metalloproteinases (MMPs).	1
319	In addition, @COMPOUND$ deficiency down-regulated @PROTEIN$ 6 mRNA expression while up-regulating toll-like receptors 2 and 5 mRNA expressions.	1
320	Effects of inhibition of @PROTEIN$, iNOS, and nNOS by N-nitro-L-arginine methyl ester (L-NAME), aminoguanidine, and @COMPOUND$, respectively, were determined on the antigen-induced systemic hypotension and portal hypertension in conscious Sprague-Dawley rats sensitized with the ovalbumin antigen.	0
321	Effects of inhibition of NOS, @PROTEIN$, and nNOS by N-nitro-L-arginine methyl ester (L-NAME), @COMPOUND$, and 7-nitroindazole, respectively, were determined on the antigen-induced systemic hypotension and portal hypertension in conscious Sprague-Dawley rats sensitized with the ovalbumin antigen.	0
322	Effects of inhibition of @PROTEIN$, iNOS, and nNOS by N-nitro-@COMPOUND$ (L-NAME), aminoguanidine, and 7-nitroindazole, respectively, were determined on the antigen-induced systemic hypotension and portal hypertension in conscious Sprague-Dawley rats sensitized with the ovalbumin antigen.	0
323	Effects of inhibition of NOS, iNOS, and @PROTEIN$ by N-nitro-@COMPOUND$ (L-NAME), aminoguanidine, and 7-nitroindazole, respectively, were determined on the antigen-induced systemic hypotension and portal hypertension in conscious Sprague-Dawley rats sensitized with the ovalbumin antigen.	0
324	Effects of inhibition of NOS, iNOS, and @PROTEIN$ by N-nitro-L-arginine methyl ester (L-NAME), @COMPOUND$, and 7-nitroindazole, respectively, were determined on the antigen-induced systemic hypotension and portal hypertension in conscious Sprague-Dawley rats sensitized with the ovalbumin antigen.	0
325	Effects of inhibition of @PROTEIN$, iNOS, and nNOS by N-nitro-L-arginine methyl ester (L-NAME), @COMPOUND$, and 7-nitroindazole, respectively, were determined on the antigen-induced systemic hypotension and portal hypertension in conscious Sprague-Dawley rats sensitized with the ovalbumin antigen.	0
326	Effects of inhibition of NOS, @PROTEIN$, and nNOS by N-nitro-@COMPOUND$ (L-NAME), aminoguanidine, and 7-nitroindazole, respectively, were determined on the antigen-induced systemic hypotension and portal hypertension in conscious Sprague-Dawley rats sensitized with the ovalbumin antigen.	0
327	Effects of inhibition of NOS, iNOS, and @PROTEIN$ by N-nitro-L-arginine methyl ester (L-NAME), aminoguanidine, and @COMPOUND$, respectively, were determined on the antigen-induced systemic hypotension and portal hypertension in conscious Sprague-Dawley rats sensitized with the ovalbumin antigen.	0
328	Effects of inhibition of NOS, @PROTEIN$, and nNOS by N-nitro-L-arginine methyl ester (L-NAME), aminoguanidine, and @COMPOUND$, respectively, were determined on the antigen-induced systemic hypotension and portal hypertension in conscious Sprague-Dawley rats sensitized with the ovalbumin antigen.	0
329	The IL-1 receptor-associated kinase 1 (IRAK-1) and @PROTEIN$ are key signaling molecules in cellular responses to @COMPOUND$ initiated through the Toll-like receptors (TLRs).	1
330	The IL-1 receptor-associated kinase 1 (IRAK-1) and IRAK-M are key signaling molecules in cellular responses to @COMPOUND$ initiated through the Toll-like receptors (@PROTEIN$).	1
331	The IL-1 receptor-associated kinase 1 (@PROTEIN$) and IRAK-M are key signaling molecules in cellular responses to @COMPOUND$ initiated through the Toll-like receptors (TLRs).	1
332	@COMPOUND$ treatment before HS (MAP of 30 mmHg for 60 min) significantly ameliorated HS-induced mucosal inflammation and apoptotic cell death in the ileum, as judged by significant decreases in gene expression of TNF-alpha, iNOS, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1, myeloperoxidase activity, the number of infiltrated neutrophils, DNA fragmentation by in situ oligo ligation assay, and activated caspase-3 expression, and by increases in gene expression of @PROTEIN$ and Bcl-2.	1
333	@COMPOUND$ treatment before HS (MAP of 30 mmHg for 60 min) significantly ameliorated HS-induced mucosal inflammation and apoptotic cell death in the ileum, as judged by significant decreases in gene expression of @PROTEIN$, iNOS, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1, myeloperoxidase activity, the number of infiltrated neutrophils, DNA fragmentation by in situ oligo ligation assay, and activated caspase-3 expression, and by increases in gene expression of IL-10 and Bcl-2.	1
334	Glutamine treatment before @COMPOUND$ (MAP of 30 mmHg for 60 min) significantly ameliorated HS-induced mucosal inflammation and apoptotic cell death in the ileum, as judged by significant decreases in gene expression of TNF-alpha, iNOS, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1, myeloperoxidase activity, the number of infiltrated neutrophils, DNA fragmentation by in situ oligo ligation assay, and activated caspase-3 expression, and by increases in gene expression of @PROTEIN$ and Bcl-2.	0
335	@COMPOUND$ treatment before HS (MAP of 30 mmHg for 60 min) significantly ameliorated HS-induced mucosal inflammation and apoptotic cell death in the ileum, as judged by significant decreases in gene expression of TNF-alpha, @PROTEIN$, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1, myeloperoxidase activity, the number of infiltrated neutrophils, DNA fragmentation by in situ oligo ligation assay, and activated caspase-3 expression, and by increases in gene expression of IL-10 and Bcl-2.	1
336	Glutamine treatment before @COMPOUND$ (MAP of 30 mmHg for 60 min) significantly ameliorated HS-induced mucosal inflammation and apoptotic cell death in the ileum, as judged by significant decreases in gene expression of TNF-alpha, @PROTEIN$, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1, myeloperoxidase activity, the number of infiltrated neutrophils, DNA fragmentation by in situ oligo ligation assay, and activated caspase-3 expression, and by increases in gene expression of IL-10 and Bcl-2.	0
337	@COMPOUND$ treatment before HS (MAP of 30 mmHg for 60 min) significantly ameliorated HS-induced mucosal inflammation and apoptotic cell death in the ileum, as judged by significant decreases in gene expression of TNF-alpha, iNOS, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1, myeloperoxidase activity, the number of infiltrated neutrophils, DNA fragmentation by in situ oligo ligation assay, and activated caspase-3 expression, and by increases in gene expression of IL-10 and @PROTEIN$.	1
338	Glutamine treatment before @COMPOUND$ (MAP of 30 mmHg for 60 min) significantly ameliorated HS-induced mucosal inflammation and apoptotic cell death in the ileum, as judged by significant decreases in gene expression of TNF-alpha, iNOS, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1, myeloperoxidase activity, the number of infiltrated neutrophils, DNA fragmentation by in situ oligo ligation assay, and activated caspase-3 expression, and by increases in gene expression of IL-10 and @PROTEIN$.	0
339	Glutamine treatment before @COMPOUND$ (MAP of 30 mmHg for 60 min) significantly ameliorated HS-induced mucosal inflammation and apoptotic cell death in the ileum, as judged by significant decreases in gene expression of @PROTEIN$, iNOS, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1, myeloperoxidase activity, the number of infiltrated neutrophils, DNA fragmentation by in situ oligo ligation assay, and activated caspase-3 expression, and by increases in gene expression of IL-10 and Bcl-2.	0
340	@COMPOUND$ treatment may thus protect mucosal cells from HS-induced oxidative damage via the anti-inflammatory and antiapoptotic properties of @PROTEIN$.	1
341	Surface plasmon resonance interaction analysis revealed that, compared to a previously reported phenyl-containing triazole conjugate @COMPOUND$ (105), peptide 156 had a higher direct binding affinity for several subtypes of HIV-1 @PROTEIN$ due mainly to the decreased dissociation rate of the conjugate-gp120 complex.	1
342	Surface plasmon resonance interaction analysis revealed that, compared to a previously reported phenyl-containing @COMPOUND$ conjugate HNG-105 (105), peptide 156 had a higher direct binding affinity for several subtypes of HIV-1 @PROTEIN$ due mainly to the decreased dissociation rate of the conjugate-gp120 complex.	1
343	Circulating leptin was negatively correlated with mRNA expression of adiponectin, LEPR and @PROTEIN$, whereas @COMPOUND$ was positively correlated with levels of PPARGC1A.	0
344	Circulating @PROTEIN$ was negatively correlated with mRNA expression of adiponectin, LEPR and LPL, whereas @COMPOUND$ was positively correlated with levels of PPARGC1A.	0
345	Circulating leptin was negatively correlated with mRNA expression of adiponectin, LEPR and LPL, whereas @COMPOUND$ was positively correlated with levels of @PROTEIN$.	1
346	Circulating leptin was negatively correlated with mRNA expression of adiponectin, @PROTEIN$ and LPL, whereas @COMPOUND$ was positively correlated with levels of PPARGC1A.	0
347	Changes in @PROTEIN$ stimulation are very close to the phosphorylation level of the E(1alpha) subunit of PDC, which regulates the activity of the complex, but it is also the target of @COMPOUND$.	1
348	@PROTEIN$, an inducible enzyme important in inflammation, catalyzes the production of prostanoids from @COMPOUND$.	1
349	cDNA probes have been developed for subsequent use in monitoring the @COMPOUND$ exposure of the clam Ruditapes decussatus and the cockle Cerastoderma glaucum using @PROTEIN$ (MT) gene expression in different tissues of these species.	0
350	@COMPOUND$ stabilizes the @PROTEIN$ activity during decolorization of dyes.	1
351	Under optimum conditions, 95% of beef tallow, in 2.5 h, was converted into @COMPOUND$ by using commercial @PROTEIN$ SDL 451.	1
352	However, the simultaneous presence of the @PROTEIN$ *1B and CYP3A5 *1A alleles was associated with a 64% increase in @COMPOUND$ clearance (P = 0.0015), independent of both sex and CYP3A activity (as determined using the erythromycin breath test).	1
353	However, the simultaneous presence of the CYP3A4 *1B and @PROTEIN$ *1A alleles was associated with a 64% increase in @COMPOUND$ clearance (P = 0.0015), independent of both sex and CYP3A activity (as determined using the erythromycin breath test).	1
354	It was found that @COMPOUND$ administration produced lower levels of @PROTEIN$ and alkaline aminotransferase than that of the untreated group.	1
355	Moreover, the concentrations of hepatic hydroxyproline, serum hyaluronic acid, interleukin-2, @PROTEIN$, tumor necrosis factor-alpha and @COMPOUND$ were all decreased in the taurine treated groups.	0
356	Moreover, the concentrations of hepatic hydroxyproline, serum @COMPOUND$, interleukin-2, @PROTEIN$, tumor necrosis factor-alpha and laminin were all decreased in the taurine treated groups.	0
357	Moreover, the concentrations of hepatic hydroxyproline, serum hyaluronic acid, interleukin-2, interleukin-6, @PROTEIN$-alpha and laminin were all decreased in the @COMPOUND$ treated groups.	1
358	Moreover, the concentrations of hepatic @COMPOUND$, serum hyaluronic acid, interleukin-2, @PROTEIN$, tumor necrosis factor-alpha and laminin were all decreased in the taurine treated groups.	0
359	Moreover, the concentrations of hepatic hydroxyproline, serum hyaluronic acid, interleukin-2, @PROTEIN$, tumor necrosis factor-alpha and laminin were all decreased in the @COMPOUND$ treated groups.	1
360	Moreover, the concentrations of hepatic hydroxyproline, serum hyaluronic acid, interleukin-2, interleukin-6, @PROTEIN$-alpha and @COMPOUND$ were all decreased in the taurine treated groups.	0
361	Moreover, the concentrations of hepatic @COMPOUND$, serum hyaluronic acid, interleukin-2, interleukin-6, @PROTEIN$-alpha and laminin were all decreased in the taurine treated groups.	0
362	Moreover, the concentrations of hepatic hydroxyproline, serum @COMPOUND$, interleukin-2, interleukin-6, @PROTEIN$-alpha and laminin were all decreased in the taurine treated groups.	0
363	Changes in @PROTEIN$ serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or @COMPOUND$.	1
364	Changes in @PROTEIN$ serum levels in patients with major depression disorder (MDD) after 6 months treatment with @COMPOUND$, escitalopram, or venlafaxine.	1
365	Changes in @PROTEIN$ serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, @COMPOUND$, or venlafaxine.	1
366	We assessed serum @PROTEIN$ levels in 21 patients with major depressive episode treated with sertraline, escitalopram, or @COMPOUND$ and 20 healthy controls.	1
367	We assessed serum @PROTEIN$ levels in 21 patients with major depressive episode treated with @COMPOUND$, escitalopram, or venlafaxine and 20 healthy controls.	1
368	We assessed serum @PROTEIN$ levels in 21 patients with major depressive episode treated with sertraline, @COMPOUND$, or venlafaxine and 20 healthy controls.	1
369	@COMPOUND$ increased @PROTEIN$ levels only after 6 months.	1
370	The increase of @COMPOUND$ was accompanied by a marked posttranslational down-regulation of liver @PROTEIN$ expression.	0
371	Taken together, a diet-induced increase of plasma and hepatic @COMPOUND$ levels leads to a posttranscriptional down-regulation of SR-BI in mouse liver via a mechanism likely involving @PROTEIN$.	0
372	Taken together, a diet-induced increase of plasma and hepatic @COMPOUND$ levels leads to a posttranscriptional down-regulation of @PROTEIN$ in mouse liver via a mechanism likely involving PDZK1.	1
373	A 5.5 kilobase-pair (kbp) @PROTEIN$-Kpn1 fragment containing gene(s) encoding for @COMPOUND$ degradation was cloned.	1
374	@COMPOUND$ also enhanced @PROTEIN$ release from VSMC.	1
375	These data suggest that @COMPOUND$ upregulates @PROTEIN$ via mechanisms distinct from TNF-alpha and contributes to the intra- and extracellular IL-6 deposits within the vasculature.	1
376	These data suggest that @COMPOUND$ upregulates IL-6 via mechanisms distinct from @PROTEIN$ and contributes to the intra- and extracellular IL-6 deposits within the vasculature.	0
377	@COMPOUND$ upregulates @PROTEIN$ via mechanisms that are distinct from those of tumor necrosis factor-alpha, in vascular smooth muscle cells.	1
378	@COMPOUND$ upregulates interleukin-6 via mechanisms that are distinct from those of @PROTEIN$-alpha, in vascular smooth muscle cells.	0
379	Among the 7 IL examined, only @PROTEIN$ transcript was increased by @COMPOUND$ treatment in human aorta smooth muscle cells.	1
380	Mechanisms of @PROTEIN$ induction by @COMPOUND$ were investigated in comparison with tumor necrosis factor (TNF)-alpha.	1
381	Mechanisms of IL-6 induction by @COMPOUND$ were investigated in comparison with tumor necrosis factor (@PROTEIN$)-alpha.	0
382	Mechanisms of IL-6 induction by @COMPOUND$ were investigated in comparison with @PROTEIN$ (TNF)-alpha.	0
383	Clinically, it has been approved that DNA methylation inhibitors, such as @COMPOUND$ (5-Aza-dC), can reverse @PROTEIN$ promoter methylation, but widespread clinical use of these inhibitors is limited by their toxicity and instability in aqueous solution.	1
384	Clinically, it has been approved that DNA methylation inhibitors, such as 5-aza-2'-deoxycytidine (@COMPOUND$), can reverse @PROTEIN$ promoter methylation, but widespread clinical use of these inhibitors is limited by their toxicity and instability in aqueous solution.	1
385	Here we demonstrate that an AR ligand, @COMPOUND$ (DHT), inhibits MCF-7 breast cancer cell growth induced by insulin like growth factor 1 (@PROTEIN$).	1
386	Here we demonstrate that an AR ligand, 5-alpha-dihydrotestosterone (@COMPOUND$), inhibits MCF-7 breast cancer cell growth induced by insulin like growth factor 1 (@PROTEIN$).	1
387	Here, we constructed variants to test whether any of these motifs may explain why @PROTEIN$-DeltaN does not respond to stimulation with either ADP ribose or @COMPOUND$.	0
388	Mechanistically, inhibition of @PROTEIN$ and p38 activity was associated with activation of various caspases and PARP cleavage, and it also stabilized the pro-apoptotic proteins Bax and Bim, thereby preventing them from degradation during @COMPOUND$ treatment.	0
389	Mechanistically, inhibition of ERK and p38 activity was associated with activation of various caspases and PARP cleavage, and it also stabilized the pro-apoptotic @PROTEIN$ and Bim, thereby preventing them from degradation during @COMPOUND$ treatment.	0
390	Mechanistically, inhibition of ERK and p38 activity was associated with activation of various caspases and @PROTEIN$ cleavage, and it also stabilized the pro-apoptotic proteins Bax and Bim, thereby preventing them from degradation during @COMPOUND$ treatment.	0
391	Mechanistically, inhibition of ERK and p38 activity was associated with activation of various caspases and PARP cleavage, and it also stabilized the pro-apoptotic proteins Bax and @PROTEIN$, thereby preventing them from degradation during @COMPOUND$ treatment.	0
392	Mechanistically, inhibition of ERK and @PROTEIN$ activity was associated with activation of various caspases and PARP cleavage, and it also stabilized the pro-apoptotic proteins Bax and Bim, thereby preventing them from degradation during @COMPOUND$ treatment.	0
393	@COMPOUND$ caused a 60% reduction in testicular interstitial fluid (IF) prostaglandin E(2) (PGE (2)) concentrations, accompanied by a compensatory increase in @PROTEIN$ mRNA expression.	1
394	@COMPOUND$ caused a 60% reduction in testicular interstitial fluid (IF) prostaglandin E(2) (@PROTEIN$ (2)) concentrations, accompanied by a compensatory increase in COX-2 mRNA expression.	1
395	However, @COMPOUND$ had no effect on @PROTEIN$ protein levels or LPS-induced expression of the inflammatory mediators interleukin-1beta, tumour necrosis factor-alpha or inducible nitric-oxide synthase.	0
396	However, @COMPOUND$ had no effect on COX-2 protein levels or LPS-induced expression of the inflammatory mediators interleukin-1beta, tumour necrosis factor-alpha or inducible @PROTEIN$.	0
397	Collectively, @PROTEIN$ supplementation increased concentrations of @COMPOUND$ in intestinal lumen, expression of proglucagon, GLP-2R, and eNOS genes, and net portal absorption of AA.	1
398	Collectively, HMB supplementation increased concentrations of @COMPOUND$ in intestinal lumen, expression of proglucagon, @PROTEIN$, and eNOS genes, and net portal absorption of AA.	0
399	Collectively, HMB supplementation increased concentrations of @COMPOUND$ in intestinal lumen, expression of proglucagon, GLP-2R, and @PROTEIN$ genes, and net portal absorption of AA.	0
400	No significant differences were observed in plasma concentrations of @COMPOUND$, @PROTEIN$, and insulin-like growth factor or hepatic triglyceride content, but all supplements tended to decrease beta hydroxybutyrate postpartum compared to CTL cows.	0
401	No significant differences were observed in plasma concentrations of glucose, @PROTEIN$, and insulin-like growth factor or hepatic triglyceride content, but all supplements tended to decrease @COMPOUND$ postpartum compared to CTL cows.	0
402	The results showed that @COMPOUND$ augmented splenic-specific IgG1 and IL-4 as well as cell proliferation but suppressed specific IgG2a and @PROTEIN$ levels.	1
403	The results showed that @COMPOUND$ augmented splenic-specific IgG1 and @PROTEIN$ as well as cell proliferation but suppressed specific IgG2a and IFN-gamma levels.	1
404	@COMPOUND$ (Pfizer, Inc.) is a multitargeted kinase inhibitor that inhibits vascular endothelial growth factor (VEGF) receptor (R)-1, 2 and 3, platelet-derived growth factor receptors (PDGFR)-alpha and beta, Flt3, @PROTEIN$, and Kit.	1
405	@COMPOUND$ (Pfizer, Inc.) is a multitargeted kinase inhibitor that inhibits vascular endothelial growth factor (VEGF) receptor (R)-1, 2 and 3, platelet-derived growth factor receptors (PDGFR)-alpha and beta, @PROTEIN$, RET, and Kit.	1
406	@COMPOUND$ (Pfizer, Inc.) is a multitargeted kinase inhibitor that inhibits vascular endothelial growth factor (@PROTEIN$) receptor (R)-1, 2 and 3, platelet-derived growth factor receptors (PDGFR)-alpha and beta, Flt3, RET, and Kit.	1
407	@PROTEIN$ deletion blocks extinction of @COMPOUND$ place preference conditioning.	1
408	In 17 adults on a fixed metabolic diet, an 11-day course of @COMPOUND$ increased serum @PROTEIN$ and basal gastric acid output, but not maximal gastric acid output, compared with a placebo.	1
409	Mineralization and dehalogenation of @COMPOUND$ was evidenced by high @PROTEIN$ removal efficiencies (approximately 95%), and by the stoichiometric release of chloride ions from the halogenated compound (approximately 80%).	1
410	Mineralization and dehalogenation of 2,4,6-TCP was evidenced by high @PROTEIN$ removal efficiencies (approximately 95%), and by the stoichiometric release of @COMPOUND$ ions from the halogenated compound (approximately 80%).	0
411	@COMPOUND$ can change the conformation of the active sites and decrease obviously the affinities between gliclazide in the active site and enzymes when it is docked in the second active sites in CYP2C9 and @PROTEIN$.	1
412	Gliclazide can change the conformation of the active sites and decrease obviously the affinities between @COMPOUND$ in the active site and enzymes when it is docked in the second active sites in @PROTEIN$ and CYP2C19.	1
413	@COMPOUND$ can change the conformation of the active sites and decrease obviously the affinities between gliclazide in the active site and enzymes when it is docked in the second active sites in @PROTEIN$ and CYP2C19.	1
414	Gliclazide can change the conformation of the active sites and decrease obviously the affinities between @COMPOUND$ in the active site and enzymes when it is docked in the second active sites in CYP2C9 and @PROTEIN$.	1
415	Metabolism of @COMPOUND$ by @PROTEIN$ in different recombinantly expressed systems and its implications for the in vitro assessment of dextromethorphan metabolism.	1
416	Metabolism of dextrorphan by @PROTEIN$ in different recombinantly expressed systems and its implications for the in vitro assessment of @COMPOUND$ metabolism.	0
417	The sequential metabolism of @COMPOUND$ during in vitro studies, particularly using recombinant systems (rCYPs) expressing human @PROTEIN$, is assumed to be negligible.	0
418	The extent of metabolism was investigated for a range of DEX and @COMPOUND$ concentrations in microsomal preparations from three different rCYPs expressing human @PROTEIN$ (yeast, Supersomes and Bactosomes) containing 10 pmol of the enzyme.	0
419	Two novel @PROTEIN$ related metabolites were identified in Bactosomes, and assigned as single hydroxylations in the phenyl rings of @COMPOUND$ and HYM using ion-trap mass spectrometry.	1
420	Two novel @PROTEIN$ related metabolites were identified in Bactosomes, and assigned as single hydroxylations in the phenyl rings of DOR and @COMPOUND$ using ion-trap mass spectrometry.	1
421	Finally, the active site of @PROTEIN$ harbors an absolutely conserved @COMPOUND$ (Glu172), which is well positioned to act as a general acid-base residue.	1
422	@COMPOUND$ treatment of stroke increases Ang1/@PROTEIN$ expression and thereby reduces BBB leakage and promotes vascular stabilization.	1
423	@COMPOUND$ treatment of stroke increases @PROTEIN$/Tie2 expression and thereby reduces BBB leakage and promotes vascular stabilization.	1
424	Suppressing the activity of @PROTEIN$ in 3T3-L1 adipocytes reduces mitochondrial biogenesis but enhances glycolysis and basal @COMPOUND$ uptake.	1
425	A significant decrease in mean total nitric oxide (NOx), nitrite, and @COMPOUND$ levels was also found after @PROTEIN$ plus dexamethasone administration.	1
426	A significant decrease in mean total nitric oxide (NOx), nitrite, and nitrate levels was also found after @PROTEIN$ plus @COMPOUND$ administration.	0
427	A significant decrease in mean total @COMPOUND$ (NOx), nitrite, and nitrate levels was also found after @PROTEIN$ plus dexamethasone administration.	1
428	@COMPOUND$ impairs @PROTEIN$-dependent gene expression in porcine kidney tubulus cells.	1
429	Therefore, in the present study, the effects of @COMPOUND$ on the nuclear translocation and transactivation of the transcription factor @PROTEIN$ as well as mRNA levels of Nrf2 target genes including glutathione-S-transferase and gamma-glutamylcysteinyl synthetase have been studied in cultured porcine kidney tubulus cells (LLC-PK1).	0
430	Therefore, in the present study, the effects of @COMPOUND$ on the nuclear translocation and transactivation of the transcription factor Nrf2 as well as mRNA levels of Nrf2 target genes including @PROTEIN$ and gamma-glutamylcysteinyl synthetase have been studied in cultured porcine kidney tubulus cells (LLC-PK1).	0
431	@PROTEIN$ was induced by @COMPOUND$, a well-known activator of this transcription factor.	1
432	@COMPOUND$ significantly decreased gamma-glutamylcysteinyl synthetase and @PROTEIN$ mRNA levels in LLC-PK1 cells.	1
433	Furthermore, @COMPOUND$ also lowered @PROTEIN$ mRNA levels.	1
434	This increase in @COMPOUND$ and plant sterols and stanols was associated with a marked decrease in hepatic and intestinal Abcg5 (ATP-binding cassette transporter G5) and @PROTEIN$ (ATP-binding cassette transporter G8) expressions in diabetic rats, as well as decreased mRNA levels of several other genes involved in sterol regulation.	1
435	This increase in @COMPOUND$ and plant sterols and stanols was associated with a marked decrease in hepatic and intestinal @PROTEIN$ (ATP-binding cassette transporter G5) and Abcg8 (ATP-binding cassette transporter G8) expressions in diabetic rats, as well as decreased mRNA levels of several other genes involved in sterol regulation.	1
436	@COMPOUND$ (SU) treatment restores insulin secretion in patients with @PROTEIN$ mutations.	0
437	@COMPOUND$ (SU) treatment restores @PROTEIN$ secretion in patients with KCNJ11 mutations.	1
438	@PROTEIN$-alpha inhibition protects against @COMPOUND$-induced endothelial glycocalyx perturbation.	1
439	The amino acid sequence deduced from the coding sequence encodes for @PROTEIN$ of 73 amino acids containing 21 @COMPOUND$ residues.	1
440	@PROTEIN$-dependent facilitation in MF synapses of WT mice was attenuated by blocking F-actin polymerization with @COMPOUND$ in hippocampal slices.	1
441	Synapsin-dependent facilitation in MF synapses of WT mice was attenuated by blocking F-@PROTEIN$ polymerization with @COMPOUND$ in hippocampal slices.	1
442	To test the hypothesis that @COMPOUND$S production from DHEA occurs in hepatic cells and that this production is augmented by the presence of sex steroids or @PROTEIN$.	0
443	To test the hypothesis that @COMPOUND$ production from DHEA occurs in hepatic cells and that this production is augmented by the presence of sex steroids or @PROTEIN$.	0
444	The differences in tissue distribution and protein levels of @PROTEIN$-B1 during the programmed cell death indicate that the receptor plays a major role in the modulation and function of @COMPOUND$ activity in Bombyx anterior silk glands.	1
445	Methylthioadenosine phosphorylase (@PROTEIN$) is involved in the metabolism of purines and converts methylthioadenosine (MTA) to @COMPOUND$.	1
446	Methylation-specific primers were used to analyze methylation of the @PROTEIN$ promoter, using DNA treated with @COMPOUND$.	0
447	Long-chain @COMPOUND$ also reduced @PROTEIN$-alpha and prostaglandin E(2) production, although the potency of inhibition for the latter was lower.	1
448	Both activity and expression of @PROTEIN$ and APS reductase in plants are modulated by the @COMPOUND$ status of the plant.	1
449	DNA array studies have revealed that @PROTEIN$ is strongly up-regulated by nitroso-glutathione (@COMPOUND$) and also displays a 12-fold increase in expression during biofilm growth of E. coli 83972 and VR50 in human urine.	1
450	E. coli thioredoxin reductase and @COMPOUND$ produced ROS and caused oxidation and oligomerization of reduced @PROTEIN$.	1
451	E. coli @PROTEIN$ and @COMPOUND$ produced ROS and caused oxidation and oligomerization of reduced YhaK.	0
452	Patients under clozapine-@COMPOUND$ therapy developed a rise of serum @PROTEIN$ levels.	1
453	Patients under @COMPOUND$-risperidone therapy developed a rise of serum @PROTEIN$ levels.	1
454	In experiment 3, administration of E(2) or @COMPOUND$ to ovariectomised wildtype, but not betaERKO, mice decreased immobility compared with vehicle administration, these data suggest that @PROTEIN$ may be required for some of the anti-depressant-like effects of E(2).	0
455	In cultured EPC, @COMPOUND$ increased the concentrations of @PROTEIN$, AKT and eNOS.	1
456	In cultured EPC, @COMPOUND$ increased the concentrations of VEGF, AKT and @PROTEIN$.	1
457	Western blots analysis showed that simvastatin increased the phosphorylation of @PROTEIN$ and FKHRL1, which can be blocked by the PI3K/AKT pathway blocker @COMPOUND$.	1
458	Western blots analysis showed that simvastatin increased the phosphorylation of eNOS and @PROTEIN$, which can be blocked by the PI3K/AKT pathway blocker @COMPOUND$.	1
459	Western blots analysis showed that @COMPOUND$ increased the phosphorylation of @PROTEIN$ and FKHRL1, which can be blocked by the PI3K/AKT pathway blocker LY294002.	1
460	Western blots analysis showed that @COMPOUND$ increased the phosphorylation of eNOS and @PROTEIN$, which can be blocked by the PI3K/AKT pathway blocker LY294002.	1
461	In in vitro study, @COMPOUND$ increases the phosphorylation of eNOS and of FKHRL1 through the @PROTEIN$/AKT signaling pathway.	1
462	In in vitro study, @COMPOUND$ increases the phosphorylation of @PROTEIN$ and of FKHRL1 through the PI3K/AKT signaling pathway.	1
463	In in vitro study, @COMPOUND$ increases the phosphorylation of eNOS and of @PROTEIN$ through the PI3K/AKT signaling pathway.	1
464	The equality of K (D) of @COMPOUND$ binding to blood platelet membranes and to membranes from nerve endings appears to encourage the use of such membranes as a model for brain @PROTEIN$.	0
465	@COMPOUND$ (NO), which is produced by nitric oxide synthase (@PROTEIN$), may play a role in the development of ASD.	1
466	@COMPOUND$ (NO), which is produced by @PROTEIN$ (NOS), may play a role in the development of ASD.	1
467	Long intercalated defects in canine ribs can be repaired successfully using porous @COMPOUND$ (beta-TCP) cylinders, infused with a biodegradable polymer (poly D,L-lactic acid-polyethylene block copolymer) containing recombinant human bone @PROTEIN$-2 (rhBMP-2).	0
468	Thus, we examined whether @COMPOUND$ might suppress @PROTEIN$ expression and consequently inhibit the process of hepatic fibrosis in vivo.	0
469	We also explored the effect of @PROTEIN$ released by @COMPOUND$ because this neuropeptide is known to affect the microvasculature environment.	0
470	We also explored the effect of substance P released by @COMPOUND$ because this @PROTEIN$ is known to affect the microvasculature environment.	0
471	Melatonin pretreatment prevented every alteration induced by @COMPOUND$, except the diminution of @PROTEIN$ plasmatic activity.	1
472	@COMPOUND$ pretreatment prevented every alteration induced by diazinon, except the diminution of @PROTEIN$ plasmatic activity.	0
473	@COMPOUND$ vector injection also reduced spontaneous pain-related behaviors in the delayed phase of the formalin test and in both CFA and formalin models suppressed spinal c-@PROTEIN$ expression.	1
474	@COMPOUND$ vector injection also reduced spontaneous pain-related behaviors in the delayed phase of the formalin test and in both @PROTEIN$ and formalin models suppressed spinal c-fos expression.	0
475	@COMPOUND$ decreases expression of osmoprotective genes via direct inhibition of @PROTEIN$ transcriptional activity.	1
476	Because @COMPOUND$ (NO) is abundantly produced in the renal medulla, the present studies addressed the effect of NO on expression of osmoprotective genes and @PROTEIN$ activation in MDCK cells.	0
477	In summary, ischaemia and @PROTEIN$ independently stimulate skeletal muscle @COMPOUND$ uptake in vivo in humans, whereas ischaemia and contraction do not.	1
478	@COMPOUND$ perfusion marginally increased @PROTEIN$ levels to 7.3 fg/microg/ml on average in the upper arm and control axilla.	1
479	@COMPOUND$ phosphorylated @PROTEIN$/42 MAP kinase.	1
480	These observations suggest that @COMPOUND$ phosphorylates @PROTEIN$/42 MAP kinase and then activates the transcription of PON1 gene and increases the PON1 protein expression in Huh7 cells.	1
481	These observations suggest that @COMPOUND$ phosphorylates p44/42 MAP kinase and then activates the transcription of @PROTEIN$ gene and increases the PON1 protein expression in Huh7 cells.	1
482	Furthermore, we speculate that @COMPOUND$ affects both the phosphorylation of SREBP-2 and the Sp1 binding to PON1 DNA through the activation of @PROTEIN$/42 MAP kinase signaling cascade.	1
483	Furthermore, we speculate that @COMPOUND$ affects both the phosphorylation of @PROTEIN$ and the Sp1 binding to PON1 DNA through the activation of p44/42 MAP kinase signaling cascade.	0
484	Furthermore, we speculate that @COMPOUND$ affects both the phosphorylation of SREBP-2 and the @PROTEIN$ binding to PON1 DNA through the activation of p44/42 MAP kinase signaling cascade.	1
485	Furthermore, we speculate that @COMPOUND$ affects both the phosphorylation of SREBP-2 and the Sp1 binding to @PROTEIN$ DNA through the activation of p44/42 MAP kinase signaling cascade.	1
486	Genetic variants of @PROTEIN$ (CYP2C9) and vitamin K epoxide reductase (VKORC1) are known to influence @COMPOUND$ dose, but the effect of other genes has not been fully elucidated.	1
487	Genetic variants of cytochrome P450 2C9 (CYP2C9) and vitamin K epoxide reductase (@PROTEIN$) are known to influence @COMPOUND$ dose, but the effect of other genes has not been fully elucidated.	1
488	Genetic variants of cytochrome P450 2C9 (@PROTEIN$) and vitamin K epoxide reductase (VKORC1) are known to influence @COMPOUND$ dose, but the effect of other genes has not been fully elucidated.	1
489	BMI and testosterone levels were evaluated for their ability to predict overall survival (OS) and prostate-specific antigen (@PROTEIN$) declines in the TAX327 clinical trial, an international phase III randomized trial of one of the two schedules of @COMPOUND$ and prednisone compared with mitoxantrone and prednisone.	0
490	BMI and @COMPOUND$ levels were evaluated for their ability to predict overall survival (OS) and prostate-specific antigen (@PROTEIN$) declines in the TAX327 clinical trial, an international phase III randomized trial of one of the two schedules of docetaxel and prednisone compared with mitoxantrone and prednisone.	0
491	BMI and testosterone levels were evaluated for their ability to predict overall survival (OS) and prostate-specific antigen (@PROTEIN$) declines in the TAX327 clinical trial, an international phase III randomized trial of one of the two schedules of docetaxel and prednisone compared with @COMPOUND$ and prednisone.	0
492	BMI and testosterone levels were evaluated for their ability to predict overall survival (OS) and prostate-specific antigen (@PROTEIN$) declines in the TAX327 clinical trial, an international phase III randomized trial of one of the two schedules of docetaxel and @COMPOUND$ compared with mitoxantrone and prednisone.	0
493	Effects of @COMPOUND$ and fentanyl on spontaneous and endotoxin (lipopolysaccharide ; 100 ng ml(-1))-stimulated cytokine release were studied in whole blood from volunteers (n = 10) cultured for 6 h. Results IL-6, TNF-alpha and @PROTEIN$ 0.01).	0
494	Effects of @COMPOUND$ and fentanyl on spontaneous and endotoxin (lipopolysaccharide ; 100 ng ml(-1))-stimulated cytokine release were studied in whole blood from volunteers (n = 10) cultured for 6 h. Results IL-6, @PROTEIN$ and IL-10 0.01).	0
495	Effects of remifentanyl and fentanyl on spontaneous and @COMPOUND$ ; 100 ng ml(-1))-stimulated cytokine release were studied in whole blood from volunteers (n = 10) cultured for 6 h. Results IL-6, @PROTEIN$ and IL-10 0.01).	0
496	Effects of remifentanyl and fentanyl on spontaneous and @COMPOUND$ ; 100 ng ml(-1))-stimulated cytokine release were studied in whole blood from volunteers (n = 10) cultured for 6 h. Results @PROTEIN$, TNF-alpha and IL-10 0.01).	0
497	Effects of remifentanyl and fentanyl on spontaneous and @COMPOUND$ ; 100 ng ml(-1))-stimulated cytokine release were studied in whole blood from volunteers (n = 10) cultured for 6 h. Results IL-6, TNF-alpha and @PROTEIN$ 0.01).	0
498	Effects of @COMPOUND$ and fentanyl on spontaneous and endotoxin (lipopolysaccharide ; 100 ng ml(-1))-stimulated cytokine release were studied in whole blood from volunteers (n = 10) cultured for 6 h. Results @PROTEIN$, TNF-alpha and IL-10 0.01).	0
499	This reduction was associated with the storage of decreased TAG and increased glycogen, which was a result of enhanced @COMPOUND$ phosphorylation of anti-insulin receptor substrate-2 and serine473 phosphporylation of protein kinase B (@PROTEIN$, Akt).	0
500	This reduction was associated with the storage of decreased TAG and increased @COMPOUND$, which was a result of enhanced tyrosine phosphorylation of anti-insulin receptor substrate-2 and serine473 phosphporylation of protein kinase B (PKB, @PROTEIN$).	0
501	This reduction was associated with the storage of decreased TAG and increased @COMPOUND$, which was a result of enhanced tyrosine phosphorylation of anti-insulin receptor substrate-2 and serine473 phosphporylation of @PROTEIN$ (PKB, Akt).	1
502	This reduction was associated with the storage of decreased TAG and increased @COMPOUND$, which was a result of enhanced tyrosine phosphorylation of anti-insulin receptor substrate-2 and serine473 phosphporylation of protein kinase B (@PROTEIN$, Akt).	1
503	This reduction was associated with the storage of decreased TAG and increased glycogen, which was a result of enhanced @COMPOUND$ phosphorylation of anti-insulin receptor substrate-2 and serine473 phosphporylation of protein kinase B (PKB, @PROTEIN$).	0
504	This reduction was associated with the storage of decreased TAG and increased glycogen, which was a result of enhanced @COMPOUND$ phosphorylation of anti-insulin receptor substrate-2 and serine473 phosphporylation of @PROTEIN$ (PKB, Akt).	0
505	Inhibition of these enzymes shows that chagasic autoantibodies up-regulation of @PROTEIN$/iNOS mRNA level is under the control of endogenous iNO/@COMPOUND$ signaling system.	1
506	Inhibition of these enzymes shows that chagasic autoantibodies up-regulation of COX-2/@PROTEIN$ mRNA level is under the control of endogenous iNO/@COMPOUND$ signaling system.	1
507	@PROTEIN$ are multi-@COMPOUND$-containing proteins that catalyze the oxidation of phenolic substrates with concomitant reduction of molecular oxygen to water.	1
508	@PROTEIN$ are multi-copper-containing proteins that catalyze the oxidation of phenolic substrates with concomitant reduction of molecular @COMPOUND$ to water.	1
509	The co-expression of @PROTEIN$ with M6B results in a significant decrease in SERT-mediated @COMPOUND$ uptake caused by a down-regulation of SERT surface expression.	1
510	The co-expression of SERT with @PROTEIN$ results in a significant decrease in SERT-mediated @COMPOUND$ uptake caused by a down-regulation of SERT surface expression.	1
511	@PROTEIN$ catalyze a calcium-dependent transamidation reaction that produces covalent cross-linking of available substrate @COMPOUND$ residues and modifies the extracellular matrix.	1
512	We fed rats @COMPOUND$ or valine deficient diet for 4 weeks and examined the mRNA expressions of serine synthesising (3-phosphoglycerate dehydrogenase, @PROTEIN$) and serine/threonine degrading enzymes (serine dehydratase, SDS) in the liver.	0
513	We fed rats lysine or @COMPOUND$ deficient diet for 4 weeks and examined the mRNA expressions of serine synthesising (3-phosphoglycerate dehydrogenase, @PROTEIN$) and serine/threonine degrading enzymes (serine dehydratase, SDS) in the liver.	0
514	We fed rats lysine or @COMPOUND$ deficient diet for 4 weeks and examined the mRNA expressions of serine synthesising (3-phosphoglycerate dehydrogenase, PHGDH) and serine/threonine degrading enzymes (serine dehydratase, @PROTEIN$) in the liver.	0
515	We fed rats @COMPOUND$ or valine deficient diet for 4 weeks and examined the mRNA expressions of serine synthesising (3-phosphoglycerate dehydrogenase, PHGDH) and serine/threonine degrading enzymes (serine dehydratase, @PROTEIN$) in the liver.	0
516	Site-directed mutation test and @COMPOUND$ treatment demonstrated that the ZNF230 promoter contained a functional @PROTEIN$ site.	1
517	Site-directed mutation test and @COMPOUND$ treatment demonstrated that the @PROTEIN$ promoter contained a functional Sp1 site.	1
518	@COMPOUND$ effects on neuronal ultrastructure and expression of @PROTEIN$ (MAP2) in rats with acute spinal cord injury.	1
519	@COMPOUND$ effects on neuronal ultrastructure and expression of microtubule-associated protein 2 (@PROTEIN$) in rats with acute spinal cord injury.	1
520	(4) Our data indicated that @COMPOUND$ maintained in part neuronal ultrastructure, attenuated chromatolysis, and preclude the loss of @PROTEIN$, suggesting a protective effect during the early phases of spinal cord injury.	1
521	For this purpose, on day 0, male Wistar rats received NTG (120 microg/kg, iv) with or without pre-administration of PKC inhibitor @COMPOUND$ (CHE), capsaicin (CAP) to deplete @PROTEIN$ from sensory nerves or mK(ATP) channel blocker 5-hydroxydecaonic acid (5HD).	0
522	For this purpose, on day 0, male Wistar rats received NTG (120 microg/kg, iv) with or without pre-administration of PKC inhibitor chelerythrine (CHE), capsaicin (CAP) to deplete @PROTEIN$ from sensory nerves or mK(ATP) channel blocker 5-hydroxydecaonic acid (@COMPOUND$).	0
523	For this purpose, on day 0, male Wistar rats received NTG (120 microg/kg, iv) with or without pre-administration of PKC inhibitor chelerythrine (CHE), @COMPOUND$ (CAP) to deplete @PROTEIN$ from sensory nerves or mK(ATP) channel blocker 5-hydroxydecaonic acid (5HD).	1
524	The anti-convulsant @COMPOUND$ acts directly on the @PROTEIN$ as a positive allosteric modulator.	1
525	With the exception of specific genetic defects in purine metabolism, increased @COMPOUND$ is generally associated with important risk factors for atherosclerosis like hypertension, abdominal obesity, @PROTEIN$ resistance, the metabolic syndrome and renal failure.	1
526	With the exception of specific genetic defects in @COMPOUND$ metabolism, increased uric acid is generally associated with important risk factors for atherosclerosis like hypertension, abdominal obesity, @PROTEIN$ resistance, the metabolic syndrome and renal failure.	0
527	High @COMPOUND$ and @PROTEIN$ synergistically stimulate MMP-1 expression in U937 macrophages by increasing transcription factor STAT1 activity.	0
528	High @COMPOUND$ and interferon gamma synergistically stimulate MMP-1 expression in U937 macrophages by increasing transcription factor @PROTEIN$ activity.	1
529	High @COMPOUND$ and interferon gamma synergistically stimulate @PROTEIN$ expression in U937 macrophages by increasing transcription factor STAT1 activity.	1
530	To test our hypothesis that hyperglycemia interplays with @PROTEIN$ (IFN gamma), a key factor involved in atherosclerosis, to up-regulate the expression of genes such as matrix metalloproteinases (MMPs) and cytokines that are involved in plaque destabilization, U937 macrophages cultured in medium containing either normal or high @COMPOUND$ were challenged with IFN gamma and the expression of MMPs and cytokines were then quantified by real-time polymerase chain reaction (PCR) and enzyme-linked immunosorbent assay (ELISA).	0
531	To test our hypothesis that hyperglycemia interplays with interferon gamma (@PROTEIN$), a key factor involved in atherosclerosis, to up-regulate the expression of genes such as matrix metalloproteinases (MMPs) and cytokines that are involved in plaque destabilization, U937 macrophages cultured in medium containing either normal or high @COMPOUND$ were challenged with IFN gamma and the expression of MMPs and cytokines were then quantified by real-time polymerase chain reaction (PCR) and enzyme-linked immunosorbent assay (ELISA).	0
532	Results showed that high @COMPOUND$ and IFN gamma had a synergistic effect on the expression of MMP-1, MMP-9 and @PROTEIN$.	1
533	Results showed that high @COMPOUND$ and IFN gamma had a synergistic effect on the expression of @PROTEIN$, MMP-9 and IL-1 beta.	1
534	Results showed that high @COMPOUND$ and @PROTEIN$ had a synergistic effect on the expression of MMP-1, MMP-9 and IL-1 beta.	0
535	Results showed that high @COMPOUND$ and IFN gamma had a synergistic effect on the expression of MMP-1, @PROTEIN$ and IL-1 beta.	1
536	@COMPOUND$, a synthetic triterpenoid, inhibits expression of IL-6 and @PROTEIN$ phosphorylation in multi-drug resistant ovarian cancer cells.	1
537	@COMPOUND$, a synthetic triterpenoid, inhibits expression of @PROTEIN$ and Stat3 phosphorylation in multi-drug resistant ovarian cancer cells.	1
538	To explore potential therapeutic strategies for interrupting signaling through this pathway, we assessed the ability of CDDO-Me, a synthetic triterpenoid, to inhibit IL-6 secretion, @PROTEIN$ phosphorylation, Stat3 nuclear translocation and @COMPOUND$ sensitivity in several cell line model systems.	0
539	To explore potential therapeutic strategies for interrupting signaling through this pathway, we assessed the ability of @COMPOUND$, a synthetic triterpenoid, to inhibit @PROTEIN$ secretion, Stat3 phosphorylation, Stat3 nuclear translocation and paclitaxel sensitivity in several cell line model systems.	0
540	To explore potential therapeutic strategies for interrupting signaling through this pathway, we assessed the ability of CDDO-Me, a synthetic triterpenoid, to inhibit @PROTEIN$ secretion, Stat3 phosphorylation, Stat3 nuclear translocation and @COMPOUND$ sensitivity in several cell line model systems.	0
541	To explore potential therapeutic strategies for interrupting signaling through this pathway, we assessed the ability of @COMPOUND$, a synthetic triterpenoid, to inhibit IL-6 secretion, @PROTEIN$ phosphorylation, Stat3 nuclear translocation and paclitaxel sensitivity in several cell line model systems.	0
542	On a molar basis, @COMPOUND$ yields a signal that is approximately 0.67 times that of @PROTEIN$.	0
543	In patients with hypertension and diabetes, @COMPOUND$, ACEi and diuretic treatment increased @PROTEIN$ activation only during the first week.	1
544	NOPE-@COMPOUND$ treatment improved @PROTEIN$ 0.0001).	1
545	Rebinding experiments with Lys-Gly-Asp, an analogue of Arg-Gly-Asp, and other different peptides, such as @PROTEIN$ C-terminal tri- and pentapeptide and @COMPOUND$, further indicated the selectivity of methacrylic acid-trimethylpropane trimethacrylate copolymer for Arg-Gly-Asp giving specific selectivity factor values 1.27, 1.98, 1.31 and 1.67, respectively.	0
546	Parents (N = 19) of children with autism spectrum disorders (ASD) and adult controls (N = 17) underwent positron emission tomography (PET) using ((18)F) @COMPOUND$ to image cortical serotonin type-2 (@PROTEIN$) receptors.	1
547	These results highlight both the interactions between @PROTEIN$ and NMDA receptors in the determination of schizophreniform behaviours and the potential for the effects of @COMPOUND$ to be mediated by NMDA receptor regulation.	0
548	Expression of @PROTEIN$ reduced the intracellular @COMPOUND$ concentration from 140 to 11 mM and resulted in maximal excretion rates of 11.2 nmol min(-1) mg(-1) as compared to 2.3 nmol min(-1) mg(-1) obtained without rhtC expression.	1
549	Hypergravity also induced a transient reorganization of @PROTEIN$ fibers in 3 min, which was inhibited by Rho-kinase inhibitor (@COMPOUND$) and tyrosine kinase inhibitors (herbimycin A and tyrphostin 46).	1
550	Hypergravity also induced a transient reorganization of @PROTEIN$ fibers in 3 min, which was inhibited by Rho-kinase inhibitor (Y27632) and tyrosine kinase inhibitors (@COMPOUND$ and tyrphostin 46).	1
551	Hypergravity also induced a transient reorganization of @PROTEIN$ fibers in 3 min, which was inhibited by Rho-kinase inhibitor (Y27632) and tyrosine kinase inhibitors (herbimycin A and @COMPOUND$).	1
552	Cell exposure to 250 microM @COMPOUND$ was able to induce @PROTEIN$ 2 up-regulation and increased in situ transglutaminase activity.	1
553	Cell exposure to 250 microM @COMPOUND$ was able to induce @PROTEIN$ up-regulation and increased in situ transglutaminase activity.	1
554	@COMPOUND$ also induced NF-kappaB activation that seemed associated with @PROTEIN$ 2 up-regulation since the specific NF-kappaB inhibition by SN50 was able to reduce transglutaminase expression and activity levels.	1
555	@COMPOUND$ also induced NF-kappaB activation that seemed associated with @PROTEIN$ up-regulation since the specific NF-kappaB inhibition by SN50 was able to reduce transglutaminase expression and activity levels.	1
556	Here, we assessed the regulation of pancreatic @PROTEIN$ release by @COMPOUND$+), mitochondrial membrane potential (Delta Psi m), and reactive oxygen species (ROS), the signals involved in acute pancreatitis.	1
557	Here, we report the efficacy of betaxolol in reducing increases in gene expression of amygdalar corticotropin-releasing factor (@PROTEIN$), a peptide known to be involved in mediating 'anxiety-like' behaviors during initial phases of @COMPOUND$ abstinence.	1
558	Here, we report the efficacy of @COMPOUND$ in reducing increases in gene expression of amygdalar @PROTEIN$ (CRF), a peptide known to be involved in mediating 'anxiety-like' behaviors during initial phases of cocaine abstinence.	1
559	Here, we report the efficacy of @COMPOUND$ in reducing increases in gene expression of amygdalar corticotropin-releasing factor (@PROTEIN$), a peptide known to be involved in mediating 'anxiety-like' behaviors during initial phases of cocaine abstinence.	1
560	Here, we report the efficacy of betaxolol in reducing increases in gene expression of amygdalar @PROTEIN$ (CRF), a peptide known to be involved in mediating 'anxiety-like' behaviors during initial phases of @COMPOUND$ abstinence.	1
561	Results showed that @COMPOUND$ treatment during early cocaine withdrawal attenuated increases in amygdalar CRF gene expression and cyclic adenosine monophosphate-dependent @PROTEIN$ regulatory and catalytic subunit (nuclear fraction) protein expression.	1
562	Results showed that betaxolol treatment during early @COMPOUND$ withdrawal attenuated increases in amygdalar @PROTEIN$ gene expression and cyclic adenosine monophosphate-dependent protein kinase regulatory and catalytic subunit (nuclear fraction) protein expression.	0
563	Results showed that @COMPOUND$ treatment during early cocaine withdrawal attenuated increases in amygdalar @PROTEIN$ gene expression and cyclic adenosine monophosphate-dependent protein kinase regulatory and catalytic subunit (nuclear fraction) protein expression.	1
564	Results showed that betaxolol treatment during early @COMPOUND$ withdrawal attenuated increases in amygdalar CRF gene expression and cyclic adenosine monophosphate-dependent @PROTEIN$ regulatory and catalytic subunit (nuclear fraction) protein expression.	0
565	Furthermore, it is demonstrated that this strain has @PROTEIN$ activity, and the activity can be optimized under suitable growing conditions where wheat bran and @COMPOUND$ are the primary sources of carbon and nitrogen.	0
566	Furthermore, it is demonstrated that this strain has @PROTEIN$ activity, and the activity can be optimized under suitable growing conditions where wheat bran and urea are the primary sources of carbon and @COMPOUND$.	0
567	Glutathione S-transferase (@PROTEIN$) isozymes catalyze nucleophilic attack by reduced Glutathione (@COMPOUND$) on a variety of electrophilic compounds and play a central role in biotransformation of xenobiotics (Hayes et al., Annu Rev Pharmacol Toxicol 45:51-88, 2005).	1
568	@PROTEIN$ (GST) isozymes catalyze nucleophilic attack by @COMPOUND$ (GSH) on a variety of electrophilic compounds and play a central role in biotransformation of xenobiotics (Hayes et al., Annu Rev Pharmacol Toxicol 45:51-88, 2005).	1
569	Glutathione S-transferase (@PROTEIN$) isozymes catalyze nucleophilic attack by @COMPOUND$ (GSH) on a variety of electrophilic compounds and play a central role in biotransformation of xenobiotics (Hayes et al., Annu Rev Pharmacol Toxicol 45:51-88, 2005).	1
570	@PROTEIN$ (GST) isozymes catalyze nucleophilic attack by reduced Glutathione (@COMPOUND$) on a variety of electrophilic compounds and play a central role in biotransformation of xenobiotics (Hayes et al., Annu Rev Pharmacol Toxicol 45:51-88, 2005).	1
571	@COMPOUND$ also activated the @PROTEIN$ (c-Jun) transcription factor.	1
572	cross-linked to @PROTEIN$ receptors and this binding was reduced by co-incubation with @COMPOUND$.	1
573	@PROTEIN$ treatment for 72 h also induced EMT in the A549 cells and this transition led to resistance to @COMPOUND$.	1
574	Glycine release was potentiated by the activation of @PROTEIN$ and diminished by increasing cyclic guanosine monophosphate levels with a phosphodiesterase inhibitor, @COMPOUND$.	0
575	Glycine release was potentiated by the activation of @PROTEIN$ and diminished by increasing @COMPOUND$ levels with a phosphodiesterase inhibitor, zaprinast.	0
576	@COMPOUND$ release was potentiated by the activation of @PROTEIN$ and diminished by increasing cyclic guanosine monophosphate levels with a phosphodiesterase inhibitor, zaprinast.	1
577	The rise in (@COMPOUND$+))(i) elicited by hGH is associated with an enhanced insulin secretion, effects that are mediated mainly through the @PROTEIN$ receptor.	1
578	The rise in (@COMPOUND$+))(i) elicited by hGH is associated with an enhanced @PROTEIN$ secretion, effects that are mediated mainly through the prolactin receptor.	1
579	SEMG I expression is upregulated by @PROTEIN$, IL-6 and @COMPOUND$.	0
580	@PROTEIN$ I expression is upregulated by IL-4, IL-6 and @COMPOUND$.	1
581	SEMG I expression is upregulated by IL-4, @PROTEIN$ and @COMPOUND$.	0
582	@COMPOUND$ down-regulates @PROTEIN$ transcript and protein levels in MCF-7 breast cancer cells.	1
583	Consumption of the trichothecene mycotoxin @COMPOUND$ (DON) induces @PROTEIN$ (IL-6)-dependent IgA nephropathy (IgAN) in mice.	1
584	Consumption of the trichothecene mycotoxin @COMPOUND$ (DON) induces interleukin-6 (@PROTEIN$)-dependent IgA nephropathy (IgAN) in mice.	1
585	The purpose of this study was to identify the signal transduction pathways by which DON up-regulates @PROTEIN$ in the peritoneal macrophage and how consumption of fish oil enriched with the n-3 PUFA @COMPOUND$ (DHA) suppresses these processes.	1
586	The aim of the present study was to determine the effects of niacin and @COMPOUND$ on HDL formation by investigating the changes in @PROTEIN$ and ApoA-1 transcription in the human hepatoblastoma cell line (HepG2 cells).	0
587	The aim of the present study was to determine the effects of @COMPOUND$ and chromium on HDL formation by investigating the changes in @PROTEIN$ and ApoA-1 transcription in the human hepatoblastoma cell line (HepG2 cells).	0
588	Niacin and @COMPOUND$ cotreatment significantly induced the expression of @PROTEIN$ (PPARalpha) mRNA by approximately 1.3-1.8-fold.	1
589	Niacin and @COMPOUND$ cotreatment significantly induced the expression of peroxisome proliferator-activated receptor-alpha (@PROTEIN$) mRNA by approximately 1.3-1.8-fold.	1
590	@COMPOUND$ and chromium cotreatment significantly induced the expression of @PROTEIN$ (PPARalpha) mRNA by approximately 1.3-1.8-fold.	1
591	@COMPOUND$ and chromium cotreatment significantly induced the expression of peroxisome proliferator-activated receptor-alpha (@PROTEIN$) mRNA by approximately 1.3-1.8-fold.	1
592	We hypothesize that the stimulation of @PROTEIN$ gene expression causes an enhanced @COMPOUND$ efflux, perhaps mediated by PPARalpha pathway(s).	1
593	We hypothesize that the stimulation of ABCA1 gene expression causes an enhanced @COMPOUND$ efflux, perhaps mediated by @PROTEIN$ pathway(s).	1
594	@PROTEIN$ involvement in the discriminative stimulus effects in rats of LSD, but not the @COMPOUND$ hallucinogen DOI.	0
595	@PROTEIN$ involvement in the discriminative stimulus effects in rats of @COMPOUND$, but not the phenethylamine hallucinogen DOI.	1
596	@PROTEIN$ involvement in the discriminative stimulus effects in rats of LSD, but not the phenethylamine hallucinogen @COMPOUND$.	0
597	We have investigated the structure-activity relationship between 63 natural @COMPOUND$ derivatives and their effects on the expression of inducible-nitric oxide synthase (@PROTEIN$) induced by lipopolysaccharide.	0
598	We have investigated the structure-activity relationship between 63 natural oxycoumarin derivatives and their effects on the expression of inducible-nitric oxide synthase (@PROTEIN$) induced by @COMPOUND$.	1
599	We have investigated the structure-activity relationship between 63 natural oxycoumarin derivatives and their effects on the expression of inducible-@PROTEIN$ (iNOS) induced by @COMPOUND$.	1
600	We have investigated the structure-activity relationship between 63 natural @COMPOUND$ derivatives and their effects on the expression of inducible-@PROTEIN$ (iNOS) induced by lipopolysaccharide.	0
601	Inhibition of protein synthesis by @COMPOUND$ reduces @PROTEIN$ expression in normoxic and hypoxic pancreatic cancer cells.	1
602	The inhibition of @PROTEIN$ translation was not specific, rather it was part of a general decrease in protein translation caused by @COMPOUND$.	1
603	Under the condition of delayed intervention (30 days after deafening) following @COMPOUND$+ furosemide deafening in rats, we conclude that chronic intracochlear electrical stimulation (ES) and continuous intracochlear administration of @PROTEIN$ (BDNF) enhance spiral ganglion cell (SGC) body and peripheral process survival and improve auditory sensitivity.	0
604	Under the condition of delayed intervention (30 days after deafening) following @COMPOUND$+ furosemide deafening in rats, we conclude that chronic intracochlear electrical stimulation (ES) and continuous intracochlear administration of brain-derived neurotrophic factor (@PROTEIN$) enhance spiral ganglion cell (SGC) body and peripheral process survival and improve auditory sensitivity.	0
605	Under the condition of delayed intervention (30 days after deafening) following gentamicin+ @COMPOUND$ deafening in rats, we conclude that chronic intracochlear electrical stimulation (ES) and continuous intracochlear administration of @PROTEIN$ (BDNF) enhance spiral ganglion cell (SGC) body and peripheral process survival and improve auditory sensitivity.	0
606	Under the condition of delayed intervention (30 days after deafening) following gentamicin+ @COMPOUND$ deafening in rats, we conclude that chronic intracochlear electrical stimulation (ES) and continuous intracochlear administration of brain-derived neurotrophic factor (@PROTEIN$) enhance spiral ganglion cell (SGC) body and peripheral process survival and improve auditory sensitivity.	0
607	The enzyme deoxyuridine 5'-triphosphate nucleotidohydrolase (@PROTEIN$) catalyses the hydrolysis of dUTP to dUMP and PPi thus controlling the incorporation of @COMPOUND$ into DNA genomes.	1
608	The enzyme @PROTEIN$ (dUTPase) catalyses the hydrolysis of dUTP to dUMP and PPi thus controlling the incorporation of @COMPOUND$ into DNA genomes.	1
609	Diastolic function and @PROTEIN$ changes during exercise predict @COMPOUND$ consumption in chronic heart failure patients.	1
610	@PROTEIN$-oncogene inactivating effect by @COMPOUND$ rich polypeptide (PRP-1) in chondrosarcoma JJ012 cells.	1
611	Like PSC, DSL6A cells secrete less @PROTEIN$ when cultured with @COMPOUND$.	1
612	Purinergic receptor agonists @COMPOUND$ and UTP selectively activate certain @PROTEIN$ family tyrosine kinases and stimulate Na,K-ATPase activity.	1
613	Purinergic receptor agonists ATP and @COMPOUND$ selectively activate certain @PROTEIN$ family tyrosine kinases and stimulate Na,K-ATPase activity.	1
614	Cyanidin-3-galactoside, a natural @COMPOUND$, was investigated for its @PROTEIN$ inhibitory activity.	0
615	@COMPOUND$, a natural anthocyanin, was investigated for its @PROTEIN$ inhibitory activity.	0
616	We have previously demonstrated that @COMPOUND$, a stable prostacyclin (PGI (2)) analogue, induces angiogenesis in vivo, through a vascular endothelial growth factor (@PROTEIN$)-dependent mechanism.	1
617	We have previously demonstrated that iloprost, a stable @COMPOUND$ (PGI (2)) analogue, induces angiogenesis in vivo, through a vascular endothelial growth factor (@PROTEIN$)-dependent mechanism.	0
618	The proportion of @PROTEIN$ molecules that are directed to the novel cleavage pathway is regulated by the ratio of free @COMPOUND$ and cholesteryl esters in cells.	1
619	In the hormone receptor-positive breast cancer cell line T47-D expression of @PROTEIN$ and its soluble isoforms was increased by treatment with estradiol and @COMPOUND$.	1
620	In the hormone receptor-positive breast cancer cell line T47-D expression of @PROTEIN$ and its soluble isoforms was increased by treatment with @COMPOUND$ and tamoxifen.	1
621	@PROTEIN$-alpha (TNF-alpha) levels were also investigated in rat serum, but there was no statistically significant difference between the TNF-alpha levels of the @COMPOUND$-treated rats groups and the control rats.	0
622	Tumor necrosis factor-alpha (@PROTEIN$) levels were also investigated in rat serum, but there was no statistically significant difference between the TNF-alpha levels of the @COMPOUND$-treated rats groups and the control rats.	0
623	Comparison of the PTM's of @PROTEIN$'s isolated from several vertebrate species reveals marked differences in their @COMPOUND$ content.	1
624	@COMPOUND$/NaPB administration increased acetylation at H4 and increased NF-kappaB @PROTEIN$ translocation to the nucleus in G93A mice, consistent with a therapeutic effect.	1
625	Riluzole/@COMPOUND$ administration increased acetylation at H4 and increased NF-kappaB @PROTEIN$ translocation to the nucleus in G93A mice, consistent with a therapeutic effect.	1
626	Due to the absence of hydrophobic solute-material interactions, which limit the scope of microstructures fabricated from poly(dimethylsiloxane) for biocatalytic applications, the new microreactor was fully compatible with the alternate enzyme substrate 2-nitro-phenyl-beta-D-galactoside and the @COMPOUND$ product resulting from its hydrolysis catalyzed by @PROTEIN$.	1
627	These findings suggest that multiple variations in the @PROTEIN$ gene are associated with remission in white non-Hispanic depressed adults treated with @COMPOUND$.	1
628	In rats, infusion of angiotensin II increases @PROTEIN$ levels and arterial thickness which are reversed by treatment with the iron chelator @COMPOUND$.	1
629	Pretreatment with extracellular signal-regulated kinase (ERK) and Jun N-terminal kinase (JNK) inhibitors, but not p38 mitogen-activated protein kinase (p38MAPK) significantly decreased @PROTEIN$-induced @COMPOUND$ anion release from macrophages in vivo.	1
630	Pretreatment with extracellular signal-regulated kinase (ERK) and Jun N-terminal kinase (JNK) inhibitors, but not p38 mitogen-activated protein kinase (@PROTEIN$) significantly decreased CRP-induced @COMPOUND$ anion release from macrophages in vivo.	0
631	The free radicals produced are thought to be generated during the production of @COMPOUND$, a reaction catalyzed by @PROTEIN$.	1
632	In the diabetic group, a decrease in the pancreatic @COMPOUND$ levels, glutathione peroxidase and superoxide dismutase activities and an increase in the pancreatic lipid peroxidation level and @PROTEIN$ activities were observed.	0
633	In the diabetic group, a decrease in the pancreatic @COMPOUND$ levels, glutathione peroxidase and @PROTEIN$ activities and an increase in the pancreatic lipid peroxidation level and catalase activities were observed.	0
634	In the diabetic group, a decrease in the pancreatic @COMPOUND$ levels, @PROTEIN$ and superoxide dismutase activities and an increase in the pancreatic lipid peroxidation level and catalase activities were observed.	0
635	The immunomodulatory effects of @COMPOUND$ are at least partially mediated through its ability to down-regulate the pathogenic over-production of tumor necrosis factor-alpha (@PROTEIN$).	1
636	The immunomodulatory effects of @COMPOUND$ are at least partially mediated through its ability to down-regulate the pathogenic over-production of @PROTEIN$-alpha (TNF-alpha).	1
637	Both cell types expressed estrogen and @PROTEIN$, although only the epithelial LM05-E cells were stimulated by @COMPOUND$ and inhibited by tamoxifen.	0
638	Both cell types expressed estrogen and @PROTEIN$, although only the epithelial LM05-E cells were stimulated by estradiol and inhibited by @COMPOUND$.	0
639	The growth of L. minor (as fresh weight) and @COMPOUND$ content were significantly reduced and @PROTEIN$ (SOD) activity was significantly decreased at microcystins concentration up to 0.5 mg/L.	0
640	The growth of L. minor (as fresh weight) and @COMPOUND$ content were significantly reduced and superoxide dismutase (@PROTEIN$) activity was significantly decreased at microcystins concentration up to 0.5 mg/L.	0
641	The purpose of this study was to investigate the solid-state properties of lyophilized formulations of protein (@PROTEIN$) containing @COMPOUND$ or trehalose across a wide range of compositions, both in the presence or absence of hydroxyethylstarch (HES).	0
642	The purpose of this study was to investigate the solid-state properties of lyophilized formulations of protein (@PROTEIN$) containing sucrose or @COMPOUND$ across a wide range of compositions, both in the presence or absence of hydroxyethylstarch (HES).	0
643	The stimulatory effects of stearic, palmitic and palmitoleic acids on resistin secretion and the stimulatory effect of @COMPOUND$ on @PROTEIN$ secretion are mediated via TLR-4.	1
644	The stimulatory effects of stearic, palmitic and palmitoleic acids on resistin secretion and the stimulatory effect of @COMPOUND$ on MCP-1 secretion are mediated via @PROTEIN$-4.	1
645	On the other hand, @COMPOUND$ increased the expression of @PROTEIN$, involved in the regulation of proliferation.	1
646	Reduction of intracellular @COMPOUND$+) levels abolished @PROTEIN$ reduction by HOG-LDL, as did pharmacological or genetic through calcium channel blockers or calcium chelator BAPTA or inhibition of NAD(P)H oxidase (with apocynin) or inhibition of calpain (calpain 1-specific siRNA).	1
647	Reduction of intracellular Ca(2+) levels abolished @PROTEIN$ reduction by HOG-LDL, as did pharmacological or genetic through calcium channel blockers or calcium chelator @COMPOUND$ or inhibition of NAD(P)H oxidase (with apocynin) or inhibition of calpain (calpain 1-specific siRNA).	1
648	Reduction of intracellular Ca(2+) levels abolished @PROTEIN$ reduction by HOG-LDL, as did pharmacological or genetic through calcium channel blockers or calcium chelator BAPTA or inhibition of NAD(P)H oxidase (with @COMPOUND$) or inhibition of calpain (calpain 1-specific siRNA).	0
649	In addition to transporting @COMPOUND$, @PROTEIN$ plays other roles in regulating GABA synthesis, reducing oxidative stress in neurons, and is important in supporting neuron viability.	1
650	In addition to transporting glutamate, @PROTEIN$ plays other roles in regulating @COMPOUND$ synthesis, reducing oxidative stress in neurons, and is important in supporting neuron viability.	1
651	We have recently shown that the antidepressant @COMPOUND$ enhances T cell proliferation and T(H)1 cytokine production in vivo, without changes on @PROTEIN$/CD8 subsets.	0
652	Here we report a case of intragenic @PROTEIN$ microdeletion in renal cell carcinoma (RCC) associated with the effect of treatment by @COMPOUND$.	1
653	Neither @PROTEIN$ expression nor UCP2 overexpression modified basal or @COMPOUND$-stimulated metabolic changes.	0
654	Neither UCP1 expression nor @PROTEIN$ overexpression modified basal or @COMPOUND$-stimulated metabolic changes.	0
655	The @PROTEIN$ activity was increased by Mn(2+), @COMPOUND$+), and Mg(2+), while strongly inhibited by Fe(2+) and Ba(2+).	1
656	The @PROTEIN$ activity was increased by @COMPOUND$+), Cu(2+), and Mg(2+), while strongly inhibited by Fe(2+) and Ba(2+).	1
657	The @PROTEIN$ activity was increased by Mn(2+), Cu(2+), and Mg(2+), while strongly inhibited by Fe(2+) and @COMPOUND$+).	1
658	The @PROTEIN$ activity was increased by Mn(2+), Cu(2+), and Mg(2+), while strongly inhibited by @COMPOUND$+) and Ba(2+).	1
659	Meanwhile, SDS, ethyleneglycoltetraacetic acid, urea, and @COMPOUND$ were found to have significantly inhibitory effect on @PROTEIN$ activity.	1
660	Meanwhile, SDS, ethyleneglycoltetraacetic acid, @COMPOUND$, and ethylenediaminetetraacetic acid were found to have significantly inhibitory effect on @PROTEIN$ activity.	1
661	Following thermal denaturation, rabbit reticulocyte lysate and @COMPOUND$ were added and @PROTEIN$ activity measured.	0
662	The expression of the ERG1, ERG3, ERG7, @PROTEIN$, ERG11 and ERG25 genes in response to incubation with @COMPOUND$ and biofilm formation was investigated using reverse-transcription PCR and real-time PCR in Candida albicans and Candida dubliniensis clinical isolates.	1
663	The expression of the ERG1, ERG3, ERG7, ERG9, @PROTEIN$ and ERG25 genes in response to incubation with @COMPOUND$ and biofilm formation was investigated using reverse-transcription PCR and real-time PCR in Candida albicans and Candida dubliniensis clinical isolates.	1
664	The expression of the ERG1, ERG3, ERG7, ERG9, ERG11 and @PROTEIN$ genes in response to incubation with @COMPOUND$ and biofilm formation was investigated using reverse-transcription PCR and real-time PCR in Candida albicans and Candida dubliniensis clinical isolates.	1
665	The expression of the ERG1, @PROTEIN$, ERG7, ERG9, ERG11 and ERG25 genes in response to incubation with @COMPOUND$ and biofilm formation was investigated using reverse-transcription PCR and real-time PCR in Candida albicans and Candida dubliniensis clinical isolates.	1
666	The expression of the @PROTEIN$, ERG3, ERG7, ERG9, ERG11 and ERG25 genes in response to incubation with @COMPOUND$ and biofilm formation was investigated using reverse-transcription PCR and real-time PCR in Candida albicans and Candida dubliniensis clinical isolates.	1
667	The expression of the ERG1, ERG3, @PROTEIN$, ERG9, ERG11 and ERG25 genes in response to incubation with @COMPOUND$ and biofilm formation was investigated using reverse-transcription PCR and real-time PCR in Candida albicans and Candida dubliniensis clinical isolates.	1
668	The expression of the @PROTEIN$ increased in the presence of @COMPOUND$ in some isolates.	1
669	In aged animals, administration of @COMPOUND$ for 21 days significantly decreased the levels of lipid peroxides and improved the activities of antioxidant enzymes like superoxide dismutase, @PROTEIN$, glutathione peroxidase and glutathione reductase.	1
670	In aged animals, administration of @COMPOUND$ for 21 days significantly decreased the levels of lipid peroxides and improved the activities of antioxidant enzymes like superoxide dismutase, catalase, glutathione peroxidase and @PROTEIN$.	1
671	In aged animals, administration of @COMPOUND$ for 21 days significantly decreased the levels of lipid peroxides and improved the activities of antioxidant enzymes like superoxide dismutase, catalase, @PROTEIN$ and glutathione reductase.	1
672	In aged animals, administration of @COMPOUND$ for 21 days significantly decreased the levels of lipid peroxides and improved the activities of antioxidant enzymes like @PROTEIN$, catalase, glutathione peroxidase and glutathione reductase.	1
673	L-Carnitine enhanced T-cell proliferative responses as evaluated by T-cell proliferation assay using (3H) @COMPOUND$ incorporation and also significantly reduced DNA damage, apoptosis and @PROTEIN$ level in lymphocytes of aged animals.	0
674	@COMPOUND$ enhanced T-cell proliferative responses as evaluated by T-cell proliferation assay using (3H) thymidine incorporation and also significantly reduced DNA damage, apoptosis and @PROTEIN$ level in lymphocytes of aged animals.	1
675	@COMPOUND$, an inhibitor of glial metabolism, inhibits the up-regulation of @PROTEIN$ expression, activity and NO production in the spinal cord induced by formalin test in rats.	1
676	In order to explore the involvement of glia in the NO-mediated nociceptive transmission, the present study was undertaken to investigate the effect of @COMPOUND$ (FC), an inhibitor of glial metabolism, on @PROTEIN$ expression and activity and NO production in the spinal cord during the process of peripheral inflammatory pain and hyperalgesia induced by formalin test in rats.	0
677	@COMPOUND$ reduces induction of @PROTEIN$ and apoptosis in UVB-irradiated human skin independent of transcriptional controls.	1
678	These effects of @PROTEIN$beta are blocked by @COMPOUND$, a pan-specific antagonist of ErbB receptors, and are mediated specifically via ErbB4 receptors, because mice harboring a targeted mutation of ErbB4 do not respond to NRG-1.	1
679	We have generated two novel chimeric @PROTEIN$-binding molecules, sFLT01 and sFLT02, which consist of the second immunoglobulin (IgG)-like domain of Flt-1 fused either to a human IgG1 Fc or solely to the CH3 domain of IgG1 Fc through a @COMPOUND$ linker 9Gly.	0
680	We have generated two novel chimeric VEGF-binding molecules, sFLT01 and sFLT02, which consist of the second immunoglobulin (IgG)-like domain of @PROTEIN$ fused either to a human IgG1 Fc or solely to the CH3 domain of IgG1 Fc through a @COMPOUND$ linker 9Gly.	1
681	We showed that in comparison to stage VI, stages I-V oocytes expressed higher levels of O-GlcNAc correlating changes in @PROTEIN$ expression, but not in @COMPOUND$ pools.	0
682	We showed that in comparison to stage VI, stages I-V oocytes expressed higher levels of @PROTEIN$ correlating changes in OGT expression, but not in @COMPOUND$ pools.	0
683	Upon @COMPOUND$ stimulation, an O-GlcNAc level burst occurred during meiotic resumption long before @PROTEIN$ and Mos-Erk2 pathways activations.	1
684	Upon @COMPOUND$ stimulation, an O-GlcNAc level burst occurred during meiotic resumption long before MPF and @PROTEIN$-Erk2 pathways activations.	1
685	Upon @COMPOUND$ stimulation, an O-GlcNAc level burst occurred during meiotic resumption long before MPF and Mos-@PROTEIN$ pathways activations.	1
686	Upon @COMPOUND$ stimulation, an @PROTEIN$ level burst occurred during meiotic resumption long before MPF and Mos-Erk2 pathways activations.	1
687	Mean plasma levels of folic acid, @COMPOUND$, and vitamin B12 did not change, but there was a significant decrease of @PROTEIN$ at T1, 0.36 mg dl(-1) on average (P = 0.01), which was maintained at T2.	0
688	Mean plasma levels of @COMPOUND$, homocysteine, and vitamin B12 did not change, but there was a significant decrease of @PROTEIN$ at T1, 0.36 mg dl(-1) on average (P = 0.01), which was maintained at T2.	0
689	Plasma total @COMPOUND$, TAG, HDL, HDL2, HDL3, LDL, C-reactive protein, @PROTEIN$, IL-18, intercellular adhesion molecule-1, oxidised LDL, oxygen radical absorbance capacity using perchloric acid (ORACPCA), whole-blood fatty acids, bleeding time and blood pressure were measured at the beginning and end of each dietary period.	0
690	Plasma total @COMPOUND$, TAG, HDL, HDL2, HDL3, LDL, C-reactive protein, IL-6, @PROTEIN$, intercellular adhesion molecule-1, oxidised LDL, oxygen radical absorbance capacity using perchloric acid (ORACPCA), whole-blood fatty acids, bleeding time and blood pressure were measured at the beginning and end of each dietary period.	0
691	Plasma total cholesterol, @PROTEIN$, HDL, HDL2, HDL3, LDL, C-reactive protein, IL-6, IL-18, intercellular adhesion molecule-1, oxidised LDL, oxygen radical absorbance capacity using @COMPOUND$ (ORACPCA), whole-blood fatty acids, bleeding time and blood pressure were measured at the beginning and end of each dietary period.	0
692	Plasma total cholesterol, TAG, HDL, HDL2, HDL3, LDL, C-reactive protein, IL-6, @PROTEIN$, intercellular adhesion molecule-1, oxidised LDL, @COMPOUND$ radical absorbance capacity using perchloric acid (ORACPCA), whole-blood fatty acids, bleeding time and blood pressure were measured at the beginning and end of each dietary period.	0
693	Plasma total cholesterol, TAG, HDL, HDL2, HDL3, LDL, C-reactive protein, IL-6, @PROTEIN$, intercellular adhesion molecule-1, oxidised LDL, oxygen radical absorbance capacity using @COMPOUND$ (ORACPCA), whole-blood fatty acids, bleeding time and blood pressure were measured at the beginning and end of each dietary period.	0
694	Plasma total @COMPOUND$, @PROTEIN$, HDL, HDL2, HDL3, LDL, C-reactive protein, IL-6, IL-18, intercellular adhesion molecule-1, oxidised LDL, oxygen radical absorbance capacity using perchloric acid (ORACPCA), whole-blood fatty acids, bleeding time and blood pressure were measured at the beginning and end of each dietary period.	0
695	Plasma total cholesterol, TAG, HDL, HDL2, HDL3, LDL, C-reactive protein, @PROTEIN$, IL-18, intercellular adhesion molecule-1, oxidised LDL, oxygen radical absorbance capacity using @COMPOUND$ (ORACPCA), whole-blood fatty acids, bleeding time and blood pressure were measured at the beginning and end of each dietary period.	0
696	Plasma total cholesterol, TAG, HDL, HDL2, HDL3, LDL, C-reactive protein, @PROTEIN$, IL-18, intercellular adhesion molecule-1, oxidised LDL, @COMPOUND$ radical absorbance capacity using perchloric acid (ORACPCA), whole-blood fatty acids, bleeding time and blood pressure were measured at the beginning and end of each dietary period.	0
697	Plasma total cholesterol, @PROTEIN$, HDL, HDL2, HDL3, LDL, C-reactive protein, IL-6, IL-18, intercellular adhesion molecule-1, oxidised LDL, @COMPOUND$ radical absorbance capacity using perchloric acid (ORACPCA), whole-blood fatty acids, bleeding time and blood pressure were measured at the beginning and end of each dietary period.	0
698	The increase of mature @PROTEIN$ by macrophages was inhibited by @COMPOUND$ : caspase-1 is known to cleave the proform of IL-18 to produce active mature IL-18.	1
699	Dopamine release and direct stimulation of dopamine D2 and serotonin @PROTEIN$ receptors also contributes to the overall action of @COMPOUND$.	1
700	Furthermore, @PROTEIN$ levels did not correlate with IL-6 levels but did with @COMPOUND$ infusion rate (Spearman r = 0.94; P = 0.02), suggesting that the extent of hemodynamic instability and not the degree of inflammation could be of importance for the occurrence of liver damage.	1
701	Furthermore, GSTA1-1 levels did not correlate with @PROTEIN$ levels but did with @COMPOUND$ infusion rate (Spearman r = 0.94; P = 0.02), suggesting that the extent of hemodynamic instability and not the degree of inflammation could be of importance for the occurrence of liver damage.	0
702	@COMPOUND$ (H2S) is a novel gaseous mediator produced by @PROTEIN$ and cystathionine-gamma-lyase in the cardiovascular system, including the heart.	1
703	Hydrogen sulfide (@COMPOUND$) is a novel gaseous mediator produced by @PROTEIN$ and cystathionine-gamma-lyase in the cardiovascular system, including the heart.	1
704	@COMPOUND$ (H2S) is a novel gaseous mediator produced by cystathionine-beta-synthase and @PROTEIN$ in the cardiovascular system, including the heart.	1
705	Hydrogen sulfide (@COMPOUND$) is a novel gaseous mediator produced by cystathionine-beta-synthase and @PROTEIN$ in the cardiovascular system, including the heart.	1
706	Chemotaxis, @PROTEIN$ release and @COMPOUND$ anion production have been measured.	0
707	Cell viability and reactive oxygen species concentration were determined, and the effects of pre-treatment with LA on these parameters were investigated together with the @PROTEIN$ and GPx activity as well as the concentration of @COMPOUND$.	0
708	Cell viability and reactive @COMPOUND$ species concentration were determined, and the effects of pre-treatment with LA on these parameters were investigated together with the @PROTEIN$ and GPx activity as well as the concentration of reduced glutathione.	0
709	@COMPOUND$-containing bisphosphonates were found to inhibit @PROTEIN$-an essential enzyme in the cholesterol biosynthesis pathway, but their effect on cholesterol synthesis per se in the central nervous system (CNS) remains unknown.	0
710	Nitrogen-containing bisphosphonates were found to inhibit @PROTEIN$-an essential enzyme in the @COMPOUND$ biosynthesis pathway, but their effect on cholesterol synthesis per se in the central nervous system (CNS) remains unknown.	1
711	hsBAFF-upregulated intracellular free @COMPOUND$+) homeostasis regulates @PROTEIN$/2 activity and cell proliferation in B cells in vitro.	1
712	This is supported by the findings that intracellular Ca(2+) chelator @COMPOUND$ attenuated phosphorylated @PROTEIN$/2 expression and cell proliferation in hsBAFF-stimulated B cells.	1
713	The enzyme @PROTEIN$ (IDO) converts @COMPOUND$ to kynurenine, blocking T-cell activation and inducing immunosuppression.	1
714	The enzyme indoleamine 2,3-dioxygenase (@PROTEIN$) converts tryptophan to @COMPOUND$, blocking T-cell activation and inducing immunosuppression.	1
715	The enzyme indoleamine 2,3-dioxygenase (@PROTEIN$) converts @COMPOUND$ to kynurenine, blocking T-cell activation and inducing immunosuppression.	1
716	The enzyme @PROTEIN$ (IDO) converts tryptophan to @COMPOUND$, blocking T-cell activation and inducing immunosuppression.	1
717	Serum l-@COMPOUND$ (l-KYN) concentrations, l-KYN/l-@PROTEIN$ ratio, and the level of IDO mRNA expression in ATLL cells were significantly increased in ATLL patients compared to those in healthy and HTLV-positive carrier subjects.	0
718	Serum l-kynurenine (l-@COMPOUND$) concentrations, l-KYN/l-@PROTEIN$ ratio, and the level of IDO mRNA expression in ATLL cells were significantly increased in ATLL patients compared to those in healthy and HTLV-positive carrier subjects.	0
719	Serum l-kynurenine (l-@COMPOUND$) concentrations, l-KYN/l-TRP ratio, and the level of @PROTEIN$ mRNA expression in ATLL cells were significantly increased in ATLL patients compared to those in healthy and HTLV-positive carrier subjects.	0
720	Serum l-@COMPOUND$ (l-KYN) concentrations, l-KYN/l-TRP ratio, and the level of @PROTEIN$ mRNA expression in ATLL cells were significantly increased in ATLL patients compared to those in healthy and HTLV-positive carrier subjects.	0
721	Peripheral administration of the acetylcholinesterase inhibitor @COMPOUND$ significantly reduced serum @PROTEIN$ levels through vagus nerve signaling, and protected against lethality during murine endotoxemia.	1
722	Administration of a centrally-acting muscarinic receptor antagonist abolished the suppression of TNF by @COMPOUND$, indicating that suppressing @PROTEIN$ activity, coupled with central muscarinic receptors, controls peripheral cytokine responses.	1
723	Administration of a centrally-acting muscarinic receptor antagonist abolished the suppression of @PROTEIN$ by @COMPOUND$, indicating that suppressing acetylcholinesterase activity, coupled with central muscarinic receptors, controls peripheral cytokine responses.	1
724	The involvement of @COMPOUND$ and nitric oxide was verified by the block of @PROTEIN$ using specific scavengers (tiron and PTIO, respectively).	0
725	The involvement of superoxide and nitric oxide was verified by the block of @PROTEIN$ using specific scavengers (@COMPOUND$ and PTIO, respectively).	1
726	The involvement of superoxide and @COMPOUND$ was verified by the block of @PROTEIN$ using specific scavengers (tiron and PTIO, respectively).	0
727	Accordingly, @PROTEIN$ were blocked by the peroxynitrite scavenger @COMPOUND$ and could be mimicked by application of exogenous peroxynitrite.	1
728	In the present study, therefore, the effect of FA/AD in presence or absence of p38MAPK inhibitor SB203580 on the proliferation, apoptosis, p38MAPK, caspase-3, location of p38MAPK and caspase-3, and interaction between p38MAPK and caspase-3 in Bel-7402 cell was investigated by @COMPOUND$ (MTT), @PROTEIN$-FITC/propidium iodide (PI) double staining, electron microscopy, immunoblot, immunofluorescence and immunoprecipitation/immunoblot assay, respectively.	0
729	In the present study, therefore, the effect of FA/AD in presence or absence of p38MAPK inhibitor SB203580 on the proliferation, apoptosis, p38MAPK, caspase-3, location of p38MAPK and caspase-3, and interaction between p38MAPK and caspase-3 in Bel-7402 cell was investigated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide (MTT), @PROTEIN$-FITC/@COMPOUND$ (PI) double staining, electron microscopy, immunoblot, immunofluorescence and immunoprecipitation/immunoblot assay, respectively.	0
730	In the present study, therefore, the effect of FA/AD in presence or absence of p38MAPK inhibitor SB203580 on the proliferation, apoptosis, p38MAPK, caspase-3, location of p38MAPK and caspase-3, and interaction between p38MAPK and caspase-3 in Bel-7402 cell was investigated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide (MTT), @PROTEIN$-@COMPOUND$/propidium iodide (PI) double staining, electron microscopy, immunoblot, immunofluorescence and immunoprecipitation/immunoblot assay, respectively.	0
731	In this study, we compared the effects of @PROTEIN$-like growth factor-I (IGF-I), basic fibroblast growth factor (bFGF), transforming growth factor beta1 (TGF-beta1), and @COMPOUND$ on porcine TMJ condylar cartilage and ankle cartilage cells in monolayer culture.	0
732	In this study, we compared the effects of insulin-like growth factor-I (IGF-I), basic fibroblast growth factor (bFGF), transforming growth factor beta1 (@PROTEIN$), and @COMPOUND$ on porcine TMJ condylar cartilage and ankle cartilage cells in monolayer culture.	0
733	In this study, we compared the effects of insulin-like growth factor-I (@PROTEIN$), basic fibroblast growth factor (bFGF), transforming growth factor beta1 (TGF-beta1), and @COMPOUND$ on porcine TMJ condylar cartilage and ankle cartilage cells in monolayer culture.	0
734	In this study, we compared the effects of insulin-like growth factor-I (IGF-I), @PROTEIN$ (bFGF), transforming growth factor beta1 (TGF-beta1), and @COMPOUND$ on porcine TMJ condylar cartilage and ankle cartilage cells in monolayer culture.	0
735	Meanwhile, both the enhanced expression of @PROTEIN$ and increased activation of NF-kappaB induced by CRH in aortas of LDLr-/-mice were also largely suppressed by @COMPOUND$, whereas these inhibitory effects were not observed in anti-Svg-30 group.	1
736	Meanwhile, both the enhanced expression of VCAM-1 and increased activation of NF-kappaB induced by @PROTEIN$ in aortas of LDLr-/-mice were also largely suppressed by @COMPOUND$, whereas these inhibitory effects were not observed in anti-Svg-30 group.	0
737	Vincristine but not @COMPOUND$ increased p-@PROTEIN$ expression whereas co-treatment with PI3K inhibitors and vincristine increased apoptosis in the three cell lines.	0
738	@COMPOUND$ but not doxorubicin increased p-@PROTEIN$ expression whereas co-treatment with PI3K inhibitors and vincristine increased apoptosis in the three cell lines.	1
739	Vincristine but not doxorubicin increased p-@PROTEIN$ expression whereas co-treatment with PI3K inhibitors and @COMPOUND$ increased apoptosis in the three cell lines.	0
740	Recent evidence for toxic @COMPOUND$ (O(2)(-)) production by marine microalgae is afforded particular attention given that release of O(2)(-) anions can be exacerbated by the binding of @PROTEIN$ to the microalgal cell wall ; a novel model for grazing-activated chemical defence is proposed.	1
741	Activation of these receptors can inhibit @PROTEIN$-release in primary cultured corticotroph adenomas and compounds that target either sst (5) (@COMPOUND$, or SOM230) or D(2) (cabergoline) have shown significant efficacy in subsets of patients in recent clinical studies.	0
742	Activation of these receptors can inhibit @PROTEIN$-release in primary cultured corticotroph adenomas and compounds that target either sst (5) (pasireotide, or SOM230) or D(2) (@COMPOUND$) have shown significant efficacy in subsets of patients in recent clinical studies.	0
743	Activation of these receptors can inhibit @PROTEIN$-release in primary cultured corticotroph adenomas and compounds that target either sst (5) (pasireotide, or @COMPOUND$) or D(2) (cabergoline) have shown significant efficacy in subsets of patients in recent clinical studies.	0
744	The @COMPOUND$ induced chemotaxis was accompanied by polarization of the @PROTEIN$ cytoskeleton, and by polymerization of F-actin.	1
745	@COMPOUND$ in anionic DSPG liposomes stimulated murine @PROTEIN$ production in RAW 264 cells at concentrations 25-to 30-fold lower than free drug.	1
746	@PROTEIN$ is one of the members of the G protein-coupled receptor family that can catalyze a GDP-@COMPOUND$ exchange reaction on the retinal G protein transducin (Gt) upon photon absorption.	1
747	Rhodopsin is one of the members of the G protein-coupled receptor family that can catalyze a @COMPOUND$-GTP exchange reaction on the retinal G protein @PROTEIN$ (Gt) upon photon absorption.	1
748	Rhodopsin is one of the members of the G protein-coupled receptor family that can catalyze a GDP-@COMPOUND$ exchange reaction on the retinal G protein @PROTEIN$ (Gt) upon photon absorption.	1
749	@PROTEIN$ is one of the members of the G protein-coupled receptor family that can catalyze a @COMPOUND$-GTP exchange reaction on the retinal G protein transducin (Gt) upon photon absorption.	1
750	In our earlier method, glutathione disulfide (@COMPOUND$) was measured by first reducing it to GSH with @PROTEIN$ (GR) in the presence of NADPH.	1
751	In our earlier method, @COMPOUND$ (GSSG) was measured by first reducing it to GSH with @PROTEIN$ (GR) in the presence of NADPH.	1
752	In our earlier method, glutathione disulfide (GSSG) was measured by first reducing it to GSH with @PROTEIN$ (GR) in the presence of @COMPOUND$.	1
753	In our earlier method, glutathione disulfide (GSSG) was measured by first reducing it to @COMPOUND$ with @PROTEIN$ (GR) in the presence of NADPH.	1
754	The @PROTEIN$ insertion/deletion polymorphism is associated with phagocytic NADPH oxidase-dependent @COMPOUND$ generation: potential implication in hypertension.	1
755	Methylation of these @COMPOUND$ sites may lead to reduced @PROTEIN$ expression in the lymphocytes of these former heroin addicts.	1
756	Two infants with elevated serum @PROTEIN$ had a decreased serum @COMPOUND$.	1
757	None of the compounds altered @PROTEIN$ gene expression, indicating that 3-@COMPOUND$ inhibits CYP11B1 activity on the protein level.	0
758	None of the compounds altered Cyp11b1 gene expression, indicating that 3-@COMPOUND$ inhibits @PROTEIN$ activity on the protein level.	1
759	Overexpression of Ets-1 enhanced significantly @PROTEIN$ mRNA levels, protein expression, GC activity and ANP-stimulated intracellular accumulation of @COMPOUND$ in transfected cells.	0
760	Overexpression of Ets-1 enhanced significantly Npr1 mRNA levels, protein expression, GC activity and @PROTEIN$-stimulated intracellular accumulation of @COMPOUND$ in transfected cells.	1
761	Overexpression of @PROTEIN$ enhanced significantly Npr1 mRNA levels, protein expression, GC activity and ANP-stimulated intracellular accumulation of @COMPOUND$ in transfected cells.	1
762	Lecithin:retinol acyltransferase (@PROTEIN$) catalyzes the esterification of retinol (@COMPOUND$).	1
763	@COMPOUND$ (RA) treatment increased this @PROTEIN$ promoter-luciferase activity in PrEC cells, but not in PC-3 cells.	1
764	@COMPOUND$ (RA) treatment increased this LRAT promoter-@PROTEIN$ activity in PrEC cells, but not in PC-3 cells.	1
765	The @COMPOUND$ functionalization was then used to immobilize bone @PROTEIN$ on the bioactive glasses.	1
766	L-Kynurenine (KYN), a tryptophan metabolite, is metabolized to kynurenic acid (@COMPOUND$), which is an antagonist of N-methyl-D-aspartate and alpha7 nicotinic acetylcholine receptors, by kynurenine aminotransferase (@PROTEIN$) I and KAT II.	1
767	L-Kynurenine (@COMPOUND$), a tryptophan metabolite, is metabolized to kynurenic acid (KYNA), which is an antagonist of N-methyl-D-aspartate and alpha7 nicotinic acetylcholine receptors, by kynurenine aminotransferase (@PROTEIN$) I and KAT II.	1
768	L-@COMPOUND$ (KYN), a tryptophan metabolite, is metabolized to kynurenic acid (KYNA), which is an antagonist of N-methyl-D-aspartate and alpha7 nicotinic acetylcholine receptors, by kynurenine aminotransferase (@PROTEIN$) I and KAT II.	1
769	L-Kynurenine (KYN), a tryptophan metabolite, is metabolized to @COMPOUND$ (KYNA), which is an antagonist of N-methyl-D-aspartate and alpha7 nicotinic acetylcholine receptors, by kynurenine aminotransferase (@PROTEIN$) I and KAT II.	1
770	L-Kynurenine (KYN), a @COMPOUND$ metabolite, is metabolized to kynurenic acid (KYNA), which is an antagonist of N-methyl-D-aspartate and alpha7 nicotinic acetylcholine receptors, by kynurenine aminotransferase (@PROTEIN$) I and KAT II.	0
771	L-Kynurenine (KYN), a tryptophan metabolite, is metabolized to kynurenic acid (KYNA), which is an antagonist of N-methyl-D-aspartate and alpha7 nicotinic acetylcholine receptors, by @COMPOUND$ aminotransferase (@PROTEIN$) I and KAT II.	1
772	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or @COMPOUND$ (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (SOD), catalase (@PROTEIN$), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
773	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of @COMPOUND$ (MDA), and superoxide dismutase (SOD), @PROTEIN$ (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
774	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with @COMPOUND$ (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (SOD), catalase (@PROTEIN$), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
775	We examined the effect of several different doses of @COMPOUND$ (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (SOD), catalase (CAT), and @PROTEIN$ (GPx) activities in human erythrocytes in vitro.	0
776	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or @COMPOUND$ (VE; 30 microM), on the levels of malondialdehyde (MDA), and @PROTEIN$ (SOD), catalase (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
777	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or @COMPOUND$ (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (SOD), @PROTEIN$ (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
778	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with @COMPOUND$ (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (@PROTEIN$), catalase (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
779	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or @COMPOUND$ (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (@PROTEIN$), catalase (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
780	We examined the effect of several different doses of @COMPOUND$ (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of malondialdehyde (MDA), and @PROTEIN$ (SOD), catalase (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
781	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of @COMPOUND$ (MDA), and superoxide dismutase (@PROTEIN$), catalase (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
782	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of @COMPOUND$ (MDA), and superoxide dismutase (SOD), catalase (CAT), and @PROTEIN$ (GPx) activities in human erythrocytes in vitro.	0
783	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with @COMPOUND$ (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (SOD), @PROTEIN$ (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
784	We examined the effect of several different doses of @COMPOUND$ (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (SOD), catalase (@PROTEIN$), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
785	We examined the effect of several different doses of @COMPOUND$ (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (@PROTEIN$), catalase (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
786	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of @COMPOUND$ (MDA), and superoxide dismutase (SOD), catalase (@PROTEIN$), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
787	We examined the effect of several different doses of @COMPOUND$ (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (SOD), @PROTEIN$ (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
788	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of @COMPOUND$ (MDA), and @PROTEIN$ (SOD), catalase (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
789	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with @COMPOUND$ (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (SOD), catalase (CAT), and @PROTEIN$ (GPx) activities in human erythrocytes in vitro.	0
790	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with vitamin C (VC; 10 microM) or @COMPOUND$ (VE; 30 microM), on the levels of malondialdehyde (MDA), and superoxide dismutase (SOD), catalase (CAT), and @PROTEIN$ (GPx) activities in human erythrocytes in vitro.	0
791	We examined the effect of several different doses of malathion (25, 75, 200 microM), or malathion in combination with @COMPOUND$ (VC; 10 microM) or vitamin E (VE; 30 microM), on the levels of malondialdehyde (MDA), and @PROTEIN$ (SOD), catalase (CAT), and glutathione peroxidase (GPx) activities in human erythrocytes in vitro.	0
792	Treatment with @COMPOUND$ alone increased the levels of MDA and decreased SOD, @PROTEIN$ 0.05).	1
793	Treatment with @COMPOUND$ alone increased the levels of MDA and decreased @PROTEIN$, CAT 0.05).	1
794	In the present study, we investigated the effect of AdM, Pb+ AdM, and Cd+ AdM treatments on superoxide dismutase (@PROTEIN$), catalase (CAT), and glutathione peroxidase (@COMPOUND$-Px) activities as well as the level of malondialdehyde (MDA) in the kidney.	0
795	In the present study, we investigated the effect of AdM, Pb+ AdM, and Cd+ AdM treatments on superoxide dismutase (SOD), catalase (CAT), and @PROTEIN$ (@COMPOUND$-Px) activities as well as the level of malondialdehyde (MDA) in the kidney.	0
796	In the present study, we investigated the effect of AdM, Pb+ AdM, and Cd+ AdM treatments on @PROTEIN$ (SOD), catalase (CAT), and glutathione peroxidase (@COMPOUND$-Px) activities as well as the level of malondialdehyde (MDA) in the kidney.	0
797	In the present study, we investigated the effect of AdM, Pb+ AdM, and Cd+ AdM treatments on superoxide dismutase (@PROTEIN$), catalase (CAT), and glutathione peroxidase (GSH-Px) activities as well as the level of @COMPOUND$ (MDA) in the kidney.	0
798	In the present study, we investigated the effect of AdM, Pb+ AdM, and Cd+ AdM treatments on superoxide dismutase (SOD), catalase (CAT), and @PROTEIN$ (GSH-Px) activities as well as the level of @COMPOUND$ (MDA) in the kidney.	0
799	In the present study, we investigated the effect of AdM, Pb+ AdM, and Cd+ AdM treatments on superoxide dismutase (SOD), catalase (@PROTEIN$), and glutathione peroxidase (@COMPOUND$-Px) activities as well as the level of malondialdehyde (MDA) in the kidney.	0
800	In the present study, we investigated the effect of AdM, Pb+ AdM, and Cd+ AdM treatments on superoxide dismutase (SOD), catalase (@PROTEIN$), and glutathione peroxidase (GSH-Px) activities as well as the level of @COMPOUND$ (MDA) in the kidney.	0
801	In the present study, we investigated the effect of AdM, Pb+ AdM, and Cd+ AdM treatments on superoxide dismutase (SOD), @PROTEIN$ (CAT), and glutathione peroxidase (@COMPOUND$-Px) activities as well as the level of malondialdehyde (MDA) in the kidney.	0
802	In the present study, we investigated the effect of AdM, Pb+ AdM, and Cd+ AdM treatments on @PROTEIN$ (SOD), catalase (CAT), and glutathione peroxidase (GSH-Px) activities as well as the level of @COMPOUND$ (MDA) in the kidney.	0
803	In the present study, we investigated the effect of AdM, Pb+ AdM, and Cd+ AdM treatments on superoxide dismutase (SOD), @PROTEIN$ (CAT), and glutathione peroxidase (GSH-Px) activities as well as the level of @COMPOUND$ (MDA) in the kidney.	0
804	We found that @PROTEIN$ expression in LH orexin neurons varied in proportion to preference for morphine, @COMPOUND$ or food.	1
805	We found that @PROTEIN$ expression in LH orexin neurons varied in proportion to preference for @COMPOUND$, cocaine or food.	1
806	MPc also increased @PROTEIN$ activity in all tissues with a concurrent decrease in @COMPOUND$ levels.	0
807	@COMPOUND$ reverses ET-1-evoked mitogenic effects in human coronary arterial cells by activating the kinase-G to inhibit @PROTEIN$-enzymes.	1
808	@COMPOUND$ reverses @PROTEIN$-evoked mitogenic effects in human coronary arterial cells by activating the kinase-G to inhibit ERK-enzymes.	1
809	On the other hand, pretreatment with the polyphenolic @COMPOUND$ resveratrol (RSVL, 1-100 microM) triggered more prominent inhibition of ET-1-evoked cell proliferation and @PROTEIN$/2 activation.	0
810	On the other hand, pretreatment with the polyphenolic stilbene @COMPOUND$ (RSVL, 1-100 microM) triggered more prominent inhibition of ET-1-evoked cell proliferation and @PROTEIN$/2 activation.	1
811	Exposure to @COMPOUND$ rapidly increased phosphorylation of several kinases, including @PROTEIN$, extracellular signal regulated kinase 1/2 (ERK1/2) and amino kinase terminal (Akt), with maximal induction at about 10 min.	1
812	Exposure to @COMPOUND$ rapidly increased phosphorylation of several kinases, including p38 MAPK, extracellular signal regulated kinase 1/2 (ERK1/2) and amino kinase terminal (@PROTEIN$), with maximal induction at about 10 min.	1
813	Exposure to @COMPOUND$ rapidly increased phosphorylation of several kinases, including p38 MAPK, @PROTEIN$/2 (ERK1/2) and amino kinase terminal (Akt), with maximal induction at about 10 min.	1
814	Exposure to @COMPOUND$ rapidly increased phosphorylation of several kinases, including p38 MAPK, extracellular signal regulated kinase 1/2 (@PROTEIN$/2) and amino kinase terminal (Akt), with maximal induction at about 10 min.	1
815	To investigate the regulatory proteins of cell cycle arrest affected by @COMPOUND$, we treated cells with 50 and 100 microM apigenin for 72 h. Apigenin caused a slight decrease in @PROTEIN$ and cyclin E expression, with no change in CDK2 and CDK4.	1
816	To investigate the regulatory proteins of cell cycle arrest affected by apigenin, we treated cells with 50 and 100 microM apigenin for 72 h. @COMPOUND$ caused a slight decrease in cyclin D and cyclin E expression, with no change in @PROTEIN$ and CDK4.	0
817	To investigate the regulatory proteins of cell cycle arrest affected by @COMPOUND$, we treated cells with 50 and 100 microM apigenin for 72 h. Apigenin caused a slight decrease in cyclin D and cyclin E expression, with no change in CDK2 and @PROTEIN$.	0
818	To investigate the regulatory proteins of cell cycle arrest affected by apigenin, we treated cells with 50 and 100 microM apigenin for 72 h. @COMPOUND$ caused a slight decrease in @PROTEIN$ and cyclin E expression, with no change in CDK2 and CDK4.	1
819	To investigate the regulatory proteins of cell cycle arrest affected by @COMPOUND$, we treated cells with 50 and 100 microM apigenin for 72 h. Apigenin caused a slight decrease in cyclin D and cyclin E expression, with no change in @PROTEIN$ and CDK4.	0
820	To investigate the regulatory proteins of cell cycle arrest affected by apigenin, we treated cells with 50 and 100 microM apigenin for 72 h. @COMPOUND$ caused a slight decrease in cyclin D and cyclin E expression, with no change in CDK2 and @PROTEIN$.	0
821	In an additional study, @COMPOUND$ also increased the accumulation of p53 and further enhanced the level of @PROTEIN$ (Cip1), with no change in p27 (Kip1).	1
822	In an additional study, @COMPOUND$ also increased the accumulation of p53 and further enhanced the level of p21 (@PROTEIN$), with no change in p27 (Kip1).	1
823	In an additional study, @COMPOUND$ also increased the accumulation of p53 and further enhanced the level of p21 (Cip1), with no change in @PROTEIN$ (Kip1).	0
824	In an additional study, @COMPOUND$ also increased the accumulation of @PROTEIN$ and further enhanced the level of p21 (Cip1), with no change in p27 (Kip1).	1
825	The expression of Bax and @PROTEIN$ of p53 downstream target was increased markedly at high concentration treatment over 50 microM @COMPOUND$.	1
826	The expression of Bax and cytochrome c of @PROTEIN$ downstream target was increased markedly at high concentration treatment over 50 microM @COMPOUND$.	1
827	The expression of @PROTEIN$ and cytochrome c of p53 downstream target was increased markedly at high concentration treatment over 50 microM @COMPOUND$.	1
828	@COMPOUND$ strongly decreased the expression of @PROTEIN$ 0.01).	1
829	In conclusion, @COMPOUND$ overload in rats induced hypertriglyceridemia and @PROTEIN$ resistance associated with an enhanced oxidative stress.	1
830	Leptin and soluble @PROTEIN$ receptor changes after pulmonary endarterectomy: relations to @COMPOUND$ and cytokine network.	1
831	@PROTEIN$ and soluble leptin receptor changes after pulmonary endarterectomy: relations to @COMPOUND$ and cytokine network.	1
832	Using this method, we also determined whether streptozotocin-induced DM in rats (4-week duration) leads to changes in renal subcellular targeting of @PROTEIN$, and evaluated the effects of tight metabolic control (insulin, 12 IU/day) and angiotensin receptor blocker, @COMPOUND$ (4 weeks, 20 mg/kg/day).	0
833	Using this method, we also determined whether streptozotocin-induced DM in rats (4-week duration) leads to changes in renal subcellular targeting of CAV-1, and evaluated the effects of tight metabolic control (@PROTEIN$, 12 IU/day) and angiotensin receptor blocker, @COMPOUND$ (4 weeks, 20 mg/kg/day).	0
834	Moreover, similar to rFGF2, injection of the zebrafish form of @PROTEIN$ (VEGF-A) induces a significant angiogenic response in the ZFYM assay that is suppressed by the VEGF receptor-2/KDR TK inhibitor @COMPOUND$.	1
835	Moreover, similar to rFGF2, injection of the zebrafish form of vascular endothelial growth factor-A (@PROTEIN$) induces a significant angiogenic response in the ZFYM assay that is suppressed by the VEGF receptor-2/KDR TK inhibitor @COMPOUND$.	1
836	@COMPOUND$ is a free radical molecule synthesized from L-arginine by @PROTEIN$ that plays a critical role in various physiological and pathological processes, including tumor growth and angiogenesis.	1
837	Nitric oxide is a free radical molecule synthesized from @COMPOUND$ by @PROTEIN$ that plays a critical role in various physiological and pathological processes, including tumor growth and angiogenesis.	1
838	We demonstrated the increase in the levels of p53, Bax, and @PROTEIN$ and decrease in the level of Bcl-2, which are associated with the induction of apoptotic cell death after 24 h treatment with @COMPOUND$ in N18 cells.	1
839	We demonstrated the increase in the levels of p53, Bax, and cytochrome c and decrease in the level of @PROTEIN$, which are associated with the induction of apoptotic cell death after 24 h treatment with @COMPOUND$ in N18 cells.	1
840	We demonstrated the increase in the levels of p53, @PROTEIN$, and cytochrome c and decrease in the level of Bcl-2, which are associated with the induction of apoptotic cell death after 24 h treatment with @COMPOUND$ in N18 cells.	1
841	We demonstrated the increase in the levels of @PROTEIN$, Bax, and cytochrome c and decrease in the level of Bcl-2, which are associated with the induction of apoptotic cell death after 24 h treatment with @COMPOUND$ in N18 cells.	1
842	@PROTEIN$ gene polymorphisms and high levels of @COMPOUND$ are associated with a high degree of steatosis and fibrosis, conditions associated with a low sustained virological response (SVR) rate.	0
843	Besides the biogenesis of lysosome-related organelles complex 1 and dystrophin-associated protein complex, several molecules in the DTNBP1 network likely provide insight into the role of DTNBP1 in biological systems: @COMPOUND$, beta-estradiol, @PROTEIN$ and tumour necrosis factor.	0
844	Besides the biogenesis of lysosome-related organelles complex 1 and dystrophin-associated protein complex, several molecules in the @PROTEIN$ network likely provide insight into the role of DTNBP1 in biological systems: @COMPOUND$, beta-estradiol, calmodulin and tumour necrosis factor.	1
845	Besides the biogenesis of lysosome-related organelles complex 1 and dystrophin-associated protein complex, several molecules in the DTNBP1 network likely provide insight into the role of DTNBP1 in biological systems: retinoic acid, @COMPOUND$, @PROTEIN$ and tumour necrosis factor.	0
846	Besides the biogenesis of lysosome-related organelles complex 1 and dystrophin-associated protein complex, several molecules in the @PROTEIN$ network likely provide insight into the role of DTNBP1 in biological systems: retinoic acid, @COMPOUND$, calmodulin and tumour necrosis factor.	1
847	Hypothetically, @PROTEIN$ influences the transport of @COMPOUND$ across the blood-brain barrier.	1
848	In contrast, the degree of (1) spinal cord inflammation and tissue injury (histological score), (2) nitrotyrosine and poly(@COMPOUND$ (ADP) ribose) formation, (3) @PROTEIN$ expression, (4) nuclear factor-kappaB activation, and (5) apoptosis (terminal deoxynucleotidyltransferase-mediated dUTP-biotin end labeling, Bax, and Bcl-2) was markedly reduced in spinal cord tissue obtained from mice treated with glycyrrhizin extract (10 mg/kg, i.p., 30 min before and 1 and 6 h after SCI).	0
849	In contrast, the degree of (1) spinal cord inflammation and tissue injury (histological score), (2) nitrotyrosine and poly(adenosine diphosphate (ADP) ribose) formation, (3) iNOS expression, (4) nuclear factor-kappaB activation, and (5) apoptosis (terminal deoxynucleotidyltransferase-mediated dUTP-biotin end labeling, @PROTEIN$, and Bcl-2) was markedly reduced in spinal cord tissue obtained from mice treated with @COMPOUND$ extract (10 mg/kg, i.p., 30 min before and 1 and 6 h after SCI).	1
850	In contrast, the degree of (1) spinal cord inflammation and tissue injury (histological score), (2) nitrotyrosine and poly(@COMPOUND$ (ADP) ribose) formation, (3) iNOS expression, (4) nuclear factor-kappaB activation, and (5) apoptosis (terminal deoxynucleotidyltransferase-mediated dUTP-biotin end labeling, Bax, and @PROTEIN$) was markedly reduced in spinal cord tissue obtained from mice treated with glycyrrhizin extract (10 mg/kg, i.p., 30 min before and 1 and 6 h after SCI).	0
851	In contrast, the degree of (1) spinal cord inflammation and tissue injury (histological score), (2) nitrotyrosine and poly(adenosine diphosphate (ADP) ribose) formation, (3) @PROTEIN$ expression, (4) nuclear factor-kappaB activation, and (5) apoptosis (terminal deoxynucleotidyltransferase-mediated dUTP-biotin end labeling, Bax, and Bcl-2) was markedly reduced in spinal cord tissue obtained from mice treated with @COMPOUND$ extract (10 mg/kg, i.p., 30 min before and 1 and 6 h after SCI).	1
852	In contrast, the degree of (1) spinal cord inflammation and tissue injury (histological score), (2) nitrotyrosine and poly(@COMPOUND$ (ADP) ribose) formation, (3) iNOS expression, (4) nuclear factor-kappaB activation, and (5) apoptosis (terminal deoxynucleotidyltransferase-mediated dUTP-biotin end labeling, @PROTEIN$, and Bcl-2) was markedly reduced in spinal cord tissue obtained from mice treated with glycyrrhizin extract (10 mg/kg, i.p., 30 min before and 1 and 6 h after SCI).	0
853	In contrast, the degree of (1) spinal cord inflammation and tissue injury (histological score), (2) nitrotyrosine and poly(@COMPOUND$ (ADP) ribose) formation, (3) iNOS expression, (4) nuclear factor-kappaB activation, and (5) apoptosis (@PROTEIN$-mediated dUTP-biotin end labeling, Bax, and Bcl-2) was markedly reduced in spinal cord tissue obtained from mice treated with glycyrrhizin extract (10 mg/kg, i.p., 30 min before and 1 and 6 h after SCI).	0
854	In contrast, the degree of (1) spinal cord inflammation and tissue injury (histological score), (2) nitrotyrosine and poly(adenosine diphosphate (ADP) ribose) formation, (3) iNOS expression, (4) nuclear factor-kappaB activation, and (5) apoptosis (@PROTEIN$-mediated dUTP-biotin end labeling, Bax, and Bcl-2) was markedly reduced in spinal cord tissue obtained from mice treated with @COMPOUND$ extract (10 mg/kg, i.p., 30 min before and 1 and 6 h after SCI).	1
855	In contrast, the degree of (1) spinal cord inflammation and tissue injury (histological score), (2) nitrotyrosine and poly(adenosine diphosphate (ADP) ribose) formation, (3) iNOS expression, (4) nuclear factor-kappaB activation, and (5) apoptosis (terminal deoxynucleotidyltransferase-mediated dUTP-biotin end labeling, Bax, and @PROTEIN$) was markedly reduced in spinal cord tissue obtained from mice treated with @COMPOUND$ extract (10 mg/kg, i.p., 30 min before and 1 and 6 h after SCI).	1
856	@COMPOUND$ attenuated mast cell recruitment thereby decreased the expressions of @PROTEIN$ and 9 in rat liver carcinogenesis.	1
857	As a result, combined @COMPOUND$ and @PROTEIN$ infusion significantly decreased plasma K+ concentration despite a significant decrease of urinary K+ excretion in sgk1+/+ but not in sgk1-/-mice.	0
858	Depletion of polyphosphatidylinositol 4-phosphate and @COMPOUND$ (PIP2) through inhibition of @PROTEIN$ activates calcium entry and membrane currents in TRPC5-expressing but not in TRPC3-or TRPC7-expressing cells.	1
859	Depletion of polyphosphatidylinositol 4-phosphate and @COMPOUND$ (PIP2) through inhibition of phosphatidylinositol 4-kinase activates calcium entry and membrane currents in TRPC5-expressing but not in @PROTEIN$-or TRPC7-expressing cells.	0
860	Depletion of polyphosphatidylinositol 4-phosphate and @COMPOUND$ (PIP2) through inhibition of phosphatidylinositol 4-kinase activates calcium entry and membrane currents in TRPC5-expressing but not in TRPC3-or @PROTEIN$-expressing cells.	0
861	Depletion of polyphosphatidylinositol 4-phosphate and @COMPOUND$ (PIP2) through inhibition of phosphatidylinositol 4-kinase activates calcium entry and membrane currents in @PROTEIN$-expressing but not in TRPC3-or TRPC7-expressing cells.	0
862	Inclusion of polyphosphatidylinositol 4-phosphate or PIP2, but not @COMPOUND$, in the patch pipette inhibited @PROTEIN$ currents.	0
863	Osteogenic differentiation was enhanced after treatment with @COMPOUND$ as confirmed by Alizarin Red S staining, elevated alkaline phosphatase activity and @PROTEIN$ mRNA expression, a greater calcium peak by energy-dispersive xray spectrophotometry, and by immunofluorescence staining against CD44 by flow cytometric analysis.	1
864	Osteogenic differentiation was enhanced after treatment with @COMPOUND$ as confirmed by Alizarin Red S staining, elevated @PROTEIN$ activity and osteocalcin mRNA expression, a greater calcium peak by energy-dispersive xray spectrophotometry, and by immunofluorescence staining against CD44 by flow cytometric analysis.	1
865	Osteogenic differentiation was enhanced after treatment with @COMPOUND$ as confirmed by Alizarin Red S staining, elevated alkaline phosphatase activity and osteocalcin mRNA expression, a greater calcium peak by energy-dispersive xray spectrophotometry, and by immunofluorescence staining against @PROTEIN$ by flow cytometric analysis.	1
866	Preliminary tests in vitro showed POP is capable of enhancing concanavalin A (@PROTEIN$)-or @COMPOUND$ (LPS)-induced lymphocyte proliferation, which suggested that POP could be a potential immunostimulating agent for use in functional foods or medicine against both pathogens and cancer.	0
867	Preliminary tests in vitro showed @PROTEIN$ is capable of enhancing concanavalin A (ConA)-or @COMPOUND$ (LPS)-induced lymphocyte proliferation, which suggested that POP could be a potential immunostimulating agent for use in functional foods or medicine against both pathogens and cancer.	1
868	Preliminary tests in vitro showed POP is capable of enhancing @PROTEIN$ (ConA)-or @COMPOUND$ (LPS)-induced lymphocyte proliferation, which suggested that POP could be a potential immunostimulating agent for use in functional foods or medicine against both pathogens and cancer.	0
869	Both expression of tac and @PROTEIN$ were induced by 2% @COMPOUND$.	1
870	In this view, this study aimed at the investigating the use of a crude @PROTEIN$ preparation from onion solid by-products for oxidising @COMPOUND$, a widespread o-diphenol, whose various derivatives may occur in food industry wastes, such as olive mill waste waters.	1
871	Here, we have investigated how the post-synthetic acetylation of @PROTEIN$ affects its interaction with negatively supercoiled DNA by employing monoacetylated at Lys2 protein, isolated from @COMPOUND$-treated cells.	0
872	@PROTEIN$ protein contains high glycine and @COMPOUND$, which concerns regulation and function of the matrix structure fiber.	1
873	@PROTEIN$ protein contains high @COMPOUND$ and tyrosine, which concerns regulation and function of the matrix structure fiber.	1
874	@COMPOUND$ inhibited MIH induced Mos expression and its phosphorylation, which in turn reduced @PROTEIN$ phosphorylation and GVBD.	1
875	@COMPOUND$ inhibited MIH induced @PROTEIN$ expression and its phosphorylation, which in turn reduced Myt1 phosphorylation and GVBD.	1
876	@COMPOUND$ inhibited @PROTEIN$ induced Mos expression and its phosphorylation, which in turn reduced Myt1 phosphorylation and GVBD.	1
877	Differentiated EBD cells in both monolayer and three-dimensional in vitro culture demonstrated fat granules by light microscopy, stained positive for lipids with @COMPOUND$, and expressed adipocyte-specific genes (lipoprotein @PROTEIN$ (LPL), peroxisome proliferator activated receptor gamma2, and adipocyte-specific fatty acid binding protein (alphaP2)).	0
878	Differentiated EBD cells in both monolayer and three-dimensional in vitro culture demonstrated fat granules by light microscopy, stained positive for lipids with @COMPOUND$, and expressed adipocyte-specific genes (lipoprotein lipase (LPL), peroxisome proliferator activated receptor gamma2, and adipocyte-specific @PROTEIN$ (alphaP2)).	0
879	Differentiated EBD cells in both monolayer and three-dimensional in vitro culture demonstrated fat granules by light microscopy, stained positive for lipids with @COMPOUND$, and expressed adipocyte-specific genes (lipoprotein lipase (@PROTEIN$), peroxisome proliferator activated receptor gamma2, and adipocyte-specific fatty acid binding protein (alphaP2)).	0
880	Differentiated EBD cells in both monolayer and three-dimensional in vitro culture demonstrated fat granules by light microscopy, stained positive for lipids with @COMPOUND$, and expressed adipocyte-specific genes (lipoprotein lipase (LPL), peroxisome proliferator activated receptor @PROTEIN$, and adipocyte-specific fatty acid binding protein (alphaP2)).	0
881	Beta1,4-@PROTEIN$-I (B4GALT1), one of seven beta1,4-galactosyltransferases, is an enzyme commonly found in the trans-Golgi complex that adds @COMPOUND$ to oligosaccharides.	1
882	Beta1,4-galactosyltransferase-I (@PROTEIN$), one of seven beta1,4-galactosyltransferases, is an enzyme commonly found in the trans-Golgi complex that adds @COMPOUND$ to oligosaccharides.	1
883	Beta1,4-galactosyltransferase-I (B4GALT1), one of seven beta1,4-@PROTEIN$, is an enzyme commonly found in the trans-Golgi complex that adds @COMPOUND$ to oligosaccharides.	1
884	To compare expression of endometrial estrogen (ER) and progesterone (PR) receptors, beta(3)-integrin subunit, leukemia inhibitory factor (LIF), interleukin-6 (@PROTEIN$), and pinopodes in Indian women using @COMPOUND$ as a contraceptive with fertile and infertile subjects during the window of implantation.	1
885	To compare expression of endometrial estrogen (ER) and progesterone (PR) receptors, beta(3)-integrin subunit, leukemia inhibitory factor (LIF), @PROTEIN$ (IL-6), and pinopodes in Indian women using @COMPOUND$ as a contraceptive with fertile and infertile subjects during the window of implantation.	1
886	To compare expression of endometrial estrogen (ER) and progesterone (PR) receptors, beta(3)-integrin subunit, leukemia inhibitory factor (@PROTEIN$), interleukin-6 (IL-6), and pinopodes in Indian women using @COMPOUND$ as a contraceptive with fertile and infertile subjects during the window of implantation.	1
887	Exposure of erythrocytes to PGNs increased cytosolic Ca(2+) concentration, increased ceramide formation, enhanced the percentage of @PROTEIN$-binding erythrocytes, decreased erythrocyte forward scatter, and lowered the intracellular @COMPOUND$ concentration.	0
888	Exposure of erythrocytes to @PROTEIN$ increased cytosolic Ca(2+) concentration, increased ceramide formation, enhanced the percentage of annexin V-binding erythrocytes, decreased erythrocyte forward scatter, and lowered the intracellular @COMPOUND$ concentration.	1
889	Exposure of erythrocytes to PGNs increased cytosolic @COMPOUND$+) concentration, increased ceramide formation, enhanced the percentage of @PROTEIN$-binding erythrocytes, decreased erythrocyte forward scatter, and lowered the intracellular ATP concentration.	0
890	Exposure of erythrocytes to @PROTEIN$ increased cytosolic @COMPOUND$+) concentration, increased ceramide formation, enhanced the percentage of annexin V-binding erythrocytes, decreased erythrocyte forward scatter, and lowered the intracellular ATP concentration.	1
891	@COMPOUND$, an anticonvulsant and mood stabilizer, up-regulates @PROTEIN$, a neurotrophic/neuroprotective protein.	1
892	These data collectively suggest that @COMPOUND$ induces Bcl-2 regulation partially through activations of the ERK and @PROTEIN$ cascades and their convergent kinase, RSK, although other unknown mechanism(s) are likely involved.	1
893	These data collectively suggest that @COMPOUND$ induces Bcl-2 regulation partially through activations of the ERK and PI3K cascades and their convergent kinase, @PROTEIN$, although other unknown mechanism(s) are likely involved.	1
894	These data collectively suggest that @COMPOUND$ induces @PROTEIN$ regulation partially through activations of the ERK and PI3K cascades and their convergent kinase, RSK, although other unknown mechanism(s) are likely involved.	1
895	These data collectively suggest that @COMPOUND$ induces Bcl-2 regulation partially through activations of the @PROTEIN$ and PI3K cascades and their convergent kinase, RSK, although other unknown mechanism(s) are likely involved.	1
896	Given the known roles of @PROTEIN$ in the central nervous system, the current findings offer a partial yet complex molecular mechanistic explanation for the known neurobiological effects of @COMPOUND$ including neurite growth, neuronal survival, and neurogenesis.	0
897	As metabolic flux for the operation of the @COMPOUND$ pathway is maintained through the activities of @PROTEIN$ and C4H, thus, catechins biosynthesis in tea is critically dependent on the products of these enzymes.	1
898	As metabolic flux for the operation of the @COMPOUND$ pathway is maintained through the activities of PAL and @PROTEIN$, thus, catechins biosynthesis in tea is critically dependent on the products of these enzymes.	1
899	Inhibition of non-small cell lung cancer cell migration by grape seed @COMPOUND$ is mediated through the inhibition of nitric oxide, guanylate cyclase, and @PROTEIN$/2.	1
900	Inhibition of non-small cell lung cancer cell migration by grape seed @COMPOUND$ is mediated through the inhibition of nitric oxide, guanylate @PROTEIN$, and ERK1/2.	1
901	GSPs inhibited @COMPOUND$ and 8-Br-cGMP-induced activation of @PROTEIN$/2 in A549 cells.	1
902	GSPs inhibited L-arginine and @COMPOUND$-induced activation of @PROTEIN$/2 in A549 cells.	1
903	Aim To investigate retrospectively the impact of @PROTEIN$ resistance on treatment response in Chinese genotype 1 CHC patients receiving a 24-week course therapy with peginterferon alpha-2b/@COMPOUND$.	1
904	@PROTEIN$ overexpression decreased plasma and liver @COMPOUND$ concentrations but did not affect glutamine or arginine homeostasis.	1
905	@PROTEIN$ overexpression decreased plasma and liver ornithine concentrations but did not affect @COMPOUND$ or arginine homeostasis.	0
906	@PROTEIN$ overexpression decreased plasma and liver ornithine concentrations but did not affect glutamine or @COMPOUND$ homeostasis.	0
907	There was an inverse relationship between @COMPOUND$ levels and @PROTEIN$ activity.	1
908	Bone marrow cells were obtained from 5-day-old Muscovy ducks and cultured with (Group A) No added factors, (B) 30ng/mL soluble @PROTEIN$ (sRANKL), (C) 30ng/mL sRANKL and 10ng/mL OPG, (D) 10ng/mL OPG, (E) 50ng/mL OPG, (F) 100ng/mL OPG and (G) 30ng/mL sRANKL, 6mmol/@COMPOUND$ and 3mmol/L P. sRANKL promoted the survival of OCs on day 2, whereas the number of OCs decreased with addition of OPG in a dose-dependent manner.	0
909	Bone marrow cells were obtained from 5-day-old Muscovy ducks and cultured with (Group A) No added factors, (B) 30ng/mL soluble RANKL (sRANKL), (C) 30ng/mL sRANKL and 10ng/mL @PROTEIN$, (D) 10ng/mL OPG, (E) 50ng/mL OPG, (F) 100ng/mL OPG and (G) 30ng/mL sRANKL, 6mmol/@COMPOUND$ and 3mmol/L P. sRANKL promoted the survival of OCs on day 2, whereas the number of OCs decreased with addition of OPG in a dose-dependent manner.	0
910	Over-expression of @PROTEIN$ decreased the yield of ethanol and 2,3-butanediol, meanwhile it increased the concentration of @COMPOUND$.	1
911	Over-expression of @PROTEIN$ decreased the yield of @COMPOUND$ and 2,3-butanediol, meanwhile it increased the concentration of acetic acid.	1
912	Over-expression of @PROTEIN$ decreased the yield of ethanol and @COMPOUND$, meanwhile it increased the concentration of acetic acid.	1
913	When the @PROTEIN$ concentration was higher than 15 U/mL, the gelation could be finished within 1 min and yielded a composite with evenly suspended and distributed @COMPOUND$ microspheres.	1
914	The culture tests using MSCs show that the level of alkaline phosphatase (@PROTEIN$) activity in the cells cultured on SPV-H increased during the 21-day culture in a medium without Dex and @COMPOUND$.	1
915	The culture tests using MSCs show that the level of @PROTEIN$ (ALP) activity in the cells cultured on SPV-H increased during the 21-day culture in a medium without Dex and @COMPOUND$.	1
916	The @PROTEIN$ and LUC genes were chosen because they can be used as markers for the easy detection of transgenic plants, while @COMPOUND$ tail better enables the isolation of protein expressed in plant tissue.	0
917	The amplification of gltA gene encoding @PROTEIN$ of TCA cycle was required for the efficient conversion of acetyl-CoA, generated during vanillin production from @COMPOUND$, to CoA, which is essential for vanillin production.	1
918	The amplification of @PROTEIN$ gene encoding citrate synthase of TCA cycle was required for the efficient conversion of acetyl-CoA, generated during vanillin production from @COMPOUND$, to CoA, which is essential for vanillin production.	1
919	The amplification of gltA gene encoding @PROTEIN$ of TCA cycle was required for the efficient conversion of acetyl-CoA, generated during @COMPOUND$ production from ferulic acid, to CoA, which is essential for vanillin production.	1
920	The amplification of @PROTEIN$ gene encoding citrate synthase of TCA cycle was required for the efficient conversion of acetyl-CoA, generated during @COMPOUND$ production from ferulic acid, to CoA, which is essential for vanillin production.	1
921	Treatment of dermal fibroblasts with @COMPOUND$) induced expression of @PROTEIN$ (1.2+/-0.2, 1.7+/-0.2, and 1.8+/-0.2 relative fold increase) and BMP-6 (9.1+/-0.3, 23.3+/-2.1, and 30.4+/-3.0 relative fold increase) at 3, 14, and 21 days, respectively.	1
922	Treatment of dermal fibroblasts with @COMPOUND$) induced expression of BMP-4 (1.2+/-0.2, 1.7+/-0.2, and 1.8+/-0.2 relative fold increase) and @PROTEIN$ (9.1+/-0.3, 23.3+/-2.1, and 30.4+/-3.0 relative fold increase) at 3, 14, and 21 days, respectively.	1
923	The aims of this study were: (i) to characterize the basal circadian rhythm of adrenocorticotropin hormone (@PROTEIN$) and cortisol in IBS vs healthy controls; (ii) to compare stimulated ACTH, cortisol and @COMPOUND$ responses to a pelvic visceral stressor (sigmoidoscopy) in IBS and controls; and (iii) to correlate neuroendocrine responses with colonic mucosal cytokine expression and symptoms in IBS.	0
924	The aims of this study were: (i) to characterize the basal circadian rhythm of adrenocorticotropin hormone (@PROTEIN$) and @COMPOUND$ in IBS vs healthy controls; (ii) to compare stimulated ACTH, cortisol and noradrenaline responses to a pelvic visceral stressor (sigmoidoscopy) in IBS and controls; and (iii) to correlate neuroendocrine responses with colonic mucosal cytokine expression and symptoms in IBS.	0
925	The aim of the present study was to examine whether increased serum Hsp70 levels are related to clinical characteristics and standard laboratory parameters of preeclamptic patients, as well as to markers of inflammation (C-reactive protein), endothelial activation (von Willebrand factor antigen) or endothelial injury (@PROTEIN$), trophoblast debris (cell-free fetal DNA) and oxidative stress (@COMPOUND$).	0
926	The aim of the present study was to examine whether increased serum @PROTEIN$ levels are related to clinical characteristics and standard laboratory parameters of preeclamptic patients, as well as to markers of inflammation (C-reactive protein), endothelial activation (von Willebrand factor antigen) or endothelial injury (fibronectin), trophoblast debris (cell-free fetal DNA) and oxidative stress (@COMPOUND$).	0
927	In preeclamptic patients, serum Hsp70 levels showed significant correlations with serum @PROTEIN$ levels (Spearman R = 0.32, p = 0.010), serum aspartate aminotransferase (R = 0.32, p = 0.008) and LDH (0.001), as well as with plasma @COMPOUND$ levels (R = 0.25, p = 0.043).	0
928	In preeclamptic patients, serum @PROTEIN$ levels showed significant correlations with serum CRP levels (Spearman R = 0.32, p = 0.010), serum aspartate aminotransferase (R = 0.32, p = 0.008) and LDH (0.001), as well as with plasma @COMPOUND$ levels (R = 0.25, p = 0.043).	1
929	In preeclamptic patients, serum Hsp70 levels showed significant correlations with serum CRP levels (Spearman R = 0.32, p = 0.010), serum @PROTEIN$ (R = 0.32, p = 0.008) and LDH (0.001), as well as with plasma @COMPOUND$ levels (R = 0.25, p = 0.043).	0
930	In preeclamptic patients, serum Hsp70 levels showed significant correlations with serum CRP levels (Spearman R = 0.32, p = 0.010), serum aspartate aminotransferase (R = 0.32, p = 0.008) and @PROTEIN$ (0.001), as well as with plasma @COMPOUND$ levels (R = 0.25, p = 0.043).	0
931	In an effort to identify agents which enhance the activity of oligos and which possess less toxicity than traditionally employed chemotherapeutics, @COMPOUND$, an immunosuppressive agent known to regulate tumor growth and signal transduction mediated by the @PROTEIN$ receptor, is compared to paclitaxel in combination therapy employing monospecific or bispecific oligos.	1
932	In an effort to identify agents which enhance the activity of oligos and which possess less toxicity than traditionally employed chemotherapeutics, Rapamycin, an immunosuppressive agent known to regulate tumor growth and signal transduction mediated by the @PROTEIN$ receptor, is compared to @COMPOUND$ in combination therapy employing monospecific or bispecific oligos.	0
933	Further study suggested that @COMPOUND$ can directly inhibit @PROTEIN$ and exhibits competitive inhibition.	1
934	Pretreatment with ER antagonist @COMPOUND$ blocked both E2-induced @PROTEIN$/2-MAPK activation and MUC5B gene expression.	1
935	Pretreatment with ER antagonist @COMPOUND$ blocked both E2-induced ERK1/2-@PROTEIN$ activation and MUC5B gene expression.	1
936	Pretreatment with ER antagonist @COMPOUND$ blocked both E2-induced ERK1/2-MAPK activation and @PROTEIN$ gene expression.	1
937	However, as opposed to exogenous @COMPOUND$, the continuous use of @PROTEIN$ during in vitro differentiation completely blocked rMSC mineralization.	0
938	@COMPOUND$ stimulates antioxidant response element-mediated expression of @PROTEIN$ in mouse macrophages.	1
939	The current study investigated whether @COMPOUND$ induces transcription of @PROTEIN$ (Gcl), via ARE driven gene expression in mouse macrophages.	0
940	The current study investigated whether @COMPOUND$ induces transcription of glutamate-cysteine ligase (@PROTEIN$), via ARE driven gene expression in mouse macrophages.	0
941	Ligand-induced @PROTEIN$-downregulation modulates cell death associated proteins and enhances chemosensitivity to @COMPOUND$ in THP-1 acute myeloid leukemia cells.	1
942	Only EGF activated @PROTEIN$ signaling and up-regulated early gene expression, while @COMPOUND$ triggered the expression of classical AR-responsive genes with the exception of the EGF-induced PSA transcript in A549 cells.	0
943	Only EGF activated ERK signaling and up-regulated early gene expression, while @COMPOUND$ triggered the expression of classical AR-responsive genes with the exception of the EGF-induced @PROTEIN$ transcript in A549 cells.	0
944	Only @PROTEIN$ activated ERK signaling and up-regulated early gene expression, while @COMPOUND$ triggered the expression of classical AR-responsive genes with the exception of the EGF-induced PSA transcript in A549 cells.	0
945	The influence of the prenylation status of @PROTEIN$ on the observed changes in endothelial cell growth under high @COMPOUND$ conditions has not previously been examined.	0
946	Calcineurin inhibitors (CsA, @COMPOUND$ and pimecrolimus) inhibited NO production and @PROTEIN$ expression in a concentration-dependent manner, CsA being more potent than FK-506 and pimecrolimus.	1
947	Calcineurin inhibitors (CsA, FK-506 and @COMPOUND$) inhibited NO production and @PROTEIN$ expression in a concentration-dependent manner, CsA being more potent than FK-506 and pimecrolimus.	1
948	In sum, @COMPOUND$ exposure lowered TOSC, a result that at least in part can be related to lowering of antioxidant enzymes like @PROTEIN$.	1
949	Biological testing of the compound demonstrated a significant antidiabetic activity by reducing the elevated blood glucose levels and restoring the @PROTEIN$ levels in @COMPOUND$-induced diabetic rats.	0
950	Biological testing of the compound demonstrated a significant antidiabetic activity by reducing the elevated blood @COMPOUND$ levels and restoring the @PROTEIN$ levels in streptozotocin-induced diabetic rats.	0
951	Both SAHA and @COMPOUND$ induced an arrest in the cell cycle along with the induction of apoptotic pathways as evidenced by flow cytometry, annexin assay, detection of activated caspase 9, and molecular analysis of @PROTEIN$/Bcl-2 expression.	1
952	Both @COMPOUND$ and MS-275 induced an arrest in the cell cycle along with the induction of apoptotic pathways as evidenced by flow cytometry, annexin assay, detection of activated caspase 9, and molecular analysis of @PROTEIN$/Bcl-2 expression.	1
953	Both SAHA and @COMPOUND$ induced an arrest in the cell cycle along with the induction of apoptotic pathways as evidenced by flow cytometry, annexin assay, detection of activated caspase 9, and molecular analysis of Bax/@PROTEIN$ expression.	1
954	Both @COMPOUND$ and MS-275 induced an arrest in the cell cycle along with the induction of apoptotic pathways as evidenced by flow cytometry, annexin assay, detection of activated caspase 9, and molecular analysis of Bax/@PROTEIN$ expression.	1
955	Immunolocalization of @PROTEIN$ in the boar epididymis: the effect of GnRH agonist @COMPOUND$.	0
956	Furthermore, inhibition of caveolin-1 expression using a caveolin-1 siRNA significantly attenuated E(2)-induced up-regulation of proto-oncogenes, @PROTEIN$, ((3)H)-@COMPOUND$ incorporation, overall cell number, and percent of the cell population in S phase, while mediating a concomitant increase in the G0/G1 population.	0
957	During the early response in AR, @COMPOUND$ has been found to be the most abundant mediator and it is associated with many symptoms of this disease mediated through the @PROTEIN$.	1
958	The effect on activation voltage but not that on amplitude was absent when expressing a cAMP-insensitive mutant (@PROTEIN$R/E), while a C-terminal truncated form of HCN2 (HCN2DeltaCx) exhibited only the voltage dependent but not the amplitude effect of @COMPOUND$.	1
959	In contrast to newborn myocytes, @COMPOUND$ had no effect on @PROTEIN$ under control conditions in adult myocytes but induced a negative shift with no change in amplitude when saturated cAMP was added to the pipette solution.	0
960	In contrast to newborn myocytes, erbstatin had no effect on @PROTEIN$ under control conditions in adult myocytes but induced a negative shift with no change in amplitude when saturated @COMPOUND$ was added to the pipette solution.	0
961	A D-amino acid oxidase gene (dao) was ligated with the P(Hase) and cloned into pGEMKT to constitutively express protein of @PROTEIN$ without the use of any inducer such as @COMPOUND$ which is poisonous to the cells and environment.	1
962	A D-amino acid oxidase gene (@PROTEIN$) was ligated with the P(Hase) and cloned into pGEMKT to constitutively express protein of DAAO without the use of any inducer such as @COMPOUND$ which is poisonous to the cells and environment.	1
963	In response to a @COMPOUND$-containing atherogenic diet, C57BL/6J mice significantly increased expression of @PROTEIN$ in the aorta, while mice lacking UCP2, in the absence of any other genetic modification, displayed significant endothelial dysfunction following the atherogenic diet.	1
964	PC-1 is the primary generator of @COMPOUND$ in osteoblastic cells; therefore, regulated expression of PC-1 by @PROTEIN$s may be a principal mechanism by which FGF signaling affects bone mineralization.	1
965	PC-1 is the primary generator of @COMPOUND$ in osteoblastic cells; therefore, regulated expression of PC-1 by @PROTEIN$ may be a principal mechanism by which FGF signaling affects bone mineralization.	1
966	In analogy to the reduction of @COMPOUND$+) oscillation frequency, the blockers impaired HCEC contraction, NF-kappaB activation, and @PROTEIN$ expression.	1
967	Cisternal SAH-CSF induces cytosolic @COMPOUND$+) oscillations in HCEC that results in cellular constriction, NF-kappaB activation, and @PROTEIN$ expression.	1
968	For proof of principle, we use L-lactate and @COMPOUND$ as representative pair of enantiomers, L-@PROTEIN$ as stereospecific signal generator, and cascade blue hydrazide as reactive signal amplifier to capture the produced pyruvate.	0
969	For proof of principle, we use @COMPOUND$ and D-lactate as representative pair of enantiomers, L-@PROTEIN$ as stereospecific signal generator, and cascade blue hydrazide as reactive signal amplifier to capture the produced pyruvate.	0
970	For proof of principle, we use L-lactate and D-lactate as representative pair of enantiomers, L-@PROTEIN$ as stereospecific signal generator, and cascade blue hydrazide as reactive signal amplifier to capture the produced @COMPOUND$.	0
971	Escherichia coli strain PC09 (DeltaxylB, cAMP-independent CRP (crp *) mutant) expressing an NADPH-dependent @PROTEIN$ from Candida boidinii (CbXR) was previously reported to produce @COMPOUND$ from xylose while metabolizing glucose (Cirino et al.	1
972	Escherichia coli strain PC09 (DeltaxylB, cAMP-independent CRP (crp *) mutant) expressing an NADPH-dependent @PROTEIN$ from Candida boidinii (CbXR) was previously reported to produce xylitol from xylose while metabolizing @COMPOUND$ (Cirino et al.	1
973	Studies in which the expression of CbXR or a @PROTEIN$ was increased suggest that enzyme activity and xylose transport are not limiting @COMPOUND$ production in PC09.	1
974	Deleting either @PROTEIN$ or sucC (TCA cycle) significantly reduces the yield from 3.4 to 2.0 and 2.3 mol xylitol (mol @COMPOUND$)(-1), respectively.	1
975	Deleting either zwf or @PROTEIN$ (TCA cycle) significantly reduces the yield from 3.4 to 2.0 and 2.3 mol @COMPOUND$ (mol glucose)(-1), respectively.	1
976	Deleting either zwf or @PROTEIN$ (TCA cycle) significantly reduces the yield from 3.4 to 2.0 and 2.3 mol xylitol (mol @COMPOUND$)(-1), respectively.	1
977	Deleting either @PROTEIN$ or sucC (TCA cycle) significantly reduces the yield from 3.4 to 2.0 and 2.3 mol @COMPOUND$ (mol glucose)(-1), respectively.	1
978	In the process studied, the enzyme cellobiose dehydrogenase (@PROTEIN$) oxidizes lactose at the C-1 position of the reducing sugar moiety to lactobionolactone, which spontaneously hydrolyzes to @COMPOUND$.	1
979	In the process studied, the enzyme cellobiose dehydrogenase (@PROTEIN$) oxidizes @COMPOUND$ at the C-1 position of the reducing sugar moiety to lactobionolactone, which spontaneously hydrolyzes to lactobionic acid.	1
980	SM (@COMPOUND$), a major steroidal alkaloid glycoside purified from Solanum incanum, triggered apoptosis of breast cancer cells (MCF-7 and SK-BR-3 cells) and non-cancerous breast epithelial cells (HBL-100 cells) within 3 h. To extend the application of trastuzumab in breast cancer patients, the regulation of @PROTEIN$/neu expression by SM was investigated.	0
981	SM (solamargine), a major @COMPOUND$ glycoside purified from Solanum incanum, triggered apoptosis of breast cancer cells (MCF-7 and SK-BR-3 cells) and non-cancerous breast epithelial cells (HBL-100 cells) within 3 h. To extend the application of trastuzumab in breast cancer patients, the regulation of HER2/@PROTEIN$ expression by SM was investigated.	0
982	SM (@COMPOUND$), a major steroidal alkaloid glycoside purified from Solanum incanum, triggered apoptosis of breast cancer cells (MCF-7 and SK-BR-3 cells) and non-cancerous breast epithelial cells (HBL-100 cells) within 3 h. To extend the application of trastuzumab in breast cancer patients, the regulation of HER2/@PROTEIN$ expression by SM was investigated.	0
983	SM (solamargine), a major @COMPOUND$ glycoside purified from Solanum incanum, triggered apoptosis of breast cancer cells (MCF-7 and SK-BR-3 cells) and non-cancerous breast epithelial cells (HBL-100 cells) within 3 h. To extend the application of trastuzumab in breast cancer patients, the regulation of @PROTEIN$/neu expression by SM was investigated.	0
984	In conclusion, dentin mineralization in a corrected @COMPOUND$ and vitamin D environment compensates the adverse effect of @PROTEIN$ mutation.	0
985	In conclusion, dentin mineralization in a corrected phosphate and @COMPOUND$ environment compensates the adverse effect of @PROTEIN$ mutation.	0
986	Prolonged L-alanine exposure induces changes in metabolism, @COMPOUND$+) handling and desensitization of @PROTEIN$ secretion in clonal pancreatic beta-cells.	0
987	Prolonged L-@COMPOUND$ exposure induces changes in metabolism, Ca(2+) handling and desensitization of @PROTEIN$ secretion in clonal pancreatic beta-cells.	1
988	Acylation-stimulating protein (@PROTEIN$) has been shown to positively stimulate fatty acid esterification and @COMPOUND$ uptake in adipocytes.	1
989	Cilostazol is a selective inhibitor of phosphodiesterase 3 that increases intracellular cyclic AMP (@COMPOUND$) levels and activates @PROTEIN$, thereby inhibiting platelet aggregation and inducing peripheral vasodilation.	0
990	@COMPOUND$ is a selective inhibitor of phosphodiesterase 3 that increases intracellular cyclic AMP (cAMP) levels and activates @PROTEIN$, thereby inhibiting platelet aggregation and inducing peripheral vasodilation.	1
991	We hypothesized that @COMPOUND$ may prevent inflammatory cytokine induced-nuclear factor (NF)-kappaB activation by activating AMP-activated protein kinase (@PROTEIN$) in vascular endothelial cells.	1
992	We hypothesized that @COMPOUND$ may prevent inflammatory cytokine induced-nuclear factor (NF)-kappaB activation by activating AMP-activated @PROTEIN$ (AMPK) in vascular endothelial cells.	1
993	A2aR stimulation inhibits HA fragment-induced pro-fibrotic genes @PROTEIN$, keratinocyte chemoattractant (KC), macrophage inflammatory protein (MIP)-2, and MIP-1alpha while simultaneously synergizing with @COMPOUND$ fragments to up-regulate the TH1 cytokine IL-12.	0
994	A2aR stimulation inhibits HA fragment-induced pro-fibrotic genes TNF-alpha, keratinocyte chemoattractant (KC), macrophage inflammatory protein (@PROTEIN$)-2, and MIP-1alpha while simultaneously synergizing with @COMPOUND$ fragments to up-regulate the TH1 cytokine IL-12.	0
995	A2aR stimulation inhibits HA fragment-induced pro-fibrotic genes TNF-alpha, keratinocyte chemoattractant (KC), macrophage inflammatory protein (MIP)-2, and @PROTEIN$ while simultaneously synergizing with @COMPOUND$ fragments to up-regulate the TH1 cytokine IL-12.	0
996	In addition, treatment of primary mouse lung fibroblasts with @COMPOUND$ stimulated @PROTEIN$ activity and collagen formation in vitro.	1
997	@COMPOUND$ stimulated @PROTEIN$ secretion (GSIS) was lower in the Glu group.	1
998	Further, they demonstrate that @PROTEIN$ blockade may also have beneficial effects on cognitive deficits induced by @COMPOUND$ depletion.	1
999	Gene expression of mitogen-activated protein kinase (@PROTEIN$) phosphatase-1 was also increased by the addition of @COMPOUND$.	1
1000	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (@PROTEIN$), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (@COMPOUND$), vitamin E and vitamin C.	0
1001	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (@PROTEIN$), catalase (CAT), glutathione peroxidase (GPx), @COMPOUND$ (GSH), vitamin E and vitamin C.	0
1002	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (@PROTEIN$) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), vitamin E and @COMPOUND$.	0
1003	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (@PROTEIN$), glutathione peroxidase (GPx), reduced glutathione (GSH), vitamin E and @COMPOUND$.	0
1004	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (@PROTEIN$), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (@COMPOUND$), vitamin E and vitamin C.	0
1005	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (@PROTEIN$) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), @COMPOUND$ (GSH), vitamin E and vitamin C.	0
1006	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), @PROTEIN$ (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), vitamin E and @COMPOUND$.	0
1007	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (@PROTEIN$), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), @COMPOUND$ (GSH), vitamin E and vitamin C.	0
1008	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (@PROTEIN$) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), @COMPOUND$ and vitamin C.	0
1009	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (@PROTEIN$), glutathione peroxidase (GPx), reduced glutathione (GSH), @COMPOUND$ and vitamin C.	0
1010	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (@PROTEIN$) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (@COMPOUND$), vitamin E and vitamin C.	0
1011	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (@PROTEIN$), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), @COMPOUND$ and vitamin C.	0
1012	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), @PROTEIN$ (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), @COMPOUND$ and vitamin C.	0
1013	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker @PROTEIN$ (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (@COMPOUND$), vitamin E and vitamin C.	0
1014	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (@PROTEIN$), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), @COMPOUND$ and vitamin C.	0
1015	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (@PROTEIN$), glutathione peroxidase (GPx), reduced glutathione (@COMPOUND$), vitamin E and vitamin C.	0
1016	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (@PROTEIN$), glutathione peroxidase (GPx), @COMPOUND$ (GSH), vitamin E and vitamin C.	0
1017	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker @PROTEIN$ (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), @COMPOUND$ and vitamin C.	0
1018	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker @PROTEIN$ (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), vitamin E and @COMPOUND$.	0
1019	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), @PROTEIN$ (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), @COMPOUND$ and vitamin C.	0
1020	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (@PROTEIN$), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), vitamin E and @COMPOUND$.	0
1021	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), @PROTEIN$ (GPx), reduced glutathione (@COMPOUND$), vitamin E and vitamin C.	0
1022	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), @PROTEIN$ (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), @COMPOUND$ (GSH), vitamin E and vitamin C.	0
1023	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like @PROTEIN$ (SOD), catalase (CAT), glutathione peroxidase (GPx), @COMPOUND$ (GSH), vitamin E and vitamin C.	0
1024	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like @PROTEIN$ (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (@COMPOUND$), vitamin E and vitamin C.	0
1025	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), @PROTEIN$ (GPx), reduced glutathione (GSH), @COMPOUND$ and vitamin C.	0
1026	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like @PROTEIN$ (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), @COMPOUND$ and vitamin C.	0
1027	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (@PROTEIN$) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (@COMPOUND$), vitamin E and vitamin C.	0
1028	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (@PROTEIN$) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), @COMPOUND$ (GSH), vitamin E and vitamin C.	0
1029	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), @PROTEIN$ (GPx), @COMPOUND$ (GSH), vitamin E and vitamin C.	0
1030	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), @PROTEIN$ (CAT), glutathione peroxidase (GPx), @COMPOUND$ (GSH), vitamin E and vitamin C.	0
1031	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), @PROTEIN$ (CAT), glutathione peroxidase (GPx), reduced glutathione (@COMPOUND$), vitamin E and vitamin C.	0
1032	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), @PROTEIN$ (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (@COMPOUND$), vitamin E and vitamin C.	0
1033	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like @PROTEIN$ (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), vitamin E and @COMPOUND$.	0
1034	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), @PROTEIN$ (GPx), reduced glutathione (GSH), vitamin E and @COMPOUND$.	0
1035	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (@PROTEIN$) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), vitamin E and @COMPOUND$.	0
1036	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), @PROTEIN$ (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), vitamin E and @COMPOUND$.	0
1037	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (@PROTEIN$), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), vitamin E and @COMPOUND$.	0
1038	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker @PROTEIN$ (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (LDH) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), @COMPOUND$ (GSH), vitamin E and vitamin C.	0
1039	Administration of B(a)P (50 mg/kg body weight) to mice resulted in increased lipid peroxides (LPO), lung specific tumor marker carcinoembryonic antigen (CEA) and serum marker enzymes aryl hydrocarbon hydroxylase (AHH), gamma glutamyl transpeptidase (GGT), 5'nucleotidase (5'ND) and lactate dehydrogenase (@PROTEIN$) with concomitant decrease in the levels of tissue antioxidants like superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), @COMPOUND$ and vitamin C.	0
1040	Achieving CCgR within 12 months and maintaining it without an increase in @PROTEIN$-ABL transcripts might indicate that low-dose @COMPOUND$ therapy can produce acceptable outcomes without excess toxicity.	1
1041	Achieving CCgR within 12 months and maintaining it without an increase in BCR-@PROTEIN$ transcripts might indicate that low-dose @COMPOUND$ therapy can produce acceptable outcomes without excess toxicity.	1
1042	Use of @PROTEIN$ and fibronectin to influence osteoblast responses to @COMPOUND$ scaffolds.	1
1043	Use of tissue transglutaminase and @PROTEIN$ to influence osteoblast responses to @COMPOUND$ scaffolds.	1
1044	To explore the possibility of controlling cell interaction with biomaterials, @COMPOUND$ scaffolds were modified using the enzyme @PROTEIN$ (tTgase) in conjunction with fibronectin.	1
1045	To explore the possibility of controlling cell interaction with biomaterials, @COMPOUND$ scaffolds were modified using the enzyme tissue transglutaminase (tTgase) in conjunction with @PROTEIN$.	1
1046	Hence, MPTP lesion, L-DOPA treatment and prevention of LID with CI-1041 and cabergoline, or reduction with @COMPOUND$ were associated with modulation of @PROTEIN$/NMDA glutamate receptors.	1
1047	Hence, MPTP lesion, @COMPOUND$ treatment and prevention of LID with CI-1041 and cabergoline, or reduction with Ro 61-8048 were associated with modulation of @PROTEIN$/NMDA glutamate receptors.	1
1048	Hence, MPTP lesion, L-DOPA treatment and prevention of LID with CI-1041 and @COMPOUND$, or reduction with Ro 61-8048 were associated with modulation of @PROTEIN$/NMDA glutamate receptors.	1
1049	@PROTEIN$ (UDP-N-acetylmuramoyl-L-alanine:D-glutamate ligase), a three-domain bacterial protein, catalyses a highly specific incorporation of D-glutamate to the cytoplasmic intermediate UDP-N-acetyl-muramoyl-L-alanine (@COMPOUND$) utilizing ATP hydrolysis to ADP and P(i).	1
1050	Although the overall amino acid identity between @PROTEIN$ and the LeuT(Aa) is only 17%, it increases to above 50% in the first shell of the putative 5-HT binding site, allowing de novo computational docking of @COMPOUND$ derivatives in atomic detail.	0
1051	Our findings suggest that @PROTEIN$ substituted with a PEG of an appropriate Mw at Lys (34) could be used as a promising type 2 anti-diabetic agent to timely control postprandial @COMPOUND$ levels.	1
1052	The antidepressant @COMPOUND$ blocks the adverse effects of stress on memory and enables spatial learning to rapidly increase neural cell adhesion molecule (@PROTEIN$) expression in the hippocampus of rats.	1
1053	Incubation of rat hepatocyte primary cultures with @COMPOUND$+) results in apoptosis induction with caspase activation and increased level of expression of @PROTEIN$.	1
1054	@COMPOUND$ reduced amounts of the caspase inhibitor XIAP, and API-2 increased amounts of the BH3-only protein @PROTEIN$.	0
1055	@PROTEIN$ accumulated in mitochondria in response to API-2, whereas release of cytochrome c from mitochondria required both API-2 and @COMPOUND$.	0
1056	Bax accumulated in mitochondria in response to API-2, whereas release of @PROTEIN$ from mitochondria required both API-2 and @COMPOUND$.	1
1057	We suggest that @COMPOUND$ elicits events that activate Bax once it translocates to mitochondria and that inactivation of @PROTEIN$ signals these events and the down-regulation of XIAP.	1
1058	We suggest that @COMPOUND$ elicits events that activate @PROTEIN$ once it translocates to mitochondria and that inactivation of cdk9 signals these events and the down-regulation of XIAP.	1
1059	These results indicate that @COMPOUND$ controls glucose homeostasis by regulating the expression of genes required for glucose-stimulated @PROTEIN$ secretion.	1
1060	These results indicate that taurine controls @COMPOUND$ homeostasis by regulating the expression of genes required for glucose-stimulated @PROTEIN$ secretion.	1
1061	Furthermore, treatment of @COMPOUND$ and EPA also synergistically blocked the activation of downstream @PROTEIN$ molecule.	1
1062	Immunocytochemical staining results revealed that @COMPOUND$ and EPA could also up-regulate the expression of apoptotic proteins such as @PROTEIN$ and Fas ligand to suppress cell survival.	1
1063	Immunocytochemical staining results revealed that @COMPOUND$ and EPA could also up-regulate the expression of apoptotic proteins such as Bax and @PROTEIN$ to suppress cell survival.	1
1064	Ependymal and displaced ependymal cells also expressed EGFR and @PROTEIN$ on their cilia but did not incorporate @COMPOUND$.	0
1065	Ependymal and displaced ependymal cells also expressed @PROTEIN$ and PDGFRalpha on their cilia but did not incorporate @COMPOUND$.	0
1066	Accordingly, the TLR3 agonist @COMPOUND$) (PIC) induced higher release of @PROTEIN$ in primary and purified astroglia than in microglia.	1
1067	Accordingly, the TLR3 agonist poly(I:C) (@COMPOUND$) induced higher release of @PROTEIN$ in primary and purified astroglia than in microglia.	1
1068	Animal evidence indicates that green tea may modulate @PROTEIN$ sensitivity, with epigallocatechin-3-gallate (@COMPOUND$) proposed as a likely health-promoting component.	0
1069	Animal evidence indicates that green tea may modulate @PROTEIN$ sensitivity, with @COMPOUND$ (EGCG) proposed as a likely health-promoting component.	0
1070	Animal evidence indicates that @COMPOUND$ may modulate @PROTEIN$ sensitivity, with epigallocatechin-3-gallate (EGCG) proposed as a likely health-promoting component.	0
1071	@COMPOUND$ treatment had no effect on @PROTEIN$ sensitivity, insulin secretion or glucose tolerance but did reduce diastolic blood pressure (mean change: placebo-0.058 (se 0.75) mmHg; EGCG-2.68 (se 0.72) mmHg; P = 0.014).	0
1072	EGCG treatment had no effect on @PROTEIN$ sensitivity, insulin secretion or @COMPOUND$ tolerance but did reduce diastolic blood pressure (mean change: placebo-0.058 (se 0.75) mmHg; EGCG-2.68 (se 0.72) mmHg; P = 0.014).	0
1073	High-level toxin production occurred after detectable spore germination in all experiments except those with C. difficile PCR ribotype 027 and @COMPOUND$, in which marked @PROTEIN$ production preceded detectable germination, which coincided with isolate recovery on fluoroquinolone-containing medium.	0
1074	Furthermore, @PROTEIN$ overexpression reduced @COMPOUND$ anion generation after H/R, whereas glutathione levels were significantly improved compared with WT controls.	1
1075	Furthermore, @PROTEIN$ overexpression reduced superoxide anion generation after H/R, whereas @COMPOUND$ levels were significantly improved compared with WT controls.	1
1076	The current study showed that alloxan-induced diabetic animals revealed hyperglycemia and was associated with an increase in the content of @COMPOUND$, @PROTEIN$ expression and PKC 0.05) simultaneously in striatum (ST), midbrain (MB), pons medulla (PM), cerebellum (CB), and cerebral cortex (CCX) from 7 days to 60 days.	0
1077	The current study showed that @COMPOUND$-induced diabetic animals revealed hyperglycemia and was associated with an increase in the content of 5-HT, PKC-alpha expression and PKC 0.05) simultaneously in striatum (ST), midbrain (MB), @PROTEIN$ medulla (PM), cerebellum (CB), and cerebral cortex (CCX) from 7 days to 60 days.	0
1078	The current study showed that alloxan-induced diabetic animals revealed hyperglycemia and was associated with an increase in the content of @COMPOUND$, @PROTEIN$-alpha expression and PKC 0.05) simultaneously in striatum (ST), midbrain (MB), pons medulla (PM), cerebellum (CB), and cerebral cortex (CCX) from 7 days to 60 days.	0
1079	The current study showed that alloxan-induced diabetic animals revealed hyperglycemia and was associated with an increase in the content of @COMPOUND$, PKC-alpha expression and PKC 0.05) simultaneously in striatum (ST), midbrain (MB), @PROTEIN$ medulla (PM), cerebellum (CB), and cerebral cortex (CCX) from 7 days to 60 days.	0
1080	The current study showed that @COMPOUND$-induced diabetic animals revealed hyperglycemia and was associated with an increase in the content of 5-HT, @PROTEIN$ expression and PKC 0.05) simultaneously in striatum (ST), midbrain (MB), pons medulla (PM), cerebellum (CB), and cerebral cortex (CCX) from 7 days to 60 days.	1
1081	The current study showed that @COMPOUND$-induced diabetic animals revealed hyperglycemia and was associated with an increase in the content of 5-HT, @PROTEIN$-alpha expression and PKC 0.05) simultaneously in striatum (ST), midbrain (MB), pons medulla (PM), cerebellum (CB), and cerebral cortex (CCX) from 7 days to 60 days.	1
1082	Although the @COMPOUND$ levels in hippocampus (HC) and hypothalamus (HT) were not altered, the @PROTEIN$ expression and PKC 0.05) in level in HC.	0
1083	Although the @COMPOUND$ levels in hippocampus (HC) and hypothalamus (HT) were not altered, the @PROTEIN$-alpha expression and PKC 0.05) in level in HC.	0
1084	The MEK inhibitor @COMPOUND$ did not inhibit neurite outgrowth, and Y-27632 and staurosporine did not induce @PROTEIN$ phosphorylation, suggesting that the inhibitory effect of ODQ on neurite outgrowth is independent of the ERK signaling pathway.	0
1085	The MEK inhibitor PD98059 did not inhibit neurite outgrowth, and Y-27632 and staurosporine did not induce @PROTEIN$ phosphorylation, suggesting that the inhibitory effect of @COMPOUND$ on neurite outgrowth is independent of the ERK signaling pathway.	0
1086	The MEK inhibitor PD98059 did not inhibit neurite outgrowth, and Y-27632 and @COMPOUND$ did not induce @PROTEIN$ phosphorylation, suggesting that the inhibitory effect of ODQ on neurite outgrowth is independent of the ERK signaling pathway.	0
1087	We used this model to identify a potent competitive inhibitor, N1,N7-dihexyl-1,7-diamino-4-azaheptane, and to develop an affinity column, 1,16-diamino4,13-diazahexadecane-linked @COMPOUND$, which was useful for the purification of @PROTEIN$.	1
1088	Effects on haemolytic activity of single @COMPOUND$ substitutions in the Bordetella pertussis @PROTEIN$ pore-forming fragment.	1
1089	The purpose of the study was to investigate the associations between uptake of (111)In-@COMPOUND$-trastuzumab, tumour @PROTEIN$ density and response to trastuzumab (Herceptin) of human breast cancer (BC) xenografts in athymic mice.	1
1090	Superoxide dismutase (SOD), @PROTEIN$ (GSH-Px), catalase (CAT) enzyme activities, antioxidant potential (AOP) value, malondialdehyde (MDA), @COMPOUND$ and triglyceride levels in the liver tissues and total cholesterol and triglyceride levels in serum samples were measured.	0
1091	Superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), @PROTEIN$ (CAT) enzyme activities, antioxidant potential (AOP) value, malondialdehyde (MDA), @COMPOUND$ and triglyceride levels in the liver tissues and total cholesterol and triglyceride levels in serum samples were measured.	0
1092	Superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), catalase (@PROTEIN$) enzyme activities, antioxidant potential (AOP) value, malondialdehyde (MDA), @COMPOUND$ and triglyceride levels in the liver tissues and total cholesterol and triglyceride levels in serum samples were measured.	0
1093	Superoxide dismutase (@PROTEIN$), glutathione peroxidase (GSH-Px), catalase (CAT) enzyme activities, antioxidant potential (AOP) value, @COMPOUND$ (MDA), cholesterol and triglyceride levels in the liver tissues and total cholesterol and triglyceride levels in serum samples were measured.	0
1094	Superoxide dismutase (SOD), @PROTEIN$ (GSH-Px), catalase (CAT) enzyme activities, antioxidant potential (AOP) value, @COMPOUND$ (MDA), cholesterol and triglyceride levels in the liver tissues and total cholesterol and triglyceride levels in serum samples were measured.	0
1095	@PROTEIN$ (SOD), glutathione peroxidase (GSH-Px), catalase (CAT) enzyme activities, antioxidant potential (AOP) value, malondialdehyde (MDA), @COMPOUND$ and triglyceride levels in the liver tissues and total cholesterol and triglyceride levels in serum samples were measured.	0
1096	Superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), catalase (@PROTEIN$) enzyme activities, antioxidant potential (AOP) value, @COMPOUND$ (MDA), cholesterol and triglyceride levels in the liver tissues and total cholesterol and triglyceride levels in serum samples were measured.	0
1097	@PROTEIN$ (SOD), glutathione peroxidase (GSH-Px), catalase (CAT) enzyme activities, antioxidant potential (AOP) value, @COMPOUND$ (MDA), cholesterol and triglyceride levels in the liver tissues and total cholesterol and triglyceride levels in serum samples were measured.	0
1098	Superoxide dismutase (@PROTEIN$), glutathione peroxidase (GSH-Px), catalase (CAT) enzyme activities, antioxidant potential (AOP) value, malondialdehyde (MDA), @COMPOUND$ and triglyceride levels in the liver tissues and total cholesterol and triglyceride levels in serum samples were measured.	0
1099	Superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), @PROTEIN$ (CAT) enzyme activities, antioxidant potential (AOP) value, @COMPOUND$ (MDA), cholesterol and triglyceride levels in the liver tissues and total cholesterol and triglyceride levels in serum samples were measured.	0
1100	Forced cytoplasmic overexpression of APE1 profoundly attenuated the upregulation of HMGB1-mediated reactive @COMPOUND$ species generation, cytokine secretion, and @PROTEIN$ expression by primary monocytes and macrophage-like THP-1 cell lines.	0
1101	Forced cytoplasmic overexpression of @PROTEIN$ profoundly attenuated the upregulation of HMGB1-mediated reactive @COMPOUND$ species generation, cytokine secretion, and cyclooxygenase-2 expression by primary monocytes and macrophage-like THP-1 cell lines.	1
1102	Forced cytoplasmic overexpression of APE1 profoundly attenuated the upregulation of @PROTEIN$-mediated reactive @COMPOUND$ species generation, cytokine secretion, and cyclooxygenase-2 expression by primary monocytes and macrophage-like THP-1 cell lines.	1
1103	As one of the very few repair systems for oxidized proteins, @PROTEIN$ and MsrB enzymes play a major role in protein homeostasis during aging and have also been involved in cellular defenses against oxidative stress, by scavenging reactive @COMPOUND$ species.	1
1104	As one of the very few repair systems for oxidized proteins, MsrA and @PROTEIN$ enzymes play a major role in protein homeostasis during aging and have also been involved in cellular defenses against oxidative stress, by scavenging reactive @COMPOUND$ species.	1
1105	Repeated injections of arsenic trioxide induced oxidative stress and hepatotoxicity in mice as revealed from elevated levels of glutamate oxaloacetate transaminases, glutamate pyruvate transaminases, acid and alkaline phosphatases, lipid peroxidation along with reduction of @PROTEIN$, catalase, @COMPOUND$ content, glutathione reductase and succinate dehydrogenase activities.	0
1106	Repeated injections of arsenic trioxide induced oxidative stress and hepatotoxicity in mice as revealed from elevated levels of glutamate oxaloacetate transaminases, glutamate pyruvate transaminases, acid and @PROTEIN$, lipid peroxidation along with reduction of superoxide dismutase, catalase, @COMPOUND$ content, glutathione reductase and succinate dehydrogenase activities.	0
1107	Repeated injections of arsenic trioxide induced oxidative stress and hepatotoxicity in mice as revealed from elevated levels of glutamate oxaloacetate transaminases, glutamate pyruvate transaminases, acid and alkaline phosphatases, lipid peroxidation along with reduction of superoxide dismutase, @PROTEIN$, @COMPOUND$ content, glutathione reductase and succinate dehydrogenase activities.	0
1108	Repeated injections of arsenic trioxide induced oxidative stress and hepatotoxicity in mice as revealed from elevated levels of glutamate oxaloacetate transaminases, glutamate pyruvate transaminases, acid and alkaline phosphatases, lipid peroxidation along with reduction of superoxide dismutase, catalase, @COMPOUND$ content, @PROTEIN$ and succinate dehydrogenase activities.	0
1109	1x10(-5) mol L(-1)), most of the site marker reacted with the quercetin-@PROTEIN$, but free @COMPOUND$ was present at higher concentrations.	0
1110	Under optimum conditions, the fluorescence intensity of @PROTEIN$-GNPs is linearly proportional to @COMPOUND$ concentration from 6.0x10(-8)mol/L to 8.0x10(-6)mol/L with a detection limit of 1.0x10(-8)mol/L.	1
1111	C18 and C20Gb(3) were, in mixtures without @COMPOUND$ :1Gb(3), dominant negative for @PROTEIN$ vesicle binding.	0
1112	Monolayer surface pressure measurement showed VT1, but not VT2, bound @COMPOUND$) at cellular DRM surface pressures, and confirmed loss of VT1 and @PROTEIN$ (but not VT2) specific C18Gb(3) binding.	0
1113	In addition, neuronal @PROTEIN$, another component of the NMDA/@COMPOUND$/cGMP intracellular pathway, has been reported to be dysregulated in schizophrenia patients.	1
1114	In addition, neuronal @PROTEIN$, another component of the NMDA/nitric oxide/@COMPOUND$ intracellular pathway, has been reported to be dysregulated in schizophrenia patients.	1
1115	Here, we proposed that @PROTEIN$, a vacuolar amino peptidase, is involved in glutathione catabolism under @COMPOUND$ stress.	1
1116	No relationships were observed among mercury, selenium, and several other neurochemical biomarkers (dopamine-2, @COMPOUND$ type A, muscarinic cholinergic, and nicotinic cholinergic receptors; @PROTEIN$ and monoamine oxidase enzymes).	0
1117	No relationships were observed among mercury, @COMPOUND$, and several other neurochemical biomarkers (dopamine-2, gamma-aminobutyric acid type A, muscarinic cholinergic, and nicotinic cholinergic receptors; @PROTEIN$ and monoamine oxidase enzymes).	0
1118	No relationships were observed among mercury, selenium, and several other neurochemical biomarkers (@COMPOUND$-2, gamma-aminobutyric acid type A, muscarinic cholinergic, and nicotinic cholinergic receptors; @PROTEIN$ and monoamine oxidase enzymes).	0
1119	No relationships were observed among mercury, @COMPOUND$, and several other neurochemical biomarkers (dopamine-2, gamma-aminobutyric acid type A, muscarinic cholinergic, and nicotinic cholinergic receptors; cholinesterase and @PROTEIN$ enzymes).	0
1120	No relationships were observed among mercury, selenium, and several other neurochemical biomarkers (@COMPOUND$-2, gamma-aminobutyric acid type A, muscarinic cholinergic, and nicotinic cholinergic receptors; cholinesterase and @PROTEIN$ enzymes).	0
1121	No relationships were observed among mercury, selenium, and several other neurochemical biomarkers (dopamine-2, @COMPOUND$ type A, muscarinic cholinergic, and nicotinic cholinergic receptors; cholinesterase and @PROTEIN$ enzymes).	0
1122	No relationships were observed among @COMPOUND$, selenium, and several other neurochemical biomarkers (dopamine-2, gamma-aminobutyric acid type A, muscarinic cholinergic, and nicotinic cholinergic receptors; cholinesterase and @PROTEIN$ enzymes).	0
1123	No relationships were observed among @COMPOUND$, selenium, and several other neurochemical biomarkers (dopamine-2, gamma-aminobutyric acid type A, muscarinic cholinergic, and nicotinic cholinergic receptors; @PROTEIN$ and monoamine oxidase enzymes).	0
1124	Despite responsive antioxidative defense (increased activities of superoxide dismutase, ascorbate @PROTEIN$, and pyrogallol peroxidase), @COMPOUND$+ caused oxidative damage to lipids and proteins as evaluated by malondialdehyde and carbonyl group levels, and induced DNA strand breaks.	0
1125	Despite responsive antioxidative defense (increased activities of @PROTEIN$, ascorbate peroxidase, and pyrogallol peroxidase), @COMPOUND$+ caused oxidative damage to lipids and proteins as evaluated by malondialdehyde and carbonyl group levels, and induced DNA strand breaks.	0
1126	However, Ref-1 inhibition followed by H2O2 treatment extensively induced the level of intracellular reactive @COMPOUND$ species (ROS) through activation of the components of NADPH oxidase, like p22 (phox), @PROTEIN$ (phox), and Nox4.	1
1127	However, Ref-1 inhibition followed by H2O2 treatment extensively induced the level of intracellular reactive @COMPOUND$ species (ROS) through activation of the components of NADPH oxidase, like @PROTEIN$ (phox), p47 (phox), and Nox4.	1
1128	However, Ref-1 inhibition followed by H2O2 treatment extensively induced the level of intracellular reactive @COMPOUND$ species (ROS) through activation of the components of NADPH oxidase, like p22 (phox), p47 (phox), and @PROTEIN$.	1
1129	Decreased expression of @PROTEIN$, the binding site for @COMPOUND$, during epileptogenesis and chronic epilepsy.	1
1130	We also demonstrated that the deletion of the @PROTEIN$ gene doubled ATP-driven @COMPOUND$ synthesis and increased cellular ATP synthetic activity.	1
1131	Selenocystine induces caspase-independent apoptosis in MCF-7 human breast carcinoma cells with involvement of @PROTEIN$ phosphorylation and reactive @COMPOUND$ species generation.	0
1132	Silencing and attenuating of @PROTEIN$ activation with RNA interference and @COMPOUND$ treatment, respectively, partially suppressed SeC-induced cell apoptosis.	1
1133	Treatment with @COMPOUND$ resulted in dose- and time-dependent inhibition of growth of BeWo cells with IC(50) values of 2.01 and 1.19 microM for 7 and 24 h respectively, accompanied by downregulation of @PROTEIN$.	1
1134	A sample preparation protocol applying a binary matrix-assisted laser desorption/ionization(MALDI) matrix containing alpha-cyano-4-hydroxy cinnamic acid (CHCA) and 2,5-dihydroxy @COMPOUND$ (DHB) on trifluoro acetic acid (TFA) etched latex glove surfaces allowed the direct determination (exact molecular weight) of Hevein, @PROTEIN$ and a truncated form of REF (tREF) within nine different brands of natural latex gloves by means of MALDI-TOF-MS in the linear mode.	0
1135	A sample preparation protocol applying a binary matrix-assisted laser desorption/ionization(MALDI) matrix containing alpha-cyano-4-hydroxy cinnamic acid (CHCA) and 2,5-dihydroxy benzoic acid (DHB) on @COMPOUND$ (TFA) etched latex glove surfaces allowed the direct determination (exact molecular weight) of Hevein, @PROTEIN$ and a truncated form of REF (tREF) within nine different brands of natural latex gloves by means of MALDI-TOF-MS in the linear mode.	0
1136	A sample preparation protocol applying a binary matrix-assisted laser desorption/ionization(MALDI) matrix containing alpha-cyano-4-hydroxy cinnamic acid (CHCA) and 2,5-dihydroxy benzoic acid (DHB) on @COMPOUND$ (TFA) etched latex glove surfaces allowed the direct determination (exact molecular weight) of @PROTEIN$, REF and a truncated form of REF (tREF) within nine different brands of natural latex gloves by means of MALDI-TOF-MS in the linear mode.	0
1137	A sample preparation protocol applying a binary matrix-assisted laser desorption/ionization(MALDI) matrix containing alpha-cyano-4-hydroxy cinnamic acid (CHCA) and 2,5-dihydroxy benzoic acid (@COMPOUND$) on trifluoro acetic acid (@PROTEIN$) etched latex glove surfaces allowed the direct determination (exact molecular weight) of Hevein, REF and a truncated form of REF (tREF) within nine different brands of natural latex gloves by means of MALDI-TOF-MS in the linear mode.	0
1138	A sample preparation protocol applying a binary matrix-assisted laser desorption/ionization(MALDI) matrix containing alpha-cyano-4-hydroxy cinnamic acid (@COMPOUND$) and 2,5-dihydroxy benzoic acid (DHB) on trifluoro acetic acid (TFA) etched latex glove surfaces allowed the direct determination (exact molecular weight) of Hevein, @PROTEIN$ and a truncated form of REF (tREF) within nine different brands of natural latex gloves by means of MALDI-TOF-MS in the linear mode.	0
1139	A sample preparation protocol applying a binary matrix-assisted laser desorption/ionization(MALDI) matrix containing alpha-cyano-4-hydroxy cinnamic acid (@COMPOUND$) and 2,5-dihydroxy benzoic acid (DHB) on trifluoro acetic acid (TFA) etched latex glove surfaces allowed the direct determination (exact molecular weight) of @PROTEIN$, REF and a truncated form of REF (tREF) within nine different brands of natural latex gloves by means of MALDI-TOF-MS in the linear mode.	0
1140	A sample preparation protocol applying a binary matrix-assisted laser desorption/ionization(MALDI) matrix containing alpha-cyano-4-hydroxy cinnamic acid (CHCA) and 2,5-dihydroxy @COMPOUND$ (DHB) on trifluoro acetic acid (TFA) etched latex glove surfaces allowed the direct determination (exact molecular weight) of @PROTEIN$, REF and a truncated form of REF (tREF) within nine different brands of natural latex gloves by means of MALDI-TOF-MS in the linear mode.	0
1141	A sample preparation protocol applying a binary matrix-assisted laser desorption/ionization(MALDI) matrix containing alpha-cyano-4-hydroxy cinnamic acid (CHCA) and 2,5-dihydroxy benzoic acid (DHB) on @COMPOUND$ (@PROTEIN$) etched latex glove surfaces allowed the direct determination (exact molecular weight) of Hevein, REF and a truncated form of REF (tREF) within nine different brands of natural latex gloves by means of MALDI-TOF-MS in the linear mode.	0
1142	A sample preparation protocol applying a binary matrix-assisted laser desorption/ionization(MALDI) matrix containing alpha-cyano-4-hydroxy cinnamic acid (@COMPOUND$) and 2,5-dihydroxy benzoic acid (DHB) on trifluoro acetic acid (@PROTEIN$) etched latex glove surfaces allowed the direct determination (exact molecular weight) of Hevein, REF and a truncated form of REF (tREF) within nine different brands of natural latex gloves by means of MALDI-TOF-MS in the linear mode.	0
1143	A sample preparation protocol applying a binary matrix-assisted laser desorption/ionization(MALDI) matrix containing alpha-cyano-4-hydroxy cinnamic acid (CHCA) and 2,5-dihydroxy @COMPOUND$ (DHB) on trifluoro acetic acid (@PROTEIN$) etched latex glove surfaces allowed the direct determination (exact molecular weight) of Hevein, REF and a truncated form of REF (tREF) within nine different brands of natural latex gloves by means of MALDI-TOF-MS in the linear mode.	0
1144	A sample preparation protocol applying a binary matrix-assisted laser desorption/ionization(MALDI) matrix containing alpha-cyano-4-hydroxy cinnamic acid (CHCA) and 2,5-dihydroxy benzoic acid (@COMPOUND$) on trifluoro acetic acid (TFA) etched latex glove surfaces allowed the direct determination (exact molecular weight) of Hevein, @PROTEIN$ and a truncated form of REF (tREF) within nine different brands of natural latex gloves by means of MALDI-TOF-MS in the linear mode.	0
1145	A sample preparation protocol applying a binary matrix-assisted laser desorption/ionization(MALDI) matrix containing alpha-cyano-4-hydroxy cinnamic acid (CHCA) and 2,5-dihydroxy benzoic acid (@COMPOUND$) on trifluoro acetic acid (TFA) etched latex glove surfaces allowed the direct determination (exact molecular weight) of @PROTEIN$, REF and a truncated form of REF (tREF) within nine different brands of natural latex gloves by means of MALDI-TOF-MS in the linear mode.	0
1146	Methods: We injected @PROTEIN$ knock out (KO) or wild type mice with @COMPOUND$ (CCl(4)) and examined the difference of liver injury by immunological or histological analysis.	1
1147	Studies using 1-@COMPOUND$ (1-MT), the specific inhibitor of IDO, showed that this enzyme is important in @PROTEIN$ (IFN-gamma)-dependent inhibition of allergic inflammation in the respiratory airway during immunotherapy.	0
1148	Studies using 1-methyl-tryptophan (@COMPOUND$), the specific inhibitor of IDO, showed that this enzyme is important in interferon-gamma (@PROTEIN$)-dependent inhibition of allergic inflammation in the respiratory airway during immunotherapy.	1
1149	Studies using 1-@COMPOUND$ (1-MT), the specific inhibitor of IDO, showed that this enzyme is important in interferon-gamma (@PROTEIN$)-dependent inhibition of allergic inflammation in the respiratory airway during immunotherapy.	1
1150	Studies using 1-methyl-tryptophan (@COMPOUND$), the specific inhibitor of IDO, showed that this enzyme is important in @PROTEIN$ (IFN-gamma)-dependent inhibition of allergic inflammation in the respiratory airway during immunotherapy.	1
1151	To observe the inhibitory effects of TSP-1 functional fragments, critical for @PROTEIN$ binding, on the activation of L-TGF-beta1, we isolated alveolar macrophages from Wistar rat lungs 7 days after @COMPOUND$ administration (5mg/kg body weight) and cultured the cells with or without TSP-1 functional or control fragments.	0
1152	To observe the inhibitory effects of @PROTEIN$ functional fragments, critical for CD36 binding, on the activation of L-TGF-beta1, we isolated alveolar macrophages from Wistar rat lungs 7 days after @COMPOUND$ administration (5mg/kg body weight) and cultured the cells with or without TSP-1 functional or control fragments.	0
1153	To observe the inhibitory effects of TSP-1 functional fragments, critical for CD36 binding, on the activation of L-@PROTEIN$, we isolated alveolar macrophages from Wistar rat lungs 7 days after @COMPOUND$ administration (5mg/kg body weight) and cultured the cells with or without TSP-1 functional or control fragments.	0
1154	The pERE@PROTEIN$9 vector was delivered to a single MCF-7 using a nanoneedle and the effect of @COMPOUND$, which is an antagonist of estrogen, was observed using the GFP expression level.	0
1155	Effect of different @PROTEIN$ dosages on cell viability and @COMPOUND$ production by Kluyveromyces marxianus in SSF processes.	1
1156	As a proof-of-concept, @PROTEIN$-coated QDs (ConA-QDs) and @COMPOUND$-coated AuNPs (Dex-AuNPs) were used to detect the mannosylated proteins.	0
1157	As a proof-of-concept, Concanavalin A-coated QDs (@PROTEIN$-QDs) and @COMPOUND$-coated AuNPs (Dex-AuNPs) were used to detect the mannosylated proteins.	0
1158	As a result, the PL intensity of QDs was found to be linearly correlated with the concentration and the number of @COMPOUND$ moiety of the @PROTEIN$.	1
1159	Angiotensin II (@PROTEIN$) stimulation of water and @COMPOUND$ intake is a classic model of the behavioural effects of hormones.	1
1160	@PROTEIN$ (AngII) stimulation of water and @COMPOUND$ intake is a classic model of the behavioural effects of hormones.	1
1161	Previous studies support the hypotheses that @PROTEIN$ is involved in AngII-induced water, but not @COMPOUND$ intake and that MAP kinase plays a role in NaCl consumption, but not water intake, after injection of AngII.	0
1162	Specific neurochemical elements in these structures include not only decreases in reward neurotransmission, such as decreases in @COMPOUND$ and opioid peptide function in the ventral striatum, but also recruitment of brain stress systems, such as corticotropin-releasing factor (@PROTEIN$), in the extended amygdala.	1
1163	Specific neurochemical elements in these structures include not only decreases in reward neurotransmission, such as decreases in @COMPOUND$ and opioid peptide function in the ventral striatum, but also recruitment of brain stress systems, such as @PROTEIN$ (CRF), in the extended amygdala.	1
1164	Neither enzymatic activity of transaminases (@PROTEIN$ and ALT) nor @COMPOUND$ levels were significantly altered.	0
1165	On other hand, @PROTEIN$ gene mutations at kinase domain in non-small cell lung cancer (NSCLC) have been examined for their ability to predict sensitivity to @COMPOUND$ or erlotinib.	1
1166	On other hand, @PROTEIN$ gene mutations at kinase domain in non-small cell lung cancer (NSCLC) have been examined for their ability to predict sensitivity to gefitinib or @COMPOUND$.	1
1167	Although the TO2 hamster heart exhibits normal function at 1 month of age (presymptomatic stage), elevated levels of myeloperoxidase, monocyte chemotactic protein-1, @COMPOUND$, osteopontin, and @PROTEIN$ were evident, indicating the presence of inflammation, oxidative stress, and osteogenic phenotype.	0
1168	Although the TO2 hamster heart exhibits normal function at 1 month of age (presymptomatic stage), elevated levels of myeloperoxidase, @PROTEIN$, @COMPOUND$, osteopontin, and alkaline phosphatase were evident, indicating the presence of inflammation, oxidative stress, and osteogenic phenotype.	0
1169	We examined @COMPOUND$ (1,25(OH)(2)D(3))-induced expression of 25-hydroxyvitamin D(3) 24-hydroxylase (CYP24) and apical calcium channel (@PROTEIN$) mRNA levels in 2-, 9-, and 15-day cultures Caco-2 cells that model proliferating, post-proliferative, and differentiated enterocytes.	1
1170	We examined @COMPOUND$ (1,25(OH)(2)D(3))-induced expression of 25-hydroxyvitamin D(3) 24-hydroxylase (@PROTEIN$) and apical calcium channel (TRPV6) mRNA levels in 2-, 9-, and 15-day cultures Caco-2 cells that model proliferating, post-proliferative, and differentiated enterocytes.	1
1171	Here, we tested the hypothesis that interactions with @PROTEIN$ play a role in the DNA-damaging properties of @COMPOUND$.	0
1172	Stabilisation of covalent @PROTEIN$ II-DNA intermediates by @COMPOUND$ was also detectable in cell culture, and here, the IIalpha isoform was preferentially targeted.	1
1173	Bone formation and maturation processes were evaluated by double staining for alkaline @PROTEIN$ and tartrate-resistant acid phosphatase, immunohistochemistry for bone matrix proteins, vital staining with @COMPOUND$, and elemental mapping with an electron probe microanalyzer.	0
1174	Bone formation and maturation processes were evaluated by double staining for alkaline phosphatase and tartrate-resistant acid phosphatase, immunohistochemistry for bone @PROTEIN$, vital staining with @COMPOUND$, and elemental mapping with an electron probe microanalyzer.	0
1175	Bone formation and maturation processes were evaluated by double staining for @PROTEIN$ and tartrate-resistant acid phosphatase, immunohistochemistry for bone matrix proteins, vital staining with @COMPOUND$, and elemental mapping with an electron probe microanalyzer.	0
1176	The progressive ankylosis gene (ank) is a @PROTEIN$ that transports intracellular @COMPOUND$ to the extracellular milieu.	1
1177	@PROTEIN$ receptor-1 is essential for LPS-induced sensitization and tolerance to @COMPOUND$-glucose deprivation in murine neonatal organotypic hippocampal slices.	1
1178	@PROTEIN$ receptor-1 is essential for LPS-induced sensitization and tolerance to oxygen-@COMPOUND$ deprivation in murine neonatal organotypic hippocampal slices.	1
1179	Cells were grown for 24 h with APAP in the presence or absence of 4-methylpyrazole (4MP), L-arginine methyl ester (L-NAME), @PROTEIN$ (SOD), or @COMPOUND$ red (RuR).	0
1180	Cells were grown for 24 h with APAP in the presence or absence of 4-methylpyrazole (4MP), L-arginine methyl ester (L-NAME), superoxide dismutase (@PROTEIN$), or @COMPOUND$ red (RuR).	0
1181	Cells were grown for 24 h with APAP in the presence or absence of 4-methylpyrazole (4MP), L-arginine methyl ester (L-NAME), @PROTEIN$ (SOD), or ruthenium red (@COMPOUND$).	0
1182	Cells were grown for 24 h with APAP in the presence or absence of 4-methylpyrazole (4MP), @COMPOUND$ (L-NAME), superoxide dismutase (@PROTEIN$), or ruthenium red (RuR).	0
1183	Cells were grown for 24 h with APAP in the presence or absence of 4-methylpyrazole (4MP), L-arginine methyl ester (L-NAME), superoxide dismutase (@PROTEIN$), or ruthenium red (@COMPOUND$).	0
1184	Cells were grown for 24 h with @COMPOUND$ in the presence or absence of 4-methylpyrazole (4MP), L-arginine methyl ester (L-NAME), @PROTEIN$ (SOD), or ruthenium red (RuR).	0
1185	Cells were grown for 24 h with APAP in the presence or absence of 4-methylpyrazole (4MP), @COMPOUND$ (L-NAME), @PROTEIN$ (SOD), or ruthenium red (RuR).	0
1186	Cells were grown for 24 h with @COMPOUND$ in the presence or absence of 4-methylpyrazole (4MP), L-arginine methyl ester (L-NAME), superoxide dismutase (@PROTEIN$), or ruthenium red (RuR).	0
1187	In the present study the effect of the convulsant drug @COMPOUND$ (MP) repetitive administration (4-7 days) on the hippocampal @PROTEIN$ subunit was studied.	1
1188	Heart glycogen represents a store of glucosyl residues which are mobilized by the catalysis of @PROTEIN$ (GP) and are mainly destined to serve as substrates for the generation of @COMPOUND$.	0
1189	The relationship between prolactin (@PROTEIN$), leptin, @COMPOUND$ (NO), and cytokines in patients with hyperprolactinemia.	0
1190	The relationship between @PROTEIN$ (PRL), leptin, @COMPOUND$ (NO), and cytokines in patients with hyperprolactinemia.	0
1191	The relationship between prolactin (PRL), @PROTEIN$, @COMPOUND$ (NO), and cytokines in patients with hyperprolactinemia.	0
1192	Effect of @PROTEIN$ *3 genotype on the stereoselective pharmacokinetics of @COMPOUND$ in healthy subjects.	1
1193	In conclusion, the present study showed that despite the evidence that @COMPOUND$ is stereoselectively metabolized, @PROTEIN$ *3 genotype did not affect stereoselective disposition of amlodipine.	0
1194	It provides the evidence that @PROTEIN$ *3genotype plays a minor role in the interindividual variability of stereoselective disposition of @COMPOUND$ in humans.	1
1195	Tissues were stained for BrdU, @PROTEIN$, vimentin, and @COMPOUND$ and eosin staining.	0
1196	Tissues were stained for @COMPOUND$, @PROTEIN$, vimentin, and haematoxylin and eosin staining.	0
1197	Tissues were stained for @COMPOUND$, Pax-7, @PROTEIN$, and haematoxylin and eosin staining.	0
1198	Tissues were stained for BrdU, Pax-7, @PROTEIN$, and @COMPOUND$ and eosin staining.	0
1199	Regulation of the phosphoinositide-3 kinase and @PROTEIN$ signaling pathways by @COMPOUND$ and its reduced metabolites in the rat brain.	1
1200	Several growth factors, such as vascular endothelial growth factor, @PROTEIN$, and insulin-like growth factor-I are involved in the actions of @COMPOUND$ in the central nervous system.	1
1201	Several growth factors, such as vascular endothelial growth factor, brain-derived neurotrophic factor, and @PROTEIN$-like growth factor-I are involved in the actions of @COMPOUND$ in the central nervous system.	1
1202	Significant increases in the phosphorylation of @PROTEIN$, in the expression of the catalytic (p110) and the regulatory (p85) subunits of PI3K and in the phosphorylation of Akt were observed in the hypothalamus, the hippocampus, and the cerebellum 24 hr after @COMPOUND$ administration.	1
1203	Significant increases in the phosphorylation of ERK, in the expression of the catalytic (p110) and the regulatory (@PROTEIN$) subunits of PI3K and in the phosphorylation of Akt were observed in the hypothalamus, the hippocampus, and the cerebellum 24 hr after @COMPOUND$ administration.	1
1204	Significant increases in the phosphorylation of ERK, in the expression of the catalytic (@PROTEIN$) and the regulatory (p85) subunits of PI3K and in the phosphorylation of Akt were observed in the hypothalamus, the hippocampus, and the cerebellum 24 hr after @COMPOUND$ administration.	1
1205	Significant increases in the phosphorylation of ERK, in the expression of the catalytic (p110) and the regulatory (p85) subunits of PI3K and in the phosphorylation of @PROTEIN$ were observed in the hypothalamus, the hippocampus, and the cerebellum 24 hr after @COMPOUND$ administration.	1
1206	Significant increases in the phosphorylation of ERK, in the expression of the catalytic (p110) and the regulatory (p85) subunits of @PROTEIN$ and in the phosphorylation of Akt were observed in the hypothalamus, the hippocampus, and the cerebellum 24 hr after @COMPOUND$ administration.	1
1207	In addition, we used PET to evaluate the striatal dopamine transporter availability (@PROTEIN$) with ((11)C)d-threo-@COMPOUND$ in the patient group.	1
1208	Toll-like receptor 4 (@PROTEIN$-4)/myeloid differentiation protein-2 complex ligation by @COMPOUND$ induces production of pro-inflammatory cytokines and co-stimulatory molecules on antigen presenting cells.	1
1209	Toll-like receptor 4 (TLR-4)/myeloid differentiation @PROTEIN$ complex ligation by @COMPOUND$ induces production of pro-inflammatory cytokines and co-stimulatory molecules on antigen presenting cells.	1
1210	The concept of a linkage between NCX and SERCA in smooth muscle was also confirmed by similar distribution of NCX and @PROTEIN$ proteins when detergent-treated microsomes were fractionated by flotation on @COMPOUND$ density gradients.	0
1211	The concept of a linkage between @PROTEIN$ and SERCA in smooth muscle was also confirmed by similar distribution of NCX and SERCA2 proteins when detergent-treated microsomes were fractionated by flotation on @COMPOUND$ density gradients.	0
1212	Identification of @PROTEIN$ as a candidate gene for regulation of responsiveness to dietary @COMPOUND$ in rats.	1
1213	Up to 72% hexose yield and 94% pentose yield were obtained using modified steam explosion with 2% @COMPOUND$ at 140 degrees C for 30 min and enzymatic hydrolysis with cellulase (15 filter per unit (FPU)/g cellulose) and @PROTEIN$ (50 cellobiose units (CBU)/g cellulose).	0
1214	Up to 72% hexose yield and 94% pentose yield were obtained using modified steam explosion with 2% @COMPOUND$ at 140 degrees C for 30 min and enzymatic hydrolysis with @PROTEIN$ (15 filter per unit (FPU)/g cellulose) and beta-glucosidase (50 cellobiose units (CBU)/g cellulose).	0
1215	Effects of @COMPOUND$ ethyl ester on @PROTEIN$ and apelin in lean and overweight (cafeteria diet-fed) rats.	0
1216	Effects of eicosapentaenoic acid @COMPOUND$ on @PROTEIN$ and apelin in lean and overweight (cafeteria diet-fed) rats.	0
1217	Effects of eicosapentaenoic acid ethyl ester on @PROTEIN$ and @COMPOUND$ in lean and overweight (cafeteria diet-fed) rats.	0
1218	In the presence of AA (Fe:AA molar ratio of 1:20), significantly more Fe was absorbed from FeSO4 (about 303 %), @PROTEIN$ (about 454 %) and P-HSF (about 371 %) when compared with ferrous @COMPOUND$ or ferritin without AA.	0
1219	In the presence of AA (Fe:AA molar ratio of 1:20), significantly more Fe was absorbed from FeSO4 (about 303 %), HSF (about 454 %) and P-HSF (about 371 %) when compared with ferrous @COMPOUND$ or @PROTEIN$ without AA.	0
1220	Insulin-like growth factor-I (@PROTEIN$) is neuroprotective against @COMPOUND$-related toxicity and promotes white matter production following a number of insults.	1
1221	@PROTEIN$-like growth factor-I (IGF-I) is neuroprotective against @COMPOUND$-related toxicity and promotes white matter production following a number of insults.	1
1222	SWCNT coatings were thus functionalized with poly(@COMPOUND$-pyrrole) and applied to the anchoring of glucose oxidase (@PROTEIN$), modified with beta-cyclodextrin.	1
1223	SWCNT coatings were thus functionalized with poly(@COMPOUND$-pyrrole) and applied to the anchoring of @PROTEIN$ (GOX), modified with beta-cyclodextrin.	1
1224	@COMPOUND$-induced bone @PROTEIN$ (BMP) 2 expression during bone regeneration: an immunohistochemical study.	1
1225	@COMPOUND$-induced bone morphogenetic protein (@PROTEIN$) 2 expression during bone regeneration: an immunohistochemical study.	1
1226	The purpose of this study was to investigate bone morphogenetic protein (BMP) 2 expression after implantation of a @COMPOUND$ and recombinant human @PROTEIN$ (rhBMP-2) and to compare the bone regeneration capability of these substances in the rabbit nasal bone using immunohistologic methods.	1
1227	The purpose of this study was to investigate bone @PROTEIN$ (BMP) 2 expression after implantation of a @COMPOUND$ and recombinant human BMP-2 (rhBMP-2) and to compare the bone regeneration capability of these substances in the rabbit nasal bone using immunohistologic methods.	1
1228	The purpose of this study was to investigate bone morphogenetic protein (@PROTEIN$) 2 expression after implantation of a @COMPOUND$ and recombinant human BMP-2 (rhBMP-2) and to compare the bone regeneration capability of these substances in the rabbit nasal bone using immunohistologic methods.	1
1229	Intracellular production of @PROTEIN$ and IL-2 after stimulation with phorbol myristate/@COMPOUND$ was flowcytometrically measured in CD4 (+) T cells from peripheral blood (PB) and cerebrospinal fluid (CSF) of 29 patients with multiple sclerosis (MS), and 16 with other inflammatory and 41 with other non-inflammatory neurological diseases.	1
1230	Intracellular production of TNFalpha and @PROTEIN$ after stimulation with @COMPOUND$ myristate/ionomycin was flowcytometrically measured in CD4 (+) T cells from peripheral blood (PB) and cerebrospinal fluid (CSF) of 29 patients with multiple sclerosis (MS), and 16 with other inflammatory and 41 with other non-inflammatory neurological diseases.	1
1231	Intracellular production of @PROTEIN$ and IL-2 after stimulation with @COMPOUND$ myristate/ionomycin was flowcytometrically measured in CD4 (+) T cells from peripheral blood (PB) and cerebrospinal fluid (CSF) of 29 patients with multiple sclerosis (MS), and 16 with other inflammatory and 41 with other non-inflammatory neurological diseases.	1
1232	Intracellular production of TNFalpha and @PROTEIN$ after stimulation with phorbol myristate/@COMPOUND$ was flowcytometrically measured in CD4 (+) T cells from peripheral blood (PB) and cerebrospinal fluid (CSF) of 29 patients with multiple sclerosis (MS), and 16 with other inflammatory and 41 with other non-inflammatory neurological diseases.	1
1233	Intracellular production of @PROTEIN$ and IL-2 after stimulation with phorbol @COMPOUND$/ionomycin was flowcytometrically measured in CD4 (+) T cells from peripheral blood (PB) and cerebrospinal fluid (CSF) of 29 patients with multiple sclerosis (MS), and 16 with other inflammatory and 41 with other non-inflammatory neurological diseases.	1
1234	Intracellular production of TNFalpha and @PROTEIN$ after stimulation with phorbol @COMPOUND$/ionomycin was flowcytometrically measured in CD4 (+) T cells from peripheral blood (PB) and cerebrospinal fluid (CSF) of 29 patients with multiple sclerosis (MS), and 16 with other inflammatory and 41 with other non-inflammatory neurological diseases.	1
1235	Although we reported that 8-Cl-cAMP induces growth inhibition via p38 mitogen-activated protein kinase (@PROTEIN$) and a metabolite of 8-Cl-cAMP, 8-Cl-@COMPOUND$ mediates this process, the action mechanism of 8-Cl-cAMP is still uncertain.	1
1236	Certain non-steroidal anti-inflammatory drugs, e.g., the @PROTEIN$-specific nonsteroidal anti-inflammatory drugs, @COMPOUND$, raise Abeta(42) levels.	1
1237	@COMPOUND$, @PROTEIN$ and CRP as markers of silent brain infarction.	0
1238	@COMPOUND$, IL-6 and @PROTEIN$ as markers of silent brain infarction.	0
1239	We then investigated whether silent brain infarction (SBI) can be detected by measuring @COMPOUND$, @PROTEIN$, or other biomarkers.	0
1240	Human skin keratinocytes HaCat attacked by Staphylococcus aureus @PROTEIN$ showed a transient drop of cellular @COMPOUND$ levels whereas in toxin-perforated bovine mammary epithelial cells (BMEC), the ATP levels dropped more slowly.	1
1241	A novel @COMPOUND$-specific @PROTEIN$ from Phaseolus coccineus seeds with potent antineoplastic and antifungal activities.	1
1242	A novel @PROTEIN$ (PCL) with specificity towards @COMPOUND$ was purified from Phaseolus coccineus L. (P. multiflorus willd) seeds using ion exchange chromatography on CM and DEAE-Sepharose, and gel filtration on Sephacryl S-200 column.	1
1243	We have previously shown that ROS-induced MUC5AC expression in NHBE cells is dependent on @COMPOUND$ depolymerization and epidermal growth factor receptor (EGFR)/mitogen-activated protein kinase (@PROTEIN$) activation.	0
1244	We have previously shown that ROS-induced MUC5AC expression in NHBE cells is dependent on @COMPOUND$ depolymerization and epidermal growth factor receptor (EGFR)/@PROTEIN$ (MAPK) activation.	0
1245	We have previously shown that ROS-induced @PROTEIN$ expression in NHBE cells is dependent on @COMPOUND$ depolymerization and epidermal growth factor receptor (EGFR)/mitogen-activated protein kinase (MAPK) activation.	1
1246	We have previously shown that ROS-induced MUC5AC expression in NHBE cells is dependent on @COMPOUND$ depolymerization and @PROTEIN$ (EGFR)/mitogen-activated protein kinase (MAPK) activation.	0
1247	We have previously shown that ROS-induced MUC5AC expression in NHBE cells is dependent on @COMPOUND$ depolymerization and epidermal growth factor receptor (@PROTEIN$)/mitogen-activated protein kinase (MAPK) activation.	0
1248	@PROTEIN$ and P53 play important roles in the signal transduction leading to neointimal growth inhibition and induction of apoptosis of smooth muscle cells due to rapamycin and @COMPOUND$.	1
1249	P27 and @PROTEIN$ play important roles in the signal transduction leading to neointimal growth inhibition and induction of apoptosis of smooth muscle cells due to @COMPOUND$ and paclitaxel.	1
1250	@PROTEIN$ and P53 play important roles in the signal transduction leading to neointimal growth inhibition and induction of apoptosis of smooth muscle cells due to @COMPOUND$ and paclitaxel.	1
1251	P27 and @PROTEIN$ play important roles in the signal transduction leading to neointimal growth inhibition and induction of apoptosis of smooth muscle cells due to rapamycin and @COMPOUND$.	1
1252	The optimal condition for the labeling of cypate to @PROTEIN$ was 4 h reaction duration at 4 degrees C and pH 8.5 under catalysis by HOBt/@COMPOUND$.	1
1253	The optimal condition for the labeling of cypate to @PROTEIN$ was 4 h reaction duration at 4 degrees C and pH 8.5 under catalysis by @COMPOUND$/HBTU.	1
1254	A mixture of poly-@COMPOUND$-structures covalently coupled to functionalized microtiter plates were identified for best binding to our model galectin His(6) @PROTEIN$.	1
1255	A mixture of poly-@COMPOUND$-structures covalently coupled to functionalized microtiter plates were identified for best binding to our model @PROTEIN$ His(6) CGL2.	1
1256	We further demonstrate for the first time that these poly-@COMPOUND$ surfaces are suitable for further @PROTEIN$-mediated binding of the ECM glycoproteins laminin and fibronectin.	1
1257	We further demonstrate for the first time that these poly-@COMPOUND$ surfaces are suitable for further galectin-mediated binding of the ECM glycoproteins laminin and @PROTEIN$.	1
1258	We further demonstrate for the first time that these poly-@COMPOUND$ surfaces are suitable for further galectin-mediated binding of the ECM @PROTEIN$ laminin and fibronectin.	1
1259	We further demonstrate for the first time that these poly-@COMPOUND$ surfaces are suitable for further galectin-mediated binding of the @PROTEIN$ glycoproteins laminin and fibronectin.	1
1260	These transcripts were predicted to synthesis of @PROTEIN$ proteins truncated of the binding site for @COMPOUND$, an essential cofactor, therefore cannot function as a decarboxylase.	1
1261	However, this stimulated the NADPH-generating enzyme activities of the @COMPOUND$ phosphate pathway, glucose-6-phosphate- and 6-phosphogluconate-dehydrogenases (G6PDH, 6PGDH), as well as enzyme activity of fermentation, @PROTEIN$ (ADH), with concomitant inhibition in the capacity of enzyme inactivator (INADH).	0
1262	However, this stimulated the NADPH-generating enzyme activities of the @COMPOUND$ phosphate pathway, glucose-6-phosphate- and 6-phosphogluconate-dehydrogenases (@PROTEIN$, 6PGDH), as well as enzyme activity of fermentation, alcohol dehydrogenase (ADH), with concomitant inhibition in the capacity of enzyme inactivator (INADH).	0
1263	However, this stimulated the NADPH-generating enzyme activities of the @COMPOUND$ phosphate pathway, glucose-6-phosphate- and 6-phosphogluconate-dehydrogenases (G6PDH, 6PGDH), as well as enzyme activity of fermentation, alcohol dehydrogenase (@PROTEIN$), with concomitant inhibition in the capacity of enzyme inactivator (INADH).	0
1264	We therefore propose @COMPOUND$-dependent homodimerization to be an essential step in the regulation of @PROTEIN$-dependent transcription.	1
1265	In order to investigate the role of spinal @PROTEIN$ in the phenomenon of @COMPOUND$-precipitated withdrawal we examined the effect of herpes simplex virus vector-mediated overexpression of proenkephalin in lumbar dorsal root ganglia in rats with neuropathic pain treated with morphine.	1
1266	The @PROTEIN$ were isolated by @COMPOUND$ treatment of crude extracts followed by chromatography on chitin.	1
1267	One hundred and forty-four HCV-2- and HCV-3-infected patients initiated Peg-@PROTEIN$-2a (180 microg/week) and @COMPOUND$ (1000 or 1200 mg/day); those with viral clearance at week 4 were randomized to either Peg-IFN alpha-2a monotherapy (n = 59) or continuing combination therapy (n = 61) until week 12.	0
1268	Urinary @COMPOUND$-reactive substances (TBARS) excretion and serum amyloid P-component (@PROTEIN$) were measured as indicators of oxidative stress and inflammation, respectively.	0
1269	Urinary @COMPOUND$-reactive substances (TBARS) excretion and @PROTEIN$ (SAP) were measured as indicators of oxidative stress and inflammation, respectively.	0
1270	Inhibition in the brain is dominated by the neurotransmitter @COMPOUND$ (GABA); operating through @PROTEIN$.	1
1271	Inhibition in the brain is dominated by the neurotransmitter gamma-aminobutyric acid (@COMPOUND$); operating through @PROTEIN$.	1
1272	The 5-HT2AR response dominated the @PROTEIN$ signaling pathway when co-expressed with 5-HT1AR, and diminution of the response by the 5-HT2AR antagonist @COMPOUND$ could not be rescued by the 5-HT1AR agonist.	1
1273	The inhibitors include mitogen-inducible gene-6 (@PROTEIN$)/receptor-associated late transducer (RALT)/Gene 33, fibroblast growth factor receptor substrate 2beta (FRS2beta)/suc1-associated neurotrophic factor target-2 (SNT-2)/FRS3, suppressor of cytokine signaling 3 (SOCS3)/SOCS4/SOCS5, and @COMPOUND$-rich repeats and immunoglobulin-like domains 1 (LRIG1).	0
1274	The inhibitors include mitogen-inducible gene-6 (Mig-6)/receptor-associated late transducer (RALT)/Gene 33, fibroblast growth factor receptor substrate 2beta (FRS2beta)/suc1-associated neurotrophic factor target-2 (SNT-2)/FRS3, suppressor of cytokine signaling 3 (SOCS3)/SOCS4/SOCS5, and @COMPOUND$-rich repeats and immunoglobulin-like domains 1 (@PROTEIN$).	0
1275	The inhibitors include mitogen-inducible gene-6 (Mig-6)/receptor-associated late transducer (RALT)/Gene 33, fibroblast growth factor receptor substrate 2beta (FRS2beta)/suc1-associated neurotrophic factor target-2 (SNT-2)/FRS3, suppressor of cytokine signaling 3 (SOCS3)/@PROTEIN$/SOCS5, and @COMPOUND$-rich repeats and immunoglobulin-like domains 1 (LRIG1).	0
1276	The inhibitors include mitogen-inducible gene-6 (Mig-6)/receptor-associated late transducer (RALT)/Gene 33, fibroblast growth factor receptor substrate 2beta (FRS2beta)/suc1-associated neurotrophic factor target-2 (SNT-2)/FRS3, suppressor of cytokine signaling 3 (SOCS3)/SOCS4/@PROTEIN$, and @COMPOUND$-rich repeats and immunoglobulin-like domains 1 (LRIG1).	0
1277	The inhibitors include mitogen-inducible gene-6 (Mig-6)/receptor-associated late transducer (RALT)/Gene 33, fibroblast growth factor receptor substrate 2beta (FRS2beta)/suc1-associated neurotrophic factor target-2 (SNT-2)/FRS3, @PROTEIN$ (SOCS3)/SOCS4/SOCS5, and @COMPOUND$-rich repeats and immunoglobulin-like domains 1 (LRIG1).	0
1278	The inhibitors include mitogen-inducible gene-6 (Mig-6)/receptor-associated late transducer (RALT)/Gene 33, fibroblast growth factor receptor substrate 2beta (FRS2beta)/suc1-associated neurotrophic factor target-2 (@PROTEIN$)/FRS3, suppressor of cytokine signaling 3 (SOCS3)/SOCS4/SOCS5, and @COMPOUND$-rich repeats and immunoglobulin-like domains 1 (LRIG1).	0
1279	The inhibitors include mitogen-inducible gene-6 (Mig-6)/receptor-associated late transducer (RALT)/Gene 33, fibroblast growth factor receptor substrate 2beta (FRS2beta)/suc1-associated neurotrophic factor target-2 (SNT-2)/@PROTEIN$, suppressor of cytokine signaling 3 (SOCS3)/SOCS4/SOCS5, and @COMPOUND$-rich repeats and immunoglobulin-like domains 1 (LRIG1).	0
1280	The inhibitors include mitogen-inducible gene-6 (Mig-6)/receptor-associated late transducer (RALT)/Gene 33, fibroblast growth factor receptor substrate 2beta (FRS2beta)/@PROTEIN$ (SNT-2)/FRS3, suppressor of cytokine signaling 3 (SOCS3)/SOCS4/SOCS5, and @COMPOUND$-rich repeats and immunoglobulin-like domains 1 (LRIG1).	0
1281	The inhibitors include mitogen-inducible gene-6 (Mig-6)/receptor-associated late transducer (RALT)/Gene 33, fibroblast growth factor receptor substrate 2beta (FRS2beta)/suc1-associated neurotrophic factor target-2 (SNT-2)/FRS3, suppressor of cytokine signaling 3 (@PROTEIN$)/SOCS4/SOCS5, and @COMPOUND$-rich repeats and immunoglobulin-like domains 1 (LRIG1).	0
1282	The inhibitors include mitogen-inducible gene-6 (Mig-6)/receptor-associated late transducer (RALT)/Gene 33, fibroblast growth factor receptor substrate 2beta (@PROTEIN$)/suc1-associated neurotrophic factor target-2 (SNT-2)/FRS3, suppressor of cytokine signaling 3 (SOCS3)/SOCS4/SOCS5, and @COMPOUND$-rich repeats and immunoglobulin-like domains 1 (LRIG1).	0
1283	Novel homo- and hetero-nuclear @COMPOUND$ (II) complexes of tetradentate Schiff bases: synthesis, characterization, solvent-extraction and @PROTEIN$-like activity studies.	1
1284	There are no controlled trials comparing @PROTEIN$ and @COMPOUND$ efficacy and therapeutic mechanisms in psoriasis.	0
1285	Cu,Zn-@PROTEIN$-driven free radical modifications: @COMPOUND$- and carbonate radical anion-initiated protein radical chemistry.	0
1286	In the absence of (bi)carbonate, site-specific radical-mediated fragmentation is produced by @PROTEIN$ active-site @COMPOUND$.	1
1287	Finally, we propose a biochemical mechanism to explain CO(*-) production from CO2, enhanced protein radical formation and protection by (bi)carbonate against @COMPOUND$-induced fragmentation of the @PROTEIN$ active site.	1
1288	Furthermore, lysosomal integrity was disrupted after addition of clioquinol and zinc to the cells, as shown by redistribution of both Acridine Orange and cathepsin D. @COMPOUND$ plus zinc resulted in a cleavage of Bid (@PROTEIN$), a hallmark of lysosome-mediated apoptotic cell death.	1
1289	Furthermore, lysosomal integrity was disrupted after addition of @COMPOUND$ and zinc to the cells, as shown by redistribution of both Acridine Orange and cathepsin D. Clioquinol plus zinc resulted in a cleavage of Bid (@PROTEIN$), a hallmark of lysosome-mediated apoptotic cell death.	1
1290	Furthermore, lysosomal integrity was disrupted after addition of clioquinol and zinc to the cells, as shown by redistribution of both @COMPOUND$ and cathepsin D. Clioquinol plus zinc resulted in a cleavage of Bid (@PROTEIN$), a hallmark of lysosome-mediated apoptotic cell death.	0
1291	In permeabilized muscle fibers, we observed, a strong inhibition of both state 3 mitochondrial respiration and functionally isolated maximal cytochrome c oxidase (@PROTEIN$) activity after 49 days of @COMPOUND$ exposure.	1
1292	In permeabilized muscle fibers, we observed, a strong inhibition of both state 3 mitochondrial respiration and functionally isolated maximal @PROTEIN$ oxidase (COX) activity after 49 days of @COMPOUND$ exposure.	1
1293	The dominant positive regulator of mTORC1 is the @COMPOUND$-charged form of the @PROTEIN$-like GTPase Rheb.	1
1294	The dominant positive regulator of mTORC1 is the @COMPOUND$-charged form of the ras-like GTPase @PROTEIN$.	1
1295	At 2 h in suspension, keratinocytes that had become committed to terminal differentiation had increased side scatter, were @COMPOUND$ (7-@PROTEIN$) positive and annexin V negative; they exhibited loss of mitochondrial membrane potential and increased cardiolipin oxidation, but with no increase in reactive oxygen species.	0
1296	At 2 h in suspension, keratinocytes that had become committed to terminal differentiation had increased side scatter, were @COMPOUND$ (7-AAD) positive and @PROTEIN$ negative; they exhibited loss of mitochondrial membrane potential and increased cardiolipin oxidation, but with no increase in reactive oxygen species.	0
1297	We have measured X-ray absorption spectra of four mutants (K86Q, K86Q/E27D, K86Q/E107D, and K86Q/E27D/E107D, involving variations of Glu to Asp on either or both sides of the dinuclear ferroxidase site) of recombinant human H-chain @PROTEIN$ (rHuHF) in their complexes with reactive Fe(II) and redox-inactive @COMPOUND$).	1
1298	We have measured X-ray absorption spectra of four mutants (K86Q, K86Q/E27D, K86Q/E107D, and K86Q/E27D/E107D, involving variations of Glu to Asp on either or both sides of the dinuclear @PROTEIN$ site) of recombinant human H-chain ferritin (rHuHF) in their complexes with reactive @COMPOUND$) and redox-inactive Zn(II).	1
1299	We have measured X-ray absorption spectra of four mutants (K86Q, K86Q/E27D, K86Q/E107D, and K86Q/E27D/E107D, involving variations of Glu to Asp on either or both sides of the dinuclear @PROTEIN$ site) of recombinant human H-chain ferritin (rHuHF) in their complexes with reactive Fe(II) and redox-inactive @COMPOUND$).	1
1300	We have measured X-ray absorption spectra of four mutants (K86Q, K86Q/E27D, K86Q/E107D, and K86Q/E27D/E107D, involving variations of Glu to Asp on either or both sides of the dinuclear ferroxidase site) of recombinant human H-chain @PROTEIN$ (rHuHF) in their complexes with reactive @COMPOUND$) and redox-inactive Zn(II).	1
1301	The aim of this study was to determine the effect of @COMPOUND$ on endothelial function in anti-tumour necrosis factor (@PROTEIN$)-naive RA patients.	1
1302	Compared with nonperfused constructs, flow perfused constructs demonstrated improved cells proliferation and differentiation according to cell viability, @COMPOUND$ consumption, @PROTEIN$ activity, and osteopontin.	0
1303	These were treated with @COMPOUND$ plasma and dipped in @PROTEIN$ solution.	0
1304	Cells from fourth subculture were seeded onto the @PROTEIN$-immobilized @COMPOUND$ surface.	1
1305	One of the best triads for bone engineering is bone marrow stromal cells, @COMPOUND$ ceramics, and bone @PROTEIN$ (BMP).	0
1306	One of the best triads for bone engineering is bone marrow stromal cells, @COMPOUND$ ceramics, and bone morphogenetic protein (@PROTEIN$).	0
1307	The cells were mixed with @COMPOUND$ (beta-TCP) granules followed by osteoblast induction with recombinant human @PROTEIN$ (rhBMP-2) (first mixture), or were first induced with rhBMP-2 on plastic dishes and then mixed with the beta-TCP granules (last mixture) just prior to the operation.	0
1308	Effect of short-time exposures to @COMPOUND$ and lead on brain @PROTEIN$ from Danio rerio and Poecilia reticulata.	1
1309	The aim of this work was to verify, in two small size freshwater teleosts Danio rerio and Poecilia reticulata, the effects of short-time exposures (24 and 72 h) to a sublethal dose (500 microg/L) of @COMPOUND$ and lead, on brain monoamine oxidase (@PROTEIN$), an important neural enzyme.	1
1310	The aim of this work was to verify, in two small size freshwater teleosts Danio rerio and Poecilia reticulata, the effects of short-time exposures (24 and 72 h) to a sublethal dose (500 microg/L) of @COMPOUND$ and lead, on brain @PROTEIN$ (MAO), an important neural enzyme.	1
1311	An oncogenetic tree model was built using data on mutations of TP53, KRAS2, APC, and @PROTEIN$ genes, methylation at @COMPOUND$ sites of MLH1 and TP16 genes, methylation in tumor (MINT) markers, and microsatellite instability (MSI) for 971 colon tumors from a population-based series.	0
1312	An oncogenetic tree model was built using data on mutations of TP53, KRAS2, @PROTEIN$, and BRAF genes, methylation at @COMPOUND$ sites of MLH1 and TP16 genes, methylation in tumor (MINT) markers, and microsatellite instability (MSI) for 971 colon tumors from a population-based series.	0
1313	An oncogenetic tree model was built using data on mutations of TP53, KRAS2, APC, and BRAF genes, methylation at @COMPOUND$ sites of @PROTEIN$ and TP16 genes, methylation in tumor (MINT) markers, and microsatellite instability (MSI) for 971 colon tumors from a population-based series.	1
1314	An oncogenetic tree model was built using data on mutations of TP53, @PROTEIN$, APC, and BRAF genes, methylation at @COMPOUND$ sites of MLH1 and TP16 genes, methylation in tumor (MINT) markers, and microsatellite instability (MSI) for 971 colon tumors from a population-based series.	0
1315	An oncogenetic tree model was built using data on mutations of @PROTEIN$, KRAS2, APC, and BRAF genes, methylation at @COMPOUND$ sites of MLH1 and TP16 genes, methylation in tumor (MINT) markers, and microsatellite instability (MSI) for 971 colon tumors from a population-based series.	0
1316	Considering the post-cAMP sites of HA action, it is shown herein that HA markedly inhibited db-cAMP-stimulated steroidogenic acute regulatory (STAR) protein expression, as well as steps catalyzed by P450-dependent enzymes, mainly the conversion of cholesterol to @COMPOUND$ by cholesterol side-chain cleavage enzyme (@PROTEIN$).	1
1317	Considering the post-cAMP sites of HA action, it is shown herein that HA markedly inhibited db-cAMP-stimulated steroidogenic acute regulatory (STAR) protein expression, as well as steps catalyzed by P450-dependent enzymes, mainly the conversion of @COMPOUND$ to pregnenolone by @PROTEIN$ (CYP11A).	1
1318	Considering the post-cAMP sites of HA action, it is shown herein that HA markedly inhibited db-cAMP-stimulated steroidogenic acute regulatory (STAR) protein expression, as well as steps catalyzed by P450-dependent enzymes, mainly the conversion of @COMPOUND$ to pregnenolone by cholesterol side-chain cleavage enzyme (@PROTEIN$).	1
1319	Considering the post-cAMP sites of HA action, it is shown herein that HA markedly inhibited db-cAMP-stimulated steroidogenic acute regulatory (STAR) protein expression, as well as steps catalyzed by P450-dependent enzymes, mainly the conversion of cholesterol to @COMPOUND$ by @PROTEIN$ (CYP11A).	1
1320	@PROTEIN$ activity and @COMPOUND$ levels may therefore be altered in 22q11DS individuals.	0
1321	@PROTEIN$ (158) genotype and plasma @COMPOUND$ levels were determined in the 22q11DS children.	0
1322	The effect of @COMPOUND$ exposure on birds was examined by measuring aerobic metabolism, blood hemoglobin content, plasma @PROTEIN$, and body weight for up to 21 d postdose.	1
1323	The effect of @COMPOUND$ exposure on birds was examined by measuring aerobic metabolism, blood @PROTEIN$ content, plasma cholinesterases, and body weight for up to 21 d postdose.	1
1324	@COMPOUND$, F41, STa, Stx1 and @PROTEIN$ were found as the most common virulence gene markers of E. coli strains isolated from calves with diarrhoea.	0
1325	K99, @COMPOUND$, STa, Stx1 and @PROTEIN$ were found as the most common virulence gene markers of E. coli strains isolated from calves with diarrhoea.	0
1326	These agents possess a range of physiological effects that are associated with improved glycaemic control in diabetes including stimulation of @COMPOUND$-dependent @PROTEIN$ secretion, suppression of glucagon secretion, slowing of gastric emptying, and reduction of food intake.	1
1327	These agents possess a range of physiological effects that are associated with improved glycaemic control in diabetes including stimulation of @COMPOUND$-dependent insulin secretion, suppression of @PROTEIN$ secretion, slowing of gastric emptying, and reduction of food intake.	0
1328	Induction of the spliced form of @PROTEIN$ as well as total XBP1 by @COMPOUND$ was significantly attenuated in patients with BD.	1
1329	It appears that GSTM1 null and GSTT1 null have a clear association with longer overall survival in patients with different malignancies who are treated with substrates for these @PROTEIN$ (mostly alkylating agents and @COMPOUND$).	1
1330	It appears that GSTM1 null and @PROTEIN$ null have a clear association with longer overall survival in patients with different malignancies who are treated with substrates for these GSTs (mostly alkylating agents and @COMPOUND$).	1
1331	It appears that @PROTEIN$ null and GSTT1 null have a clear association with longer overall survival in patients with different malignancies who are treated with substrates for these GSTs (mostly alkylating agents and @COMPOUND$).	1
1332	@COMPOUND$ attenuates antigen-specific IgE production through the modulation of @PROTEIN$/Th2 balance in ovalbumin-sensitized BALB/c mice.	1
1333	BALB/c mice were either left untreated or administered daily with vehicle (VH; saline) and/or @COMPOUND$ (200 or 400 mg/kg) by gavage for 3 consecutive days prior to sensitization with @PROTEIN$ (OVA).	0
1334	Consequently, the primary mechanism of resistance to @COMPOUND$ is a function of the activity of the DNA repair enzyme O(6)-methylguanine DNA @PROTEIN$ (MGMT).	1
1335	Consequently, the primary mechanism of resistance to @COMPOUND$ is a function of the activity of the DNA repair enzyme O(6)-methylguanine DNA methyltransferase (@PROTEIN$).	1
1336	Despite their inhibitory effects on inflammatory gene expression, loss of @PROTEIN$ or LXRs in macrophages did not exert major effects on obesity or @COMPOUND$ tolerance induced by a high-fat diet.	0
1337	A considerable body of evidence exists suggesting a link among reduced @COMPOUND$ plasma levels, type 2 diabetes (T2D), and @PROTEIN$ resistance (IR).	1
1338	Androgen therapy of hypogonadal men improves @PROTEIN$ sensitivity, fasting @COMPOUND$, and HbA1c levels.	0
1339	Effects of conjugated linoleic acid plus n-3 @COMPOUND$ on @PROTEIN$ secretion and estimated insulin sensitivity in men.	1
1340	Effects of @COMPOUND$ plus n-3 polyunsaturated fatty acids on @PROTEIN$ secretion and estimated insulin sensitivity in men.	1
1341	A mechanism for the bioreduction of H2PtCl6 and PtCl2 into @COMPOUND$ nanoparticles by a @PROTEIN$ enzyme from Fusarium oxysporum is proposed.	1
1342	The results indicated that @PROTEIN$ receptors within the nucleus accumbens are involved in the acquisition and expression of @COMPOUND$-induced CPP in sensitized rats.	1
1343	The potentiated effect of obestatin on @COMPOUND$-induced @PROTEIN$ output was not observed in the presence of diazoxide, an agent that activates ATP-dependent K(+) channels, thus suggesting that these channels might be sensitive to this peptide.	1
1344	The potentiated effect of @PROTEIN$ on @COMPOUND$-induced insulin output was not observed in the presence of diazoxide, an agent that activates ATP-dependent K(+) channels, thus suggesting that these channels might be sensitive to this peptide.	1
1345	The potentiated effect of obestatin on glucose-induced @PROTEIN$ output was not observed in the presence of @COMPOUND$, an agent that activates ATP-dependent K(+) channels, thus suggesting that these channels might be sensitive to this peptide.	1
1346	The potentiated effect of @PROTEIN$ on glucose-induced insulin output was not observed in the presence of @COMPOUND$, an agent that activates ATP-dependent K(+) channels, thus suggesting that these channels might be sensitive to this peptide.	1
1347	Four brain areas (cortex, hippocampus, thalamus and hypothalamus) were analyzed for EB extravasation, water and electrolyte (@COMPOUND$ (+), K(+), Cl (-)) contents, immunostained for albumin and glial fibrillary @PROTEIN$ (GFAP), and examined for neuronal, glial and axonal alterations using standard light and electron microscopy.	0
1348	Four brain areas (cortex, hippocampus, thalamus and hypothalamus) were analyzed for EB extravasation, water and electrolyte (@COMPOUND$ (+), K(+), Cl (-)) contents, immunostained for albumin and glial fibrillary acidic protein (@PROTEIN$), and examined for neuronal, glial and axonal alterations using standard light and electron microscopy.	0
1349	Four brain areas (cortex, hippocampus, thalamus and hypothalamus) were analyzed for EB extravasation, water and electrolyte (Na (+), K(+), @COMPOUND$ (-)) contents, immunostained for albumin and glial fibrillary acidic protein (@PROTEIN$), and examined for neuronal, glial and axonal alterations using standard light and electron microscopy.	0
1350	Four brain areas (cortex, hippocampus, thalamus and hypothalamus) were analyzed for EB extravasation, water and electrolyte (Na (+), K(+), @COMPOUND$ (-)) contents, immunostained for albumin and glial fibrillary @PROTEIN$ (GFAP), and examined for neuronal, glial and axonal alterations using standard light and electron microscopy.	0
1351	We administered @COMPOUND$ to newborn rats on postnatal days (PN) 1-4 at doses spanning the threshold for detectable @PROTEIN$ inhibition (0.1 mg/kg/day) and the first signs of loss of viability (0.2 mg/kg/day).	1
1352	The Arg105 in @PROTEIN$ is highly conserved across species and its replacement with @COMPOUND$ is predicted to be pathogenic.	1
1353	We also assess prostaglandin (PGE (2)) and thromboxane (@COMPOUND$ (2)) inhibition to establish the correlation between behavioural measures and the degree of selectivity for COX-1 and @PROTEIN$.	0
1354	We also assess prostaglandin (PGE (2)) and thromboxane (@COMPOUND$ (2)) inhibition to establish the correlation between behavioural measures and the degree of selectivity for @PROTEIN$ and COX-2.	0
1355	We also assess prostaglandin (PGE (2)) and @COMPOUND$ (TXB (2)) inhibition to establish the correlation between behavioural measures and the degree of selectivity for COX-1 and @PROTEIN$.	0
1356	We also assess prostaglandin (PGE (2)) and @COMPOUND$ (TXB (2)) inhibition to establish the correlation between behavioural measures and the degree of selectivity for @PROTEIN$ and COX-2.	0
1357	We also assess prostaglandin (@PROTEIN$ (2)) and thromboxane (@COMPOUND$ (2)) inhibition to establish the correlation between behavioural measures and the degree of selectivity for COX-1 and COX-2.	0
1358	We also assess prostaglandin (@PROTEIN$ (2)) and @COMPOUND$ (TXB (2)) inhibition to establish the correlation between behavioural measures and the degree of selectivity for COX-1 and COX-2.	0
1359	Niemann-Pick C disease (NPC) is an autosomal recessive neurodegenerative disorder caused by the abnormal function of @PROTEIN$ or NPC2 proteins, leading to an accumulation of unesterified @COMPOUND$ and glycosphingolipids (GSLs) in the lysosomes.	1
1360	Niemann-Pick C disease (NPC) is an autosomal recessive neurodegenerative disorder caused by the abnormal function of NPC1 or @PROTEIN$ proteins, leading to an accumulation of unesterified @COMPOUND$ and glycosphingolipids (GSLs) in the lysosomes.	1
1361	The present study explored the effects of flaxseed-derived @COMPOUND$ on inflammatory factors and @PROTEIN$ concentrations in type 2 diabetics, who have higher levels of these biomarkers.	1
1362	These include typical G-protein (Galphaq/11)-coupled cascades, such as activation of phospholipase C (PLC), and subsequent accumulation of inositol-(1,4,5)-triphosphate (IP3), intracellular @COMPOUND$+) mobilization, and activation of @PROTEIN$.	0
1363	Polymorphism in the @PROTEIN$ gene, plasma lipoprotein(a), cardiovascular disease, and low-dose @COMPOUND$ therapy.	0
1364	We investigated whether this allele was associated with elevated @PROTEIN$ and cardiovascular risk in the Women's Health Study, a randomized trial of low-dose @COMPOUND$, and whether aspirin reduced cardiovascular risk in minor allele carriers.	0
1365	The study was prompted to characterize the B-type @PROTEIN$ activities in the terrestrial snail Xeropicta derbentina and to evaluate its sensitivity to organophosphorus and @COMPOUND$ pesticides.	1
1366	Linear regression analyses showed that @COMPOUND$ and phospholipid efflux and cellular apoA-I binding correlated significantly with the ability of @PROTEIN$ to form cell surface lipid domains.	1
1367	Linear regression analyses showed that @COMPOUND$ and phospholipid efflux and cellular @PROTEIN$ binding correlated significantly with the ability of ABCA1 to form cell surface lipid domains.	0
1368	Given the anti-inflammatory role of @COMPOUND$ (RSV), we hypothesized that RSV would attenuate inflammation and @PROTEIN$ resistance caused by 10,12 CLA in human adipocytes.	1
1369	We determined effects of the vasopeptidase inhibitor (VPI) omapatrilat and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) @COMPOUND$ in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-nitric-oxide-synthase (iNOS), oxidant-generating myeloperoxidase (MPO), and cytokines @PROTEIN$ (TNF)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
1370	We determined effects of the vasopeptidase inhibitor (VPI) @COMPOUND$ and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) candesartan in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-nitric-oxide-synthase (iNOS), oxidant-generating myeloperoxidase (MPO), and cytokines @PROTEIN$ (TNF)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
1371	We determined effects of the vasopeptidase inhibitor (VPI) @COMPOUND$ and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) candesartan in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-@PROTEIN$ (iNOS), oxidant-generating myeloperoxidase (MPO), and cytokines tumor-necrosis-factor (TNF)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
1372	We determined effects of the vasopeptidase inhibitor (VPI) @COMPOUND$ and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) candesartan in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-nitric-oxide-synthase (@PROTEIN$), oxidant-generating myeloperoxidase (MPO), and cytokines tumor-necrosis-factor (TNF)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
1373	We determined effects of the vasopeptidase inhibitor (VPI) omapatrilat and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) @COMPOUND$ in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-nitric-oxide-synthase (iNOS), oxidant-generating myeloperoxidase (@PROTEIN$), and cytokines tumor-necrosis-factor (TNF)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
1374	We determined effects of the vasopeptidase inhibitor (VPI) @COMPOUND$ and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) candesartan in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (@PROTEIN$)-3, inducible-nitric-oxide-synthase (iNOS), oxidant-generating myeloperoxidase (MPO), and cytokines tumor-necrosis-factor (TNF)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
1375	We determined effects of the vasopeptidase inhibitor (VPI) omapatrilat and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) @COMPOUND$ in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-nitric-oxide-synthase (iNOS), oxidant-generating myeloperoxidase (MPO), and cytokines tumor-necrosis-factor (@PROTEIN$)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
1376	We determined effects of the vasopeptidase inhibitor (VPI) omapatrilat and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) @COMPOUND$ in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-nitric-oxide-synthase (@PROTEIN$), oxidant-generating myeloperoxidase (MPO), and cytokines tumor-necrosis-factor (TNF)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
1377	We determined effects of the vasopeptidase inhibitor (VPI) @COMPOUND$ and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) candesartan in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-nitric-oxide-synthase (iNOS), oxidant-generating myeloperoxidase (MPO), and cytokines tumor-necrosis-factor (TNF)-alpha, interleukin (IL)-6 and @PROTEIN$, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
1378	We determined effects of the vasopeptidase inhibitor (VPI) @COMPOUND$ and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) candesartan in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-nitric-oxide-synthase (iNOS), oxidant-generating myeloperoxidase (@PROTEIN$), and cytokines tumor-necrosis-factor (TNF)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
1379	We determined effects of the vasopeptidase inhibitor (VPI) @COMPOUND$ and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) candesartan in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-nitric-oxide-synthase (iNOS), oxidant-generating myeloperoxidase (MPO), and cytokines tumor-necrosis-factor (@PROTEIN$)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
1380	We determined effects of the vasopeptidase inhibitor (VPI) omapatrilat and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) @COMPOUND$ in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (@PROTEIN$)-3, inducible-nitric-oxide-synthase (iNOS), oxidant-generating myeloperoxidase (MPO), and cytokines tumor-necrosis-factor (TNF)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
1381	We determined effects of the vasopeptidase inhibitor (VPI) omapatrilat and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) @COMPOUND$ in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-nitric-oxide-synthase (iNOS), oxidant-generating myeloperoxidase (MPO), and cytokines tumor-necrosis-factor (TNF)-alpha, interleukin (IL)-6 and @PROTEIN$, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
1382	We determined effects of the vasopeptidase inhibitor (VPI) omapatrilat and angiotensin II type 1 receptor (AT(1)R) blocker (ARB) @COMPOUND$ in rats during healing between day-2 and day-21 after reperfused myocardial infarction (RMI) on left ventricular (LV) remodeling and function, and regional matrix metalloproteinase (MMP)-9, tissue inhibitor of MMP (TIMP)-3, inducible-@PROTEIN$ (iNOS), oxidant-generating myeloperoxidase (MPO), and cytokines tumor-necrosis-factor (TNF)-alpha, interleukin (IL)-6 and IL-10, and transforming-growth-factor (TGF)-beta(1), and collagens.	0
1383	We recently reported @COMPOUND$ (Hcy)-induced @PROTEIN$-phosphorylation was suppressed by pertussis toxin (PTX), which suggested the involvement of GPCRs in initiating signal transduction.	1
1384	The results of the present work show that this replacement does not considerably affect the DNA modifications by this drug, recognition of these modifications by @PROTEIN$ protein, their repair, and reactivity of the @COMPOUND$ with GSH.	0
1385	The results of the present work show that this replacement does not considerably affect the DNA modifications by this drug, recognition of these modifications by @PROTEIN$ protein, their repair, and reactivity of the platinum complex with @COMPOUND$.	0
1386	Anti-P mAb promoted @PROTEIN$ overproduction in a dose- and time-dependent manner in both @COMPOUND$ (LPS)-activated RAW 264.7 cells and primary human macrophages.	0
1387	Increased secretion of hyperimmune antibodies following @COMPOUND$ stimulation of @PROTEIN$-activated human B cells in vitro.	1
1388	We have investigated the pre-receptor metabolism of @COMPOUND$ in primary hOSE cells and an immortalised hOSE cell line, OSE-C2, focusing on transcriptional regulation of 3beta-hydroxysteroid dehydrogenase (@PROTEIN$) by inflammatory, anti-inflammatory and apoptotic factors.	0
1389	We have investigated the pre-receptor metabolism of @COMPOUND$ in primary hOSE cells and an immortalised hOSE cell line, OSE-C2, focusing on transcriptional regulation of @PROTEIN$ (3beta-HSD) by inflammatory, anti-inflammatory and apoptotic factors.	0
1390	Coexpression with H6PDH potentiated @PROTEIN$ reductase activity at high @COMPOUND$.	1
1391	Variability of AChE, BChE, and @PROTEIN$ genes in the late-onset form of Alzheimer's disease and relationships with response to treatment with @COMPOUND$ and Rivastigmine.	1
1392	Variability of AChE, BChE, and @PROTEIN$ genes in the late-onset form of Alzheimer's disease and relationships with response to treatment with Donepezil and @COMPOUND$.	1
1393	Variability of @PROTEIN$, BChE, and ChAT genes in the late-onset form of Alzheimer's disease and relationships with response to treatment with Donepezil and @COMPOUND$.	1
1394	Variability of @PROTEIN$, BChE, and ChAT genes in the late-onset form of Alzheimer's disease and relationships with response to treatment with @COMPOUND$ and Rivastigmine.	1
1395	Spectrofluorimetric determination of vitamin B(1) using horseradish @PROTEIN$ as catalyst in the presence of @COMPOUND$.	1
1396	Bevacizumab (Avastin), ranibizumab (Lucentis) and pegaptanib sodium (@COMPOUND$) are anti-@PROTEIN$ medications that have been used in the treatment of CNV.	1
1397	Bevacizumab (Avastin), ranibizumab (Lucentis) and @COMPOUND$ (Macugen) are anti-@PROTEIN$ medications that have been used in the treatment of CNV.	1
1398	Some of the peptide derivatives inhibited @PROTEIN$-mediated uptake of ((3)H) @COMPOUND$-Sar.	1
1399	Effect of enzyme supplementation at moderate @PROTEIN$ loadings on initial @COMPOUND$ and xylose release from corn stover solids pretreated by leading technologies.	0
1400	PCFT/@PROTEIN$ could therefore play a physiological role in Fe nutrition and the data highlight the potential for the interaction of @COMPOUND$ and haem at the level of intestinal absorption.	1
1401	Adult female X. laevis were injected three times at weekly intervals with the hapten-carrier complex, trinitrophenylated bovine @PROTEIN$ (@COMPOUND$-BSA).	1
1402	Adult female X. laevis were injected three times at weekly intervals with the hapten-carrier complex, trinitrophenylated bovine serum albumin (@COMPOUND$-@PROTEIN$).	1
1403	Downregulation of @PROTEIN$, or pretreatment with @COMPOUND$, attenuated hyperoxia-induced cell migration and capillary tube formation, suggesting that ROS generated by Nox4 regulate endothelial cell motility.	0
1404	Using newly designed degenerate primers targeting the @PROTEIN$ gene we analysed the potential for @COMPOUND$ utilization in DNA and cDNA libraries constructed from a phytoplankton bloom in the Western English Channel during July 2006.	1
1405	Low-density lipoprotein @COMPOUND$ and non-@PROTEIN$ cholesterol and the incidence of cardiovascular disease in an urban Japanese cohort study: The Suita study.	0
1406	It is a serious problem that effective treatment choices to T315I, in the @PROTEIN$ kinase domain that shows a strong tolerance in @COMPOUND$ do not exist clinically.	1
1407	Long-term blinded placebo-controlled study of SNT-MC17/@COMPOUND$ in the @PROTEIN$ deficient mdx mouse: cardiac protection and improved exercise performance.	1
1408	Long-term blinded placebo-controlled study of @COMPOUND$/idebenone in the @PROTEIN$ deficient mdx mouse: cardiac protection and improved exercise performance.	1
1409	We previously reported that inhibition of @PROTEIN$-kinase (ROCK) by hydroxyl @COMPOUND$ improves cognitive deficit and neuronal damage in rats with chronic cerebral ischemia (Huang et al., Cell Mol Neurobiol 28:757-768, 2008).	1
1410	Silencing of @PROTEIN$, the key entry-point enzyme for @COMPOUND$ biosynthesis led to flavonoid-deficient roots.	1
1411	Compensatory adaptations for the functional serotonergic impairment were evidenced, such as an enhanced release of @COMPOUND$ in response to a meal allied to up-regulated hypothalamic @PROTEIN$ and transporter expression.	1
1412	@COMPOUND$ controls cytosolic Ca2+ and @PROTEIN$ secretion in mouse islets lacking adenosine triphosphate-sensitive K+ channels owing to a knockout of the pore-forming subunit Kir6.2.	1
1413	Glucose controls cytosolic Ca2+ and @PROTEIN$ secretion in mouse islets lacking @COMPOUND$-sensitive K+ channels owing to a knockout of the pore-forming subunit Kir6.2.	1
1414	In this study, the degradation of @PROTEIN$- and R-@COMPOUND$ under anaerobic conditions was studied.	0
1415	@PROTEIN$ expression analysis in chemotherapy-naive patients with advanced non-small-cell lung cancer treated with gefitinib or placebo in combination with @COMPOUND$-based chemotherapy.	1
1416	To achieve sustained delivery of a novel bone-induced growth factor, chitosan microspheres loaded with synthetic oligopeptide (S((@COMPOUND$))KIPKASSVPTELSAISTLYLDDD, P24) were prepared by an emulsion-ionic cross-linking method in the presence of tripolyphosphate, with bovine serum albumin (@PROTEIN$) as a control.	0
1417	To achieve sustained delivery of a novel bone-induced growth factor, chitosan microspheres loaded with synthetic oligopeptide (S((@COMPOUND$))KIPKASSVPTELSAISTLYLDDD, P24) were prepared by an emulsion-ionic cross-linking method in the presence of tripolyphosphate, with bovine @PROTEIN$ (BSA) as a control.	0
1418	Colon cancer cells maintain low levels of @COMPOUND$ to avoid cell death caused by inhibition of @PROTEIN$/HDAC3.	0
1419	Colon cancer cells maintain low levels of @COMPOUND$ to avoid cell death caused by inhibition of HDAC1/@PROTEIN$.	0
1420	This process is associated with an increase in intracellular levels of @COMPOUND$, increase in the acetylation status of @PROTEIN$, and enhanced cell death.	0
1421	In the present study, we have investigated the effect of @PROTEIN$ on ABCA1 expression and @COMPOUND$ efflux in THP-1 macrophage-derived foam cells.	1
1422	In the present study, we have investigated the effect of IFN-gamma on @PROTEIN$ expression and @COMPOUND$ efflux in THP-1 macrophage-derived foam cells.	0
1423	Every 12 weeks intestinal permeability (@COMPOUND$/mannitol ratio), haemoglobin, plasma albumin, alpha-1-acid @PROTEIN$, IgG and Giardia-specific IgM (GSIgM) and eggs of the three common geohelminths and G. intestinalis cysts were determined.	0
1424	Every 12 weeks intestinal permeability (lactulose/@COMPOUND$ ratio), haemoglobin, plasma albumin, @PROTEIN$-acid glycoprotein, IgG and Giardia-specific IgM (GSIgM) and eggs of the three common geohelminths and G. intestinalis cysts were determined.	0
1425	Every 12 weeks intestinal permeability (@COMPOUND$/mannitol ratio), haemoglobin, plasma albumin, @PROTEIN$-acid glycoprotein, IgG and Giardia-specific IgM (GSIgM) and eggs of the three common geohelminths and G. intestinalis cysts were determined.	0
1426	Every 12 weeks intestinal permeability (lactulose/@COMPOUND$ ratio), haemoglobin, plasma albumin, alpha-1-acid @PROTEIN$, IgG and Giardia-specific IgM (GSIgM) and eggs of the three common geohelminths and G. intestinalis cysts were determined.	0
1427	As such, the aim of the present study was to investigate whether @PROTEIN$-inhibition with @COMPOUND$, a molecule distinctly different from torcetrapib, impacts on vascular function, a well-established surrogate of atherosclerotic vascular disease, as well as markers of inflammation and oxidative stress in patients with type II hyperlipidemia.	1
1428	Pathways involved in the hydrolysis of nitrile pollutants (aliphatic nitriles, @COMPOUND$ analogues) and the corresponding enzymes (@PROTEIN$, nitrile hydratase) are described in detail.	1
1429	Since stellate cells have been found to express the beta but not the alpha isoform of the @PROTEIN$, it can be predicted that nutritional intakes of the soy isoflavone @COMPOUND$-a selective agonist for ERbeta in the low nanomolar plasma concentrations achievable with these intakes-have potential for suppressing hepatic fibrosis, in both men and women.	0
1430	Since stellate cells have been found to express the beta but not the alpha isoform of the @PROTEIN$, it can be predicted that nutritional intakes of the soy @COMPOUND$ genistein-a selective agonist for ERbeta in the low nanomolar plasma concentrations achievable with these intakes-have potential for suppressing hepatic fibrosis, in both men and women.	1
1431	To investigate the effects of selenium on mRNA expressions of proinflammatory cytokines and inducible nitric oxide synthase (@PROTEIN$) in the pancreas of streptozotocin-induced diabetic mice, the animals were divided into three groups in this study: a normal control group, an untreated diabetes mellitus group and a @COMPOUND$-treated diabetes mellitus group.	0
1432	To investigate the effects of selenium on mRNA expressions of proinflammatory cytokines and inducible @PROTEIN$ (iNOS) in the pancreas of streptozotocin-induced diabetic mice, the animals were divided into three groups in this study: a normal control group, an untreated diabetes mellitus group and a @COMPOUND$-treated diabetes mellitus group.	0
1433	To investigate the effects of @COMPOUND$ on mRNA expressions of proinflammatory cytokines and inducible @PROTEIN$ (iNOS) in the pancreas of streptozotocin-induced diabetic mice, the animals were divided into three groups in this study: a normal control group, an untreated diabetes mellitus group and a selenite-treated diabetes mellitus group.	1
1434	To investigate the effects of @COMPOUND$ on mRNA expressions of proinflammatory cytokines and inducible nitric oxide synthase (@PROTEIN$) in the pancreas of streptozotocin-induced diabetic mice, the animals were divided into three groups in this study: a normal control group, an untreated diabetes mellitus group and a selenite-treated diabetes mellitus group.	1
1435	The results showed that pancreatic @COMPOUND$ content and @PROTEIN$.05), respectively, in selenite-treated diabetes mellitus group compared with untreated diabetes mellitus group.	0
1436	The results showed that pancreatic selenium content and @PROTEIN$.05), respectively, in @COMPOUND$-treated diabetes mellitus group compared with untreated diabetes mellitus group.	0
1437	Meanwhile, pancreatic mRNA expressions of proinflammatory cytokines interleukin-1beta, @PROTEIN$-alpha and interferon-gamma ; mRNA expression and activity of iNOS.05), respectively, in @COMPOUND$-treated diabetes mellitus group compared with untreated diabetes mellitus group.	1
1438	Meanwhile, pancreatic mRNA expressions of proinflammatory cytokines interleukin-1beta, tumor necrosis factor-alpha and interferon-gamma ; mRNA expression and activity of @PROTEIN$.05), respectively, in @COMPOUND$-treated diabetes mellitus group compared with untreated diabetes mellitus group.	1
1439	Meanwhile, pancreatic mRNA expressions of proinflammatory cytokines interleukin-1beta, tumor necrosis factor-alpha and @PROTEIN$ ; mRNA expression and activity of iNOS.05), respectively, in @COMPOUND$-treated diabetes mellitus group compared with untreated diabetes mellitus group.	1
1440	This study suggests that the loss of PNNs, aggrecan and @COMPOUND$ is a consequence of @PROTEIN$ (BSE) accumulation.	0
1441	This study suggests that the loss of @PROTEIN$, aggrecan and @COMPOUND$ is a consequence of PrP (BSE) accumulation.	0
1442	These effects were probably associated with the increase of intracellular @COMPOUND$ in mitochondrial signaling pathway which attributed to the down-regulation of @PROTEIN$ (SOD).	1
1443	These effects were probably associated with the increase of intracellular @COMPOUND$ in mitochondrial signaling pathway which attributed to the down-regulation of superoxide dismutase (@PROTEIN$).	1
1444	This initiates a @COMPOUND$ signalling cascade resulting in the translocation of @PROTEIN$-bearing vesicles to the apical membrane.	1
1445	Chemopreventive potential of @COMPOUND$ in mouse skin tumors through regulation of mitochondrial and @PROTEIN$/AKT signaling pathways.	1
1446	This phase II study, evaluated the activity and cardiotoxicity of first-line @COMPOUND$ plus low-dose trastuzumab (LD-T) in patients with @PROTEIN$ positive MBC.	0
1447	Each of the developed consortium has a phosphate solubilizer, @COMPOUND$ fixer, @PROTEIN$ producer, heterotrophic member and an antagonist.	0
1448	Each of the developed consortium has a @COMPOUND$ solubilizer, nitrogen fixer, @PROTEIN$ producer, heterotrophic member and an antagonist.	0
1449	Pre-gravid physical activity and reduced risk of @COMPOUND$ intolerance in pregnancy : the role of @PROTEIN$ sensitivity.	1
1450	When myosin molecules work as an aggregate, the sliding movement of a myosin filament driven by the power strokes of some myosin heads makes other myosin heads that have completed their power strokes detach from the @PROTEIN$ without consuming @COMPOUND$.	0
1451	Our results suggest a more prominent role for H2 as electron carrier in the syntrophic conversion of @COMPOUND$, when the essential trace metals W and Mo for the functioning of @PROTEIN$ are depleted.	1
1452	Mice lacking Niemann-Pick C1-Like 1 (@PROTEIN$) (NPC1L1 (-/-)mice) exhibit a defect in intestinal absorption of cholesterol and @COMPOUND$.	1
1453	In this study, we examined the role of @PROTEIN$ in @COMPOUND$ and cholesterol trafficking in mice lacking ATP-binding cassette (ABC) transporters G5 and G8 (G5/G8(-/-) mice).	0
1454	The slow BSO-induced @COMPOUND$ depletion allows separation of two redox-related phases, namely, early thiol disequilibrium and late frank oxidative stress; each phase contributes to the progressive activation of a @PROTEIN$-p50 homodimer.	0
1455	Effects of exhaustion and calcium supplementation on @PROTEIN$ and @COMPOUND$ levels in athletes.	0
1456	One-month supplementation with calcium does not influence the @COMPOUND$ and @PROTEIN$ 0.05).	0
1457	Effects of nonspecific targeting of @PROTEIN$ were evaluated with addition of imatinib (@COMPOUND$) to cell cultures.	0
1458	In the pericentral necrotic zone after @COMPOUND$-treatment, no induction of @PROTEIN$ was found.	0
1459	In @COMPOUND$-treated heart failure, venous responses to @PROTEIN$ are preserved but arterial responses are reduced compared with healthy controls.	0
1460	High @COMPOUND$ attenuates VEGF expression in rat multipotent adult progenitor cells in association with inhibition of JAK2/@PROTEIN$ signalling.	0
1461	High @COMPOUND$ attenuates VEGF expression in rat multipotent adult progenitor cells in association with inhibition of @PROTEIN$/STAT3 signalling.	0
1462	High @COMPOUND$ attenuates @PROTEIN$ expression in rat multipotent adult progenitor cells in association with inhibition of JAK2/STAT3 signalling.	1
1463	This study was to investigate the effect of high @COMPOUND$ (HG) on vascular endothelial growth factor (VEGF) expression in bone marrow stem cells and JAK2/@PROTEIN$-3 signalling.	0
1464	This study was to investigate the effect of high @COMPOUND$ (HG) on vascular endothelial growth factor (VEGF) expression in bone marrow stem cells and @PROTEIN$/STAT-3 signalling.	0
1465	This study was to investigate the effect of high glucose (@COMPOUND$) on vascular endothelial growth factor (@PROTEIN$) expression in bone marrow stem cells and JAK2/STAT-3 signalling.	0
1466	This study was to investigate the effect of high glucose (@COMPOUND$) on vascular endothelial growth factor (VEGF) expression in bone marrow stem cells and @PROTEIN$/STAT-3 signalling.	0
1467	This study was to investigate the effect of high glucose (@COMPOUND$) on vascular endothelial growth factor (VEGF) expression in bone marrow stem cells and JAK2/@PROTEIN$-3 signalling.	0
1468	This study was to investigate the effect of high @COMPOUND$ (HG) on vascular endothelial growth factor (@PROTEIN$) expression in bone marrow stem cells and JAK2/STAT-3 signalling.	0
1469	Expression of @COMPOUND$ and inducible @PROTEIN$ was rarely seen in focal nodular hyperplasia without a central scar, focal nodular hyperplasia-like nodules, or nodular regenerative hyperplasia.	0
1470	The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for serotonin (5-HT), @COMPOUND$ (D cells), glucagon, motilin, polypeptide YY (@PROTEIN$) and insulin.	0
1471	The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for @COMPOUND$ (5-HT), somatostatin (D cells), @PROTEIN$, motilin, polypeptide YY (PYY) and insulin.	0
1472	The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for serotonin (@COMPOUND$), somatostatin (D cells), glucagon, motilin, polypeptide YY (PYY) and @PROTEIN$.	0
1473	The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for @COMPOUND$ (5-HT), somatostatin (D cells), glucagon, @PROTEIN$, polypeptide YY (PYY) and insulin.	0
1474	The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for serotonin (@COMPOUND$), somatostatin (D cells), glucagon, @PROTEIN$, polypeptide YY (PYY) and insulin.	0
1475	The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for serotonin (5-HT), @COMPOUND$ (D cells), @PROTEIN$, motilin, polypeptide YY (PYY) and insulin.	0
1476	The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for @COMPOUND$ (5-HT), somatostatin (D cells), glucagon, motilin, polypeptide YY (PYY) and @PROTEIN$.	0
1477	The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for @COMPOUND$ (5-HT), somatostatin (D cells), glucagon, motilin, polypeptide YY (@PROTEIN$) and insulin.	0
1478	The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for serotonin (@COMPOUND$), somatostatin (D cells), @PROTEIN$, motilin, polypeptide YY (PYY) and insulin.	0
1479	The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for serotonin (5-HT), @COMPOUND$ (D cells), glucagon, motilin, polypeptide YY (PYY) and @PROTEIN$.	0
1480	The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for serotonin (@COMPOUND$), somatostatin (D cells), glucagon, motilin, polypeptide YY (@PROTEIN$) and insulin.	0
1481	The main purpose of this study was to evaluate the regional distribution pattern and relative frequency of some endocrine cells in the three portions of the gastrointestinal tract (GIT)--the proventriculus, gizzard and duodenum-of the rufous-collared sparrow (Zonotrichia capensis subtorquata), by immunohistochemical methods using six types of polyclonal antisera, specific for serotonin (5-HT), @COMPOUND$ (D cells), glucagon, @PROTEIN$, polypeptide YY (PYY) and insulin.	0
1482	In the final part of the gizzard, endocrine cells secreting @COMPOUND$ were more frequent, and cells secreting somatostatin and @PROTEIN$ were not detected.	0
1483	In the final part of the gizzard, endocrine cells secreting 5-HT were more frequent, and cells secreting @COMPOUND$ and @PROTEIN$ were not detected.	0
1484	However, there are conflicting data regarding the role of Gpr30 as an @PROTEIN$ (ER): several laboratories were unable to demonstrate @COMPOUND$ binding to GPR30 or estradiol-activated signal transduction in Gpr30-expressing cells.	0
1485	Here we characterize @PROTEIN$ mRNA and SORD expression during mouse spermatogenesis and examine the ability of @COMPOUND$ to support epididymal sperm motility and tyrosine phosphorylation.	0
1486	Here we characterize Sord mRNA and @PROTEIN$ expression during mouse spermatogenesis and examine the ability of @COMPOUND$ to support epididymal sperm motility and tyrosine phosphorylation.	0
1487	Here we characterize Sord mRNA and @PROTEIN$ expression during mouse spermatogenesis and examine the ability of sorbitol to support epididymal sperm motility and @COMPOUND$ phosphorylation.	0
1488	Here we characterize @PROTEIN$ mRNA and SORD expression during mouse spermatogenesis and examine the ability of sorbitol to support epididymal sperm motility and @COMPOUND$ phosphorylation.	0
1489	Increase in @COMPOUND$ clearance in the early postnatal period likely reflects maturation of @PROTEIN$-mediated N-demethylation.	1
1490	The @PROTEIN$-selective antidepressant @COMPOUND$ (DMI) was chronically administered for 14 days to WKY rats and the strain from which it was outbred that does not show depressive-like behavior, the Wistar rat.	1
1491	The present study was designed to evaluate the impact of zinc status before burn on the recovery of injury with focus on plasma @PROTEIN$ and @COMPOUND$ levels.	0
1492	Blood and tissue samples were collected 3, 6, and 24 h after injury in order to study biochemical parameters and the @COMPOUND$/@PROTEIN$ response in relation with the zinc status.	0
1493	In addition, the burn-induced insulin resistance, leading to protein catabolism, was emphasized, with higher plasma insulin, @COMPOUND$, and @PROTEIN$ levels in zinc-deficient animals versus normal-fed rats.	0
1494	In addition, the burn-induced @PROTEIN$ resistance, leading to protein catabolism, was emphasized, with higher plasma insulin, @COMPOUND$, and leptin levels in zinc-deficient animals versus normal-fed rats.	0
1495	The most predictive model of @PROTEIN$ response for the pediatric cohort had, as the major variables, @COMPOUND$ clearance x dialysis duration/total body water (Kt/V), urea reduction ratio (URR), intact parathyroid hormone (iPTH), blood loss, normalized protein catabolic rates (nPCR) and indices of malnutrition and inflammation, whereas adults had iron and folate deficiencies as the dominant variables.	1
1496	The most predictive model of @PROTEIN$ response for the pediatric cohort had, as the major variables, urea clearance x dialysis duration/total body water (Kt/V), urea reduction ratio (URR), intact parathyroid hormone (iPTH), blood loss, normalized protein catabolic rates (nPCR) and indices of malnutrition and inflammation, whereas adults had iron and @COMPOUND$ deficiencies as the dominant variables.	1
1497	In summary @PROTEIN$ resistance in the pediatric dialysis cohort was predicted by nutritional deficits, inflammation, poor dialysis, and hyperparathyroidism, while iron and @COMPOUND$ deficits were the major determinants in adults.	1
1498	@COMPOUND$ selectively causes Bax- and @PROTEIN$-mediated apoptosis in human lung cancer cells.	1
1499	@COMPOUND$ selectively causes @PROTEIN$- and Bak-mediated apoptosis in human lung cancer cells.	1
1500	This report reveals a singular effect of the combination of @COMPOUND$ and @PROTEIN$, one of the mayor cytokines produced in response to CpG administration in vivo.	1
1501	@COMPOUND$ has a three-fold higher binding affinity for ERalpha than for @PROTEIN$.	1
1502	@COMPOUND$ has a three-fold higher binding affinity for @PROTEIN$ than for ERbeta.	1
1503	In the present study, we examined the effect of gliclazide, a second generation @COMPOUND$ with antioxidant properties, on LOX-1 expression and LOX-1-mediated @PROTEIN$ expression and apoptosis in oxLDL-treated human aortic endothelial cells (HAECs).	0
1504	In the present study, we examined the effect of @COMPOUND$, a second generation sulfonylurea with antioxidant properties, on LOX-1 expression and LOX-1-mediated @PROTEIN$ expression and apoptosis in oxLDL-treated human aortic endothelial cells (HAECs).	1
1505	In the present study, we examined the effect of @COMPOUND$, a second generation sulfonylurea with antioxidant properties, on @PROTEIN$ expression and LOX-1-mediated MMP-9 expression and apoptosis in oxLDL-treated human aortic endothelial cells (HAECs).	1
1506	In the present study, we examined the effect of gliclazide, a second generation @COMPOUND$ with antioxidant properties, on @PROTEIN$ expression and LOX-1-mediated MMP-9 expression and apoptosis in oxLDL-treated human aortic endothelial cells (HAECs).	0
1507	The phenolics: @COMPOUND$ (ATH), sinapoyl esters and activity of antioxidant enzymes: superoxide dismutase (SOD), catalase (CAT), guaiacol peroxidase (@PROTEIN$), ascorbate peroxidase (APX), glutathione peroxidase (GPX) and glutathione reductase (GR), in red cabbage seedlings subjected to Cu2+ stress were investigated.	0
1508	The phenolics: @COMPOUND$ (ATH), sinapoyl esters and activity of antioxidant enzymes: superoxide dismutase (SOD), @PROTEIN$ (CAT), guaiacol peroxidase (POX), ascorbate peroxidase (APX), glutathione peroxidase (GPX) and glutathione reductase (GR), in red cabbage seedlings subjected to Cu2+ stress were investigated.	0
1509	The phenolics: @COMPOUND$ (ATH), sinapoyl esters and activity of antioxidant enzymes: superoxide dismutase (SOD), catalase (@PROTEIN$), guaiacol peroxidase (POX), ascorbate peroxidase (APX), glutathione peroxidase (GPX) and glutathione reductase (GR), in red cabbage seedlings subjected to Cu2+ stress were investigated.	0
1510	The phenolics: @COMPOUND$ (ATH), sinapoyl esters and activity of antioxidant enzymes: superoxide dismutase (SOD), catalase (CAT), guaiacol peroxidase (POX), ascorbate peroxidase (APX), glutathione peroxidase (@PROTEIN$) and glutathione reductase (GR), in red cabbage seedlings subjected to Cu2+ stress were investigated.	0
1511	The phenolics: @COMPOUND$ (ATH), sinapoyl esters and activity of antioxidant enzymes: superoxide dismutase (SOD), catalase (CAT), guaiacol peroxidase (POX), ascorbate peroxidase (APX), glutathione peroxidase (GPX) and @PROTEIN$ (GR), in red cabbage seedlings subjected to Cu2+ stress were investigated.	0
1512	The phenolics: @COMPOUND$ (ATH), sinapoyl esters and activity of antioxidant enzymes: superoxide dismutase (SOD), catalase (CAT), guaiacol peroxidase (POX), ascorbate peroxidase (APX), @PROTEIN$ (GPX) and glutathione reductase (GR), in red cabbage seedlings subjected to Cu2+ stress were investigated.	0
1513	The phenolics: @COMPOUND$ (ATH), sinapoyl esters and activity of antioxidant enzymes: superoxide dismutase (@PROTEIN$), catalase (CAT), guaiacol peroxidase (POX), ascorbate peroxidase (APX), glutathione peroxidase (GPX) and glutathione reductase (GR), in red cabbage seedlings subjected to Cu2+ stress were investigated.	0
1514	The phenolics: @COMPOUND$ (ATH), sinapoyl esters and activity of antioxidant enzymes: superoxide dismutase (SOD), catalase (CAT), guaiacol peroxidase (POX), ascorbate peroxidase (@PROTEIN$), glutathione peroxidase (GPX) and glutathione reductase (GR), in red cabbage seedlings subjected to Cu2+ stress were investigated.	0
1515	The phenolics: @COMPOUND$ (ATH), sinapoyl esters and activity of antioxidant enzymes: @PROTEIN$ (SOD), catalase (CAT), guaiacol peroxidase (POX), ascorbate peroxidase (APX), glutathione peroxidase (GPX) and glutathione reductase (GR), in red cabbage seedlings subjected to Cu2+ stress were investigated.	0
1516	The phenolics: @COMPOUND$ (ATH), sinapoyl esters and activity of antioxidant enzymes: superoxide dismutase (SOD), catalase (CAT), guaiacol @PROTEIN$ (POX), ascorbate peroxidase (APX), glutathione peroxidase (GPX) and glutathione reductase (GR), in red cabbage seedlings subjected to Cu2+ stress were investigated.	0
1517	The affinity characteristics of developed immunosensors were investigated in reaction with @COMPOUND$, and @PROTEIN$.	1
1518	The detection limit for @COMPOUND$ was 10 ngmL(-1) and for @PROTEIN$ 0.01 ngmL(-1).	0
1519	Following @COMPOUND$ injection, ASIC1 (-/-) and ASIC2 (-/-), but not @PROTEIN$ (-/-) or TRPV1 (-/-), mice showed enhanced pain behaviour, predominantly in the second phase of the test.	0
1520	Following @COMPOUND$ injection, ASIC1 (-/-) and @PROTEIN$ (-/-), but not ASIC3 (-/-) or TRPV1 (-/-), mice showed enhanced pain behaviour, predominantly in the second phase of the test.	1
1521	Following @COMPOUND$ injection, ASIC1 (-/-) and ASIC2 (-/-), but not ASIC3 (-/-) or @PROTEIN$ (-/-), mice showed enhanced pain behaviour, predominantly in the second phase of the test.	0
1522	Following @COMPOUND$ injection, @PROTEIN$ (-/-) and ASIC2 (-/-), but not ASIC3 (-/-) or TRPV1 (-/-), mice showed enhanced pain behaviour, predominantly in the second phase of the test.	1
1523	The biochemical parameters studied are: albumin (ALB), alanine aminotransferase (ALT), amylase (@PROTEIN$), total @COMPOUND$ (TBI), blood urea nitrogen (BUN), creatinine (CRE), glucose, globulin, total proteins (TP), and the ions calcium, phosphorus, sodium, and potassium.	0
1524	The biochemical parameters studied are: albumin (ALB), alanine aminotransferase (ALT), amylase (@PROTEIN$), total bilirubin (TBI), blood urea nitrogen (BUN), creatinine (CRE), glucose, globulin, total proteins (TP), and the ions calcium, @COMPOUND$, sodium, and potassium.	0
1525	The biochemical parameters studied are: albumin (@PROTEIN$), alanine aminotransferase (ALT), amylase (AMY), total @COMPOUND$ (TBI), blood urea nitrogen (BUN), creatinine (CRE), glucose, globulin, total proteins (TP), and the ions calcium, phosphorus, sodium, and potassium.	0
1526	The biochemical parameters studied are: albumin (@PROTEIN$), alanine aminotransferase (ALT), amylase (AMY), total bilirubin (TBI), blood urea nitrogen (BUN), creatinine (CRE), glucose, globulin, total proteins (TP), and the ions calcium, @COMPOUND$, sodium, and potassium.	0
1527	The biochemical parameters studied are: albumin (ALB), alanine aminotransferase (ALT), amylase (@PROTEIN$), total bilirubin (TBI), blood urea nitrogen (BUN), @COMPOUND$ (CRE), glucose, globulin, total proteins (TP), and the ions calcium, phosphorus, sodium, and potassium.	0
1528	The biochemical parameters studied are: albumin (@PROTEIN$), alanine aminotransferase (ALT), amylase (AMY), total bilirubin (TBI), blood urea nitrogen (BUN), creatinine (CRE), @COMPOUND$, globulin, total proteins (TP), and the ions calcium, phosphorus, sodium, and potassium.	0
1529	The biochemical parameters studied are: albumin (@PROTEIN$), alanine aminotransferase (ALT), amylase (AMY), total bilirubin (TBI), blood urea nitrogen (BUN), @COMPOUND$ (CRE), glucose, globulin, total proteins (TP), and the ions calcium, phosphorus, sodium, and potassium.	0
1530	The biochemical parameters studied are: albumin (ALB), alanine aminotransferase (ALT), amylase (@PROTEIN$), total bilirubin (TBI), blood urea nitrogen (BUN), creatinine (CRE), @COMPOUND$, globulin, total proteins (TP), and the ions calcium, phosphorus, sodium, and potassium.	0
1531	@COMPOUND$ drives @PROTEIN$ expression from a simple glucocorticoid-response element containing reporter gene in a GR-dependent manner (EC50 4 microm), with a similar amplitude response to the partial GR agonist RU486.	1
1532	The @PROTEIN$ isolated from the youngest group had the highest capacity to form @COMPOUND$ and AGEs under glycation in vitro.	1
1533	A vitreous fraction showing @PROTEIN$ 1000 Da, consistent with @COMPOUND$.	0
1534	The secretion of endorphins, @COMPOUND$ (P(4)), human chorionic gonadotropin, 17beta-estradiol, and @PROTEIN$ by trophoblasts that lie adjacent to the embryoblast in the blastocyst suggests that these pregnancy-associated factors may directly signal the growth and development of the embryoblast.	0
1535	The secretion of endorphins, progesterone (P(4)), human chorionic gonadotropin, @COMPOUND$, and @PROTEIN$ by trophoblasts that lie adjacent to the embryoblast in the blastocyst suggests that these pregnancy-associated factors may directly signal the growth and development of the embryoblast.	0
1536	A specific @COMPOUND$-labelled probe, obtained by PCR amplification of a 270-bp fragment of the gene coding the LCDV @PROTEIN$, was used for ISH.	1
1537	Having compared four kinds of antibody immobilizations on Au surface, an optimized mAb 8G3 was immobilized onto the Au electrode with @PROTEIN$ on a mixed self-assembled monolayer (SAM) of @COMPOUND$ (11-MUA) and 6-mercaptohexan-1-ol (6-MHO) as adhesive layer.	0
1538	Having compared four kinds of antibody immobilizations on Au surface, an optimized mAb 8G3 was immobilized onto the Au electrode with @PROTEIN$ on a mixed self-assembled monolayer (SAM) of 11-mercaptoundecanoic acid (11-@COMPOUND$) and 6-mercaptohexan-1-ol (6-MHO) as adhesive layer.	0
1539	Having compared four kinds of antibody immobilizations on Au surface, an optimized mAb 8G3 was immobilized onto the Au electrode with @PROTEIN$ on a mixed self-assembled monolayer (SAM) of 11-mercaptoundecanoic acid (11-MUA) and 6-mercaptohexan-1-ol (6-@COMPOUND$) as adhesive layer.	0
1540	Having compared four kinds of antibody immobilizations on Au surface, an optimized mAb 8G3 was immobilized onto the Au electrode with @PROTEIN$ on a mixed self-assembled monolayer (SAM) of 11-mercaptoundecanoic acid (11-MUA) and @COMPOUND$ (6-MHO) as adhesive layer.	0
1541	@COMPOUND$ is a potent glucocorticoid with high affinity for the @PROTEIN$, which is now used for the treatment of inflammatory bowel diseases.	1
1542	Studies on the antioxidant effect and interaction of @COMPOUND$ and dicholesteroyl diselenide with hepatic @PROTEIN$ and isoforms of lactate dehydrogenase.	0
1543	A single @COMPOUND$ insertion/deletion (4G/5G) polymorphism in the promoter region of the @PROTEIN$ gene, may play an important role in the regulation of PAI-1 expression.	1
1544	A single guanosine insertion/deletion (4G/@COMPOUND$) polymorphism in the promoter region of the @PROTEIN$ gene, may play an important role in the regulation of PAI-1 expression.	1
1545	@COMPOUND$ also recovered the depletion of I-kappaBalpha via @PROTEIN$ 2 inhibition, which resulted in a decrease of NF-kappaB activity in EcR293/TG cells.	1
1546	@COMPOUND$ also recovered the depletion of @PROTEIN$ via TGase 2 inhibition, which resulted in a decrease of NF-kappaB activity in EcR293/TG cells.	1
1547	The objective of the present experiment was to examine the influence of mean physiological concentration of insulin-like growth factor-I (@PROTEIN$) on frozen-thawed Surti buffalo (Bubalus bubalis) spermatozoa functional parameters, i.e., motility, plasmalemma integrity, acrosomal integrity, functional membrane integrity, lipid peroxidation and @COMPOUND$ uptake in vitro.	1
1548	Frozen-thawed semen samples (n=6) were washed in @COMPOUND$ and divided into two equal parts (control and @PROTEIN$ groups).	0
1549	@COMPOUND$ utilization was significantly higher in @PROTEIN$ 0.01) of incubation.	0
1550	This diagnosis was confirmed by genetic testing, which revealed a novel point mutation in the @PROTEIN$ gene, c.2545G--&gt;C, leading to a codon encoding for @COMPOUND$ instead of glycine (p.Gly849Arg).	1
1551	This diagnosis was confirmed by genetic testing, which revealed a novel point mutation in the @PROTEIN$ gene, c.2545G--&gt;C, leading to a codon encoding for arginine instead of @COMPOUND$ (p.Gly849Arg).	1
1552	Differential effects of @PROTEIN$ receptor activation by WAY 161503 on @COMPOUND$-induced place conditioning and locomotor activity in rats.	0
1553	Engineered @COMPOUND$-containing glutaredoxin displays strong @PROTEIN$ activity rivaling natural enzyme.	0
1554	Engineered @COMPOUND$-containing @PROTEIN$ displays strong glutathione peroxidase activity rivaling natural enzyme.	1
1555	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, morpholinium, phosphonium, piperidinium, @COMPOUND$, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and Acetylcholinesterase (@PROTEIN$) using only their empirical formulas (elemental composition) and molecular weights.	0
1556	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of @COMPOUND$, imidazolium, morpholinium, phosphonium, piperidinium, pyridinium, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and Acetylcholinesterase (@PROTEIN$) using only their empirical formulas (elemental composition) and molecular weights.	0
1557	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, morpholinium, phosphonium, piperidinium, pyridinium, @COMPOUND$ and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and @PROTEIN$ (AChE) using only their empirical formulas (elemental composition) and molecular weights.	0
1558	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, morpholinium, @COMPOUND$, piperidinium, pyridinium, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and @PROTEIN$ (AChE) using only their empirical formulas (elemental composition) and molecular weights.	0
1559	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, morpholinium, @COMPOUND$, piperidinium, pyridinium, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and Acetylcholinesterase (@PROTEIN$) using only their empirical formulas (elemental composition) and molecular weights.	0
1560	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, morpholinium, phosphonium, @COMPOUND$, pyridinium, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and Acetylcholinesterase (@PROTEIN$) using only their empirical formulas (elemental composition) and molecular weights.	0
1561	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, morpholinium, phosphonium, @COMPOUND$, pyridinium, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and @PROTEIN$ (AChE) using only their empirical formulas (elemental composition) and molecular weights.	0
1562	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, @COMPOUND$, morpholinium, phosphonium, piperidinium, pyridinium, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and @PROTEIN$ (AChE) using only their empirical formulas (elemental composition) and molecular weights.	0
1563	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, morpholinium, phosphonium, piperidinium, pyridinium, pyrrolidinium and @COMPOUND$ ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and @PROTEIN$ (AChE) using only their empirical formulas (elemental composition) and molecular weights.	0
1564	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of @COMPOUND$, imidazolium, morpholinium, phosphonium, piperidinium, pyridinium, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and @PROTEIN$ (AChE) using only their empirical formulas (elemental composition) and molecular weights.	0
1565	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, @COMPOUND$, phosphonium, piperidinium, pyridinium, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and Acetylcholinesterase (@PROTEIN$) using only their empirical formulas (elemental composition) and molecular weights.	0
1566	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, morpholinium, phosphonium, piperidinium, pyridinium, @COMPOUND$ and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and Acetylcholinesterase (@PROTEIN$) using only their empirical formulas (elemental composition) and molecular weights.	0
1567	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, @COMPOUND$, phosphonium, piperidinium, pyridinium, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and @PROTEIN$ (AChE) using only their empirical formulas (elemental composition) and molecular weights.	0
1568	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, morpholinium, phosphonium, piperidinium, @COMPOUND$, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and @PROTEIN$ (AChE) using only their empirical formulas (elemental composition) and molecular weights.	0
1569	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, imidazolium, morpholinium, phosphonium, piperidinium, pyridinium, pyrrolidinium and @COMPOUND$ ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and Acetylcholinesterase (@PROTEIN$) using only their empirical formulas (elemental composition) and molecular weights.	0
1570	Multiple linear regression (MLR), radial basis network (RB), and multilayer perceptron (MLP) neural network (NN) models have been explored for the estimation of toxicity of ammonium, @COMPOUND$, morpholinium, phosphonium, piperidinium, pyridinium, pyrrolidinium and quinolinium ionic liquid salts in the Leukemia Rat Cell Line (IPC-81) and Acetylcholinesterase (@PROTEIN$) using only their empirical formulas (elemental composition) and molecular weights.	0
1571	The beneficial effect of DHA on the treatment groups was accompanied by decreases in blood-brain barrier disruption, brain edema, @COMPOUND$ (MDA) production, inflammatory cell infiltration, interleukin-6 (@PROTEIN$) expression and caspase-3 activity.	0
1572	The beneficial effect of DHA on the treatment groups was accompanied by decreases in blood-brain barrier disruption, brain edema, @COMPOUND$ (MDA) production, inflammatory cell infiltration, @PROTEIN$ (IL-6) expression and caspase-3 activity.	0
1573	Elevation of antioxidative capacity, as evidenced by decreased MDA level and increased @PROTEIN$ activity and @COMPOUND$ level, was detected only in the chronic daily-administration group.	0
1574	@PROTEIN$ secretion is highly sensitive to desorption of plasma membrane @COMPOUND$.	1
1575	Suppression of retinal @PROTEIN$ in experimental diabetes and @COMPOUND$-induced retinopathy: role of NADPH oxidase.	0
1576	TKTL 1 was highest expressed in cell lines derived from more invasive tumors but the expression level was not strongly correlated to proliferation rate, to @PROTEIN$ expression or to the response to @COMPOUND$.	0
1577	Magnesium (Mg), @PROTEIN$ (IL-8), and @COMPOUND$ levels were analyzed in blood, while edema, neutrophil infiltration, eosinophilia, loss of striation, and nucleolization were evaluated in histopathological examination.	0
1578	Magnesium (Mg), interleukin 8 (@PROTEIN$), and @COMPOUND$ levels were analyzed in blood, while edema, neutrophil infiltration, eosinophilia, loss of striation, and nucleolization were evaluated in histopathological examination.	0
1579	@COMPOUND$ (Mg), @PROTEIN$ (IL-8), and malondialdehyde levels were analyzed in blood, while edema, neutrophil infiltration, eosinophilia, loss of striation, and nucleolization were evaluated in histopathological examination.	0
1580	@COMPOUND$ (Mg), interleukin 8 (@PROTEIN$), and malondialdehyde levels were analyzed in blood, while edema, neutrophil infiltration, eosinophilia, loss of striation, and nucleolization were evaluated in histopathological examination.	0
1581	Study of multiple binding constants of @COMPOUND$ with human @PROTEIN$ by capillary electrophoresis-frontal analysis and multivariate regression.	1
1582	Arthropod @PROTEIN$ transport and store @COMPOUND$ and are composed of six subunits, or multiples thereof depending on the species.	0
1583	Enzymatic activities of an H(2)O(2) independent oxidase along with @PROTEIN$ and an azoreductase suggest their prominent role during the decolorization of reactive yellow @COMPOUND$.	1
1584	Enzymatic activities of an H(2)O(2) independent oxidase along with laccase and an @PROTEIN$ suggest their prominent role during the decolorization of reactive yellow @COMPOUND$.	1
1585	@PROTEIN$ activity was prominent in presence of cofactors @COMPOUND$ and NADP in mineral salt medium.	1
1586	@PROTEIN$ activity was prominent in presence of cofactors NADH and @COMPOUND$ in mineral salt medium.	1
1587	The increase of @COMPOUND$ availability caused the induction of the antioxidant enzyme @PROTEIN$, which indicates that the defensive mechanisms of the cells against oxidative stress were effective and cells could cope with increased pressure.	1
1588	Concentrations of aqueous-phase perfluorooctanoic acid (PFOA), a representative perfluorinated aliphatic (PFA) compound, are shown to be reduced effectively via reaction with horseradish peroxidase (@PROTEIN$), hydrogen peroxide, and a phenolic cosubstrate (@COMPOUND$).	1
1589	Concentrations of aqueous-phase perfluorooctanoic acid (PFOA), a representative perfluorinated aliphatic (PFA) compound, are shown to be reduced effectively via reaction with horseradish @PROTEIN$ (HRP), hydrogen peroxide, and a phenolic cosubstrate (@COMPOUND$).	1
1590	Concentrations of aqueous-phase perfluorooctanoic acid (PFOA), a representative perfluorinated aliphatic (PFA) compound, are shown to be reduced effectively via reaction with horseradish @PROTEIN$ (HRP), @COMPOUND$, and a phenolic cosubstrate (4-methoxyphenol).	1
1591	Concentrations of aqueous-phase perfluorooctanoic acid (PFOA), a representative perfluorinated aliphatic (PFA) compound, are shown to be reduced effectively via reaction with horseradish peroxidase (@PROTEIN$), @COMPOUND$, and a phenolic cosubstrate (4-methoxyphenol).	1
1592	@PROTEIN$ monogalactosyldiacylglycerol synthases are involved in @COMPOUND$ starvation-induced lipid remodeling, and are crucial for low-phosphate adaptation.	1
1593	The mechanisms may include the recently revealed anti-inflammatory effects of @PROTEIN$ as well as its conventional @COMPOUND$ and free fatty acids lowering effects, and possibly may also include changes in body fat distribution and plasma adiponectin level.	1
1594	In cultures treated together ghrelin and (D-Lys-3)-GHRP-6, @COMPOUND$ secretion, @PROTEIN$ activity and cell proliferation returned to control levels.	0
1595	In cultures treated together @PROTEIN$ and (D-Lys-3)-GHRP-6, @COMPOUND$ secretion, aromatase activity and cell proliferation returned to control levels.	1
1596	Expression levels of the functional activities (albumin secretion and @COMPOUND$ removal) and the cell-cell adhesion molecules (cadherin and @PROTEIN$) were higher in the hepatocytes that formed spheroids compared to those which assumed a monolayer configuration, and these levels were maintained for at least 10 days.	0
1597	This is the first finding that @COMPOUND$ plays a role in innate immunity by cooperating with natural ligands, @PROTEIN$.	1
1598	At week 2 of the study, parotid gland of diabetic rats presented a reduction of total protein concentration (55%) and an increase of amylase (120%) and @PROTEIN$ (160%) activities, free (150%) and total (170%) @COMPOUND$ concentration.	0
1599	Considering the common metabolic pathway and synergism between dopamine and @COMPOUND$, the role of dopamine transporter (SLC6A3, DAT) and @PROTEIN$ A (MAOA) genes in SIDS and stillbirth (sudden intrauterine unexplained death, SIUD) was investigated.	0
1600	Considering the common metabolic pathway and synergism between dopamine and @COMPOUND$, the role of dopamine transporter (SLC6A3, DAT) and monoamine oxidase A (@PROTEIN$) genes in SIDS and stillbirth (sudden intrauterine unexplained death, SIUD) was investigated.	0
1601	Considering the common metabolic pathway and synergism between dopamine and @COMPOUND$, the role of dopamine transporter (@PROTEIN$, DAT) and monoamine oxidase A (MAOA) genes in SIDS and stillbirth (sudden intrauterine unexplained death, SIUD) was investigated.	0
1602	Considering the common metabolic pathway and synergism between dopamine and @COMPOUND$, the role of dopamine transporter (SLC6A3, @PROTEIN$) and monoamine oxidase A (MAOA) genes in SIDS and stillbirth (sudden intrauterine unexplained death, SIUD) was investigated.	0
1603	DHEA, DHEA-S, @COMPOUND$, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, cortisol, insulin, @PROTEIN$, IGFBP-1, IGFBP-3, and adiponectin in plasma or serum were measured.	0
1604	DHEA, DHEA-S, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, @COMPOUND$, estradiol, cortisol, insulin, @PROTEIN$, IGFBP-1, IGFBP-3, and adiponectin in plasma or serum were measured.	0
1605	DHEA, DHEA-S, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, @COMPOUND$, insulin, IGF-1, IGFBP-1, @PROTEIN$, and adiponectin in plasma or serum were measured.	0
1606	DHEA, DHEA-S, dihydro@COMPOUND$, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, cortisol, insulin, IGF-1, IGFBP-1, @PROTEIN$, and adiponectin in plasma or serum were measured.	0
1607	DHEA, @COMPOUND$, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, cortisol, insulin, @PROTEIN$, IGFBP-1, IGFBP-3, and adiponectin in plasma or serum were measured.	0
1608	DHEA, @COMPOUND$, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, cortisol, @PROTEIN$, IGF-1, IGFBP-1, IGFBP-3, and adiponectin in plasma or serum were measured.	0
1609	DHEA, DHEA-S, @COMPOUND$, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, cortisol, @PROTEIN$, IGF-1, IGFBP-1, IGFBP-3, and adiponectin in plasma or serum were measured.	0
1610	DHEA, DHEA-S, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, @COMPOUND$, @PROTEIN$, IGF-1, IGFBP-1, IGFBP-3, and adiponectin in plasma or serum were measured.	0
1611	DHEA, DHEA-S, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, estrone, @COMPOUND$, cortisol, insulin, IGF-1, @PROTEIN$, IGFBP-3, and adiponectin in plasma or serum were measured.	0
1612	DHEA, DHEA-S, dihydro@COMPOUND$, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, cortisol, insulin, @PROTEIN$, IGFBP-1, IGFBP-3, and adiponectin in plasma or serum were measured.	0
1613	DHEA, @COMPOUND$, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, cortisol, insulin, IGF-1, IGFBP-1, @PROTEIN$, and adiponectin in plasma or serum were measured.	0
1614	DHEA, DHEA-S, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, estrone, @COMPOUND$, cortisol, @PROTEIN$, IGF-1, IGFBP-1, IGFBP-3, and adiponectin in plasma or serum were measured.	0
1615	DHEA, DHEA-S, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, estrone, @COMPOUND$, cortisol, insulin, @PROTEIN$, IGFBP-1, IGFBP-3, and adiponectin in plasma or serum were measured.	0
1616	DHEA, @COMPOUND$, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, cortisol, insulin, IGF-1, @PROTEIN$, IGFBP-3, and adiponectin in plasma or serum were measured.	0
1617	DHEA, DHEA-S, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, @COMPOUND$, insulin, IGF-1, @PROTEIN$, IGFBP-3, and adiponectin in plasma or serum were measured.	0
1618	DHEA, DHEA-S, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, @COMPOUND$, estradiol, cortisol, @PROTEIN$, IGF-1, IGFBP-1, IGFBP-3, and adiponectin in plasma or serum were measured.	0
1619	DHEA, DHEA-S, @COMPOUND$, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, cortisol, insulin, IGF-1, @PROTEIN$, IGFBP-3, and adiponectin in plasma or serum were measured.	0
1620	DHEA, DHEA-S, dihydro@COMPOUND$, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, cortisol, @PROTEIN$, IGF-1, IGFBP-1, IGFBP-3, and adiponectin in plasma or serum were measured.	0
1621	DHEA, DHEA-S, @COMPOUND$, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, cortisol, insulin, IGF-1, IGFBP-1, @PROTEIN$, and adiponectin in plasma or serum were measured.	0
1622	DHEA, DHEA-S, dihydro@COMPOUND$, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, cortisol, insulin, IGF-1, @PROTEIN$, IGFBP-3, and adiponectin in plasma or serum were measured.	0
1623	DHEA, DHEA-S, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, @COMPOUND$, estradiol, cortisol, insulin, IGF-1, @PROTEIN$, IGFBP-3, and adiponectin in plasma or serum were measured.	0
1624	DHEA, DHEA-S, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, estrone, estradiol, @COMPOUND$, insulin, @PROTEIN$, IGFBP-1, IGFBP-3, and adiponectin in plasma or serum were measured.	0
1625	DHEA, DHEA-S, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, estrone, @COMPOUND$, cortisol, insulin, IGF-1, IGFBP-1, @PROTEIN$, and adiponectin in plasma or serum were measured.	0
1626	DHEA, DHEA-S, dihydrotestosterone, total testosterone, free testosterone, sex hormone-binding globulin, @COMPOUND$, estradiol, cortisol, insulin, IGF-1, IGFBP-1, @PROTEIN$, and adiponectin in plasma or serum were measured.	0
1627	Our data indicate that genetic differences in @PROTEIN$ gene expression may predispose individual differences in the responsivity to repeated intake of @COMPOUND$.	1
1628	Angiotensin II (@PROTEIN$) is the key peptide hormone in the renin-angiotensin-@COMPOUND$ system (RAAS).	1
1629	Angiotensin II (Ang II) is the key @PROTEIN$ in the renin-angiotensin-@COMPOUND$ system (RAAS).	1
1630	Angiotensin II (Ang II) is the key peptide hormone in the renin-@PROTEIN$-@COMPOUND$ system (RAAS).	1
1631	@PROTEIN$ (Ang II) is the key peptide hormone in the renin-angiotensin-@COMPOUND$ system (RAAS).	1
1632	These results suggest that adrenaline may selectively protect mesenchymal C3H10T1/2 cells from oxidative stress through a mechanism related to the promoted biosynthesis of @COMPOUND$ in association with transient @PROTEIN$ expression after activation of beta(2)AdR.	1
1633	Two principal signaling pathways that regulate proliferation are PI3K/@COMPOUND$/Akt and @PROTEIN$/Ras/ERK1/2.	0
1634	Two principal signaling pathways that regulate proliferation are PI3K/@COMPOUND$/Akt and Shc/@PROTEIN$/ERK1/2.	0
1635	Two principal signaling pathways that regulate proliferation are @PROTEIN$/@COMPOUND$/Akt and Shc/Ras/ERK1/2.	1
1636	Two principal signaling pathways that regulate proliferation are PI3K/@COMPOUND$/@PROTEIN$ and Shc/Ras/ERK1/2.	1
1637	Two principal signaling pathways that regulate proliferation are PI3K/@COMPOUND$/Akt and Shc/Ras/@PROTEIN$/2.	0
1638	@COMPOUND$ (imatinib) is a potent and selective inhibitor of the tyrosine kinases, Bcr-Abl, @PROTEIN$ and platelet-derived growth factor receptors (PDGFRs).	1
1639	Imatinib mesylate (@COMPOUND$) is a potent and selective inhibitor of the tyrosine kinases, Bcr-@PROTEIN$, c-Kit and platelet-derived growth factor receptors (PDGFRs).	1
1640	@COMPOUND$ (imatinib) is a potent and selective inhibitor of the tyrosine kinases, @PROTEIN$-Abl, c-Kit and platelet-derived growth factor receptors (PDGFRs).	1
1641	Imatinib mesylate (@COMPOUND$) is a potent and selective inhibitor of the tyrosine kinases, Bcr-Abl, @PROTEIN$ and platelet-derived growth factor receptors (PDGFRs).	1
1642	Imatinib mesylate (@COMPOUND$) is a potent and selective inhibitor of the tyrosine kinases, @PROTEIN$-Abl, c-Kit and platelet-derived growth factor receptors (PDGFRs).	1
1643	@COMPOUND$ (imatinib) is a potent and selective inhibitor of the tyrosine kinases, Bcr-@PROTEIN$, c-Kit and platelet-derived growth factor receptors (PDGFRs).	1
1644	The large and diverse family of @PROTEIN$ monooxygenases (CYPs) was systematically analyzed to identify selectivity- and specificity-determining residues in the substrate recognition site 5, which is located in close vicinity to the @COMPOUND$ center.	1
1645	The large and diverse family of cytochrome P450 monooxygenases (@PROTEIN$) was systematically analyzed to identify selectivity- and specificity-determining residues in the substrate recognition site 5, which is located in close vicinity to the @COMPOUND$ center.	0
1646	The observed fluorescence quenching of @PROTEIN$ by @COMPOUND$ is due to a complex formation by a static quenching process with a quenching constant of the order of 10(5) M(-1).	1
1647	From the observed Förster-type fluorescence resonance energy transfer (FRET), the donor (Trp 214 in @PROTEIN$) to acceptor (@COMPOUND$) distance is calculated to be 3.2 nm.	1
1648	A number of site-specific modifications of the nucleosome core histones-including the trimethylated forms of @PROTEIN$ lysines K4, K9, and @COMPOUND$-are of particular interest for postmortem research, because these marks differentiate between active and inactive chromatin and seem to remain relatively stable during tissue autolysis.	1
1649	We here demonstrate that @PROTEIN$ confers a sensitivity towards near ultraviolet (UVA) light, which rapidly causes @COMPOUND$+) entry.	1
1650	In the presence of the photosensitising agents @COMPOUND$ (100 nM) or hypericin (10 nM), the sensitivity of light-induced @PROTEIN$ activation was increased and extended towards the visible spectrum.	1
1651	In the presence of the photosensitising agents acridine orange (100 nM) or @COMPOUND$ (10 nM), the sensitivity of light-induced @PROTEIN$ activation was increased and extended towards the visible spectrum.	1
1652	Quantitative proteomics analysis of macrophage rafts reveals compartmentalized activation of the proteasome and of proteasome-mediated @PROTEIN$ activation in response to @COMPOUND$.	1
1653	@COMPOUND$ toxicity and @PROTEIN$-dependent detoxification in astrocytes.	1
1654	Lower expression of IGFBP1 and @PROTEIN$ mRNA and protein was observed in hESF from women with vs. those without endometriosis in response to @COMPOUND$, but not P4, suggesting a blunted response of these decidual biomarkers to activation of the PKA pathway in eutopic endometrium in women with disease.	1
1655	Lower expression of @PROTEIN$ and prolactin mRNA and protein was observed in hESF from women with vs. those without endometriosis in response to @COMPOUND$, but not P4, suggesting a blunted response of these decidual biomarkers to activation of the PKA pathway in eutopic endometrium in women with disease.	1
1656	Furthermore, constitutive expression of an @COMPOUND$-insensitive, active form of @PROTEIN$ protein mimicked the effects of low oxygen, inhibiting the differentiation of trophoblast giant cells.	0
1657	@COMPOUND$ deficiency due to the methylenetetrahydrofolate reductase (@PROTEIN$) and methionine synthase (MS) variants leads to carcinogenesis by affecting DNA synthesis, repair, and methylation.	1
1658	@COMPOUND$ deficiency due to the methylenetetrahydrofolate reductase (MTHFR) and @PROTEIN$ (MS) variants leads to carcinogenesis by affecting DNA synthesis, repair, and methylation.	1
1659	@COMPOUND$ deficiency due to the @PROTEIN$ (MTHFR) and methionine synthase (MS) variants leads to carcinogenesis by affecting DNA synthesis, repair, and methylation.	1
1660	@COMPOUND$ has been the mainstay of endocrine therapy for @PROTEIN$-positive breast cancer.	1
1661	The inhibition of female rabbit sexual behavior by @COMPOUND$ : @PROTEIN$-dependent and-independent effects.	1
1662	Reproductive experience alters @COMPOUND$ and @PROTEIN$ levels in the rat dam.	0
1663	Total serum @COMPOUND$ and @PROTEIN$ were assayed from five groups; multiparous, primiparous, nulliparous, primip-no-pups, and sensitized rats during gestation (days 14 and 19) and the postpartum period (days 1, 5, 14, 21, and 35).	0
1664	After incubation with 4- androstene-3,17-dione (4-dione), there are no estrogens, estrone (E1) and @COMPOUND$ (E2), detected suggesting that the pathway of @PROTEIN$ is not important in these cell lines.	0
1665	After incubation with 4- androstene-3,17-dione (4-dione), there are no estrogens, @COMPOUND$ (E1) and estradiol (E2), detected suggesting that the pathway of @PROTEIN$ is not important in these cell lines.	0
1666	Oral administration of (PhSe)(2) in rats did not change plasma alanine and @PROTEIN$ activities (AST and ALT) as well as @COMPOUND$ and creatinine levels.	0
1667	Oral administration of (PhSe)(2) in rats did not change plasma alanine and aspartate aminotransferase activities (@PROTEIN$ and ALT) as well as @COMPOUND$ and creatinine levels.	0
1668	Oral administration of (PhSe)(2) in rats did not change plasma alanine and @PROTEIN$ activities (AST and ALT) as well as urea and @COMPOUND$ levels.	0
1669	Oral administration of (PhSe)(2) in rats did not change plasma alanine and aspartate aminotransferase activities (@PROTEIN$ and ALT) as well as urea and @COMPOUND$ levels.	0
1670	Immunohistochemical colabeling for nesfatin-1 and @PROTEIN$, histidine decarboxylase, or @COMPOUND$ revealed two subtypes of nesfatin-1-positive endocrine cells.	0
1671	Immunohistochemical colabeling for nesfatin-1 and ghrelin, @PROTEIN$, or @COMPOUND$ revealed two subtypes of nesfatin-1-positive endocrine cells.	0
1672	Cells in the midportion of the glands coexpressed nesfatin-1 and @PROTEIN$, whereas few cells in the glandular base coexpressed nesfatin-1 and @COMPOUND$ or histidine decarboxylase.	0
1673	Cells in the midportion of the glands coexpressed nesfatin-1 and ghrelin, whereas few cells in the glandular base coexpressed nesfatin-1 and @COMPOUND$ or @PROTEIN$.	0
1674	To determine whether hCG stimulation of tPA and @PROTEIN$ requires PGE2, granulosa cells obtained at 0 h were cultured with hCG plus @COMPOUND$ to inhibit PG production; some cells also received PGE2 or an agonist selective for one PGE2 receptor (EP).	0
1675	To determine whether hCG stimulation of @PROTEIN$ and PAI-1 requires PGE2, granulosa cells obtained at 0 h were cultured with hCG plus @COMPOUND$ to inhibit PG production; some cells also received PGE2 or an agonist selective for one PGE2 receptor (EP).	0
1676	The role of @COMPOUND$ in the treatment of obesity through @PROTEIN$ antagonism.	1
1677	The @PROTEIN$ proto-oncogene and microRNA-@COMPOUND$ comprise an active autoregulatory feedback loop in human hematopoietic cells.	1
1678	Occupancy of one canonical @PROTEIN$ binding site was demonstrated by chromatin immunoprecipitation analysis and shown to be required for miR-@COMPOUND$ expression in K562 cells.	1
1679	In aggregate, these findings suggest the presence of a @PROTEIN$-miR-@COMPOUND$ autoregulatory feedback loop of potential importance in human hematopoiesis.	1
1680	This review provides an introduction to epigenetic concepts for renal investigators and an overview of our work detailing an epigenetic pathway for @COMPOUND$ signaling and the control of epithelial @PROTEIN$-alpha (ENaCalpha) subunit gene expression in the collecting duct.	0
1681	We aim to evaluate whether an E1A, E1B double-restricted oncolytic adenovirus, AxdAdB-3, can improve the efficacy for gallbladder cancers (GBCs) of the replication-deficient adenovirus-based herpes simplex virus thymidine kinase (HSVtk)/@COMPOUND$ (GCV) therapy directed by the @PROTEIN$ (CEA) promoter.	1
1682	We aim to evaluate whether an E1A, E1B double-restricted oncolytic adenovirus, AxdAdB-3, can improve the efficacy for gallbladder cancers (GBCs) of the replication-deficient adenovirus-based herpes simplex virus thymidine kinase (HSVtk)/ganciclovir (@COMPOUND$) therapy directed by the carcinoembryonic antigen (@PROTEIN$) promoter.	1
1683	We aim to evaluate whether an E1A, E1B double-restricted oncolytic adenovirus, AxdAdB-3, can improve the efficacy for gallbladder cancers (GBCs) of the replication-deficient adenovirus-based herpes simplex virus thymidine kinase (HSVtk)/@COMPOUND$ (GCV) therapy directed by the carcinoembryonic antigen (@PROTEIN$) promoter.	1
1684	We aim to evaluate whether an E1A, E1B double-restricted oncolytic adenovirus, AxdAdB-3, can improve the efficacy for gallbladder cancers (GBCs) of the replication-deficient adenovirus-based herpes simplex virus thymidine kinase (HSVtk)/ganciclovir (@COMPOUND$) therapy directed by the @PROTEIN$ (CEA) promoter.	1
1685	The parameters measured in E. albidus whole body were: lipid peroxidation (LPO), total @COMPOUND$ (TG), as well as the enzymatic activities of superoxide dismutase (SOD), catalase (@PROTEIN$), glutathione reductase (GR), glutathione peroxidase (GPx) and glutathione S-transferase (GST).	0
1686	The parameters measured in E. albidus whole body were: lipid peroxidation (LPO), total @COMPOUND$ (TG), as well as the enzymatic activities of superoxide dismutase (SOD), catalase (CAT), glutathione reductase (GR), glutathione peroxidase (GPx) and glutathione S-transferase (@PROTEIN$).	0
1687	The parameters measured in E. albidus whole body were: lipid peroxidation (LPO), total @COMPOUND$ (TG), as well as the enzymatic activities of superoxide dismutase (@PROTEIN$), catalase (CAT), glutathione reductase (GR), glutathione peroxidase (GPx) and glutathione S-transferase (GST).	0
1688	The parameters measured in E. albidus whole body were: lipid peroxidation (LPO), total @COMPOUND$ (TG), as well as the enzymatic activities of superoxide dismutase (SOD), catalase (CAT), glutathione reductase (GR), glutathione peroxidase (GPx) and @PROTEIN$ (GST).	0
1689	The parameters measured in E. albidus whole body were: lipid peroxidation (LPO), total @COMPOUND$ (TG), as well as the enzymatic activities of @PROTEIN$ (SOD), catalase (CAT), glutathione reductase (GR), glutathione peroxidase (GPx) and glutathione S-transferase (GST).	0
1690	The parameters measured in E. albidus whole body were: lipid peroxidation (LPO), total @COMPOUND$ (TG), as well as the enzymatic activities of superoxide dismutase (SOD), catalase (CAT), @PROTEIN$ (GR), glutathione peroxidase (GPx) and glutathione S-transferase (GST).	0
1691	The parameters measured in E. albidus whole body were: lipid peroxidation (LPO), total @COMPOUND$ (TG), as well as the enzymatic activities of superoxide dismutase (SOD), catalase (CAT), glutathione reductase (GR), @PROTEIN$ (GPx) and glutathione S-transferase (GST).	0
1692	The parameters measured in E. albidus whole body were: lipid peroxidation (LPO), total @COMPOUND$ (TG), as well as the enzymatic activities of superoxide dismutase (SOD), @PROTEIN$ (CAT), glutathione reductase (GR), glutathione peroxidase (GPx) and glutathione S-transferase (GST).	0
1693	As with @PROTEIN$, they are involved in making @COMPOUND$ available to apo-enzymes inside the cell.	1
1694	Therefore, we queried whether @COMPOUND$ is prosurvival in podocytes through a @PROTEIN$-dependent pathway.	0
1695	Treatment with pioglitazone, associated with @COMPOUND$, showed a reduction of @PROTEIN$ monocyte production after their in vitro activation with LPS.	1
1696	The supernatant of the majority of the strains did not release the aglycone from @COMPOUND$, suggesting that cell-associated beta-glucosidases (beta-@PROTEIN$) are mainly responsible for the metabolism of soybean glyco-conjugates.	0
1697	The supernatant of the majority of the strains did not release the aglycone from @COMPOUND$, suggesting that cell-associated @PROTEIN$ (beta-Glu) are mainly responsible for the metabolism of soybean glyco-conjugates.	0
1698	In the absence of @PROTEIN$ in the zona glomerulosa, C21 deoxy steroids are produced, leading to the mineralocorticoid, @COMPOUND$.	0
1699	In the presence of the 17alpha-hydroxylase but not the 17,20 lyase activity of @PROTEIN$ in the zona fasciculata, C21, 17-hydroxy steroids are produced, leading to the glucocorticoid, @COMPOUND$.	0
1700	Furthermore, the effect of @COMPOUND$ on @PROTEIN$ has not been reported previously.	1
1701	The objective of this study was to examine the impact of polymorphisms in the acyl-CoA:diacylglycerol acyltransferase (DGAT1), @PROTEIN$ and growth hormone receptor genes on body energy (body condition score, total body energy content and cumulative effective energy balance) and blood metabolic traits (levels of @COMPOUND$, glucose and non-esterified fatty acids), measured once before the first calving and then repeatedly throughout first lactation in 497 Holstein cows.	0
1702	The objective of this study was to examine the impact of polymorphisms in the acyl-CoA:diacylglycerol acyltransferase (@PROTEIN$), leptin and growth hormone receptor genes on body energy (body condition score, total body energy content and cumulative effective energy balance) and blood metabolic traits (levels of @COMPOUND$, glucose and non-esterified fatty acids), measured once before the first calving and then repeatedly throughout first lactation in 497 Holstein cows.	0
1703	The objective of this study was to examine the impact of polymorphisms in the acyl-CoA:diacylglycerol acyltransferase (DGAT1), leptin and @PROTEIN$ receptor genes on body energy (body condition score, total body energy content and cumulative effective energy balance) and blood metabolic traits (levels of beta-hydroxybutyrate, @COMPOUND$ and non-esterified fatty acids), measured once before the first calving and then repeatedly throughout first lactation in 497 Holstein cows.	0
1704	The objective of this study was to examine the impact of polymorphisms in the acyl-CoA:diacylglycerol acyltransferase (DGAT1), @PROTEIN$ and growth hormone receptor genes on body energy (body condition score, total body energy content and cumulative effective energy balance) and blood metabolic traits (levels of beta-hydroxybutyrate, @COMPOUND$ and non-esterified fatty acids), measured once before the first calving and then repeatedly throughout first lactation in 497 Holstein cows.	0
1705	The objective of this study was to examine the impact of polymorphisms in the acyl-CoA:diacylglycerol acyltransferase (@PROTEIN$), leptin and growth hormone receptor genes on body energy (body condition score, total body energy content and cumulative effective energy balance) and blood metabolic traits (levels of beta-hydroxybutyrate, @COMPOUND$ and non-esterified fatty acids), measured once before the first calving and then repeatedly throughout first lactation in 497 Holstein cows.	0
1706	The objective of this study was to examine the impact of polymorphisms in the acyl-CoA:diacylglycerol acyltransferase (DGAT1), leptin and @PROTEIN$ receptor genes on body energy (body condition score, total body energy content and cumulative effective energy balance) and blood metabolic traits (levels of @COMPOUND$, glucose and non-esterified fatty acids), measured once before the first calving and then repeatedly throughout first lactation in 497 Holstein cows.	0
1707	Inhibition of @PROTEIN$ by @COMPOUND$ analogues: Implications for anticancer activity.	1
1708	An isocratic fluorescence HPLC assay for the monitoring of @PROTEIN$ activity and l-@COMPOUND$ depletion in children receiving E. colil-asparaginase for the treatment of acute lymphoblastic leukaemia.	0
1709	Effects of CYP2C19 and @PROTEIN$ genotype on the eradication rate of Helicobacter pylori infection by triple therapy with pantoprazole, amoxycillin and @COMPOUND$.	0
1710	Effects of @PROTEIN$ and MDR1 genotype on the eradication rate of Helicobacter pylori infection by triple therapy with pantoprazole, amoxycillin and @COMPOUND$.	0
1711	Anti-gastric cancer effects of @COMPOUND$, a selective COX-2 inhibitor, through inhibition of @PROTEIN$ signaling.	1
1712	Effect of renin-angiotensin-@COMPOUND$ system inhibition, dietary sodium restriction, and/or diuretics on urinary @PROTEIN$ excretion in nondiabetic proteinuric kidney disease: a post hoc analysis of a randomized controlled trial.	0
1713	We determined the plasma concentrations of tryptophan (TRP), @COMPOUND$, 3-hydroxykynurenine (3-HKYN); two distinct SOX markers: Cu/Zn @PROTEIN$ (Cu/Zn SOD) and total peroxide ; and high sensitivity C-reactive protein (hs CRP) as a indicator of inflammation in 146 ESRD patients and healthy controls.	0
1714	We determined the plasma concentrations of @COMPOUND$ (TRP), KYN, 3-hydroxykynurenine (3-HKYN); two distinct SOX markers: Cu/Zn superoxide dismutase (Cu/Zn @PROTEIN$) and total peroxide ; and high sensitivity C-reactive protein (hs CRP) as a indicator of inflammation in 146 ESRD patients and healthy controls.	0
1715	We determined the plasma concentrations of @COMPOUND$ (TRP), KYN, 3-hydroxykynurenine (3-HKYN); two distinct SOX markers: Cu/Zn @PROTEIN$ (Cu/Zn SOD) and total peroxide ; and high sensitivity C-reactive protein (hs CRP) as a indicator of inflammation in 146 ESRD patients and healthy controls.	0
1716	We determined the plasma concentrations of tryptophan (TRP), @COMPOUND$, 3-hydroxykynurenine (3-HKYN); two distinct SOX markers: Cu/Zn superoxide dismutase (Cu/Zn SOD) and total peroxide ; and high sensitivity C-reactive protein (hs @PROTEIN$) as a indicator of inflammation in 146 ESRD patients and healthy controls.	0
1717	We determined the plasma concentrations of tryptophan (TRP), KYN, 3-hydroxykynurenine (3-HKYN); two distinct SOX markers: Cu/Zn su@COMPOUND$ dismutase (Cu/Zn SOD) and total peroxide ; and high sensitivity C-reactive protein (hs @PROTEIN$) as a indicator of inflammation in 146 ESRD patients and healthy controls.	0
1718	We determined the plasma concentrations of tryptophan (TRP), KYN, @COMPOUND$ (3-HKYN); two distinct SOX markers: Cu/Zn superoxide dismutase (Cu/Zn @PROTEIN$) and total peroxide ; and high sensitivity C-reactive protein (hs CRP) as a indicator of inflammation in 146 ESRD patients and healthy controls.	0
1719	We determined the plasma concentrations of tryptophan (TRP), @COMPOUND$, 3-hydroxykynurenine (3-HKYN); two distinct SOX markers: Cu/Zn superoxide dismutase (Cu/Zn @PROTEIN$) and total peroxide ; and high sensitivity C-reactive protein (hs CRP) as a indicator of inflammation in 146 ESRD patients and healthy controls.	0
1720	We determined the plasma concentrations of tryptophan (TRP), KYN, @COMPOUND$ (3-HKYN); two distinct SOX markers: Cu/Zn @PROTEIN$ (Cu/Zn SOD) and total peroxide ; and high sensitivity C-reactive protein (hs CRP) as a indicator of inflammation in 146 ESRD patients and healthy controls.	0
1721	We determined the plasma concentrations of @COMPOUND$ (TRP), KYN, 3-hydroxykynurenine (3-HKYN); two distinct SOX markers: Cu/Zn superoxide dismutase (Cu/Zn SOD) and total peroxide ; and high sensitivity C-reactive protein (hs @PROTEIN$) as a indicator of inflammation in 146 ESRD patients and healthy controls.	0
1722	We determined the plasma concentrations of tryptophan (TRP), KYN, 3-hydroxykynurenine (3-HKYN); two distinct SOX markers: Cu/Zn su@COMPOUND$ dismutase (Cu/Zn @PROTEIN$) and total peroxide ; and high sensitivity C-reactive protein (hs CRP) as a indicator of inflammation in 146 ESRD patients and healthy controls.	0
1723	We determined the plasma concentrations of tryptophan (TRP), KYN, @COMPOUND$ (3-HKYN); two distinct SOX markers: Cu/Zn superoxide dismutase (Cu/Zn SOD) and total peroxide ; and high sensitivity C-reactive protein (hs @PROTEIN$) as a indicator of inflammation in 146 ESRD patients and healthy controls.	0
1724	ESRD patients showed a significant increase in Cu/Zn @PROTEIN$, total @COMPOUND$ and hs CRP levels between controls and all patients group.	0
1725	ESRD patients showed a significant increase in Cu/Zn SOD, total @COMPOUND$ and hs @PROTEIN$ levels between controls and all patients group.	0
1726	THII significantly diminished these changes in @COMPOUND$ and @PROTEIN$.	0
1727	Using HPLC techniques we evaluated the electrical field stimulation-evoked overflow of noradrenaline (NA), adenosine 5 '-triphosphate (ATP), and @COMPOUND$ (beta-NAD) in the presence of low nanomolar concentrations of omega-conotoxin GVIA or @PROTEIN$ in the canine mesenteric arteries and veins.	0
1728	Using HPLC techniques we evaluated the electrical field stimulation-evoked overflow of noradrenaline (@COMPOUND$), adenosine 5 '-triphosphate (ATP), and beta-nicotinamide adenine dinucleotide (beta-NAD) in the presence of low nanomolar concentrations of omega-@PROTEIN$ GVIA or omega-agatoxin IVA in the canine mesenteric arteries and veins.	0
1729	Using HPLC techniques we evaluated the electrical field stimulation-evoked overflow of noradrenaline (NA), adenosine 5 '-triphosphate (ATP), and beta-nicotinamide adenine dinucleotide (@COMPOUND$) in the presence of low nanomolar concentrations of omega-@PROTEIN$ GVIA or omega-agatoxin IVA in the canine mesenteric arteries and veins.	0
1730	Using HPLC techniques we evaluated the electrical field stimulation-evoked overflow of noradrenaline (@COMPOUND$), adenosine 5 '-triphosphate (ATP), and beta-nicotinamide adenine dinucleotide (beta-NAD) in the presence of low nanomolar concentrations of omega-conotoxin GVIA or @PROTEIN$ in the canine mesenteric arteries and veins.	0
1731	Using HPLC techniques we evaluated the electrical field stimulation-evoked overflow of noradrenaline (NA), adenosine 5 '-triphosphate (ATP), and @COMPOUND$ (beta-NAD) in the presence of low nanomolar concentrations of omega-@PROTEIN$ GVIA or omega-agatoxin IVA in the canine mesenteric arteries and veins.	0
1732	Using HPLC techniques we evaluated the electrical field stimulation-evoked overflow of @COMPOUND$ (NA), adenosine 5 '-triphosphate (ATP), and beta-nicotinamide adenine dinucleotide (beta-NAD) in the presence of low nanomolar concentrations of omega-@PROTEIN$ GVIA or omega-agatoxin IVA in the canine mesenteric arteries and veins.	0
1733	Using HPLC techniques we evaluated the electrical field stimulation-evoked overflow of @COMPOUND$ (NA), adenosine 5 '-triphosphate (ATP), and beta-nicotinamide adenine dinucleotide (beta-NAD) in the presence of low nanomolar concentrations of omega-conotoxin GVIA or @PROTEIN$ in the canine mesenteric arteries and veins.	0
1734	Using HPLC techniques we evaluated the electrical field stimulation-evoked overflow of noradrenaline (NA), adenosine 5 '-triphosphate (ATP), and beta-nicotinamide adenine dinucleotide (@COMPOUND$) in the presence of low nanomolar concentrations of omega-conotoxin GVIA or @PROTEIN$ in the canine mesenteric arteries and veins.	0
1735	An extensive kinetic profile towards a plethora of purines and mutational analyses have established models on how @PROTEIN$ recognizes the @COMPOUND$ and revealed specific amino acid residues involved in proper folding, topogenesis, function and specificity.	1
1736	Three enzymes function in biosynthesis of GDP-mannose from the glycolytic intermediate @COMPOUND$ : phosphomannose isomerase (PMI), phosphomannomutase (PMM) and @PROTEIN$ (GMPP).	1
1737	Three enzymes function in biosynthesis of GDP-mannose from the glycolytic intermediate @COMPOUND$ : phosphomannose isomerase (PMI), @PROTEIN$ (PMM) and GDP-mannose pyrophosphorylase (GMPP).	1
1738	Three enzymes function in biosynthesis of GDP-mannose from the glycolytic intermediate @COMPOUND$ : @PROTEIN$ (PMI), phosphomannomutase (PMM) and GDP-mannose pyrophosphorylase (GMPP).	1
1739	Three enzymes function in biosynthesis of GDP-@COMPOUND$ from the glycolytic intermediate fructose 6-phosphate : @PROTEIN$ (PMI), phosphomannomutase (PMM) and GDP-mannose pyrophosphorylase (GMPP).	1
1740	Three enzymes function in biosynthesis of GDP-@COMPOUND$ from the glycolytic intermediate fructose 6-phosphate : phosphomannose isomerase (PMI), phosphomannomutase (@PROTEIN$) and GDP-mannose pyrophosphorylase (GMPP).	1
1741	Three enzymes function in biosynthesis of GDP-@COMPOUND$ from the glycolytic intermediate fructose 6-phosphate : phosphomannose isomerase (PMI), phosphomannomutase (PMM) and @PROTEIN$ (GMPP).	1
1742	Three enzymes function in biosynthesis of GDP-mannose from the glycolytic intermediate @COMPOUND$ : phosphomannose isomerase (@PROTEIN$), phosphomannomutase (PMM) and GDP-mannose pyrophosphorylase (GMPP).	1
1743	Three enzymes function in biosynthesis of GDP-mannose from the glycolytic intermediate @COMPOUND$ : phosphomannose isomerase (PMI), phosphomannomutase (@PROTEIN$) and GDP-mannose pyrophosphorylase (GMPP).	1
1744	Three enzymes function in biosynthesis of GDP-@COMPOUND$ from the glycolytic intermediate fructose 6-phosphate : phosphomannose isomerase (@PROTEIN$), phosphomannomutase (PMM) and GDP-mannose pyrophosphorylase (GMPP).	1
1745	Three enzymes function in biosynthesis of GDP-@COMPOUND$ from the glycolytic intermediate fructose 6-phosphate : phosphomannose isomerase (PMI), @PROTEIN$ (PMM) and GDP-mannose pyrophosphorylase (GMPP).	1
1746	Preincubation of airway epithelial cells with @COMPOUND$ (dissolved in tetrahydrofuran) delivered lycopene into the cells and resulted in a 24% reduction in interleukin-6 after rhinovirus-1B infection, 31% reduction in @PROTEIN$ after rhinovirus-43 infection and 85% reduction in rhinovirus-1B replication.	1
1747	Preincubation of airway epithelial cells with lycopene (dissolved in @COMPOUND$) delivered lycopene into the cells and resulted in a 24% reduction in interleukin-6 after rhinovirus-1B infection, 31% reduction in @PROTEIN$ after rhinovirus-43 infection and 85% reduction in rhinovirus-1B replication.	0
1748	Preincubation of airway epithelial cells with @COMPOUND$ (dissolved in tetrahydrofuran) delivered lycopene into the cells and resulted in a 24% reduction in @PROTEIN$ after rhinovirus-1B infection, 31% reduction in IP-10 after rhinovirus-43 infection and 85% reduction in rhinovirus-1B replication.	1
1749	Preincubation of airway epithelial cells with lycopene (dissolved in @COMPOUND$) delivered lycopene into the cells and resulted in a 24% reduction in @PROTEIN$ after rhinovirus-1B infection, 31% reduction in IP-10 after rhinovirus-43 infection and 85% reduction in rhinovirus-1B replication.	0
1750	Also, our previous studies implicated the SphK1/@PROTEIN$ pathway in the induction of the @COMPOUND$ cascade, a major inflammatory pathway involved in colon carcinogenesis.	1
1751	Uptake of @COMPOUND$, losartan, and cefadroxil was quantified in HeLa cells after heterologous expression of human @PROTEIN$ (hPEPT1).	0
1752	Uptake of valsartan, @COMPOUND$, and cefadroxil was quantified in HeLa cells after heterologous expression of human @PROTEIN$ (hPEPT1).	0
1753	Uptake of valsartan, losartan, and @COMPOUND$ was quantified in HeLa cells after heterologous expression of human @PROTEIN$ (hPEPT1).	0
1754	In contrast to cefadroxil, no @PROTEIN$-specific uptake of @COMPOUND$ and losartan was found.	0
1755	In contrast to cefadroxil, no @PROTEIN$-specific uptake of valsartan and @COMPOUND$ was found.	0
1756	In contrast to @COMPOUND$, no @PROTEIN$-specific uptake of valsartan and losartan was found.	1
1757	The objective of the present study was to test the @PROTEIN$, @COMPOUND$ and metabolic syndrome hypotheses as promoters of BPH.	0
1758	@PROTEIN$ and free @COMPOUND$ appear to be independent risk factors for BPH, confirming both the insulin and the oestradiol hypotheses.	0
1759	Insulin and free @COMPOUND$ appear to be independent risk factors for BPH, confirming both the @PROTEIN$ and the oestradiol hypotheses.	0
1760	@COMPOUND$ plus single-dose @PROTEIN$ glargine: a safe regimen for low-risk type 2 diabetic patients who insist on fasting in Ramadan.	0
1761	To evaluate @COMPOUND$ (AVP) and @PROTEIN$ plasma concentrations in patients with vasodilatory shock after cardiac surgery.	0
1762	Eight newly synthesized carbacylamidophosphates with the general formula RC(O) NHP (O) Cl2 with R = pCl-C6H4 1a, pBr-C6H4 2a, C6H5 3a, and pMe-C6H4 4a and RC(O) NHP (O)(NC4H8O)2 R = pCl-C6H4 1b, pBr-C6H4 2b, C6H5 3b, pMe-C6H4 4b, were selected to compare the inhibition kinetic parameters, IC50, Ki, kp and KD, on human erythrocyte @PROTEIN$ (hAChE) and bovine serum butyrylcholinesterase (BuChE), Also, the in vivo inhibition potency of @COMPOUND$, 2b and 3a, were studied.	0
1763	Eight newly synthesized carbacylamidophosphates with the general formula RC(O) @COMPOUND$ (O) Cl2 with R = pCl-C6H4 1a, pBr-C6H4 2a, C6H5 3a, and pMe-C6H4 4a and RC(O) NHP (O)(NC4H8O)2 R = pCl-C6H4 1b, pBr-C6H4 2b, C6H5 3b, pMe-C6H4 4b, were selected to compare the inhibition kinetic parameters, IC50, Ki, kp and KD, on human erythrocyte @PROTEIN$ (hAChE) and bovine serum butyrylcholinesterase (BuChE), Also, the in vivo inhibition potency of compound 2a, 2b and 3a, were studied.	0
1764	Eight newly synthesized carbacylamidophosphates with the general formula RC(O) NHP (O) Cl2 with R = pCl-C6H4 1a, @COMPOUND$-C6H4 2a, C6H5 3a, and pMe-C6H4 4a and RC(O) NHP (O)(NC4H8O)2 R = pCl-C6H4 1b, pBr-C6H4 2b, C6H5 3b, pMe-C6H4 4b, were selected to compare the inhibition kinetic parameters, IC50, Ki, kp and KD, on human erythrocyte @PROTEIN$ (hAChE) and bovine serum butyrylcholinesterase (BuChE), Also, the in vivo inhibition potency of compound 2a, 2b and 3a, were studied.	0
1765	Eight newly synthesized carbacylamidophosphates with the general formula RC(O) NHP (O) Cl2 with R = pCl-C6H4 1a, pBr-C6H4 2a, C6H5 3a, and @COMPOUND$-C6H4 4a and RC(O) NHP (O)(NC4H8O)2 R = pCl-C6H4 1b, pBr-C6H4 2b, C6H5 3b, pMe-C6H4 4b, were selected to compare the inhibition kinetic parameters, IC50, Ki, kp and KD, on human erythrocyte @PROTEIN$ (hAChE) and bovine serum butyrylcholinesterase (BuChE), Also, the in vivo inhibition potency of compound 2a, 2b and 3a, were studied.	0
1766	Among them, @COMPOUND$ and 5 had significant @PROTEIN$ inhibitory activities.	1
1767	Here we report the docking study of four @COMPOUND$ catechins and four alkylating anticancer drugs into the @PROTEIN$ model, as GSTs were found to be affected by tea catechins.	1
1768	Here we report the docking study of four @COMPOUND$ catechins and four alkylating anticancer drugs into the GST P1-1 model, as @PROTEIN$ were found to be affected by tea catechins.	1
1769	The protein glycation inhibitory activity of ethanolic extract of Lawsonia inermis (henna) plant tissues was evaluated in vitro using the model system of bovine @PROTEIN$ and @COMPOUND$.	0
1770	In vitro effects of @COMPOUND$ treatment on fish liver @PROTEIN$ activity.	1
1771	Effects of acceptor composition and mechanism of @PROTEIN$-mediated cellular free @COMPOUND$ efflux.	1
1772	@PROTEIN$ vesicles and red blood cells as carriers of @COMPOUND$ prior to oxygen for resuscitation after hemorrhagic shock in a rat model.	1
1773	@PROTEIN$ vesicles and red blood cells as carriers of carbon monoxide prior to @COMPOUND$ for resuscitation after hemorrhagic shock in a rat model.	1
1774	The outer membrane @PROTEIN$ is involved in @COMPOUND$ tolerance and overproduction in Escherichia coli.	1
1775	Toll-like receptor (@PROTEIN$) 4 is a critical receptor and signal transducer for @COMPOUND$ (LPS), a major component of Gram-negative bacteria.	1
1776	Colonization of germ-free (GF) mice has been shown to induce the gastrointestinal form of the @COMPOUND$-dependent glutathione peroxidases, @PROTEIN$.	1
1777	Colonization of germ-free (GF) mice has been shown to induce the gastrointestinal form of the @COMPOUND$-dependent @PROTEIN$, GPx2.	1
1778	The purpose of this study was to investigate whether or not the role of docosahexaenoic acid (DHA) supplementation on cognitive capability was related with brain-derived neurotrophic factor (@PROTEIN$), @COMPOUND$ (NO) and dopamine (DA) in aged mice.	0
1779	The purpose of this study was to investigate whether or not the role of docosahexaenoic acid (DHA) supplementation on cognitive capability was related with @PROTEIN$ (BDNF), nitric oxide (NO) and @COMPOUND$ (DA) in aged mice.	0
1780	The purpose of this study was to investigate whether or not the role of @COMPOUND$ (DHA) supplementation on cognitive capability was related with brain-derived neurotrophic factor (@PROTEIN$), nitric oxide (NO) and dopamine (DA) in aged mice.	0
1781	The purpose of this study was to investigate whether or not the role of docosahexaenoic acid (DHA) supplementation on cognitive capability was related with @PROTEIN$ (BDNF), @COMPOUND$ (NO) and dopamine (DA) in aged mice.	0
1782	The purpose of this study was to investigate whether or not the role of @COMPOUND$ (DHA) supplementation on cognitive capability was related with @PROTEIN$ (BDNF), nitric oxide (NO) and dopamine (DA) in aged mice.	1
1783	The purpose of this study was to investigate whether or not the role of docosahexaenoic acid (DHA) supplementation on cognitive capability was related with brain-derived neurotrophic factor (@PROTEIN$), nitric oxide (NO) and @COMPOUND$ (DA) in aged mice.	0
1784	Model analysis of local @COMPOUND$ delivery with liposome-encapsulated @PROTEIN$.	1
1785	Therefore, the @COMPOUND$+)-sensitive @PROTEIN$, which was localized in elongated spermatids and spermatozoa, is a likely candidate for a water channel responsible for physiological sperm volume regulation crucial to in vivo fertilization.	1
1786	Complex modulation of L-type @COMPOUND$+) current inactivation by @PROTEIN$ in isolated rabbit cardiomyocytes.	1
1787	Donor testicular cells were prepared from heterozygous chicken beta actin (CAG)/enhanced @PROTEIN$ (EGFP)-transgenic rats (EGFP Tg rats) during the second week after birth and injected into the seminiferous tubules of the MT-myc Tg rats (line-A and-B; both subfertile) or rats pretreated with @COMPOUND$ to remove endogenous spermatogonia.	0
1788	Donor testicular cells were prepared from heterozygous chicken beta actin (@PROTEIN$)/enhanced green fluorescent protein (EGFP)-transgenic rats (EGFP Tg rats) during the second week after birth and injected into the seminiferous tubules of the MT-myc Tg rats (line-A and-B; both subfertile) or rats pretreated with @COMPOUND$ to remove endogenous spermatogonia.	0
1789	Donor testicular cells were prepared from heterozygous chicken @PROTEIN$ (CAG)/enhanced green fluorescent protein (EGFP)-transgenic rats (EGFP Tg rats) during the second week after birth and injected into the seminiferous tubules of the MT-myc Tg rats (line-A and-B; both subfertile) or rats pretreated with @COMPOUND$ to remove endogenous spermatogonia.	0
1790	Toward this goal, models of the noncoupled @COMPOUND$ centers found in the enzymes peptidyl alpha-hydroxylating monooxygenase (@PROTEIN$), dopamine beta-monooxygenase (DBM), and nitrite reductase (NiR) were designed into the small soluble protein azurin.	1
1791	Toward this goal, models of the noncoupled @COMPOUND$ centers found in the enzymes peptidyl alpha-hydroxylating monooxygenase (PHM), dopamine beta-monooxygenase (DBM), and nitrite reductase (NiR) were designed into the small soluble protein @PROTEIN$.	1
1792	Toward this goal, models of the noncoupled @COMPOUND$ centers found in the enzymes peptidyl alpha-hydroxylating monooxygenase (PHM), dopamine beta-monooxygenase (DBM), and nitrite reductase (@PROTEIN$) were designed into the small soluble protein azurin.	1
1793	Toward this goal, models of the noncoupled @COMPOUND$ centers found in the enzymes peptidyl alpha-hydroxylating monooxygenase (PHM), @PROTEIN$ (DBM), and nitrite reductase (NiR) were designed into the small soluble protein azurin.	1
1794	The esterase and @PROTEIN$ activities were determined by the hydrolysis of pNPB and @COMPOUND$, respectively.	1
1795	The @PROTEIN$ and lipase activities were determined by the hydrolysis of pNPB and @COMPOUND$, respectively.	1
1796	QSAR studies for the inhibition of the transmembrane @PROTEIN$ isozyme XIV with @COMPOUND$ using PRECLAV software.	1
1797	QSAR studies for the inhibition of isozyme XIV of human @PROTEIN$ (CA, EC 4.2.1.1) by a series of @COMPOUND$ including clinically used derivatives (acetazolamide, methazolamide, ethoxzolamide, dichlorophenamide, dorzolamide, brinzolamide, benzolamide, and zonisamide) are presented.	1
1798	The order of the cytotoxicity of the compounds was; IV &gt; III &gt; II &gt; I &gt; V. @COMPOUND$, had the highest Hammett and log P values (0.23 and 4.21, respectively) and exerted both highest cytotoxicity and strongest @PROTEIN$ inhibition.	1
1799	Tests were carried out on cell cultures of human keratinocytes and mouse 3T3 fibroblasts incubated with radiolabeled acetate, and on homogenates prepared from yeast cells expressing human @PROTEIN$, incubated with radiolabeled @COMPOUND$.	0
1800	The concentration required for 50% inhibition (IC(50)) by @COMPOUND$ was 88 nM for cathepsin B and 163 nM for @PROTEIN$.	1
1801	The concentration required for 50% inhibition (IC(50)) by @COMPOUND$ was 88 nM for @PROTEIN$ and 163 nM for cathepsin L.	1
1802	Preliminary structure-activity relationships and a molecular modeling study for 9a have revealed that the @COMPOUND$ moiety plays a key role in the interaction of this series of derivatives with @PROTEIN$ by acting as an anchor in its peripheral anionic site.	1
1803	One potential target for reducing T cell migration is inhibition of the @COMPOUND$+)-activated neutral protease @PROTEIN$.	1
1804	One potential target for reducing T cell migration is inhibition of the @COMPOUND$+)-activated @PROTEIN$ calpain.	0
1805	@COMPOUND$, a newer anticonvulsant, does not undergo @PROTEIN$ metabolism and does not alter the pharmacokinetics of chemotherapy, antiemetics, and corticosteroids, which are metabolized by the liver.	0
1806	The main mechanism of resistance to @COMPOUND$ was extra-chromosomal amplification of the @PROTEIN$ gene.	1
1807	In the LNCaP prostate cancer cell line, induction of apoptosis and caspase-3/7 activities by staurosporine (STS) abolished ((3)H) @COMPOUND$ (3) binding and @PROTEIN$ protein, suggesting that the VDR may be targeted for inactivation by caspases during apoptosis.	0
1808	In the LNCaP prostate cancer cell line, induction of apoptosis and caspase-3/7 activities by @COMPOUND$ (STS) abolished ((3)H) 1,25-dihydroxy vitamin D (3) binding and @PROTEIN$ protein, suggesting that the VDR may be targeted for inactivation by caspases during apoptosis.	0
1809	These data suggest that an ovulatory stimulus rapidly mobilizes stored cholesterol esters for use as a @COMPOUND$ substrate and that as these are depleted, new cholesterol esters are obtained through an LDLR- and/or @PROTEIN$-mediated mechanism.	0
1810	These data suggest that an ovulatory stimulus rapidly mobilizes stored cholesterol esters for use as a @COMPOUND$ substrate and that as these are depleted, new cholesterol esters are obtained through an @PROTEIN$- and/or SR-BI-mediated mechanism.	0
1811	As this effect might be related to deregulation of @PROTEIN$ (Cx43) synthesis, trafficking, or degradation, we investigated the impact of @COMPOUND$ on these events.	1
1812	As this effect might be related to deregulation of connexin 43 (@PROTEIN$) synthesis, trafficking, or degradation, we investigated the impact of @COMPOUND$ on these events.	1
1813	Inhibition of either proteasomes or lysosomes with their specific inhibitors largely restored total @PROTEIN$ protein levels, thus suggesting that both proteasomes and lysosomes may participate in the @COMPOUND$-enhanced Cx43 internalization and degradation.	1
1814	Taken together, multiple modes of action seem to contribute to downregulation of @PROTEIN$ in @COMPOUND$-treated rat liver epithelial cells.	1
1815	The accelerated rate of kindling was partially repressed by inhibiting N-methyl-D-aspartic acid receptor (NMDAR) with @COMPOUND$ or @PROTEIN$ receptor with 2-methyl-6-(phenylethynyl)-pyridine (MPEP).	0
1816	The accelerated rate of kindling was partially repressed by inhibiting N-methyl-D-aspartic acid receptor (NMDAR) with MK-801 or @PROTEIN$ receptor with 2-methyl-6-(phenylethynyl)-pyridine (@COMPOUND$).	1
1817	The accelerated rate of kindling was partially repressed by inhibiting N-methyl-D-aspartic acid receptor (NMDAR) with MK-801 or @PROTEIN$ receptor with @COMPOUND$ (MPEP).	1
1818	Here, PCA is applied to three problems in @PROTEIN$ research: (i) distinguishing origins of heparin preparations, (ii) structural analysis of heparin derivatives, and (iii) classification of @COMPOUND$ (CS).	1
1819	Recent studies have provided important insight into the homeoprotein LIM homeobox transcription factor 1alpha (@PROTEIN$) and its role in the commitment of cells to a midbrain @COMPOUND$ (mDA) fate in the developing mouse.	1
1820	Recent studies have provided important insight into the homeoprotein @PROTEIN$ homeobox transcription factor 1alpha (Lmx1a) and its role in the commitment of cells to a midbrain @COMPOUND$ (mDA) fate in the developing mouse.	1
1821	By using a combination of fluorescence microscopy, flow cytometry, and force spectroscopy, it has been possible to demonstrate, for the first time, specific binding of a pectin @COMPOUND$ to the recombinant form of human @PROTEIN$.	1
1822	It was identified as producer of extended-spectrum @PROTEIN$ (ESBL) by double-disk synergy test between @COMPOUND$-clavulanate and cefotaxime, ceftriaxone, ceftazidime and aztreonam.	1
1823	It was identified as producer of extended-spectrum @PROTEIN$ (ESBL) by double-disk synergy test between amoxicillin-clavulanate and cefotaxime, ceftriaxone, @COMPOUND$ and aztreonam.	1
1824	It was identified as producer of extended-spectrum @PROTEIN$ (ESBL) by double-disk synergy test between amoxicillin-clavulanate and @COMPOUND$, ceftriaxone, ceftazidime and aztreonam.	1
1825	It was identified as producer of extended-spectrum @PROTEIN$ (ESBL) by double-disk synergy test between amoxicillin-clavulanate and cefotaxime, @COMPOUND$, ceftazidime and aztreonam.	1
1826	It was identified as producer of extended-spectrum @PROTEIN$ (ESBL) by double-disk synergy test between amoxicillin-clavulanate and cefotaxime, ceftriaxone, ceftazidime and @COMPOUND$.	1
1827	It was identified as producer of extended-spectrum @PROTEIN$ (ESBL) by double-disk synergy test between amoxicillin-@COMPOUND$ and cefotaxime, ceftriaxone, ceftazidime and aztreonam.	1
1828	Sex steroids enhance @PROTEIN$ and @COMPOUND$ oxidation in Chang liver cells.	0
1829	Examination of @COMPOUND$-induced expression of the small heat shock protein gene, @PROTEIN$, in Xenopus laevis A6 kidney epithelial cells.	1
1830	Immunocytochemical analysis of @COMPOUND$-treated A6 cells revealed @PROTEIN$ accumulation primarily in the cytoplasm in a punctate pattern supplemented with larger HSP30 staining structures.	1
1831	Also, @PROTEIN$ co-localized with the F-actin cytoskeleton at higher @COMPOUND$ concentrations.	1
1832	Also, HSP30 co-localized with the F-@PROTEIN$ cytoskeleton at higher @COMPOUND$ concentrations.	0
1833	Cloning, expression, and characterization of @COMPOUND$-induced @PROTEIN$ from the earthworms Metaphire posthuma and Polypheretima elongata.	1
1834	Complementary (c)DNA was verified as the @PROTEIN$ gene by the characteristics of its predicted translation product, namely a high @COMPOUND$ content, conserved CXC motifs, and a molecular weight of around 8 kDa.	1
1835	The most active compound to emerge from the in vitro and in vivo murine studies was 2b, suggesting an antimalarial activity via inhibition of @PROTEIN$ hydrolysis, however, not as efficient as @COMPOUND$.	0
1836	Surprisingly, no role of @PROTEIN$/2 or STAT-3 was found in the protein-mediated protection of hepatocytes during @COMPOUND$ exposure.	0
1837	Surprisingly, no role of ERK1/2 or @PROTEIN$-3 was found in the protein-mediated protection of hepatocytes during @COMPOUND$ exposure.	0
1838	Mutations at M57 (M57L) and H210 (H210G, H210M, and H210N), both of which are involved in interactions with the C2 carbonyl oxygen in uracil or @COMPOUND$, cause substantial reductions in XDG and @PROTEIN$ activities.	0
1839	Mutations at M57 (M57L) and H210 (H210G, H210M, and H210N), both of which are involved in interactions with the C2 carbonyl @COMPOUND$ in uracil or xanthine, cause substantial reductions in XDG and @PROTEIN$ activities.	0
1840	Mutations at M57 (M57L) and H210 (H210G, H210M, and H210N), both of which are involved in interactions with the C2 carbonyl oxygen in @COMPOUND$ or xanthine, cause substantial reductions in XDG and @PROTEIN$ activities.	0
1841	Most interestingly, a proline substitution at the G63 position switches the Gme SMUG1 enzyme to an exclusive @PROTEIN$ as demonstrated by the uniform excision of @COMPOUND$ in both double-stranded and single-stranded DNA and the complete loss of XDG activity.	1
1842	Most interestingly, a proline substitution at the G63 position switches the Gme @PROTEIN$ enzyme to an exclusive UDG as demonstrated by the uniform excision of @COMPOUND$ in both double-stranded and single-stranded DNA and the complete loss of XDG activity.	1
1843	Most interestingly, a @COMPOUND$ substitution at the G63 position switches the Gme @PROTEIN$ enzyme to an exclusive UDG as demonstrated by the uniform excision of uracil in both double-stranded and single-stranded DNA and the complete loss of XDG activity.	1
1844	Most interestingly, a proline substitution at the G63 position switches the @PROTEIN$ SMUG1 enzyme to an exclusive UDG as demonstrated by the uniform excision of @COMPOUND$ in both double-stranded and single-stranded DNA and the complete loss of XDG activity.	1
1845	Most interestingly, a @COMPOUND$ substitution at the G63 position switches the Gme SMUG1 enzyme to an exclusive @PROTEIN$ as demonstrated by the uniform excision of uracil in both double-stranded and single-stranded DNA and the complete loss of XDG activity.	1
1846	Most interestingly, a @COMPOUND$ substitution at the G63 position switches the @PROTEIN$ SMUG1 enzyme to an exclusive UDG as demonstrated by the uniform excision of uracil in both double-stranded and single-stranded DNA and the complete loss of XDG activity.	1
1847	We report herein some novel phenomena between hemin-H(2)O(2)-NO(2)(-) and @COMPOUND$ (SIN-1)-mediated oxidation and nitration reactions of glutamate dehydrogenase (@PROTEIN$).	1
1848	We report herein some novel phenomena between hemin-H(2)O(2)-NO(2)(-) and @COMPOUND$ (SIN-1)-mediated oxidation and nitration reactions of @PROTEIN$ (GDH).	1
1849	After intravenous administration of either DOTAP/@COMPOUND$ or DOTMA/cholesterol liposomes, serum @PROTEIN$ and ALT levels were normal, suggesting that liver injury as well as cytokine production was caused by lipoplexes, but not by cationic liposomes.	0
1850	After intravenous administration of either DOTAP/cholesterol or @COMPOUND$/cholesterol liposomes, serum @PROTEIN$ and ALT levels were normal, suggesting that liver injury as well as cytokine production was caused by lipoplexes, but not by cationic liposomes.	0
1851	After intravenous administration of either @COMPOUND$/cholesterol or DOTMA/cholesterol liposomes, serum @PROTEIN$ and ALT levels were normal, suggesting that liver injury as well as cytokine production was caused by lipoplexes, but not by cationic liposomes.	0
1852	Functional inactivation of @PROTEIN$/@COMPOUND$ in human mesothelioma.	0
1853	The tumor suppressor @COMPOUND$ is encoded by the neurofibromatosis type 2 gene (@PROTEIN$) which is located on chromosome 22q12 and mutations in this gene have been found in 40% of mesothelioma.	1
1854	Here, we report that @COMPOUND$-mediated induction of @PROTEIN$ expression at the protein, mRNA, and promoter levels in MA-10 cells involves different mechanisms.	1
1855	In addition, our detailed analysis of the @PROTEIN$ promoter in MA-10 cells revealed that distinct regulatory elements are involved in basal and @COMPOUND$-induced Nur77 transcription.	1
1856	LDL from all subjects stimulated both the basal and @PROTEIN$-induced @COMPOUND$ and cortisol release from adrenocortical cells.	1
1857	LDL from all subjects stimulated both the basal and @PROTEIN$-induced aldosterone and @COMPOUND$ release from adrenocortical cells.	1
1858	Here we present evidence of distinct @COMPOUND$-induced modulation of @PROTEIN$ functions using high-resolution live-cell imaging approaches.	1
1859	Association of the @PROTEIN$ gene polymorphisms 2677G&gt;T/A and 3435C&gt;T with clinical outcomes of @COMPOUND$ monotherapy in metastatic breast cancer patients.	1
1860	@PROTEIN$/KC was detected as early as 6 hours after @COMPOUND$ instillation and returned to basal levels after Day 8.	1
1861	DF2162 treatment reduced @COMPOUND$-induced expression of @PROTEIN$, a marker of angiogenesis, in the lung.	1
1862	@COMPOUND$ (KYNA) is an agonist of the G-protein-coupled receptor @PROTEIN$, which is predominantly expressed in gastrointestinal tissues.	1
1863	Kynurenic acid (@COMPOUND$) is an agonist of the G-protein-coupled receptor @PROTEIN$, which is predominantly expressed in gastrointestinal tissues.	1
1864	Inhibiting @PROTEIN$ signalling in SUR1 (-/-) beta-cells blunted the @COMPOUND$-induced decrease of (Ca(2+))(c).	0
1865	In the mouse model of demyelination-remyelination induced by oral administration of @COMPOUND$, in situ hybridization showed an upregulation of the @PROTEIN$ gene in three different white matter areas (corpus callosum, dorsal fornix, and external capsule) during the remyelination period.	1
1866	Therapeutic strategy to rescue mutation-induced exon skipping in @PROTEIN$ by adaptation of @COMPOUND$ snRNA.	1
1867	As a therapeutic strategy, @COMPOUND$ snRNAs were adapted to the novel @PROTEIN$ mutation and tested for its potential to reverse missplicing.	1
1868	After 120 min, @COMPOUND$ and @PROTEIN$ responses declined, but remained higher after the Pol 0.05) in parallel to the inhibition of lipolysis.	0
1869	Keeping @COMPOUND$ out of DNA: physiological role, structure and catalytic mechanism of @PROTEIN$.	1
1870	The @PROTEIN$ binding pocket is highly specific for @COMPOUND$.	1
1871	@COMPOUND$ chain coordination involves Mg2+ and is analogous to that of @PROTEIN$.	1
1872	We present a robust and simple method for the direct detection of multiple point mutations in the Mycobacterium tuberculosis @PROTEIN$ gene during the development of @COMPOUND$ (RIF) resistance using an electrochemical genosensor.	1
1873	The main source of extracellular @COMPOUND$ stems from a coordinated two-step enzymatic conversion of precursor nucleotides via the @PROTEIN$ (CD39) and the ecto-5'-nucleotidase (CD73).	1
1874	The main source of extracellular @COMPOUND$ stems from a coordinated two-step enzymatic conversion of precursor nucleotides via the ecto-apyrase (@PROTEIN$) and the ecto-5'-nucleotidase (CD73).	1
1875	The main source of extracellular @COMPOUND$ stems from a coordinated two-step enzymatic conversion of precursor nucleotides via the ecto-apyrase (CD39) and the @PROTEIN$ (CD73).	1
1876	Mechanism-based inactivation of @PROTEIN$ by tienilic acid and (+/-)-@COMPOUND$ : a comparison of kinetics and probe substrate selection.	1
1877	Mechanism-based inactivation of @PROTEIN$ by @COMPOUND$ and (+/-)-suprofen : a comparison of kinetics and probe substrate selection.	1
1878	In vitro experiments were conducted to compare k(inact), K(I) and inactivation efficiency (k(inact)/K(I)) of @PROTEIN$ (P450) 2C9 by @COMPOUND$ and (+/-)-suprofen using (S)-flurbiprofen, diclofenac, and (S)-warfarin as reporter substrates.	1
1879	In vitro experiments were conducted to compare k(inact), K(I) and inactivation efficiency (k(inact)/K(I)) of @PROTEIN$ (P450) 2C9 by tienilic acid and (+/-)-@COMPOUND$ using (S)-flurbiprofen, diclofenac, and (S)-warfarin as reporter substrates.	1
1880	In addition to @COMPOUND$ and hyperforin, the anticancer drug paclitaxel has also been shown to be an inducer of CYP3A4 via activation of the pregnane X receptor (@PROTEIN$).	0
1881	In addition to rifampicin and @COMPOUND$, the anticancer drug paclitaxel has also been shown to be an inducer of CYP3A4 via activation of the pregnane X receptor (@PROTEIN$).	0
1882	In addition to rifampicin and hyperforin, the anticancer drug @COMPOUND$ has also been shown to be an inducer of CYP3A4 via activation of the @PROTEIN$ (PXR).	1
1883	In addition to rifampicin and @COMPOUND$, the anticancer drug paclitaxel has also been shown to be an inducer of CYP3A4 via activation of the @PROTEIN$ (PXR).	0
1884	In addition to @COMPOUND$ and hyperforin, the anticancer drug paclitaxel has also been shown to be an inducer of CYP3A4 via activation of the @PROTEIN$ (PXR).	0
1885	In addition to rifampicin and hyperforin, the anticancer drug @COMPOUND$ has also been shown to be an inducer of CYP3A4 via activation of the pregnane X receptor (@PROTEIN$).	1
1886	The comparison of s-@PROTEIN$ with plasma @COMPOUND$ indicated that s-CysC was superior to plasma creatinine in five of 13 studies; four studies showed no difference, and, in four studies, no statistical comparison was made.	0
1887	S-@PROTEIN$ is most likely superior to plasma @COMPOUND$ and at least equal to creatinine-based formulas.	0
1888	@PROTEIN$-based prediction equations are at least as good as @COMPOUND$-based formulas but cannot replace exogenous methods.	0
1889	Intracellular @COMPOUND$ (-) is required for the motor function of @PROTEIN$, a unique plasma membrane molecular motor of these cells.	1
1890	Intramuscular triacylglycerol does not appear to be a ubiquitous marker of @PROTEIN$ resistance, although specific IMCL intermediates such as long-chain fatty acyl-CoAs, ceramide, and @COMPOUND$ may inhibit insulin signal transduction.	1
1891	Inhibition of gamma-glutamyl transferase (@PROTEIN$, EC 2.3.2.2)-catalyzed extracellular GSH degradation with @COMPOUND$ significantly blocked GSH efflux, suggesting that GSH breakdown is a driving force for GSH export.	0
1892	We injected females with human chorionic gonadotropin (@PROTEIN$), estradiol, estradiol plus progesterone, saline, or HCG plus @COMPOUND$ (an aromatase blocker) and tested their responses to mating calls.	0
1893	We injected females with human chorionic gonadotropin (@PROTEIN$), @COMPOUND$, estradiol plus progesterone, saline, or HCG plus fadrozole (an aromatase blocker) and tested their responses to mating calls.	0
1894	We injected females with human chorionic gonadotropin (@PROTEIN$), estradiol, estradiol plus @COMPOUND$, saline, or HCG plus fadrozole (an aromatase blocker) and tested their responses to mating calls.	0
1895	Here we use an array of flow cytometric analyses to characterize silkworm hemocytes with various molecular probes, such as @COMPOUND$, green fluorescence protein, monoclonal antibodies, and fluorescent @PROTEIN$.	0
1896	Amino acid 1092 (AA1092) in @PROTEIN$ 1 of coxsackievirus B3 (CVB3) is located in close vicinity to the central @COMPOUND$ group of capsid binders (i.e.	1
1897	In vivo assays confirmed that the three resulting genotypes differed in their ability to produce @COMPOUND$ in response to intravenous insulin injection implicating @PROTEIN$ as the primary cause of the observed hypocortisolism.	1
1898	In vivo assays confirmed that the three resulting genotypes differed in their ability to produce @COMPOUND$ in response to intravenous @PROTEIN$ injection implicating CYP17 as the primary cause of the observed hypocortisolism.	1
1899	Overall, @PROTEIN$ is the cell surface receptor responsible for selective uptake of lipoprotein @COMPOUND$ and its ultimate delivery to sites of hormone synthesis in steroidogenic tissues.	1
1900	Susceptibility to esophageal cancer may be modified by functional polymorphisms in genes along the @COMPOUND$ metabolic pathway, such as methylenetetrahydrofolate reductase (@PROTEIN$).	1
1901	Susceptibility to esophageal cancer may be modified by functional polymorphisms in genes along the @COMPOUND$ metabolic pathway, such as @PROTEIN$ (MTHFR).	1
1902	We previously determined that @PROTEIN$ Tyr51 is a canonical and Trp150 an anti-canonical TEM-1-contact residue, where canonical refers to the @COMPOUND$ substitution resulting in a matched change in the hydrophobicity of binding free energy.	1
1903	We previously determined that BLIP Tyr51 is a canonical and Trp150 an anti-canonical @PROTEIN$-contact residue, where canonical refers to the @COMPOUND$ substitution resulting in a matched change in the hydrophobicity of binding free energy.	1
1904	This explains the anti-canonical nature of the Trp150 to @COMPOUND$ substitution, and also reveals a strong long distance coupling between Trp150 and Asp49 of @PROTEIN$, because these two residues are more than 25 angstroms apart.	1
1905	This effect is independent of any change in neutrophil adhesion or adhesion molecule expression but is related to the ability of statins to reduce @COMPOUND$-induced @PROTEIN$ activity in neutrophils.	1
1906	This was confirmed by the ability of the @PROTEIN$ precursor @COMPOUND$ to rescue the statin-mediated reduction in neutrophil transendothelial migration.	1
1907	Suppression of @COMPOUND$-induced @PROTEIN$ 2 expression in astrocytes by a novel diindolylmethane analog protects striatal neurons against apoptosis.	1
1908	Suppression of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced @PROTEIN$ 2 expression in astrocytes by a novel @COMPOUND$ analog protects striatal neurons against apoptosis.	1
1909	Involvement of the @PROTEIN$/Rho kinase (ROCK) pathway in diabetic microvasculopathy and therapeutic potential of @COMPOUND$, a selective ROCK inhibitor, are investigated.	1
1910	@PROTEIN$ cytokine profile may be related to the risk of the vaginal erosions following placement of @COMPOUND$ meshes.	1
1911	Cell viability (MTT colorimetric determination) and transmembrane mitochondrial potential (J-C1 fluorescence) were concentration-dependently reduced 24 h after NaN (3); neither nuclear fragmentation by @COMPOUND$, nor @PROTEIN$ positivity by flow cytometry were detected, ruling out the occurrence of apoptosis.	0
1912	We evaluated whether inhibition of @PROTEIN$ (hsp90) function by @COMPOUND$ derivatives could induce the degradation of signal transducers that drive cancer cell growth and thereby promote apoptosis.	1
1913	We evaluated whether inhibition of heat shock protein 90 (@PROTEIN$) function by @COMPOUND$ derivatives could induce the degradation of signal transducers that drive cancer cell growth and thereby promote apoptosis.	1
1914	These observations provide novel insights into the functional roles of the endogenous coactivators in @COMPOUND$ induction of the human CYP1A1 and @PROTEIN$ genes in their natural chromosomal configurations.	1
1915	These observations provide novel insights into the functional roles of the endogenous coactivators in @COMPOUND$ induction of the human @PROTEIN$ and CYP1B1 genes in their natural chromosomal configurations.	1
1916	Each residue was modified with one to three @COMPOUND$ units, and the most dominant @PROTEIN$ glycoform was modified with nine hexose units.	1
1917	Following @COMPOUND$ there was a time-dependent redistribution of total @PROTEIN$ from predominantly intracellular vesicles to the apical plasma membrane, clathrin-coated vesicles, early endosomal compartments, and lysosomes.	1
1918	The relationships among obesity, metabolic syndrome, ED, sex hormone-binding globulin (@PROTEIN$) and serum total and free @COMPOUND$ levels are complex and often confusing to the physician.	1
1919	We now show that treatment of cells with phosphomimic @PROTEIN$ (uPA138E/303E, @COMPOUND$ 138 and 303 substituted with glutamic acid) strongly inhibits matrix-induced cell migration.	1
1920	When cells were subjected to hypoxia (1% @COMPOUND$), the expression of @PROTEIN$ had a significant increase in cancer cells.	1
1921	The nuclear NF-kappaB @PROTEIN$ expression after treatment with the SFN-@COMPOUND$ combination was also evaluated by western blot analysis.	0
1922	Human genetic diseases that affect N-glycosylation result from the defective synthesis of the N-linked sugar moiety (@COMPOUND$) of @PROTEIN$.	1
1923	Rats subcutaneously injected with ISO (85 mg/kg) at an interval of 24 h for 2 days resulted in a significant increase in the levels of mitochondrial lipid peroxides with a significant decrease in the activities/levels of mitochondrial antioxidants (@PROTEIN$, catalase, glutathione peroxidase, glutathione-S-transferase and @COMPOUND$).	0
1924	Rats subcutaneously injected with ISO (85 mg/kg) at an interval of 24 h for 2 days resulted in a significant increase in the levels of mitochondrial lipid peroxides with a significant decrease in the activities/levels of mitochondrial antioxidants (superoxide dismutase, catalase, glutathione peroxidase, @PROTEIN$ and @COMPOUND$).	0
1925	Rats subcutaneously injected with ISO (85 mg/kg) at an interval of 24 h for 2 days resulted in a significant increase in the levels of mitochondrial lipid peroxides with a significant decrease in the activities/levels of mitochondrial antioxidants (superoxide dismutase, @PROTEIN$, glutathione peroxidase, glutathione-S-transferase and @COMPOUND$).	0
1926	Rats subcutaneously injected with ISO (85 mg/kg) at an interval of 24 h for 2 days resulted in a significant increase in the levels of mitochondrial lipid peroxides with a significant decrease in the activities/levels of mitochondrial antioxidants (superoxide dismutase, catalase, @PROTEIN$, glutathione-S-transferase and @COMPOUND$).	0
1927	This inhibitory effect of @COMPOUND$ on adipocyte differentiation was accompanied by @PROTEIN$ inhibition in rosiglitazone-treated cells.	1
1928	Experiments using a classical inhibitor of phosphotyrosine @PROTEIN$, @COMPOUND$, also showed that the ecto-phosphatase activity was inhibited in a dose-dependent manner.	1
1929	Both promoters are partially regulated by @COMPOUND$ via @PROTEIN$ and other RARs.	1
1930	Currently, adreno-corticotrophic hormone (@PROTEIN$), steroids and @COMPOUND$ (VGB) form the mainstay of its treatment.	0
1931	The addition of a protein kinase C (PKC) activator, @COMPOUND$, rescued PhIP-inhibited @PROTEIN$ expression in LTA-stimulated cells.	1
1932	Diabetes was induced in C57BL/6 Gal-3(+/+) and Gal-3 (-/-) mice and disease monitored by blood @COMPOUND$ level, immuno-histology, insulin content of islets and expression of the proinflammatory cytokines, @PROTEIN$, IFN-gamma, IL-17, and iNOS in pancreatic lymph nodes.	0
1933	Diabetes was induced in C57BL/6 Gal-3(+/+) and Gal-3 (-/-) mice and disease monitored by blood @COMPOUND$ level, immuno-histology, @PROTEIN$ content of islets and expression of the proinflammatory cytokines, TNF-alpha, IFN-gamma, IL-17, and iNOS in pancreatic lymph nodes.	0
1934	Diabetes was induced in C57BL/6 Gal-3(+/+) and Gal-3 (-/-) mice and disease monitored by blood @COMPOUND$ level, immuno-histology, insulin content of islets and expression of the proinflammatory cytokines, TNF-alpha, IFN-gamma, @PROTEIN$, and iNOS in pancreatic lymph nodes.	0
1935	Diabetes was induced in C57BL/6 Gal-3(+/+) and Gal-3 (-/-) mice and disease monitored by blood @COMPOUND$ level, immuno-histology, insulin content of islets and expression of the proinflammatory cytokines, TNF-alpha, IFN-gamma, IL-17, and @PROTEIN$ in pancreatic lymph nodes.	0
1936	Diabetes was induced in C57BL/6 Gal-3(+/+) and Gal-3 (-/-) mice and disease monitored by blood @COMPOUND$ level, immuno-histology, insulin content of islets and expression of the proinflammatory cytokines, TNF-alpha, @PROTEIN$, IL-17, and iNOS in pancreatic lymph nodes.	0
1937	They secreted @PROTEIN$ in response to @COMPOUND$ and could correct hyperglycemia in vivo when cotransplanted with vascular cells.	1
1938	Deletion of the G protein-coupled receptor 30 impairs glucose tolerance, reduces bone growth, increases blood pressure, and eliminates @COMPOUND$-stimulated @PROTEIN$ release in female mice.	1
1939	The aim of this study was to assess in rats the effect of protein feeding on the: 1) distribution of endogenous @COMPOUND$ production (EGP) among gluconeogenic organs, and 2) repercussion on the @PROTEIN$ sensitivity of glucose metabolism.	1
1940	In this study, we attempted to evaluate the effects of @COMPOUND$ on F-@PROTEIN$ and microtubular cytoskeletons in human hepatoma HepG2 cells and its possible molecular mechanisms.	1
1941	Because many drug-drug interactions may occur at the level of drug transporting proteins, we studied interactions of @COMPOUND$ with apical ATP-binding cassette (ABC) @PROTEIN$.	1
1942	@PROTEIN$ (MTs) are @COMPOUND$-rich, metal-binding proteins that are useful biomarkers for monitoring pollution by heavy metals.	1
1943	Muscular oxidative stress and inflammation induced by @COMPOUND$ or MS were assessed by measurements of isoprostanes and @PROTEIN$ levels.	1
1944	In control rats, @COMPOUND$, @PROTEIN$ and MS significantly enhanced the HFV response.	0
1945	@COMPOUND$ injection and MS elicited significant and similar increases in isoprostanes and @PROTEIN$.	1
1946	These @PROTEIN$ are likely to perform similar functions to those reported for other mammalian ADHs in the metabolism of ingested and endogenous @COMPOUND$ and aldehydes.	1
1947	Blood was collected before and repeatedly afterward for determination of NF-kappaB activity, leukocyte subset numbers, @COMPOUND$, norepinephrine, and in vitro-stimulated @PROTEIN$ production.	0
1948	Blood was collected before and repeatedly afterward for determination of NF-kappaB activity, leukocyte subset numbers, cortisol, @COMPOUND$, and in vitro-stimulated @PROTEIN$ production.	0
1949	Higher NF-kappaB stress responses were associated with lower @COMPOUND$ stress responses (beta=-.37, p=.05), higher pre-stress @PROTEIN$ production (beta=.38, p=.043), and high chronic in combination with low acute stress, or vice versa (beta=-.61, p=.06).	0
1950	The combination of @COMPOUND$-rich repeat (LRR) and immunoglobulin-like (Ig) domains is found in the domain architecture of the @PROTEIN$ neurotrophin receptor protein.	1
1951	Given the significant biological roles of @PROTEIN$ and such newly identified proteins, we have searched the public database for human proteins with LRR and Ig domains (collectively termed the @COMPOUND$-rich repeat and Ig domain-containing protein, LRRIG protein, in this study), and have analyzed the mRNA expression pattern of mouse orthologs of obtained human LRRIG proteins at embryonic day 10.	0
1952	Pretreatment with oligonol diminished the levels of proliferating cell nuclear antigen and expression of @PROTEIN$ in papillomas and carcinomas, respectively, as compared to @COMPOUND$ plus TPA treatment alone.	1
1953	Pretreatment with oligonol diminished the levels of @PROTEIN$ and expression of COX-2 in papillomas and carcinomas, respectively, as compared to @COMPOUND$ plus TPA treatment alone.	1
1954	A role for @PROTEIN$ receptors in @COMPOUND$ signalling pathways involved in the regulation of IL-12 and IL-23 in microglial cells.	1
1955	2-Deoxyglucose decreased @COMPOUND$H/NAD (+) and NADPH/NADP(+) ratios by 59 and 50%, respectively, and intact cell @PROTEIN$ activity by 74%; lactate restored NADH/NAD (+), but not NADPH/NADP(+) or NQO1 activity.	0
1956	We propose that the coordinated regulation of @PROTEIN$ cytoskeletal reorganization and macropinocytosis-mediated retrograde membrane trafficking may contribute to @COMPOUND$+)-induced axon growth inhibition.	1
1957	Total and bioavailable testosterone were positively associated with common cIMT independent of age, BMI, hypertension, smoking, HDL-@COMPOUND$, LDL-cholesterol and @PROTEIN$ sensitivity (p=0.009 and p=0.002, respectively).	0
1958	In addition to lipid peroxidation, the activities of antioxidant enzymes such as superoxide dismutase, @PROTEIN$, glutathione peroxidase, glutathione reductase and glutathione S-transferase and two non-enzymatic antioxidants (ascorbic acid and @COMPOUND$) were investigated in order to understand their variation with respect to pollution status of the sampling locations.	0
1959	In addition to lipid peroxidation, the activities of antioxidant enzymes such as superoxide dismutase, catalase, glutathione peroxidase, @PROTEIN$ and glutathione S-transferase and two non-enzymatic antioxidants (ascorbic acid and @COMPOUND$) were investigated in order to understand their variation with respect to pollution status of the sampling locations.	0
1960	In addition to lipid peroxidation, the activities of antioxidant enzymes such as @PROTEIN$, catalase, glutathione peroxidase, glutathione reductase and glutathione S-transferase and two non-enzymatic antioxidants (ascorbic acid and @COMPOUND$) were investigated in order to understand their variation with respect to pollution status of the sampling locations.	0
1961	In addition to lipid peroxidation, the activities of antioxidant enzymes such as superoxide dismutase, catalase, glutathione peroxidase, glutathione reductase and @PROTEIN$ and two non-enzymatic antioxidants (@COMPOUND$ and reduced glutathione) were investigated in order to understand their variation with respect to pollution status of the sampling locations.	0
1962	In addition to lipid peroxidation, the activities of antioxidant enzymes such as superoxide dismutase, @PROTEIN$, glutathione peroxidase, glutathione reductase and glutathione S-transferase and two non-enzymatic antioxidants (@COMPOUND$ and reduced glutathione) were investigated in order to understand their variation with respect to pollution status of the sampling locations.	0
1963	In addition to lipid peroxidation, the activities of antioxidant enzymes such as superoxide dismutase, catalase, glutathione peroxidase, @PROTEIN$ and glutathione S-transferase and two non-enzymatic antioxidants (@COMPOUND$ and reduced glutathione) were investigated in order to understand their variation with respect to pollution status of the sampling locations.	0
1964	In addition to lipid peroxidation, the activities of antioxidant enzymes such as superoxide dismutase, catalase, @PROTEIN$, glutathione reductase and glutathione S-transferase and two non-enzymatic antioxidants (ascorbic acid and @COMPOUND$) were investigated in order to understand their variation with respect to pollution status of the sampling locations.	0
1965	In addition to lipid peroxidation, the activities of antioxidant enzymes such as @PROTEIN$, catalase, glutathione peroxidase, glutathione reductase and glutathione S-transferase and two non-enzymatic antioxidants (@COMPOUND$ and reduced glutathione) were investigated in order to understand their variation with respect to pollution status of the sampling locations.	0
1966	In addition to lipid peroxidation, the activities of antioxidant enzymes such as superoxide dismutase, catalase, @PROTEIN$, glutathione reductase and glutathione S-transferase and two non-enzymatic antioxidants (@COMPOUND$ and reduced glutathione) were investigated in order to understand their variation with respect to pollution status of the sampling locations.	0
1967	In addition to lipid peroxidation, the activities of antioxidant enzymes such as superoxide dismutase, catalase, glutathione peroxidase, glutathione reductase and @PROTEIN$ and two non-enzymatic antioxidants (ascorbic acid and @COMPOUND$) were investigated in order to understand their variation with respect to pollution status of the sampling locations.	0
1968	This study shows that changes in lipid peroxidation, @PROTEIN$, catalase, glutathione reductase, glutathione S-transferase and @COMPOUND$ in tissues of P. viridis can be used as molecular biomarkers in environmental monitoring programs.	0
1969	This study shows that changes in lipid peroxidation, superoxide dismutase, @PROTEIN$, glutathione reductase, glutathione S-transferase and @COMPOUND$ in tissues of P. viridis can be used as molecular biomarkers in environmental monitoring programs.	0
1970	This study shows that changes in lipid peroxidation, superoxide dismutase, catalase, @PROTEIN$, glutathione S-transferase and @COMPOUND$ in tissues of P. viridis can be used as molecular biomarkers in environmental monitoring programs.	0
1971	This study shows that changes in lipid peroxidation, superoxide dismutase, catalase, glutathione reductase, @PROTEIN$ and @COMPOUND$ in tissues of P. viridis can be used as molecular biomarkers in environmental monitoring programs.	0
1972	This inhibitory effect is possibly mediated by a @COMPOUND$-dependent activation of the small GTPase @PROTEIN$ via Epac.	1
1973	This inhibitory effect is possibly mediated by a @COMPOUND$-dependent activation of the small GTPase Rap1 via @PROTEIN$.	1
1974	Although females in both proestrus and diestrus showed significant increases in plasma @PROTEIN$ and @COMPOUND$ and CRF mRNA expression in the PVN in response to PS, no significant responses of the HPA axis to PS were found in males.	0
1975	Although females in both proestrus and diestrus showed significant increases in plasma ACTH and @COMPOUND$ and @PROTEIN$ mRNA expression in the PVN in response to PS, no significant responses of the HPA axis to PS were found in males.	0
1976	BDNF, NGF, adrenocorticotropic hormone (ACTH), @COMPOUND$ and growth hormone (GH) were determined at baseline on postnatal days (@PROTEIN$) 14, 30 and 60 by means of specific ELISA and RIA procedures.	0
1977	@PROTEIN$, NGF, adrenocorticotropic hormone (ACTH), @COMPOUND$ and growth hormone (GH) were determined at baseline on postnatal days (PND) 14, 30 and 60 by means of specific ELISA and RIA procedures.	0
1978	BDNF, NGF, @PROTEIN$ (ACTH), @COMPOUND$ and growth hormone (GH) were determined at baseline on postnatal days (PND) 14, 30 and 60 by means of specific ELISA and RIA procedures.	0
1979	BDNF, NGF, adrenocorticotropic hormone (ACTH), @COMPOUND$ and growth hormone (GH) were determined at baseline on postnatal days (PND) 14, 30 and 60 by means of specific ELISA and @PROTEIN$ procedures.	0
1980	BDNF, @PROTEIN$, adrenocorticotropic hormone (ACTH), @COMPOUND$ and growth hormone (GH) were determined at baseline on postnatal days (PND) 14, 30 and 60 by means of specific ELISA and RIA procedures.	0
1981	BDNF, NGF, adrenocorticotropic hormone (@PROTEIN$), @COMPOUND$ and growth hormone (GH) were determined at baseline on postnatal days (PND) 14, 30 and 60 by means of specific ELISA and RIA procedures.	0
1982	BDNF, NGF, adrenocorticotropic hormone (ACTH), @COMPOUND$ and @PROTEIN$ (GH) were determined at baseline on postnatal days (PND) 14, 30 and 60 by means of specific ELISA and RIA procedures.	0
1983	In vitro and in vivo models simulating the bee sting have been developed using live honeybees and, as the envenomation sites, pig ears and rat legs; MALDI MSI has been used to map, over time, the diffusion and distribution of three venom allergens (@COMPOUND$ m 1, Api m 4, and Api m 6) and two venom toxins (apamine and @PROTEIN$).	0
1984	During lactation, @COMPOUND$ and @PROTEIN$ profiles after a standard meal did not differ between sows from treatment groups.	0
1985	Effects of gram-negative bacterial @COMPOUND$ (LPS) and supplemental dietary Met on N balance, serum hormones and @PROTEIN$, and plasma urea-N and AA were evaluated in 20 Angus-cross steers (BW = 262+/-6.3 kg).	0
1986	Effects of gram-negative bacterial lipopolysaccharide (LPS) and supplemental dietary Met on N balance, serum hormones and @PROTEIN$, and plasma @COMPOUND$-N and AA were evaluated in 20 Angus-cross steers (BW = 262+/-6.3 kg).	0
1987	Plasma @COMPOUND$-N was greater for+LPS than-LPS steers (LPS; P = 0.03), and serum @PROTEIN$ was not affected (P &gt; or = 0.26) by LPS or Met.	0
1988	Domain shape annealing is observed from branched to rounded shapes after @PROTEIN$ activity quenching by @COMPOUND$, with a decay halftime of approximately 10 min.	0
1989	Chondroitin lyases (or @PROTEIN$) are a family of enzymes that depolymerize @COMPOUND$ (CS) and dermatan sulfate (DS) galactosaminoglycans, which have gained prominence as important players in central nervous system biology.	1
1990	We have assessed the impact of the functional C-1019G variant of the @PROTEIN$ receptor on the response to @COMPOUND$ or haloperidol in a prospective, randomized, double-blind study.	1
1991	We have assessed the impact of the functional C-1019G variant of the @PROTEIN$ receptor on the response to risperidone or @COMPOUND$ in a prospective, randomized, double-blind study.	1
1992	This downregulation was abolished following treatment with the histone deacetylase (HDAC) inhibitor trichostatin A (TSA) and cytosine methylation inhibitor @COMPOUND$ (5-Aza), suggesting that an epigenetic regulatory mechanism may be involved in @PROTEIN$ silencing by hypoxia.	1
1993	This downregulation was abolished following treatment with the histone deacetylase (HDAC) inhibitor @COMPOUND$ (TSA) and cytosine methylation inhibitor 5-aza-2-deoxycytidine (5-Aza), suggesting that an epigenetic regulatory mechanism may be involved in @PROTEIN$ silencing by hypoxia.	1
1994	@COMPOUND$ overcomes cell-adhesion-mediated drug resistance through downregulation of @PROTEIN$ expression in multiple myeloma.	1
1995	@COMPOUND$-@PROTEIN$ conjugate selectively overcomes multidrug resistance in leukaemia cells.	1
1996	The purpose of this study was to examine the distribution and action of @COMPOUND$-@PROTEIN$ conjugate (DOXTRF) in a leukaemia cell line (HL60), a multidrug-resistant leukaemia cell line (HL60ADR) and a normal tissue cell line (human fibroblasts).	1
1997	The purified @PROTEIN$ does not seem to be involved in the modification of buttery and lactic notes or to be involved in the specific formation of volatile @COMPOUND$ during MLF.	0
1998	All strains tested positive for @PROTEIN$ activity while none where capable of @COMPOUND$ degradation.	0
1999	@PROTEIN$ receptors are membrane cation channels gated by extracellular @COMPOUND$.	1
2000	Addition of SOD (@PROTEIN$) doubled the amount of @COMPOUND$ detected.	1
2001	Addition of @PROTEIN$ (superoxide dismutase) doubled the amount of @COMPOUND$ detected.	1
2002	This study investigated the effects of atorvastatin on @PROTEIN$ and ABCC1 mRNA expression on peripheral blood mononuclear cells (PBMC) and their relationship with gene polymorphisms and lowering-@COMPOUND$ response.	0
2003	This study investigated the effects of atorvastatin on ABCB1 and @PROTEIN$ mRNA expression on peripheral blood mononuclear cells (PBMC) and their relationship with gene polymorphisms and lowering-@COMPOUND$ response.	0
2004	While the three @PROTEIN$ isotypes showed comparable Km and k(cat) for L-serine and acetyl-CoA, they showed remarkable differences in their sensitivity to inhibition by @COMPOUND$.	1
2005	While the three @PROTEIN$ isotypes showed comparable Km and k(cat) for @COMPOUND$ and acetyl-CoA, they showed remarkable differences in their sensitivity to inhibition by L-cysteine.	1
2006	We propose that multiple @PROTEIN$ isotypes with different properties may play complementary roles in the regulation of the @COMPOUND$ biosynthetic pathway in E. histolytica under different conditions, e.g.	1
2007	These early results indicate that treatment with @PROTEIN$ and to a lesser extent @COMPOUND$ reduces some of the direct inflammatory response and damage associated with SM-induced lung injury.	0
2008	Spermine oxidase (@PROTEIN$) is a FAD-containing enzyme involved in animal cell polyamines (PA) homeostasis, selectively active on @COMPOUND$ and producing H(2)O(2), spermidine, and the 3-aminopropanal.	1
2009	@PROTEIN$ (SMO) is a FAD-containing enzyme involved in animal cell polyamines (PA) homeostasis, selectively active on @COMPOUND$ and producing H(2)O(2), spermidine, and the 3-aminopropanal.	1
2010	The aim of this study was to evaluate the activity of semicarbazide-sensitive amine oxidase (@PROTEIN$) and the total nitrite and @COMPOUND$ (NO(x)) concentrations in serum from type 2 diabetic patients and control subjects in order to evaluate if they could be used as novel diabetic markers.	0
2011	The aim of this study was to evaluate the activity of @PROTEIN$ (SSAO) and the total nitrite and @COMPOUND$ (NO(x)) concentrations in serum from type 2 diabetic patients and control subjects in order to evaluate if they could be used as novel diabetic markers.	0
2012	@COMPOUND$ activity showed highest correlations to @PROTEIN$ II and microtubule targeting drugs.	1
2013	Serum NO, @PROTEIN$ and @COMPOUND$ were measured.	0
2014	The effects of industrial storage on the changes of the cell viability and the activities of intracellular alcohol dehydrogenase (@PROTEIN$) and glucose-6-phosphate dehydrogenase (G6PDH) in brewer's yeast, and the corresponding capacity for the bioconversion of ethyl-3-oxobutanoate (@COMPOUND$) to ethyl (S)-3-hydroxybutanoate ((S)-EHB), were investigated.	1
2015	The effects of industrial storage on the changes of the cell viability and the activities of intracellular alcohol dehydrogenase (@PROTEIN$) and glucose-6-phosphate dehydrogenase (G6PDH) in brewer's yeast, and the corresponding capacity for the bioconversion of ethyl-3-oxobutanoate (EOB) to ethyl (@COMPOUND$ ((S)-EHB), were investigated.	1
2016	The effects of industrial storage on the changes of the cell viability and the activities of intracellular alcohol dehydrogenase (ADH) and glucose-6-phosphate dehydrogenase (@PROTEIN$) in brewer's yeast, and the corresponding capacity for the bioconversion of @COMPOUND$ (EOB) to ethyl (S)-3-hydroxybutanoate ((S)-EHB), were investigated.	1
2017	The effects of industrial storage on the changes of the cell viability and the activities of intracellular @PROTEIN$ (ADH) and glucose-6-phosphate dehydrogenase (G6PDH) in brewer's yeast, and the corresponding capacity for the bioconversion of @COMPOUND$ (EOB) to ethyl (S)-3-hydroxybutanoate ((S)-EHB), were investigated.	1
2018	The effects of industrial storage on the changes of the cell viability and the activities of intracellular alcohol dehydrogenase (@PROTEIN$) and glucose-6-phosphate dehydrogenase (G6PDH) in brewer's yeast, and the corresponding capacity for the bioconversion of ethyl-3-oxobutanoate (EOB) to ethyl (S)-3-hydroxybutanoate ((S)-@COMPOUND$), were investigated.	1
2019	The effects of industrial storage on the changes of the cell viability and the activities of intracellular @PROTEIN$ (ADH) and glucose-6-phosphate dehydrogenase (G6PDH) in brewer's yeast, and the corresponding capacity for the bioconversion of ethyl-3-oxobutanoate (EOB) to ethyl (S)-3-hydroxybutanoate ((S)-@COMPOUND$), were investigated.	1
2020	The effects of industrial storage on the changes of the cell viability and the activities of intracellular @PROTEIN$ (ADH) and glucose-6-phosphate dehydrogenase (G6PDH) in brewer's yeast, and the corresponding capacity for the bioconversion of ethyl-3-oxobutanoate (@COMPOUND$) to ethyl (S)-3-hydroxybutanoate ((S)-EHB), were investigated.	1
2021	The effects of industrial storage on the changes of the cell viability and the activities of intracellular alcohol dehydrogenase (ADH) and glucose-6-phosphate dehydrogenase (@PROTEIN$) in brewer's yeast, and the corresponding capacity for the bioconversion of ethyl-3-oxobutanoate (EOB) to ethyl (S)-3-hydroxybutanoate ((S)-@COMPOUND$), were investigated.	1
2022	The effects of industrial storage on the changes of the cell viability and the activities of intracellular alcohol dehydrogenase (ADH) and glucose-6-phosphate dehydrogenase (@PROTEIN$) in brewer's yeast, and the corresponding capacity for the bioconversion of ethyl-3-oxobutanoate (EOB) to ethyl (@COMPOUND$ ((S)-EHB), were investigated.	1
2023	The effects of industrial storage on the changes of the cell viability and the activities of intracellular @PROTEIN$ (ADH) and glucose-6-phosphate dehydrogenase (G6PDH) in brewer's yeast, and the corresponding capacity for the bioconversion of ethyl-3-oxobutanoate (EOB) to ethyl (@COMPOUND$ ((S)-EHB), were investigated.	1
2024	The effects of industrial storage on the changes of the cell viability and the activities of intracellular alcohol dehydrogenase (ADH) and glucose-6-phosphate dehydrogenase (@PROTEIN$) in brewer's yeast, and the corresponding capacity for the bioconversion of ethyl-3-oxobutanoate (@COMPOUND$) to ethyl (S)-3-hydroxybutanoate ((S)-EHB), were investigated.	1
2025	The effects of industrial storage on the changes of the cell viability and the activities of intracellular alcohol dehydrogenase (@PROTEIN$) and glucose-6-phosphate dehydrogenase (G6PDH) in brewer's yeast, and the corresponding capacity for the bioconversion of @COMPOUND$ (EOB) to ethyl (S)-3-hydroxybutanoate ((S)-EHB), were investigated.	1
2026	The intracellular levels of @PROTEIN$ and G6PDH after permeabilization of these stored cells with cetyltrimetylammonium bromide (@COMPOUND$) were much higher, which showed only slight decrease within 2 weeks during the industrial storage.	1
2027	The intracellular levels of ADH and @PROTEIN$ after permeabilization of these stored cells with cetyltrimetylammonium bromide (@COMPOUND$) were much higher, which showed only slight decrease within 2 weeks during the industrial storage.	1
2028	High @COMPOUND$ causes increased cell damage and NO generation in RPE cells by a process of @PROTEIN$ expression that requires the activation of p38MAPK and ERK.	1
2029	High @COMPOUND$ causes increased cell damage and NO generation in RPE cells by a process of iNOS expression that requires the activation of p38MAPK and @PROTEIN$.	0
2030	High @COMPOUND$ causes increased cell damage and NO generation in RPE cells by a process of iNOS expression that requires the activation of @PROTEIN$ and ERK.	0
2031	A crude peel extract and purified fraction of Flemingia vestita, as well as a crude rhizome extract of Stephania glabra and fractions were tested with respect to the activity of @PROTEIN$, NO efflux and @COMPOUND$ concentration in the cestode Raillietina echinobothrida in order to find out the possible mode of anthelmintic action of these plant-derived components.	0
2032	In this study, we describe the crystal structure of yeast @PROTEIN$ in complex with @COMPOUND$ (chitobiose).	1
2033	Prediction of the effect of erythromycin, @COMPOUND$, and their metabolites, alone and in combination, on @PROTEIN$ inhibition.	0
2034	Prediction of the effect of @COMPOUND$, diltiazem, and their metabolites, alone and in combination, on @PROTEIN$ inhibition.	0
2035	Previous studies have suggested a regulatory relationship between serum @COMPOUND$, vitamin D, and fibroblast growth factor 23 (@PROTEIN$), a hormone that promotes renal excretion of phosphate.	1
2036	Previous studies have suggested a regulatory relationship between serum phosphorus, @COMPOUND$, and fibroblast growth factor 23 (@PROTEIN$), a hormone that promotes renal excretion of phosphate.	1
2037	This condition is caused by mutations in the PTH/@PROTEIN$ receptor that result in ligand-independent @COMPOUND$ accumulation, thus rendering the receptor constitutively active.	1
2038	This condition is caused by mutations in the @PROTEIN$/PTHrP receptor that result in ligand-independent @COMPOUND$ accumulation, thus rendering the receptor constitutively active.	1
2039	@PROTEIN$ is involved in @COMPOUND$-stimulated proglucagon expression and hormone production but not hormone secretion in pancreatic alpha- and intestinal L-cell lines.	1
2040	Expression of @COMPOUND$ : @PROTEIN$ in gastric mucosa, intestinal metaplasia, and gastric carcinoma.	0
2041	We conclude that block of @PROTEIN$ by @COMPOUND$ may ameliorate several pathologic effects associated with inflammation that lead to cortical dysfunction after SAH.	1
2042	The COMT enzyme breaks down extracellular @COMPOUND$ (DA) and has a particularly important role in the prefrontal cortex (PFC) where @PROTEIN$ are sparse.	1
2043	The @PROTEIN$ enzyme breaks down extracellular @COMPOUND$ (DA) and has a particularly important role in the prefrontal cortex (PFC) where DA transporters are sparse.	1
2044	CYP719A subfamily of @PROTEIN$ oxygenases and @COMPOUND$ alkaloid biosynthesis in Eschscholzia californica.	0
2045	Currently, @COMPOUND$ (PLP)-dependent @PROTEIN$ (CBS) is thought to be the major H(2)S-producing enzyme in the brain.	1
2046	This injury induces central sensitization leading to tactile allodynia and is mediated by activation of @COMPOUND$+) permeable AMPA/kainate receptors through @PROTEIN$ and PKA.	1
2047	Transport properties of PIs by the drug efflux transporters P-gp and @PROTEIN$ (MRP1) were assessed by measuring the cellular uptake of (3)H-@COMPOUND$ or (3)H-ritonavir in P-gp and MRP1 overexpressing cells as well as hCMEC/D3.	1
2048	Transport properties of PIs by the drug efflux transporters P-gp and @PROTEIN$ (MRP1) were assessed by measuring the cellular uptake of (3)H-atazanavir or (3)H-@COMPOUND$ in P-gp and MRP1 overexpressing cells as well as hCMEC/D3.	1
2049	Functional @PROTEIN$ is not required for macrophage @COMPOUND$ efflux to human serum.	0
2050	The AbfR/S two-component system is required to activate the expression of the suite of enzymes that remove the numerous side chains from @COMPOUND$, but not the @PROTEIN$ that hydrolyze the beta1,4-linked xylose polymeric backbone of this polysaccharide.	0
2051	Treatment with acidified saline reduced fetal basal pH from 7.35+/-0.01 to 7.29+/-0.01 but did not alter basal cardiovascular variables, blood @COMPOUND$, or plasma concentrations of catecholamines, @PROTEIN$, and cortisol.	0
2052	Treatment with acidified saline reduced fetal basal pH from 7.35+/-0.01 to 7.29+/-0.01 but did not alter basal cardiovascular variables, blood glucose, or plasma concentrations of catecholamines, @PROTEIN$, and @COMPOUND$.	0
2053	During hypoxemia, treatment with acidified saline increased the magnitude of the fetal bradycardia and femoral vasoconstriction and concomitantly increased chemoreflex function and enhanced the increments in plasma concentrations of catecholamines, @PROTEIN$, and @COMPOUND$.	0
2054	The induction of @PROTEIN$ by YC-1 was unchanged by the sGC inhibitor, 1H-(1,2,4)oxadiazolo(4,3-alpha)quinozalin-1-one (ODQ) or by the protein kinase pyrimidin-4-ylamine (@COMPOUND$).	0
2055	The induction of @PROTEIN$ by @COMPOUND$ was unchanged by the sGC inhibitor, 1H-(1,2,4)oxadiazolo(4,3-alpha)quinozalin-1-one (ODQ) or by the protein kinase pyrimidin-4-ylamine (BAY 41-2272).	1
2056	The induction of @PROTEIN$ by YC-1 was unchanged by the sGC inhibitor, 1H-(1,2,4)oxadiazolo(4,3-alpha)quinozalin-1-one (ODQ) or by the protein kinase @COMPOUND$ (BAY 41-2272).	0
2057	The induction of @PROTEIN$ by YC-1 was unchanged by the sGC inhibitor, 1H-(1,2,4)oxadiazolo(4,3-alpha)quinozalin-1-one (@COMPOUND$) or by the protein kinase pyrimidin-4-ylamine (BAY 41-2272).	0
2058	In this study, we evaluated the distribution of the principal CD44 ligand @COMPOUND$ (HA) and the expressions of HA synthases (HAS: @PROTEIN$, HAS2, and HAS3) during atresia in pig ovaries.	0
2059	In this study, we evaluated the distribution of the principal CD44 ligand @COMPOUND$ (HA) and the expressions of @PROTEIN$ (HAS: HAS1, HAS2, and HAS3) during atresia in pig ovaries.	0
2060	In this study, we evaluated the distribution of the principal CD44 ligand @COMPOUND$ (HA) and the expressions of HA synthases (HAS: HAS1, HAS2, and @PROTEIN$) during atresia in pig ovaries.	0
2061	In this study, we evaluated the distribution of the principal CD44 ligand @COMPOUND$ (HA) and the expressions of HA synthases (HAS: HAS1, @PROTEIN$, and HAS3) during atresia in pig ovaries.	0
2062	Requirement of @PROTEIN$ for antidepressive efficiency of @COMPOUND$ : implication in adult hippocampal neurogenesis.	1
2063	Collectively, these findings suggest that @PROTEIN$ is required for the antidepressive action of @COMPOUND$ via regulating adult hippocampal neurogenesis.	1
2064	Previous work has shown that repeated @COMPOUND$ treatment causes downregulation of the norepinephrine transporter (@PROTEIN$) and persistent antidepressant-like effects on behavior, ie effects observed 2 days after discontinuation of drug treatment when acute effects are minimized.	1
2065	Previous work has shown that repeated @COMPOUND$ treatment causes downregulation of the @PROTEIN$ (NET) and persistent antidepressant-like effects on behavior, ie effects observed 2 days after discontinuation of drug treatment when acute effects are minimized.	1
2066	Brains from persons with major depressive disorder reveal decreased expression for genes in @COMPOUND$ transport and metabolism, neurotrophic signaling (eg, @PROTEIN$, BDNF and VGF), and MAP kinase pathways.	0
2067	Brains from persons with major depressive disorder reveal decreased expression for genes in @COMPOUND$ transport and metabolism, neurotrophic signaling (eg, FGF, @PROTEIN$ and VGF), and MAP kinase pathways.	0
2068	Brains from persons with major depressive disorder reveal decreased expression for genes in @COMPOUND$ transport and metabolism, neurotrophic signaling (eg, FGF, BDNF and @PROTEIN$), and MAP kinase pathways.	0
2069	However, detection of @COMPOUND$ and Zn in @PROTEIN$ after PAGE-LA-ICP-MS depends on the conditions of the PAGE method because possible metal losses can occur (either with SDS-PAGE or with native PAGE).	1
2070	Despite this lack of oxidative and cytotoxic action, exposure of hepatoma cells to @COMPOUND$+) resulted in a significant activation of @PROTEIN$ that was abrogated by inhibitors of PI3K.	1
2071	Gas exchange was monitored and blood samples were collected during exercise for GH, @PROTEIN$, insulin, and blood glucose and @COMPOUND$ determination.	0
2072	Gas exchange was monitored and blood samples were collected during exercise for GH, ACTH, @PROTEIN$, and blood @COMPOUND$ and lactate determination.	0
2073	Gas exchange was monitored and blood samples were collected during exercise for GH, ACTH, @PROTEIN$, and blood glucose and @COMPOUND$ determination.	0
2074	Gas exchange was monitored and blood samples were collected during exercise for GH, @PROTEIN$, insulin, and blood @COMPOUND$ and lactate determination.	0
2075	Because o-quinones are very unstable, we used an oxymetric method to characterize the kinetics of this substrate, based on measurements of the @COMPOUND$ consumed in the @PROTEIN$ reaction.	1
2076	Plasma levels of @COMPOUND$, cortisol, and @PROTEIN$ were measured.	0
2077	Plasma levels of citalopram, @COMPOUND$, and @PROTEIN$ were measured.	0
2078	It was found from this group that @COMPOUND$ was the best alternative to warfarin for examining the interactions of drugs at Sudlow site I on @PROTEIN$.	1
2079	Effects of @PROTEIN$/ANKK1 gene variations and clinical factors on @COMPOUND$ efficacy in schizophrenic patients.	1
2080	Effects of DRD2/@PROTEIN$ gene variations and clinical factors on @COMPOUND$ efficacy in schizophrenic patients.	1
2081	However, the ethyl ester of commipheric acid (150 mg/kg, twice daily) lowered fasting blood @COMPOUND$ and plasma @PROTEIN$, and plasma triglycerides without affecting food intake or body weight.	0
2082	This finding led the authors to propose that @PROTEIN$ may be involved in the pathogenesis of psoriasis through its potential role in @COMPOUND$ biosynthesis and stimulation of keratinocyte proliferation.	1
2083	The preference for NAD(+) suggests that @PROTEIN$ is likely to function in the oxidative direction in vivo, further supporting its potential role in the oxidation of retinol to retinaldehyde for @COMPOUND$ biosynthesis in human keratinocytes.	1
2084	@COMPOUND$ is the most powerful intracellular antioxidant and plays a role in the detoxification of a variety of electrophilic compounds and peroxides via catalysis by glutathione-S-transferases (@PROTEIN$) and glutathione peroxidases (GPx).	1
2085	@COMPOUND$ is the most powerful intracellular antioxidant and plays a role in the detoxification of a variety of electrophilic compounds and peroxides via catalysis by glutathione-S-transferases (GST) and @PROTEIN$ (GPx).	1
2086	@COMPOUND$ is the most powerful intracellular antioxidant and plays a role in the detoxification of a variety of electrophilic compounds and peroxides via catalysis by @PROTEIN$ (GST) and glutathione peroxidases (GPx).	1
2087	It inhibited Trypanosoma brucei @PROTEIN$ with an IC(50) value of 240 microM and has been shown to be a competitive reversible inhibitor (Ki=200+/-10 microM) of this enzyme with respect to its cofactor @COMPOUND$ (+).	1
2088	@COMPOUND$ oligonucleotide-induced expression of truncated @PROTEIN$ in the brains of mdx mice, but not in the muscle, ameliorated the abnormal freezing response to restraint.	1
2089	Vernakalant was metabolized rapidly via 4-O-demethylation by @PROTEIN$ (CYP)2D6 to its major metabolite RSD1385, which then circulated predominantly as an inactive @COMPOUND$ conjugate.	0
2090	Vernakalant was metabolized rapidly via 4-O-demethylation by cytochrome P450 (@PROTEIN$)2D6 to its major metabolite RSD1385, which then circulated predominantly as an inactive @COMPOUND$ conjugate.	0
2091	We assessed in vivo carotid sinus nerve activity (CSNA) at baseline, in response to acute hypoxia, in response to infused @COMPOUND$, and in response to infused endothelin-1 (@PROTEIN$) with and without MK-801, an NMDA receptor blocker.	0
2092	We assessed in vivo carotid sinus nerve activity (CSNA) at baseline, in response to acute hypoxia, in response to infused @COMPOUND$, and in response to infused @PROTEIN$ (ET-1) with and without MK-801, an NMDA receptor blocker.	0
2093	Independent lines of research involving biochemical and behavioral approaches in normal and/or genetically modified mice provide converging evidence for an involvement of the signaling molecules Akt and glycogen synthase kinase-3 (@PROTEIN$) in the regulation of behavior by dopamine and serotonin (@COMPOUND$).	1
2094	Independent lines of research involving biochemical and behavioral approaches in normal and/or genetically modified mice provide converging evidence for an involvement of the signaling molecules @PROTEIN$ and glycogen synthase kinase-3 (GSK3) in the regulation of behavior by dopamine and @COMPOUND$ (5-HT).	1
2095	Independent lines of research involving biochemical and behavioral approaches in normal and/or genetically modified mice provide converging evidence for an involvement of the signaling molecules Akt and glycogen synthase kinase-3 (@PROTEIN$) in the regulation of behavior by dopamine and @COMPOUND$ (5-HT).	1
2096	Independent lines of research involving biochemical and behavioral approaches in normal and/or genetically modified mice provide converging evidence for an involvement of the signaling molecules @PROTEIN$ and glycogen synthase kinase-3 (GSK3) in the regulation of behavior by @COMPOUND$ and serotonin (5-HT).	1
2097	Independent lines of research involving biochemical and behavioral approaches in normal and/or genetically modified mice provide converging evidence for an involvement of the signaling molecules Akt and glycogen synthase kinase-3 (@PROTEIN$) in the regulation of behavior by @COMPOUND$ and serotonin (5-HT).	1
2098	Independent lines of research involving biochemical and behavioral approaches in normal and/or genetically modified mice provide converging evidence for an involvement of the signaling molecules @PROTEIN$ and glycogen synthase kinase-3 (GSK3) in the regulation of behavior by dopamine and serotonin (@COMPOUND$).	1
2099	The capacity for osmotic adjustment, superoxide dismutase (@PROTEIN$) and ascorbate peroxidase (APX) activities and @COMPOUND$ content were also elevated in the transgenic Arabidopsis plants.	0
2100	The capacity for osmotic adjustment, superoxide dismutase (SOD) and ascorbate peroxidase (@PROTEIN$) activities and @COMPOUND$ content were also elevated in the transgenic Arabidopsis plants.	0
2101	The capacity for osmotic adjustment, @PROTEIN$ (SOD) and ascorbate peroxidase (APX) activities and @COMPOUND$ content were also elevated in the transgenic Arabidopsis plants.	0
2102	A naturally occurring glycine to @COMPOUND$ mutation at position 169 (G169D) in the putative transmembrane domain 4 (@PROTEIN$) makes mice susceptible to Salmonella typhimurim, Leishmania donovani, and Mycobacterium bovis.	1
2103	A naturally occurring @COMPOUND$ to aspartic acid mutation at position 169 (G169D) in the putative transmembrane domain 4 (@PROTEIN$) makes mice susceptible to Salmonella typhimurim, Leishmania donovani, and Mycobacterium bovis.	1
2104	Serum free @COMPOUND$ in association with @PROTEIN$ as a diagnostic marker of acute myocardial infarction.	1
2105	L-@COMPOUND$ was the most effective promoter of @PROTEIN$ absorption compared with others CPPs.	1
2106	A dose-dependent relationship of L-@COMPOUND$ and @PROTEIN$ bioavailability was statically significant.	1
2107	There was no significant difference in the release of @PROTEIN$ in nasal lavage fluid and the integrity of nasal respiratory epithelium when L-@COMPOUND$ was present.	0
2108	Consistently, the totality of striatal neurons responded to capsaicin (10 nM or 10 microM) after prevention of desensitization of @PROTEIN$ channels with the protein kinase C (PKC) activator phorbol 12-myristate 13-acetate (@COMPOUND$).	1
2109	Consistently, the totality of striatal neurons responded to @COMPOUND$ (10 nM or 10 microM) after prevention of desensitization of @PROTEIN$ channels with the protein kinase C (PKC) activator phorbol 12-myristate 13-acetate (PMA).	1
2110	Consistently, the totality of striatal neurons responded to capsaicin (10 nM or 10 microM) after prevention of desensitization of @PROTEIN$ channels with the protein kinase C (PKC) activator @COMPOUND$ (PMA).	1
2111	The effects of capsaicin and of @COMPOUND$ were absent after pharmacological or genetic inactivation of @PROTEIN$ channels.	1
2112	The effects of @COMPOUND$ and of PMA were absent after pharmacological or genetic inactivation of @PROTEIN$ channels.	1
2113	With the exception of significantly elevated serum @PROTEIN$ after @COMPOUND$, no effects in the secondary outcome measures were detected.	1
2114	The cellular response to dsRNA or its synthetic analog @COMPOUND$ (poly I:C) results in IRF-3-, @PROTEIN$- and NF-kB-mediated activation of type 1 IFNs and pro-inflammatory cytokines critical for innate antiviral immune responses.	1
2115	The cellular response to dsRNA or its synthetic analog polyinosinic-polycytidylic acid (@COMPOUND$) results in @PROTEIN$-, IRF-7- and NF-kB-mediated activation of type 1 IFNs and pro-inflammatory cytokines critical for innate antiviral immune responses.	1
2116	The cellular response to dsRNA or its synthetic analog @COMPOUND$ (poly I:C) results in @PROTEIN$-, IRF-7- and NF-kB-mediated activation of type 1 IFNs and pro-inflammatory cytokines critical for innate antiviral immune responses.	1
2117	The cellular response to dsRNA or its synthetic analog polyinosinic-polycytidylic acid (@COMPOUND$) results in IRF-3-, @PROTEIN$- and NF-kB-mediated activation of type 1 IFNs and pro-inflammatory cytokines critical for innate antiviral immune responses.	1
2118	@COMPOUND$ toxicity is aggravated in people deficient of 6-glucose phosphate dehydrogenase or @PROTEIN$.	1
2119	Seleno-L-methionine (SeMet) can be oxidized to L-methionine selenoxide (MetSeO) by flavin-containing monooxygenase 3 (@PROTEIN$) and rat liver microsomes in the presence of @COMPOUND$.	1
2120	Regulatory roles for Tiam1, a guanine nucleotide exchange factor for @PROTEIN$, in @COMPOUND$-stimulated insulin secretion in pancreatic beta-cells.	0
2121	Regulatory roles for Tiam1, a guanine nucleotide exchange factor for Rac1, in @COMPOUND$-stimulated @PROTEIN$ secretion in pancreatic beta-cells.	1
2122	Regulatory roles for @PROTEIN$, a guanine nucleotide exchange factor for Rac1, in @COMPOUND$-stimulated insulin secretion in pancreatic beta-cells.	0
2123	@COMPOUND$-bound form) and membrane association of @PROTEIN$ in INS 832/13 cells and rat islets.	0
2124	Interestingly, however, in contrast to the inhibitory effects of @COMPOUND$, @PROTEIN$ gene depletion potentiated GSIS in these cells; such a potentiation of GSIS was sensitive to extracellular calcium.	0
2125	This vector allows the co-expression of alpha-Hb as a fusion protein with @PROTEIN$ (GST-alpha-Hb) and beta-Hb with an additional @COMPOUND$ at the N-terminal extremity (rbeta-Hb).	0
2126	This vector allows the co-expression of alpha-Hb as a fusion protein with Glutathione S-Transferase (@PROTEIN$-alpha-Hb) and beta-Hb with an additional @COMPOUND$ at the N-terminal extremity (rbeta-Hb).	0
2127	A search of publicly available microarray data reveals that expression of mitochondrial manganese superoxide dismutase (@PROTEIN$), responsible for the conversion of superoxide (O(2)(-)) to @COMPOUND$ (H(2)O(2)), is consistently increased in high-grade and advanced-stage bladder tumors.	1
2128	A search of publicly available microarray data reveals that expression of mitochondrial manganese @PROTEIN$ (Sod2), responsible for the conversion of superoxide (O(2)(-)) to @COMPOUND$ (H(2)O(2)), is consistently increased in high-grade and advanced-stage bladder tumors.	1
2129	@PROTEIN$ (HIF-1alpha) is a transcription factor that plays an essential role in @COMPOUND$ homeostasis.	1
2130	Hypoxia-inducible factor-1alpha (@PROTEIN$) is a transcription factor that plays an essential role in @COMPOUND$ homeostasis.	1
2131	However, @PROTEIN$, a protein with no active site @COMPOUND$, was covalently modified in vitro by 0.5mM 10-fluoroethoxyphosphinyl-N-biotinamido pentyldecanamide, chlorpyrifos oxon, diisopropylfluorophosphate, dichlorvos, sarin, and soman.	0
2132	The mechanism of lysoPAF-mediated inhibition of neutrophils involves an elevation in the intracellular @COMPOUND$ level, and pharmacological blockade of @PROTEIN$ completely reverses the inhibitory effect of lysoPAF.	1
2133	MerH was found to transport mercuric ions in Escherichia coli via a pair of essential @COMPOUND$ residues but only when coexpressed with the @PROTEIN$.	0
2134	The effect of tropomyosin on @PROTEIN$ filaments was independent of ionic strength, but became stronger as the @COMPOUND$ concentration increased.	1
2135	The effect of @PROTEIN$ on actin filaments was independent of ionic strength, but became stronger as the @COMPOUND$ concentration increased.	1
2136	Activation of Bax and @PROTEIN$ was demonstrated in peripheral blood mononuclear cells, and induction of apoptosis was related to overall @COMPOUND$ exposure, as monitored by the plasma concentration of oligonucleosomal DNA/histone complexes.	0
2137	Activation of @PROTEIN$ and Bak was demonstrated in peripheral blood mononuclear cells, and induction of apoptosis was related to overall @COMPOUND$ exposure, as monitored by the plasma concentration of oligonucleosomal DNA/histone complexes.	0
2138	The acyl @PROTEIN$ peptide features a unique post-translational modification of O-n-octanoylation at @COMPOUND$ 3, and is the only gastrointestinal signal that increases meal size.	1
2139	TyrA had a relatively higher affinity to @COMPOUND$ substrate L-dihydroxyphenylalanine (L-dopa) than many other @PROTEIN$.	0
2140	TyrA had a relatively higher affinity to diphenol substrate L-dihydroxyphenylalanine (@COMPOUND$) than many other @PROTEIN$.	0
2141	@PROTEIN$ had a relatively higher affinity to @COMPOUND$ substrate L-dihydroxyphenylalanine (L-dopa) than many other tyrosinases.	0
2142	TyrA had a relatively higher affinity to diphenol substrate L-@COMPOUND$ (L-dopa) than many other @PROTEIN$.	0
2143	@PROTEIN$ had a relatively higher affinity to diphenol substrate L-dihydroxyphenylalanine (@COMPOUND$) than many other tyrosinases.	1
2144	@PROTEIN$ had a relatively higher affinity to diphenol substrate L-@COMPOUND$ (L-dopa) than many other tyrosinases.	1
2145	These results suggest that @PROTEIN$ is the first reported distinct tyrosinase involved in @COMPOUND$ production in the genus Aeromonas.	1
2146	These results suggest that TyrA is the first reported distinct @PROTEIN$ involved in @COMPOUND$ production in the genus Aeromonas.	1
2147	Magnesium and calcium ions also inhibited goldfish muscle @PROTEIN$, as did phosphate and @COMPOUND$ ; at a concentration of 8 mM, each anion reduced activity by about 66%.	1
2148	Magnesium and calcium ions also inhibited goldfish muscle @PROTEIN$, as did @COMPOUND$ and fluoride ; at a concentration of 8 mM, each anion reduced activity by about 66%.	1
2149	Unfolding and inactivation of abalone (Haliotis diversicolor) @PROTEIN$ during denaturation by @COMPOUND$.	1
2150	The levels of @COMPOUND$ and @PROTEIN$ were lower in ginkgo groups but not significantly.	0
2151	Moreover, the dopaminergic and glutamatergic regulation of @PROTEIN$ gene activation by @COMPOUND$ was investigated.	1
2152	The acute @COMPOUND$-mediated activation of @PROTEIN$ gene was regulated by D1 but not D2 dopamine receptors.	1
2153	Activation of @PROTEIN$ gene may contribute to the @COMPOUND$-mediated synaptic and behavioral plasticity.	1
2154	Eukaryotes plus their archaebacterial sisters form the clade neomura, which evolved from a radically modified derivative of an actinobacterial posibacterium that had replaced the ancestral eubacterial murein peptidoglycan by N-linked @PROTEIN$, radically modified its DNA-handling enzymes, and evolved cotranslational protein secretion, but not the isoprenoid-@COMPOUND$ lipids of archaebacteria.	0
2155	Eukaryotes plus their archaebacterial sisters form the clade neomura, which evolved from a radically modified derivative of an actinobacterial posibacterium that had replaced the ancestral eubacterial murein @COMPOUND$ by N-linked @PROTEIN$, radically modified its DNA-handling enzymes, and evolved cotranslational protein secretion, but not the isoprenoid-ether lipids of archaebacteria.	1
2156	@COMPOUND$, a new inhibitor of non-apoptotic death, rescued cells from death by @PROTEIN$, although the effect was also partial and temporary.	1
2157	@COMPOUND$ is present in lipid deposits in the primate retina: potential implication in the induction of @PROTEIN$ and CNV formation.	1
2158	ETEC infection also caused a drastic inhibition of host @PROTEIN$ activity, as measured by @COMPOUND$ fluorescence.	0
2159	@COMPOUND$ is a nonnucleoside inhibitor of the hepatitis C virus (HCV) nonstructural protein 5B (@PROTEIN$) polymerase, and boceprevir is an inhibitor of the NS3 serine protease.	1
2160	Mutations known to confer resistance to @COMPOUND$ (@PROTEIN$ C316Y) and boceprevir (NS3 V170A) were present in the combination-resistant replicons.	1
2161	Mutations known to confer resistance to @COMPOUND$ (NS5B C316Y) and boceprevir (@PROTEIN$ V170A) were present in the combination-resistant replicons.	0
2162	A role for @COMPOUND$ and @PROTEIN$ combination in protecting from liver injury in a model of type 2 diabetes with hyperlipidemia.	0
2163	Genetic type 2 diabetic Goto-Kakizaki rats were fed with a high-fat diet to test hepatic effects of type 2 diabetes with hyperlipidemia and the effect of @COMPOUND$ and @PROTEIN$, individually and in combination, in systemic and hepatic inflammatory and oxidative stress markers.	0
2164	The aim of this study was to assess the influence of the cytochrome (CYP450)3A5 and multidrug resistance (@PROTEIN$) gene polymorphisms on @COMPOUND$ (CsA) trough concentration during the early stage after renal transplantation in Chinese patients co-treated with diltiazem.	0
2165	The aim of this study was to assess the influence of the cytochrome (CYP450)3A5 and multidrug resistance (@PROTEIN$) gene polymorphisms on cyclosporine A (CsA) trough concentration during the early stage after renal transplantation in Chinese patients co-treated with @COMPOUND$.	0
2166	Here, the reversible unfolding of @COMPOUND$-@PROTEIN$ has been investigated by (1)H-NMR relaxometry, circular dichroism, and absorption spectroscopy.	1
2167	Possible relation of @COMPOUND$-induced @PROTEIN$ expression to the upregulation of VEGF and BDNF mRNA levels in rat C6 glioma cells.	1
2168	Possible relation of @COMPOUND$-induced HO-1 expression to the upregulation of @PROTEIN$ and BDNF mRNA levels in rat C6 glioma cells.	1
2169	Possible relation of @COMPOUND$-induced HO-1 expression to the upregulation of VEGF and @PROTEIN$ mRNA levels in rat C6 glioma cells.	1
2170	Furthermore, we study the @PROTEIN$ activation after As(2)O(3) treatment and the HCC cells proliferation after combination of As(2)O(3) with PI3K inhibitor @COMPOUND$.	0
2171	The interaction of propafenone (@COMPOUND$) enantiomers with human plasma, human @PROTEIN$ (HSA), alpha(1)-acid glycoprotein (AGP), as well as with plasma from rat, rabbit, and cow was investigated using indirect chiral high performance liquid chromatography (HPLC) and ultrafiltration techniques.	0
2172	The interaction of propafenone (@COMPOUND$) enantiomers with human plasma, human serum albumin (@PROTEIN$), alpha(1)-acid glycoprotein (AGP), as well as with plasma from rat, rabbit, and cow was investigated using indirect chiral high performance liquid chromatography (HPLC) and ultrafiltration techniques.	0
2173	The interaction of @COMPOUND$ (PPF) enantiomers with human plasma, human serum albumin (@PROTEIN$), alpha(1)-acid glycoprotein (AGP), as well as with plasma from rat, rabbit, and cow was investigated using indirect chiral high performance liquid chromatography (HPLC) and ultrafiltration techniques.	0
2174	The interaction of @COMPOUND$ (PPF) enantiomers with human plasma, human @PROTEIN$ (HSA), alpha(1)-acid glycoprotein (AGP), as well as with plasma from rat, rabbit, and cow was investigated using indirect chiral high performance liquid chromatography (HPLC) and ultrafiltration techniques.	0
2175	Taken together, our results, obtained with endogenously expressed proteins, are consistent with a @COMPOUND$/Epac2/@PROTEIN$-mediated signaling that could exert its action, among others, through RA-RhoGAP to promote the progression of spermatogenesis.	1
2176	Taken together, our results, obtained with endogenously expressed proteins, are consistent with a @COMPOUND$/@PROTEIN$/Rap1-mediated signaling that could exert its action, among others, through RA-RhoGAP to promote the progression of spermatogenesis.	1
2177	Cholesterol promotes basal and @COMPOUND$-induced ATPase activity of P-@PROTEIN$ (P-gp).	1
2178	This study examines the structural basis for @PROTEIN$ binding of @COMPOUND$ and Cu-ATSM via competition with drugs having known albumin binding sites.	1
2179	This study examines the structural basis for @PROTEIN$ binding of Cu-PTSM and @COMPOUND$ via competition with drugs having known albumin binding sites.	1
2180	0.05) in the overall @COMPOUND$-mediated @PROTEIN$ response.	1
2181	@COMPOUND$-stimulated @PROTEIN$ levels were not significantly different from controls.	1
2182	@COMPOUND$ linkages were identified for @PROTEIN$, Kv3.1, 3.3, 3.4, 1.1, 1.2 and 1.4, by evaluating their electrophoretic migration patterns in adult rat brain membranes digested with various glycosidases.	1
2183	No regional difference in @PROTEIN$ occupancy by the second-generation antipsychotic drug @COMPOUND$ in humans: a positron emission tomography study.	1
2184	@PROTEIN$ expression coupled with infusion of the IGF binding protein inhibitor @COMPOUND$ significantly prevented corticospinal motor neuron death 0.05), but did not promote corticospinal axon regeneration.	1
2185	We showed previously that activation of the angiotensin type 1 receptor (AT1R), which belongs to the G protein-coupled receptor (GPCR) family, leads to c-Src-dependent @COMPOUND$ phosphorylation of beta2-adaptin, a subunit of the clathrin adaptor @PROTEIN$.	1
2186	We showed previously that activation of the angiotensin type 1 receptor (AT1R), which belongs to the G protein-coupled receptor (GPCR) family, leads to @PROTEIN$-dependent @COMPOUND$ phosphorylation of beta2-adaptin, a subunit of the clathrin adaptor AP-2.	1
2187	Extensive neutrophil infiltration and chemoattractant factor interleukin 8 (@PROTEIN$) expression in IL-10 KO mice were observed after @COMPOUND$ administration.	1
2188	Extensive neutrophil infiltration and chemoattractant factor @PROTEIN$ (IL-8) expression in IL-10 KO mice were observed after @COMPOUND$ administration.	1
2189	In addition, increased signal transducer and activator of transcription factors (@PROTEIN$) 1 and STAT3 were observed in @COMPOUND$ treated IL-10 KO mice.	1
2190	In addition, increased signal transducer and activator of transcription factors (STAT) 1 and @PROTEIN$ were observed in @COMPOUND$ treated IL-10 KO mice.	1
2191	We studied the gene-environment interaction in the pathogenesis of KD by assessing the association of low blood @COMPOUND$ and polymorphisms in @PROTEIN$ (GPx-1) gene.	1
2192	We studied the gene-environment interaction in the pathogenesis of KD by assessing the association of low blood @COMPOUND$ and polymorphisms in glutathione peroxidase-1 (@PROTEIN$) gene.	1
2193	However, these events were blocked by treatment with the antioxidant, @COMPOUND$ (NAC), as well as @PROTEIN$ overexpression.	0
2194	It decreased TG levels in tyloxapol-induced hyperlipidemia and increased @PROTEIN$ @COMPOUND$ (HDL-C) and reduced atherogenic index in normotensive rats.	1
2195	Changes in @COMPOUND$ consumption and the RQ ratio during sedentary and low-intensity exercise were not different between alpha(1)-@PROTEIN$-DN and WT.	0
2196	Effects of DHT on COX-2 and @PROTEIN$ were attenuated by @COMPOUND$.	0
2197	Effects of @COMPOUND$ on COX-2 and @PROTEIN$ were attenuated by flutamide.	1
2198	Effects of DHT on @PROTEIN$ and iNOS were attenuated by @COMPOUND$.	0
2199	Effects of @COMPOUND$ on @PROTEIN$ and iNOS were attenuated by flutamide.	1
2200	In conclusion, activation of the NFkappaB-mediated COX-2/@PROTEIN$ pathway by the selective androgen receptor agonist, @COMPOUND$, results in a state of vascular inflammation.	1
2201	In conclusion, activation of the NFkappaB-mediated @PROTEIN$/iNOS pathway by the selective androgen receptor agonist, @COMPOUND$, results in a state of vascular inflammation.	1
2202	Effects of dissolved @COMPOUND$ tension and agitation rate on the production of heat-shock protein @PROTEIN$ 96 by MethA tumor cell suspension culture in stirred-tank bioreactors.	0
2203	Therapeutic efficacy of 177Lu-CHX-A''-DTPA-hu3S193 radioimmunotherapy in prostate cancer is enhanced by @PROTEIN$ inhibition or @COMPOUND$ chemotherapy.	0
2204	On hexanoamide the @PROTEIN$ exhibited a K(m) value of 5.5 mM compared to 0.07 mM for @COMPOUND$.	1
2205	On @COMPOUND$ the @PROTEIN$ exhibited a K(m) value of 5.5 mM compared to 0.07 mM for p-nitroacetanilide.	1
2206	A decrease in @PROTEIN$ (7)R expression was observed in cultured OPCs after exposure to oxygen-@COMPOUND$ deprivation (OGD) for 2 h in vitro.	1
2207	Acylcarnitines have been suggested to play a role in @PROTEIN$ resistance, as well as other @COMPOUND$ metabolites.	0
2208	In the present study we investigated whether muscle long-chain acylcarnitines increase during fasting and we investigated their relationship with @COMPOUND$/fat oxidation and @PROTEIN$ sensitivity in lean healthy humans.	0
2209	@COMPOUND$ attenuates the HFS-induced, @PROTEIN$-mediated LTP in a dose-dependent manner in rat striatum.	1
2210	These results suggest that @PROTEIN$ delivers @COMPOUND$ to mitochondria where regulatory oxysterols are generated.	1
2211	17beta-Hydroxysteroid dehydrogenase type 1 (@PROTEIN$) is a key enzyme of @COMPOUND$ biosynthesis, which might play an important role in follicular development of the ovary.	1
2212	@PROTEIN$ (HSD17B1) is a key enzyme of @COMPOUND$ biosynthesis, which might play an important role in follicular development of the ovary.	1
2213	@COMPOUND$ binding to human @PROTEIN$ : a study of protein conformation and binding affinity.	1
2214	Deletion of the first @COMPOUND$-rich region of the varicella-zoster virus @PROTEIN$ ectodomain abolishes the gE and gI interaction and differentially affects cell-cell spread and viral entry.	1
